<?xml version="1.0" encoding="UTF-8"?>
<ekb complete="true" id="2841635" timestamp="20160614T192320">
  <input>
    <paragraphs>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/0T.xml" id="paragraph0" sec-type="title">&lt;article-title&gt;Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation&lt;/article-title&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/1A_01a_01.xml" id="paragraph1" sec-type="abstract">&lt;p&gt;The AKT/PKB kinase is a key signaling component of one of the most frequently activated pathways in cancer and is a major target of cancer drug development. Most studies have focused on its activation by Receptor Tyrosine Kinase (RTK) mediated Phosphatidylinositol-3-OH kinase (PI3K) activation or loss of Phosphatase and Tensin homolog (PTEN). We have uncovered that growth factors binding to RTKs lead to activation of a non-receptor tyrosine kinase, Ack1 (also known as ACK or TNK2), which directly phosphorylates AKT at an evolutionarily conserved tyrosine 176 in the kinase domain. Tyr176-phosphorylated AKT localizes to the plasma membrane and promotes Thr308/Ser473-phosphorylation leading to AKT activation. Mice expressing activated Ack1 specifically in the prostate exhibit AKT Tyr176-phosphorylation and develop murine prostatic intraepithelial neoplasia (mPINs). Further, expression levels of Tyr176-phosphorylated-AKT and Tyr284-phosphorylated-Ack1 were positively correlated with the severity of disease progression, and inversely correlated with the survival of breast cancer patients. Thus, RTK/Ack1/AKT pathway provides a novel target for drug discovery.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_01i_01.xml" id="paragraph2" sec-type="introduction">&lt;p&gt;Protein kinase AKT plays a central role in growth, proliferation and cell survival &lt;xref&gt;[1]&lt;/xref&gt;, &lt;xref&gt;[2]&lt;/xref&gt;, &lt;xref&gt;[3]&lt;/xref&gt;. AKT activation occurs when ligand binding to RTK facilitates translocation of AKT to the plasma membrane &lt;xref&gt;[4]&lt;/xref&gt;, &lt;xref&gt;[5]&lt;/xref&gt;, &lt;xref&gt;[6]&lt;/xref&gt;, &lt;xref&gt;[7]&lt;/xref&gt; where it is phosphorylated at Thr308 by phosphoinositide-dependent protein kinase-1 (PDK1) and at Ser473 by the ‘PDK2’, a class of about 10 different kinases &lt;xref&gt;[8]&lt;/xref&gt; including the mTORC2 complex &lt;xref&gt;[9]&lt;/xref&gt;. Phosphorylation of AKT at Thr308 and Ser473 leads to its kinase activation &lt;xref&gt;[10]&lt;/xref&gt;. Upon activation, AKT phosphorylates its substrates to transduce survival signals &lt;xref&gt;[1]&lt;/xref&gt;, &lt;xref&gt;[3]&lt;/xref&gt;, &lt;xref&gt;[11]&lt;/xref&gt;, &lt;xref&gt;[12]&lt;/xref&gt;. During AKT activation, the first step is the production of phosphatidylinositol 3,4,5 trisphosphate (PIP3) by PI3K. PDK1 and AKT bind the phospholipid PIP3 via their PH domains and are recruited to the plasma membrane. While RTK/PI3K mediated recruitment of AKT to the plasma membrane is a well characterized mechanism, mounting evidence indicate that AKT activation can occur in a PI3K-independent fashion &lt;xref&gt;[13]&lt;/xref&gt;, &lt;xref&gt;[14]&lt;/xref&gt;, &lt;xref&gt;[15]&lt;/xref&gt;, &lt;xref&gt;[16]&lt;/xref&gt;, &lt;xref&gt;[17]&lt;/xref&gt;, &lt;xref&gt;[18]&lt;/xref&gt;. About a third of the breast and prostate tumors and majority of the pancreatic tumors that exhibit AKT activation, retain normal PTEN and PI3K activity &lt;xref&gt;[15]&lt;/xref&gt; &lt;xref&gt;[19]&lt;/xref&gt;, &lt;xref&gt;[20]&lt;/xref&gt;. Interestingly, normal PTEN expression was also seen in breast, ovarian and prostate tumors that exhibit activated AKT &lt;xref&gt;[15]&lt;/xref&gt;. While RTKs are suggested to be involved &lt;xref&gt;[21]&lt;/xref&gt;, the molecular mechanisms regulating RTK mediated AKT activation in cancers with normal PTEN and PI3K activity is poorly understood &lt;xref&gt;[22]&lt;/xref&gt;. Further, &lt;italic&gt;PIK3CA&lt;/italic&gt; activating mutation has recently been shown to be neither necessary nor sufficient for full AKT activation in situ &lt;xref&gt;[23]&lt;/xref&gt;. Thus, collectively these data suggest the existence of additional pathways that regulate AKT activation in response to growth factors.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_01i_02.xml" id="paragraph3" sec-type="introduction">&lt;p&gt;Ack1, a nonreceptor tyrosine kinase has emerged as a critical early transducer of variety of extracellular growth factor stimuli including heregulin, insulin, EGF and PDGF signaling &lt;xref&gt;[24]&lt;/xref&gt;, &lt;xref&gt;[25]&lt;/xref&gt;, &lt;xref&gt;[26]&lt;/xref&gt;, &lt;xref&gt;[27]&lt;/xref&gt;, &lt;xref&gt;[28]&lt;/xref&gt;. Ack1 is ubiquitously expressed and primarily phosphorylated at Tyr284 leading to its kinase activation &lt;xref&gt;[25]&lt;/xref&gt;, &lt;xref&gt;[27]&lt;/xref&gt;. Our earlier studies demonstrated that Ack1 regulates prostate cancer progression to androgen independence by positively regulating androgen receptor (AR) and negatively regulating the tumor suppressor, Wwox &lt;xref&gt;[25]&lt;/xref&gt;, &lt;xref&gt;[26]&lt;/xref&gt;, &lt;xref&gt;[29]&lt;/xref&gt;. Ack1 gene is also shown to be amplified in primary lung, ovarian and prostate tumors which correlated with poor prognosis &lt;xref&gt;[30]&lt;/xref&gt;. In this report, we have identified a novel mechanism of Ack1 mediated AKT activation wherein phosphorylation of Tyrosine 176 in the AKT kinase domain results in its translocation to the plasma membrane and subsequent kinase activation.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r-pone-0009646-g001_01.xml" id="paragraph4" sec-type="results">&lt;p&gt;(&lt;bold&gt;A&lt;/bold&gt;) MEF2KO cells were serum starved (24 h) and treated with EGF (10 ng/ml). The lysates were immunoprecipitated or IP with anti-Ack1 (top panel), anti-AKT (second panel) and anti-EGFR (fourth panel) antibodies followed by immunoblotting or IB with anti-pTyr antibodies. Remaining panel represents IB with antibodies as shown. (&lt;bold&gt;B&lt;/bold&gt;) MEFs were serum starved (24 h) and treated with EGF (10 ng/ml for 10 mins) or pretreated with LY294002 (10 µM for 1 h) and EGF. The lysates were IP with Ack1 antibodies followed by IB with pan-AKT antibodies (top panel). (&lt;bold&gt;C&lt;/bold&gt;) HA-tagged Tyr-phosphorylated AKT was purified (see &lt;xref ref-type="supplementary-material" rid="pone.0009646.s002"&gt;Fig. S2A&lt;/xref&gt;) followed by trypsin/chymotrypsin digestion. The peptide was detected at 13.83 mins in the total ion chromatogram (&lt;bold&gt;C&lt;/bold&gt;) with mass-to-charge ratio 647.8132, which represents an error of 0.38 ppm (&lt;bold&gt;D&lt;/bold&gt;)&lt;bold&gt;.&lt;/bold&gt; (&lt;bold&gt;E&lt;/bold&gt;) The tandem mass spectrum matched the sequence, VKEKATGRY&lt;bold&gt;&lt;underline&gt;pY&lt;/underline&gt;&lt;/bold&gt; indicating that the C-terminal tyrosine was phosphorylated; the detection of the phosphotyrosine y&lt;sub&gt;1&lt;/sub&gt; is consistent with this localization. (&lt;bold&gt;F&lt;/bold&gt;) Alignment of AKT protein sequences revealed that tyrosine at 176 is invariant from yeast to humans and all the three known human AKT isoforms. (&lt;bold&gt;G&lt;/bold&gt;) MEF1&amp;amp;2KO cells expressing HA-tagged AKT or Y176F mutant were serum-starved (24 h), treated with EGF for 15 mins and lysates were IP with anti-Ack1 Abs followed by IB with anti-AKT antibodies (top panel). The lysates were also IP with anti-Ack1 antibodies followed by IB with pTyr antibodies (panel 4). The same blot was stripped and IB with anti-Ack1 antibodies (Bottom panel). These lysates were also subjected to IP with anti-HA antibodies followed by IB with Ser473, pTyr and AKT antibodies (panels 2, 3 and 5, respectively). (&lt;bold&gt;H&lt;/bold&gt;) Flow cytometry of AKT and Y176F mutant expressing MEF1&amp;amp;2KO cells. Cells were serum starved for 24 h, treated with EGF for 15 mins, fixed and stained with HA-antibodies conjugated to Alexa488 and phosphoSer473-antibodies conjugated to Alexa 647. Upper right quadrant represents cells which express HA-tagged AKT or Y176F mutant that are also Ser473-phosphorylated.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r-pone-0009646-g002_01.xml" id="paragraph5" sec-type="results">&lt;p&gt;(&lt;bold&gt;A&lt;/bold&gt;) RWPE, normal prostate epithelial cells were treated with EGF (10 ng/ml,10 mins) and heregulin (10 ng/ml, 35 mins), whole cell protein lysates were subjected to IB with indicated antibodies. (&lt;bold&gt;B, C&lt;/bold&gt;) MCF-7 cells were serum starved (24 h) and treated with (&lt;bold&gt;B&lt;/bold&gt;) insulin (50 ng/ml) or (&lt;bold&gt;C&lt;/bold&gt;) heregulin (30 ng/ml) for indicated times. Cell lysates were fractionated and IB with the indicated antibodies. Input panels pAck1(Tyr), pIR(Tyr) and pHER-2(Tyr) represents IP with respective antibodies followed by IB with pTyr antibodies. (&lt;bold&gt;D&lt;/bold&gt;) MEF 1&amp;amp;2KO cells were transfected with HA-tagged AKT or Y176F mutant, serum starved (24 h) and treated with EGF for 15 mins. Cell lysates were fractionated and IB with anti-HA (top panel) and indicated antibodies (bottom panels). (&lt;bold&gt;E&lt;/bold&gt;) MCF7 cells were transfected with control or Ack1-specific siRNAs (40 nM) for 48 h and treated with heregulin for 40 mins. Cell lysates were fractionated and IB with indicated antibodies. In this experiment we have used half the volumes buffer for extraction of cytosolic proteins. Thus, the cytosolic extracts are 2X concentrated as compared to &lt;xref ref-type="fig" rid="pone-0009646-g002"&gt;Fig. 2B–C&lt;/xref&gt;, which explains more p176-AKT in cytosol fraction than the plasma membrane fraction.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r-pone-0009646-g003_01.xml" id="paragraph6" sec-type="results">&lt;p&gt;(&lt;bold&gt;A&lt;/bold&gt;) MCF-7 cells were pretreated with LY294002 (10 µM, 1 h) followed by heregulin for 40 mins. Cell lysates were fractionated and membrane fraction was subjected to IB with indicated antibodies. (&lt;bold&gt;B&lt;/bold&gt;) MCF-7 cells were mock transfected or transfected with control, Ack1 and PI3K siRNAs, followed by insulin treatment for 30 mins. Cell lysates were subjected to IP with pTyr-antibodies, followed by IB with pTyr176-AKT antibodies (top panel). Lower panels show IB with indicated antibodies. The experiment was performed with two different Ack1 siRNAs (Qiagen).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r-pone-0009646-g004_01.xml" id="paragraph7" sec-type="results">&lt;p&gt;(&lt;bold&gt;A&lt;/bold&gt;) MEF1&amp;amp;2KO cells were transfected with caAck and HA-tagged AKT or Y176F, serum starved (24 h) and harvested. Total RNA was prepared and quantitative RT-PCR was performed. Data are representative of three independent experiments. *&lt;italic&gt;p≤&lt;/italic&gt;0.05; **&lt;italic&gt;p&lt;/italic&gt;≤0.03; ***&lt;italic&gt;p&lt;/italic&gt;≤0.02; ****&lt;italic&gt;p&lt;/italic&gt;≤0.02. (&lt;bold&gt;B&lt;/bold&gt;) MEF2KO cells were transfected with control or Ack1-specific siRNAs (40 nM) for 48 h and treated with EGF for 30 mins. Total RNA was prepared and quantitative RT-PCR was performed. *&lt;italic&gt;p&lt;/italic&gt;≤0.01; **&lt;italic&gt;p&lt;/italic&gt;≤0.05; ***&lt;italic&gt;p&lt;/italic&gt;≤0.06; ****&lt;italic&gt;p≤&lt;/italic&gt;0.05. (&lt;bold&gt;C&lt;/bold&gt;) Schematic representation of myr-AKT and myr-Y176F point mutants. SDM of myr-AKT was performed to generate the Y176F mutation. PH, Pleckstrin homology domain; Kinase, Kinase domain and CT, Carboxy Terminal regulatory region. (&lt;bold&gt;D&lt;/bold&gt;) AKT MEF1&amp;amp;2 KO cells were transfected with HA-tagged myr-AKT or myr-Y176F mutant and harvested 24 h and 48 h post-transfection. Cells were fixed and stained with anti-HA antibodies conjugated with Alexa 488 and anti-pSerine10-Histone3 conjugated with Alexa 647, a marker used to distinguish cells in late G2 and early M phase, and analyzed by flow cytometry. HA-myrAKT expressing cells showed 75% increase in the number of cells undergoing mitosis (upper right quadrant), while, HA-myrY176F-AKT expressing mitotic cells remain unchanged.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r-pone-0009646-g005_01.xml" id="paragraph8" sec-type="results">&lt;p&gt;(&lt;bold&gt;A&lt;/bold&gt;) Transgenic construct (Prob-Ack1) is shown. (&lt;bold&gt;B&lt;/bold&gt;) A 25 wk old Probasin-Ack1 transgenic (TG) and wild type &lt;xref ref-type="bibr" rid="pone.0009646-Zhou1"&gt;[21]&lt;/xref&gt; male mice prostate lysates were subjected to IP using anti-Myc antibodies followed by IB with pTyr antibodies (top panel). For bottom panels, lysates were subjected to IB with indicated antibodies. (&lt;bold&gt;C&lt;/bold&gt;) Prostate lysates from 21 and 25 wk old TG and the WT siblings were IB with respective antibodies. The bottom 2 panels represent tail-PCR of these mice. IL-2 was an internal control for PCR. (&lt;bold&gt;D–L&lt;/bold&gt;) Haematoxylin and eosin (H&amp;amp;E) stained WT and TG mice prostates. Histological appearance of the prostate lateral lobe from a 22 wk old WT mouse (&lt;bold&gt;D&lt;/bold&gt;), and corresponding lobe from age-matched TG mice with intraepithelial hyperplasia (&lt;italic&gt;E&lt;/italic&gt;). The lateral prostate from 49 wk old TG mice exhibiting mPIN (&lt;bold&gt;F&lt;/bold&gt;) is shown. Contrasting histological appearance of the lateral, ventral and dorsal lobes of the prostate glands from a WT mouse (&lt;bold&gt;G–I&lt;/bold&gt;), and corresponding lobes from TG mice (49 week old) are shown (&lt;bold&gt;J–L&lt;/bold&gt;).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r-pone-0009646-g006_01.xml" id="paragraph9" sec-type="results">&lt;p&gt;(&lt;bold&gt;A&lt;/bold&gt;) TMA sections representing different breast cancer stages stained with pTyr284-Ack1 and pTyr176-AKT antibodies. (&lt;bold&gt;B&lt;/bold&gt;) Box plots to summarize distributions of staining intensities for pTyr284-Ack1 in different stages of breast cancer. A significant increasing trend of intensity across progression stages was detected (Mantel-Haenszel &lt;inline-formula&gt;&lt;inline-graphic xlink:href="pone.0009646.e001.jpg" mimetype="image"/&gt;&lt;/inline-formula&gt; test, &lt;italic&gt;p&lt;/italic&gt; = 0.02). The box has lines at the lower quartile (25%), median (50%), and upper quartile values (75%) while the red-cross within the circle marks the mean value. Whiskers extend from each end of the box to the most extreme values within 1.5 times the interquartile range from the ends of the box. The data with values beyond the ends of the whiskers, displayed with black circles, are potential outliers. (&lt;bold&gt;C&lt;/bold&gt;) Box plots to summarize distributions of staining intensities for pTyr176-AKT in different stages of breast cancer. A significant increasing trend of intensity across progression stages was detected (Mantel-Haenszel &lt;inline-formula&gt;&lt;inline-graphic xlink:href="pone.0009646.e002.jpg" mimetype="image"/&gt;&lt;/inline-formula&gt; test, &lt;italic&gt;p&lt;/italic&gt;&amp;lt;0.0001). (&lt;bold&gt;D&lt;/bold&gt;) Kaplan–Meier analysis shows that individuals with breast cancer that have moderate to strong staining (&amp;gt;4) of pTyr284-Ack1 have a lower probability of survival (log rank test, &lt;italic&gt;p = &lt;/italic&gt;0.08). (&lt;bold&gt;E&lt;/bold&gt;) Kaplan–Meier analysis of the breast cancer patients that have moderate to strong staining (&amp;gt;4) of pTyr176-AKT have significantly lower probability of survival (log rank test, &lt;italic&gt;p&lt;/italic&gt; = 0.02).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_01.xml" id="paragraph10" sec-type="results">&lt;p&gt;We observed that EGF treatment of mouse embryonic fibroblasts (MEFs) resulted in rapid Tyr-phosphorylation of Ack1 as well as Akt1 at 5 and 10 mins respectively, suggesting that these two Tyr-phosphorylation events could be linked (&lt;xref&gt;&lt;bold&gt;Fig. 1A&lt;/bold&gt;&lt;/xref&gt;). To test this hypothesis, we examined whether Ack1 could bind and Tyr-phosphorylate AKT following RTK activation. Co-immunoprecipitation of lysates derived from Akt1, Akt2, and Akt1&amp;amp; 2 knockout mouse embryo fibroblasts (MEF1KO, MEF2KO, and MEF1&amp;amp;2KO, respectively, &lt;bold&gt;&lt;xref&gt;Fig. S1A&lt;/xref&gt;&lt;/bold&gt;) that were treated with EGF, either with or without pretreatment with LY294002, a PI3K inhibitor, revealed that endogenous Akt1 (AKT here onwards) and Ack1 formed a stable complex which was not abrogated by LY294002 (&lt;xref&gt;&lt;bold&gt;Fig. 1B&lt;/bold&gt;&lt;/xref&gt;). The bottom panel shows that upon LY294002 addition there was substantial decrease in AKT Ser473-phosphorylation, suggesting that LY294002 is functional. Akt2 interacted weakly with Ack1, while Akt3 present at low levels in the MEF1&amp;amp;2KO cells was not detectable in the complex.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_02.xml" id="paragraph11" sec-type="results">&lt;p&gt;To test whether Ack1 directly phosphorylates AKT, &lt;italic&gt;in vitro&lt;/italic&gt; binding assay was performed and AKT Tyr-phosphorylation was assessed. Myc-tagged Ack1 and HA-tagged AKT constructs were expressed and purified using respective antibody beads followed by elution, as described in &lt;xref&gt;methods&lt;/xref&gt; section (&lt;bold&gt;&lt;xref&gt;Fig. S1B&lt;/xref&gt;&lt;/bold&gt;). &lt;italic&gt;In vitro&lt;/italic&gt; binding assay revealed that purified Ack1 interacted directly with AKT resulting in AKT Tyr176-phosphorylation (&lt;bold&gt;&lt;xref&gt;Fig. S1B&lt;/xref&gt;–D&lt;/bold&gt;). Further, we generated GST-Ack construct that harbors kinase, SH3 and CRIB domain (schematic shown in &lt;bold&gt;&lt;xref&gt;Fig. S1E&lt;/xref&gt;&lt;/bold&gt;) and expressed it in &lt;italic&gt;E. coli&lt;/italic&gt; (&lt;bold&gt;&lt;xref&gt;Fig. S1E&lt;/xref&gt;&lt;/bold&gt;) &lt;xref&gt;[25]&lt;/xref&gt;, &lt;xref&gt;[31]&lt;/xref&gt;. Androgen-receptor (AR), another Ack1 substrate &lt;xref&gt;[26]&lt;/xref&gt; was expressed as FLAG-tagged construct in HEK293 cells and purified using FLAG-beads (&lt;bold&gt;&lt;xref&gt;Fig. S1E&lt;/xref&gt;&lt;/bold&gt;, left panel). GST-tagged Ack1 or GST (as control) bound to glutathione beads were incubated with purified AKT or Y176F mutant of AKT or AR (shown in &lt;bold&gt;&lt;xref&gt;Fig. S1B&lt;/xref&gt;&lt;/bold&gt; and &lt;bold&gt;E&lt;/bold&gt;). GST-Ack1 bound to purified AKT and AR but not the Y176F mutant of AKT suggesting that AKT and AR are direct binding partners of Ack1 (&lt;bold&gt;&lt;xref&gt;Fig. S1F&lt;/xref&gt;&lt;/bold&gt;).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_03.xml" id="paragraph12" sec-type="results">&lt;p&gt;Affinity purification of AKT coexpressed with Ack1 (&lt;bold&gt;&lt;xref&gt;Fig. S2A&lt;/xref&gt;&lt;/bold&gt;), followed by mass spectrometry analysis revealed that AKT was phosphorylated at Tyrosine 176 (&lt;xref&gt;&lt;bold&gt;Fig. 1C–E&lt;/bold&gt;&lt;/xref&gt;). Tyr176, located in the kinase domain, is evolutionarily conserved from unicellular eukaryotes to mammals and within all the three AKT isoforms (&lt;xref&gt;&lt;bold&gt;Fig. 1F&lt;/bold&gt;&lt;/xref&gt;). Two other phosphorylation events, Ser473 and Thr308 were also identified in the same preparation (&lt;bold&gt;&lt;xref&gt;Fig. S2B&lt;/xref&gt;–G&lt;/bold&gt;). &lt;italic&gt;In-silico&lt;/italic&gt; analysis revealed that Tyr176 and Ser473 are located in regions with increased conformational flexibility and phosphorylation at Tyr176 is likely to induce substantial conformational change and thus affect the loop harboring Ser473 (&lt;bold&gt;&lt;xref&gt;Fig. S3&lt;/xref&gt;&lt;/bold&gt;). To determine whether AKT Tyr176-phosphorylation is an upstream event that regulates AKT activation (or Ser473 phosphorylation, hereafter), site directed mutagenesis was performed to generate AKT phospho-tyrosine (Y176F) mutant (&lt;bold&gt;&lt;xref&gt;Fig. S4A&lt;/xref&gt;&lt;/bold&gt;). The Y176F mutant interacted poorly with Ack1 in the absence of ligand, and in the presence of ligand failed to interact with Ack1 resulting in decreased AKT Tyr/Ser-phosphorylations (&lt;xref&gt;&lt;bold&gt;Fig. 1G&lt;/bold&gt;&lt;/xref&gt;, lane 6). Flow cytometric analysis of EGF treated cells revealed significant reduction in Ser473-phosphorylation in MEF1&amp;amp;2KO cells expressing Y176F as compared to AKT (&lt;xref&gt;&lt;bold&gt;Fig. 1H&lt;/bold&gt;&lt;/xref&gt; and &lt;bold&gt;&lt;xref&gt;Fig. S4B&lt;/xref&gt;&lt;/bold&gt;). These results imply that Ack1 mediated AKT Tyr-phosphorylation results in subsequent AKT activation.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_04.xml" id="paragraph13" sec-type="results">&lt;p&gt;To identify domains involved in Ack1-AKT interaction, various deletions of Ack1 and AKT were generated (&lt;bold&gt;&lt;xref&gt;Fig. S4A&lt;/xref&gt;&lt;/bold&gt;). MEF1&amp;amp;2KO cells were co-transfected with HA-tagged AKT deletions and activated Ack1 or caAck. Immunoprecipitation using HA antibodies followed by immunoblotting with pTyr antibodies revealed Tyr-phosphorylation of full-length AKT and AKT lacking carboxy terminus (ΔCT-AKT), however, AKT deletion construct lacking the PH domain (ΔPH-AKT) exhibited significant decrease in Tyr-phosphorylation (&lt;bold&gt;&lt;xref&gt;Fig. S4C&lt;/xref&gt;&lt;/bold&gt;, top panel). The decreased phosphorylation of AKT deletion construct lacking PH domain could be due to poor binding with activated Ack1. To assess this interaction in further detail, co-immunoprecipitation experiment was performed. It revealed that in contrast to AKT or ΔCT-AKT, ΔPH-AKT weakly binds Ack1 (&lt;bold&gt;&lt;xref&gt;Fig. S4D&lt;/xref&gt;&lt;/bold&gt;, top panel). We have demonstrated that Tyr176 residue in AKT kinase domain is necessary for Ack1/AKT interaction, thus, collectively it indicates that the Ack1 need both the PH domain and tyrosine176 in AKT kinase domain for complex formation.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_05.xml" id="paragraph14" sec-type="results">&lt;p&gt;To identify the region in Ack1 that recognize AKT, MEF1&amp;amp;2KO cells were transfected with Myc-tagged Ack1 deletions (shown in &lt;bold&gt;&lt;xref&gt;Fig. S4A&lt;/xref&gt;&lt;/bold&gt;) and HA-tagged AKT. The lysates were immunoprecipitated using Myc antibodies followed by immunoblotting with AKT antibodies. The Ack1 construct expressing SAM and kinase domains (cAck) was able to bind AKT, however, construct lacking a part of kinase domain (dAck) bound poorly to endogeneous AKT (&lt;bold&gt;&lt;xref&gt;Fig. S4E&lt;/xref&gt;&lt;/bold&gt;, top panel). GST-Ack1 that possess Kinase-SH3-CRIB domains but lacking SAM domain was able to bind AKT (&lt;bold&gt;&lt;xref&gt;Fig. S1F&lt;/xref&gt;&lt;/bold&gt;). Taken together it indicates that the kinase domain in Ack1 and tyrosine176 in the kinase domain along with AKT PH domain appear to be minimal domains required for efficient Ack1/AKT complex formation.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_06.xml" id="paragraph15" sec-type="results">&lt;p&gt;While growth factor binding to RTK or amplification of the Ack1 gene causes Ack1 kinase activation &lt;xref&gt;[25]&lt;/xref&gt;, &lt;xref&gt;[26]&lt;/xref&gt;, &lt;xref&gt;[30]&lt;/xref&gt;, somatic autoactivating mutations in Ack1 have not yet been identified. Recently, four point mutations in Ack1, i.e. R34L, R99Q, E346K, M409I have been identified in the COSMIC database. Using site-directed mutagenesis, we generated HA-tagged point mutants (&lt;bold&gt;&lt;xref&gt;Fig. S5A&lt;/xref&gt;&lt;/bold&gt;). We tested these mutants and observed that E346K mutant undergoes autoactivation and causes AKT Tyr/Ser/Thr-phosphorylation in serum starved cells (&lt;bold&gt;&lt;xref&gt;Fig. S5B&lt;/xref&gt;&lt;/bold&gt; and &lt;bold&gt;C&lt;/bold&gt;). Earlier we and others have characterized a point mutant (L487F mutation) that leads to constitutive activation of Ack1, also called caAck &lt;xref&gt;[26]&lt;/xref&gt;, &lt;xref&gt;[32]&lt;/xref&gt;. Both caAck(L487F mutant) and E346K autoactivating mutant of Ack1 exhibited Tyr284-phosphorylation in the activation loop (&lt;bold&gt;&lt;xref&gt;Fig. S5D&lt;/xref&gt;&lt;/bold&gt;). We also measured the intrinsic kinase activity of the Y176F mutant and the wildtype AKT in the absence and presence of activated Ack1. The wildtype AKT displays significant increase in the kinase activity as compared to the Y176F mutant when coexpressed with either one of the Ack1 constructs, E346K and caAck (&lt;bold&gt;&lt;xref&gt;Fig. S5E&lt;/xref&gt;&lt;/bold&gt; and &lt;bold&gt;F&lt;/bold&gt;). These results demonstrate that the somatic autoactivating mutations in Ack1 are sufficient to activate AKT. Taken together with the earlier evidence indicating direct Ack1-AKT interaction, it opens an intriguing possibility of RTK/PI3K-independent AKT activation in tumors that is mediated by (auto) activated Ack1.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_07.xml" id="paragraph16" sec-type="results">&lt;p&gt;Mechanistically, targeting AKT to the plasma membrane is necessary for AKT activation &lt;xref&gt;[1]&lt;/xref&gt;, &lt;xref&gt;[6]&lt;/xref&gt;, &lt;xref&gt;[7]&lt;/xref&gt;, &lt;xref&gt;[13]&lt;/xref&gt;. Loss of the PH domain resulted in decrease in AKT Tyr-phosphorylation upon co-expression with activated Ack1 (&lt;bold&gt;&lt;xref&gt;Fig. S4A&lt;/xref&gt;, C&lt;/bold&gt; and &lt;bold&gt;D&lt;/bold&gt;). Further, Ack1 interacts with RTKs which are located in the membrane &lt;xref&gt;[25]&lt;/xref&gt;, &lt;xref&gt;[26]&lt;/xref&gt;, &lt;xref&gt;[28]&lt;/xref&gt;. These attributes suggest that activated Ack1 could engage AKT at the plasma membrane. To investigate the role of AKT Tyr176-phosphorylation on its cellular compartmentalization, we generated phospho-antibodies that specifically recognized Tyr176-phosphorylated AKT or pTyr176-AKT (details in SI &lt;xref&gt;methods&lt;/xref&gt;). The antibodies were extensively validated (&lt;xref&gt;&lt;bold&gt;Fig. 2A&lt;/bold&gt;&lt;/xref&gt;, &lt;bold&gt;&lt;xref&gt;Fig. S6A&lt;/xref&gt;&lt;/bold&gt;, also see top panels of &lt;xref&gt;&lt;bold&gt;Fig. 2B, C and E&lt;/bold&gt;&lt;/xref&gt;, &lt;bold&gt;&lt;xref&gt;Fig. S6B&lt;/xref&gt;&lt;/bold&gt;). Normal prostate epithelial cells, RWPE, exhibited pTyr176-AKT expression upon treatment with EGF and heregulin ligand (&lt;xref&gt;&lt;bold&gt;Fig. 2A&lt;/bold&gt;&lt;/xref&gt;). The pTyr176-AKT was detected when activated Ack1 was coexpressed with AKT but not the Y176F mutant. Further, incubation of the pTyr176-AKT-antibody with phosphoAKT-Y176-peptide resulted in loss of binding to Tyr176-phosphorylated AKT (&lt;bold&gt;&lt;xref&gt;Fig. S6A&lt;/xref&gt;&lt;/bold&gt;). Cell fractionation studies revealed that heregulin, insulin and EGF treatment resulted in a time-dependent accumulation of pTyr176-AKT at the plasma membrane that lead to AKT activation (&lt;xref&gt;&lt;bold&gt;Fig. 2B, C&lt;/bold&gt;&lt;/xref&gt; and &lt;bold&gt;&lt;xref&gt;Fig. S6B&lt;/xref&gt;&lt;/bold&gt;, top panels). Optimal AKT Tyr-176 phosphorylation and plasma membrane accumulation was observed at 10, 30 and 40 mins upon EGF, insulin and heregulin ligand treatments, respectively (&lt;bold&gt;&lt;xref&gt;Fig. S6B&lt;/xref&gt;&lt;/bold&gt; and &lt;xref&gt;&lt;bold&gt;Fig. 2B, C&lt;/bold&gt;&lt;/xref&gt;). To assess whether EGF mediated AKT activation is dependent upon Tyr176-phosphorylation, MEF1&amp;amp;2KO cells expressing AKT or Y176F mutant were treated with EGF ligand. The Y176F mutant failed to translocate to the plasma membrane and become activated by EGF (&lt;xref&gt;&lt;bold&gt;Fig. 2D&lt;/bold&gt;&lt;/xref&gt;). The basal levels of pTyr176-AKT seen in cytosolic fraction (&lt;xref&gt;&lt;bold&gt;Fig. 2D&lt;/bold&gt;&lt;/xref&gt;, panel 2, lanes 4–6) is likely to be Tyr-phosphorylated AKT3. Depletion of Ack1 by siRNA abrogated heregulin mediated AKT Tyr176-phosphorylation, plasma membrane localization and activation in MCF-7 cells (&lt;xref&gt;&lt;bold&gt;Fig. 2E&lt;/bold&gt;&lt;/xref&gt;) and MEFs (unpublished data). Further, GFP-E346K recruited dsRed-AKT but not the dsRed-Y176F mutant to the plasma membrane as assessed by immunofluorescence (&lt;bold&gt;&lt;xref&gt;Fig. S6C&lt;/xref&gt;–J&lt;/bold&gt;). Taken together, these data suggest that Ack1 is a key intermediate signaling entity necessary for RTK mediated AKT Tyr176-phosphorylation.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_08.xml" id="paragraph17" sec-type="results">&lt;p&gt;Because Ack1/AKT interaction was unaffected by LY294002 treatment (&lt;xref&gt;&lt;bold&gt;Fig. 1B&lt;/bold&gt;&lt;/xref&gt;) we assessed whether AKT Tyr176-phosphorylation could occur upon inhibition of PI3K activity. First, LY294002 treatment neither affected endogenous AKT Tyr176-phosphorylation nor its membrane localization (&lt;xref&gt;&lt;bold&gt;Fig. 3A&lt;/bold&gt;&lt;/xref&gt;). Second, in contrast to Ack1 knockdown, depletion of PI3K 110α subunit by siRNA did not inhibit pTyr176-AKT levels in MCF7 cells treated with insulin (&lt;xref&gt;&lt;bold&gt;Fig. 3B&lt;/bold&gt;&lt;/xref&gt;). However, Ser473 phosphorylation of AKT was reduced upon knockdown of either Ack1 or PI3K, suggesting existence of two distinct pathways of AKT activation. Third, membrane fraction of AKT was phosphorylated at Ser473 even in the presence of LY294002 when coexpressed with activated Ack1 in serum starved MEF1&amp;amp;2KO cells (&lt;bold&gt;&lt;xref&gt;Fig. S7A&lt;/xref&gt;&lt;/bold&gt;, panel 2). To determine whether Tyr-phosphorylated AKT can translocate to the plasma membrane in the absence of PIP3, AKT point mutant R25C that binds PIP3 inefficiently &lt;xref&gt;[4]&lt;/xref&gt; was generated (&lt;bold&gt;&lt;xref&gt;Fig. S7B&lt;/xref&gt;&lt;/bold&gt;). The R25C mutant was Tyr-phosphorylated and recruited to membrane when coexpressed with activated Ack1, in the absence of ligand (&lt;bold&gt;&lt;xref&gt;Fig. S7C&lt;/xref&gt;&lt;/bold&gt; and &lt;bold&gt;D&lt;/bold&gt;). Interestingly, in contrast to AKT which bound PIP3, Tyr-phosphorylated AKT bound another membrane phospholipid, phosphatidic acid (PA) (&lt;bold&gt;&lt;xref&gt;Fig. S8&lt;/xref&gt;&lt;/bold&gt;). Combined together, our data indicates that RTK/Ack1 pathway could directly facilitate AKT plasma membrane localization and activation and a fraction of AKT that is Tyr176-phosphorylated can translocate to the membrane and undergo Ser473-phosphorylation even when PI3K is inhibited.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_09.xml" id="paragraph18" sec-type="results">&lt;p&gt;Earlier we have observed that Ack1 translocates to the nucleus upon it's Tyr-phosphorylation &lt;xref&gt;[26]&lt;/xref&gt;. We assessed the localization of pTyr176-AKT when Ack1 was activated. Ligand treatment facilitated nuclear translocation of both endogenous pTyr284-Ack1 and pTyr176-AKT (&lt;bold&gt;&lt;xref&gt;Fig. S9A&lt;/xref&gt;&lt;/bold&gt;). FoxO subgroup of transcription factors are phosphorylated by AKT leading to rapid relocalization of FoxO proteins from nucleus to cytoplasm, thus, preventing transactivation of target genes &lt;xref&gt;[1]&lt;/xref&gt;, &lt;xref&gt;[11]&lt;/xref&gt;, &lt;xref&gt;[12]&lt;/xref&gt;. FoxO proteins regulate genes involved in cell cycle arrest (&lt;italic&gt;e.g. p21&lt;/italic&gt;, &lt;italic&gt;p27KIP1&lt;/italic&gt;), cell death (&lt;italic&gt;e.g&lt;/italic&gt;. &lt;italic&gt;Bim-1&lt;/italic&gt;) and DNA repair &lt;italic&gt;(e.g. GADD45&lt;/italic&gt;) &lt;xref&gt;[11]&lt;/xref&gt;. Real time quantitative RT-PCR analysis revealed that in MEF1&amp;amp;2KO cells co-expressing caAck and AKT, expression of &lt;italic&gt;p21, p27, Bim-1&lt;/italic&gt; and &lt;italic&gt;GADD45&lt;/italic&gt; is down regulated as opposed to the activated Ack and Y176F mutant co-expressing cells (&lt;xref&gt;&lt;bold&gt;Fig. 4A&lt;/bold&gt;&lt;/xref&gt;). Consistent with this observation, depletion of Ack1 protein by siRNA resulted in increased FoxO-responsive gene expression (&lt;xref&gt;&lt;bold&gt;Fig. 4B&lt;/bold&gt;&lt;/xref&gt;).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_10.xml" id="paragraph19" sec-type="results">&lt;p&gt;To further understand the molecular role of Tyr176 in cell growth, we generated a HA-tagged myristoylated Y176F or myr-Y176F (&lt;xref&gt;&lt;bold&gt;Fig. 4C&lt;/bold&gt;&lt;/xref&gt;). As the myristoylated version of AKT is constitutively anchored at the membrane, it exhibits high levels of AKT activation, as seen by Thr308-phosphorylation (&lt;bold&gt;&lt;xref&gt;Fig. S9B&lt;/xref&gt;&lt;/bold&gt;). MEF1&amp;amp;2KO cells expressing myr-Y176F exhibited significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation is an important event for subsequent AKT activation. Further, MEF1&amp;amp;2KO cells expressing myr-AKT grow exponentially as observed by an increase in the number of the double-positive HA and phospho-H3 (Ser10) stained cells, indicative of cells undergoing mitosis (&lt;xref&gt;&lt;bold&gt;Fig. 4D&lt;/bold&gt;&lt;/xref&gt;). In contrast, the number of double-positive myr-Y176F expressing cells remained unchanged after 24 hours (&lt;xref&gt;&lt;bold&gt;Fig. 4D&lt;/bold&gt;&lt;/xref&gt;). Thus, AKT Tyr176-phosphorylation can both suppress pro-apoptotic gene transcription and promote mitotic progression.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_11.xml" id="paragraph20" sec-type="results">&lt;p&gt;We generated a transgenic mouse model in which Myc-tagged activated Ack1 was expressed under the control of modified Probasin (PB) promoter, ARR2PB (&lt;xref&gt;&lt;bold&gt;Fig. 5A&lt;/bold&gt; and &lt;bold&gt;B&lt;/bold&gt;&lt;/xref&gt;). PB-Ack1 transgenic mice (TG) display significant increase in AKT Tyr176-phosphorylation leading to Ser473/Thr308-phosphorylation (&lt;xref&gt;&lt;bold&gt;Fig. 5C&lt;/bold&gt;&lt;/xref&gt;, top 3 panels) and AKT substrate FOXO3a Ser318/321-phosphorylation (&lt;xref&gt;&lt;bold&gt;Fig. 5B&lt;/bold&gt;&lt;/xref&gt;, panel 2) in the prostates. These mice developed intraepithelial hyperplasia by 22 weeks (&lt;xref&gt;&lt;bold&gt;Fig. 5E&lt;/bold&gt;&lt;/xref&gt;) and mPINs by 44 weeks (&lt;xref&gt;&lt;bold&gt;Fig. 5F, J–L&lt;/bold&gt;&lt;/xref&gt;). The prostate epithelium of TG mice was crowded with round to polygonal stratified nuclei, forming micropapillary projections and tufts (&lt;xref&gt;&lt;bold&gt;Fig. 5E&lt;/bold&gt;&lt;/xref&gt;). The acini were lined by a rim of basal cells (&lt;xref&gt;&lt;bold&gt;Fig. 5F&lt;/bold&gt;&lt;/xref&gt;). The areas of mPINs were easily identifiable and were characterized by prostatic acini containing intraluminal papillary structures lined by atypical cells with elongated nuclei exhibiting prominent nucleoli. Focally, the papillae merged into each other within the acini generating a cribiform pattern of growth (&lt;xref&gt;&lt;bold&gt;Fig. 5J–L&lt;/bold&gt;&lt;/xref&gt;). Dorsal lobe exhibited an increased number of small acini lined by cells containing nuclei exhibiting prominent nucleoli and the neoplastic acini were devoid of myoepithelial cells (&lt;xref&gt;&lt;bold&gt;Fig. 5L&lt;/bold&gt;&lt;/xref&gt;). We previously demonstrated that Ack1 regulates phosphorylation of androgen receptor &lt;xref&gt;[&lt;bold&gt;26&lt;/bold&gt;]&lt;/xref&gt; and tumor suppressor Wwox &lt;xref&gt;[25]&lt;/xref&gt; in human prostate tumors. Neoplasia observed in PB-Ack1 mice could be due to the combined effect of Ack1 mediated AKT, AR and Wwox Tyr-phosphorylations. AR and Wwox Tyr-phosphorylations appear to be involved in late stage progression of prostate cancer to androgen-independence &lt;xref&gt;[26]&lt;/xref&gt;. Ack1 mediated AKT Tyr176-phosphorylation and activation may be more proximal stage initiating processes in neoplastic progression that mimic or serve as an alternative to those of PTEN loss which has been prominently emphasized in other mouse models of prostate cancer &lt;xref&gt;[33]&lt;/xref&gt;.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_02r_12.xml" id="paragraph21" sec-type="results">&lt;p&gt;To examine the role of pTyr284-Ack1 and pTyr176-AKT in breast tumor progression, we performed an extensive tissue microarray analysis (TMA) of clinically annotated breast (n = 476) tumor samples. Tyr284 is the primary autophosphorylation site in Ack1, hence, phospho-Ack1(Tyr284) antibodies were used to assess Ack1 activation &lt;xref&gt;[27]&lt;/xref&gt;, &lt;xref&gt;[29]&lt;/xref&gt;. Immunohistochemical analysis revealed that pTyr284-Ack1 and pTyr176-AKT were expressed in both membrane and nucleus (&lt;bold&gt;&lt;xref&gt;Fig. S10A&lt;/xref&gt;,B&lt;/bold&gt;). A significant increase in expression of pTyr284-Ack1 and pTyr176-AKT was seen when breast cancers from progressive stages were examined, i.e. normal to hyperplasia (ADH), ductal carcinoma &lt;italic&gt;in situ&lt;/italic&gt; (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages (&lt;xref&gt;&lt;bold&gt;Fig. 6A–C&lt;/bold&gt;&lt;/xref&gt; and &lt;xref&gt;&lt;bold&gt;Table 1&lt;/bold&gt;&lt;/xref&gt;). In contrast to pTyr284-Ack1, the total Ack1 levels remained unchanged between normal and tumor samples (compare &lt;bold&gt;&lt;xref&gt;Fig. S10D&lt;/xref&gt;&lt;/bold&gt; and &lt;bold&gt;E&lt;/bold&gt; with &lt;bold&gt;F&lt;/bold&gt; and &lt;bold&gt;G&lt;/bold&gt;). ANOVA results indicated that both pTyr284-Ack1 and pTyr176-AKT expression differed significantly among progression stages (&lt;italic&gt;p&lt;/italic&gt;&amp;lt;0.0001). When using Tukey-Kramer method to examine all pairwise differences between different stages, the expression levels of pTyr284-Ack1 and pTyr176-AKT in LNMM were significantly higher than those of all the earlier tumor stages; the expression levels were significantly lower in the normal samples when compared to those of all the later stages except for hyperplasia (&lt;xref&gt;&lt;bold&gt;Tables 2&lt;/bold&gt;&lt;/xref&gt; and &lt;xref&gt;&lt;bold&gt;3&lt;/bold&gt;&lt;/xref&gt;). Kaplan-Meir analyses revealed that patients with high expression of pTyr284-Ack1 and pTyr176-AKT are at a higher risk for cancer-related deaths (&lt;xref&gt;&lt;bold&gt;Fig. 6D, E&lt;/bold&gt;&lt;/xref&gt; and &lt;xref&gt;&lt;bold&gt;Table 4&lt;/bold&gt;&lt;/xref&gt;). Furthermore, expression of pTyr284-Ack1 was significantly correlated with pTyr176-AKT &lt;italic&gt;in situ&lt;/italic&gt; (Spearman rank correlation coefficient &lt;italic&gt;ρ = &lt;/italic&gt;0.43, &lt;italic&gt;p&lt;/italic&gt;&amp;lt;0.0001; &lt;bold&gt;&lt;xref&gt;Fig. S10C&lt;/xref&gt;&lt;/bold&gt;).&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_03d-pone-0009646-g007_01.xml" id="paragraph22" sec-type="discussion">&lt;p&gt;Our data demonstrates an alternate pathway of AKT activation wherein RTKs facilitate Ack1 phosphorylation at Tyr284 leading to its kinase activation. Ack1 could also be activated in some tumors by autoactivating somatic mutations, e.g. E346K. Activated Ack1 phosphorylates AKT at Tyr176 resulting in its binding to the anionic plasma membrane phospholipid PA. pTyr176-AKT localizes to the plasma membrane, where it is targeted by PDK1 and PDK2 (mTORC2 complex) for Thr308/Ser473 phosphorylations, respectively, leading to optimal AKT kinase activation. Activated AKT translocates to the nucleus, phosphorylates FoxO transcription factors to downregulate expression of FoxO target genes.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_03d_01.xml" id="paragraph23" sec-type="discussion">&lt;p&gt;Our study indicates that cells employ multiple and possibly mutually exclusive mechanisms to activate AKT (&lt;xref&gt;&lt;bold&gt;Fig. 7&lt;/bold&gt;&lt;/xref&gt;). The reasons why RTKs would employ two distinct modes of AKT activation are not entirely clear. However, a fraction of AKT appears to utilize this alternative mode of activation in normal and prominently in cancerous cells. Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB-2 or EGFR activated Ack1 which in turn Tyr-phosphorylated and activated AKT. AKT is frequently activated in pancreatic cancer which has been shown to be highly correlated to HER-2/&lt;italic&gt;neu&lt;/italic&gt; overexpression &lt;xref&gt;[34]&lt;/xref&gt;. Moreover, many of the pancreatic cell lines and tumors expressing activated AKT had retained wild-type PTEN &lt;xref&gt;[35]&lt;/xref&gt;, &lt;xref&gt;[36]&lt;/xref&gt;. We noticed that PanIN, pancreatic adenocarcinoma and breast tumors of MMTV-&lt;italic&gt;neu&lt;/italic&gt; mice exhibit significantly higher levels of pTyr284-Ack1 and pTyr176-AKT (unpublished data). Taken collectively, our data may explain AKT activation in those tumors that display amplification/activation of RTKs but have normal PI3K/PTEN levels. We propose that other tumors that possess somatic autoactivating mutations or amplification in non-receptor tyrosine kinases could use similar mechanisms for AKT activation &lt;xref&gt;[37]&lt;/xref&gt;.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_03d_02.xml" id="paragraph24" sec-type="discussion">&lt;p&gt;Are there conditions when Tyr176 modification is not needed for AKT activation? Some of the conditions when Tyr176 phosphorylation of AKT is not required for AKT activation could be; 1) Presence of constitutively active &lt;italic&gt;PIK3CA&lt;/italic&gt; mutations, observed in colorectal, glioblastomas, gastric breast and lung cancers &lt;xref&gt;[38]&lt;/xref&gt;. 2) Loss of tumor suppressor PTEN resulting in increased levels of cellular PIP3, occur commonly in prostate cancer, endometrial cancer, and glioblastoma, among others &lt;xref&gt;[3]&lt;/xref&gt;. 3) A rare somatic activating mutation, E17K in the pH domain which facilitates AKT recruitment to the membrane in PIP3-independent manner &lt;xref&gt;[13]&lt;/xref&gt;.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_03d_03.xml" id="paragraph25" sec-type="discussion">&lt;p&gt;We have used the term AKT ‘translocation’ to indicate emergence of (cytosolic) AKT in the plasma membrane in response to growth factors. Our data (&lt;xref&gt;&lt;bold&gt;Fig. 2B and 2C&lt;/bold&gt;&lt;/xref&gt;) demonstrate that AKT in the plasma membrane is phosphorylated at Tyr 176 and mutation of this site in AKT abrogates appearance of AKT in the plasma membrane (&lt;xref&gt;&lt;bold&gt;Fig. 2D&lt;/bold&gt;&lt;/xref&gt;). Based on the evidence, our model (&lt;xref&gt;&lt;bold&gt;Fig. 7&lt;/bold&gt;&lt;/xref&gt;) suggests that as Ack1 signaling pathway is initiated at the plasma membrane by RTKs. Ack1 associates with growth factor-bound RTKs (via Mig6 homology domain in Ack1 carboxy terminal proline rich region) and is activated &lt;xref&gt;[25]&lt;/xref&gt;, &lt;xref&gt;[26]&lt;/xref&gt;, &lt;xref&gt;[39]&lt;/xref&gt;. Ack1 is constitutively bound to AKT (&lt;xref&gt;&lt;bold&gt;Fig. 1B&lt;/bold&gt; and &lt;bold&gt;G&lt;/bold&gt;&lt;/xref&gt;); Activated Ack1 directly phosphorylates AKT at Tyr176, thus facilitating accumulation of Tyr176-phosphorylated AKT at the plasma membrane. Tyr176-phosphorylated AKT preferentially binds PA, a plasma membrane phospholipid as opposed to unphosphorylated AKT (refer to &lt;bold&gt;&lt;xref&gt;Fig. S8&lt;/xref&gt;&lt;/bold&gt; for details). PH domain in AKT is a lipid binding domain and thus might be involved in the membrane binding of Tyr176-phosphorylated AKT. Collectively, our data suggests that Ack1 mediated AKT Tyr176-phosphorylation is driving this translocation process. Thus, although AKT Tyr176-phosphorylation and its migration to the plasma membrane is PIP3 independent, the recruitment of Tyr176 AKT in the plasma membrane may require a functional PH domain.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_03d_04.xml" id="paragraph26" sec-type="discussion">&lt;p&gt;In contrast to AKT, pTyr176-AKT specifically binds the plasma membrane anionic phospholipid, PA (&lt;bold&gt;&lt;xref&gt;Fig. S8&lt;/xref&gt;&lt;/bold&gt;). Tyr176-phosphorylation could induce conformational changes in the AKT PH domain to enable binding to PA. The PH domain of Son of sevenless (SOS) and PX domains of p47&lt;sup&gt;phox&lt;/sup&gt; have previously been shown to possess a phosphoinositide-binding pocket and a second anion binding pocket which enables them to interact with PA facilitating plasma membrane recruitment &lt;xref&gt;[40]&lt;/xref&gt;, &lt;xref&gt;[41]&lt;/xref&gt;. We speculate that AKT too might possess a masked anion binding pocket, and Tyr-phosphorylation induced conformational changes could unmask this pocket allowing it to bind PA.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_03d_05.xml" id="paragraph27" sec-type="discussion">&lt;p&gt;In endogenous systems Ack1 associates with AKT2 albeit weakly as compared to AKT1 (&lt;xref&gt;&lt;bold&gt;Fig. 1B&lt;/bold&gt;&lt;/xref&gt;). AKT isoforms are differentially distributed among different cellular compartments &lt;xref&gt;[42]&lt;/xref&gt; with majority of AKT1 in the cytosol, and AKT2 in the mitochondria. Additionally AKT2 protein appears to be not as abundant as AKT1 in MCF-7 and MEFs (&lt;bold&gt;&lt;xref&gt;Fig. S1A&lt;/xref&gt;&lt;/bold&gt;). Thus, weak interaction with AKT2 could be a combined outcome of differential cellular distribution and lower protein levels. However, our unpublised data demonstrates significant tyrosine phosphorylation of AKT2 upon coexpression of Ack1 and AKT2 in HEK293T cells, suggesting that both AKT1 and 2 are Ack1 substrates.&lt;/p&gt;
</paragraph>
      <paragraph file="/Users/lgalescu/work/drum/data/pmc/2841635/2B_03d_06.xml" id="paragraph28" sec-type="discussion">&lt;p&gt;This study demonstrates that Tyr176-phosphorylation is sufficient for AKT membrane localization followed by PDK1/PDK2 mediated activation, defining the upstream Ack1 kinase activity as ‘PDK3’. We do not rule out the possibility that other tyrosine kinases may be able to target AKT for Tyr176-phosphorylation. Ack1 knockout mice are not currently available. However, when they are developed, they would allow us to investigate whether AKT can be phosphorylated at Tyr176 by other receptor or non-receptor tyrosine kinases in response to growth factors. Multiple non-receptor tyrosine kinases were earlier shown to increase AKT activity &lt;xref&gt;[43]&lt;/xref&gt;, &lt;xref&gt;[44]&lt;/xref&gt;, however, precise mechanism of AKT activation by any of the Tyr-modifications is not clear, nor is their role in initiation or progression of cancer. To our knowledge, this report provides the first demonstration for a role of Tyr-phosphorylated AKT in its compartmentalization, which allowed us to delineate its critical role in AKT kinase activation, its potential to initiate neoplasia in mouse prostates and promote disease progression in human breast cancers. Large numbers of tumors are reliant upon AKT activation for survival and growth making it an attractive target for molecular therapeutics &lt;xref&gt;[45]&lt;/xref&gt;. The assay that was used during development of AKT inhibitors was primarily based on AKT Ser473-phosphorylation. Our data indicates that a new class of AKT inhibitors can be identified based on AKT Tyr176-phosphorylation. These novel inhibitors that block AKT membrane localization and activation could have major implications in cancer, diabetes and obesity research.&lt;/p&gt;
</paragraph>
    </paragraphs>
    <sentences>
      <sentence id="1" pid="paragraph0">Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation</sentence>
      <sentence id="2" pid="paragraph1">The AKT/PKB kinase is a key signaling component of one of the most frequently activated pathways in cancer and is a major target of cancer drug development.</sentence>
      <sentence id="3" pid="paragraph1">Most studies have focused on its activation by Receptor Tyrosine Kinase (RTK) mediated Phosphatidylinositol-3-OH kinase (PI3K) activation or loss of Phosphatase and Tensin homolog (PTEN).</sentence>
      <sentence id="4" pid="paragraph1">We have uncovered that growth factors binding to RTKs lead to activation of a non-receptor tyrosine kinase, Ack1 (also known as ACK or TNK2), which directly phosphorylates AKT at an evolutionarily conserved tyrosine 176 in the kinase domain.</sentence>
      <sentence id="5" pid="paragraph1">Tyr176-phosphorylated AKT localizes to the plasma membrane and promotes Thr308/Ser473-phosphorylation leading to AKT activation.</sentence>
      <sentence id="6" pid="paragraph1">Mice expressing activated Ack1 specifically in the prostate exhibit AKT Tyr176-phosphorylation and develop murine prostatic intraepithelial neoplasia (mPINs).</sentence>
      <sentence id="7" pid="paragraph1">Further, expression levels of Tyr176-phosphorylated-AKT and Tyr284-phosphorylated-Ack1 were positively correlated with the severity of disease progression, and inversely correlated with the survival of breast cancer patients.</sentence>
      <sentence id="8" pid="paragraph1">Thus, RTK/Ack1/AKT pathway provides a novel target for drug discovery.</sentence>
      <sentence id="9" pid="paragraph2">Protein kinase AKT plays a central role in growth, proliferation and cell survival [1] , [2] , [3] .</sentence>
      <sentence id="10" pid="paragraph2">AKT activation occurs when ligand binding to RTK facilitates translocation of AKT to the plasma membrane [4] , [5] , [6] , [7] where it is phosphorylated at Thr308 by phosphoinositide-dependent protein kinase-1 (PDK1) and at Ser473 by the ‘PDK2’, a class of about 10 different kinases [8] including the mTORC2 complex [9] .</sentence>
      <sentence id="11" pid="paragraph2">Phosphorylation of AKT at Thr308 and Ser473 leads to its kinase activation [10] .</sentence>
      <sentence id="12" pid="paragraph2">Upon activation, AKT phosphorylates its substrates to transduce survival signals [1] , [3] , [11] , [12] .</sentence>
      <sentence id="13" pid="paragraph2">During AKT activation, the first step is the production of phosphatidylinositol 3,4,5 trisphosphate (PIP3) by PI3K.</sentence>
      <sentence id="14" pid="paragraph2">PDK1 and AKT bind the phospholipid PIP3 via their PH domains and are recruited to the plasma membrane.</sentence>
      <sentence id="15" pid="paragraph2">While RTK/PI3K mediated recruitment of AKT to the plasma membrane is a well characterized mechanism, mounting evidence indicate that AKT activation can occur in a PI3K-independent fashion [13] , [14] , [15] , [16] , [17] , [18] .</sentence>
      <sentence id="16" pid="paragraph2">About a third of the breast and prostate tumors and majority of the pancreatic tumors that exhibit AKT activation, retain normal PTEN and PI3K activity [15] [19] , [20] .</sentence>
      <sentence id="17" pid="paragraph2">Interestingly, normal PTEN expression was also seen in breast, ovarian and prostate tumors that exhibit activated AKT [15] .</sentence>
      <sentence id="18" pid="paragraph2">While RTKs are suggested to be involved [21] , the molecular mechanisms regulating RTK mediated AKT activation in cancers with normal PTEN and PI3K activity is poorly understood [22] .</sentence>
      <sentence id="19" pid="paragraph2">Further, PIK3CA activating mutation has recently been shown to be neither necessary nor sufficient for full AKT activation in situ [23] .</sentence>
      <sentence id="20" pid="paragraph2">Thus, collectively these data suggest the existence of additional pathways that regulate AKT activation in response to growth factors.</sentence>
      <sentence id="21" pid="paragraph3">Ack1, a nonreceptor tyrosine kinase has emerged as a critical early transducer of variety of extracellular growth factor stimuli including heregulin, insulin, EGF and PDGF signaling [24] , [25] , [26] , [27] , [28] .</sentence>
      <sentence id="22" pid="paragraph3">Ack1 is ubiquitously expressed and primarily phosphorylated at Tyr284 leading to its kinase activation [25] , [27] .</sentence>
      <sentence id="23" pid="paragraph3">Our earlier studies demonstrated that Ack1 regulates prostate cancer progression to androgen independence by positively regulating androgen receptor (AR) and negatively regulating the tumor suppressor, Wwox [25] , [26] , [29] .</sentence>
      <sentence id="24" pid="paragraph3">Ack1 gene is also shown to be amplified in primary lung, ovarian and prostate tumors which correlated with poor prognosis [30] .</sentence>
      <sentence id="25" pid="paragraph3">In this report, we have identified a novel mechanism of Ack1 mediated AKT activation wherein phosphorylation of Tyrosine 176 in the AKT kinase domain results in its translocation to the plasma membrane and subsequent kinase activation.</sentence>
      <sentence id="26" pid="paragraph4">( A ) MEF2KO cells were serum starved (24 h) and treated with EGF (10 ng/ml).</sentence>
      <sentence id="27" pid="paragraph4">The lysates were immunoprecipitated or IP with anti-Ack1 (top panel), anti-AKT (second panel) and anti-EGFR (fourth panel) antibodies followed by immunoblotting or IB with anti-pTyr antibodies.</sentence>
      <sentence id="28" pid="paragraph4">Remaining panel represents IB with antibodies as shown.</sentence>
      <sentence id="29" pid="paragraph4">( B ) MEFs were serum starved (24 h) and treated with EGF (10 ng/ml for 10 mins) or pretreated with LY294002 (10 µM for 1 h) and EGF.</sentence>
      <sentence id="30" pid="paragraph4">The lysates were IP with Ack1 antibodies followed by IB with pan-AKT antibodies (top panel).</sentence>
      <sentence id="31" pid="paragraph4">( C ) HA-tagged Tyr-phosphorylated AKT was purified (see Fig. S2A ) followed by trypsin/chymotrypsin digestion.</sentence>
      <sentence id="32" pid="paragraph4">The peptide was detected at 13.83 mins in the total ion chromatogram ( C ) with mass-to-charge ratio 647.8132, which represents an error of 0.38 ppm ( D ) .</sentence>
      <sentence id="33" pid="paragraph4">( E ) The tandem mass spectrum matched the sequence, VKEKATGRY pY indicating that the C-terminal tyrosine was phosphorylated; the detection of the phosphotyrosine y 1 is consistent with this localization.</sentence>
      <sentence id="34" pid="paragraph4">( F ) Alignment of AKT protein sequences revealed that tyrosine at 176 is invariant from yeast to humans and all the three known human AKT isoforms.</sentence>
      <sentence id="35" pid="paragraph4">( G ) MEF1 2KO cells expressing HA-tagged AKT or Y176F mutant were serum-starved (24 h), treated with EGF for 15 mins and lysates were IP with anti-Ack1 Abs followed by IB with anti-AKT antibodies (top panel).</sentence>
      <sentence id="36" pid="paragraph4">The lysates were also IP with anti-Ack1 antibodies followed by IB with pTyr antibodies (panel 4).</sentence>
      <sentence id="37" pid="paragraph4">The same blot was stripped and IB with anti-Ack1 antibodies (Bottom panel).</sentence>
      <sentence id="38" pid="paragraph4">These lysates were also subjected to IP with anti-HA antibodies followed by IB with Ser473, pTyr and AKT antibodies (panels 2, 3 and 5, respectively).</sentence>
      <sentence id="39" pid="paragraph4">( H ) Flow cytometry of AKT and Y176F mutant expressing MEF1 2KO cells.</sentence>
      <sentence id="40" pid="paragraph4">Cells were serum starved for 24 h, treated with EGF for 15 mins, fixed and stained with HA-antibodies conjugated to Alexa488 and phosphoSer473-antibodies conjugated to Alexa 647.</sentence>
      <sentence id="41" pid="paragraph4">Upper right quadrant represents cells which express HA-tagged AKT or Y176F mutant that are also Ser473-phosphorylated.</sentence>
      <sentence id="42" pid="paragraph5">( A ) RWPE, normal prostate epithelial cells were treated with EGF (10 ng/ml,10 mins) and heregulin (10 ng/ml, 35 mins), whole cell protein lysates were subjected to IB with indicated antibodies.</sentence>
      <sentence id="43" pid="paragraph5">( B, C ) MCF-7 cells were serum starved (24 h) and treated with ( B ) insulin (50 ng/ml) or ( C ) heregulin (30 ng/ml) for indicated times.</sentence>
      <sentence id="44" pid="paragraph5">Cell lysates were fractionated and IB with the indicated antibodies.</sentence>
      <sentence id="45" pid="paragraph5">Input panels pAck1(Tyr), pIR(Tyr) and pHER-2(Tyr) represents IP with respective antibodies followed by IB with pTyr antibodies.</sentence>
      <sentence id="46" pid="paragraph5">( D ) MEF 1 2KO cells were transfected with HA-tagged AKT or Y176F mutant, serum starved (24 h) and treated with EGF for 15 mins.</sentence>
      <sentence id="47" pid="paragraph5">Cell lysates were fractionated and IB with anti-HA (top panel) and indicated antibodies (bottom panels).</sentence>
      <sentence id="48" pid="paragraph5">( E ) MCF7 cells were transfected with control or Ack1-specific siRNAs (40 nM) for 48 h and treated with heregulin for 40 mins.</sentence>
      <sentence id="49" pid="paragraph5">Cell lysates were fractionated and IB with indicated antibodies.</sentence>
      <sentence id="50" pid="paragraph5">In this experiment we have used half the volumes buffer for extraction of cytosolic proteins.</sentence>
      <sentence id="51" pid="paragraph5">Thus, the cytosolic extracts are 2X concentrated as compared to Fig. 2B–C , which explains more p176-AKT in cytosol fraction than the plasma membrane fraction.</sentence>
      <sentence id="52" pid="paragraph6">( A ) MCF-7 cells were pretreated with LY294002  (10 µM, 1 h) followed by heregulin for 40 mins.</sentence>
      <sentence id="53" pid="paragraph6">Cell lysates were fractionated and membrane fraction was subjected to IB with indicated antibodies.</sentence>
      <sentence id="54" pid="paragraph6">( B ) MCF-7 cells were mock transfected or transfected with control, Ack1 and PI3K siRNAs, followed by insulin treatment for 30 mins.</sentence>
      <sentence id="55" pid="paragraph6">Cell lysates were subjected to IP with pTyr-antibodies, followed by IB with pTyr176-AKT antibodies (top panel).</sentence>
      <sentence id="56" pid="paragraph6">Lower panels show IB with indicated antibodies.</sentence>
      <sentence id="57" pid="paragraph6">The experiment was performed with two different Ack1 siRNAs (Qiagen).</sentence>
      <sentence id="58" pid="paragraph7">( A ) MEF1 2KO cells were transfected with caAck and HA-tagged AKT or Y176F, serum starved (24 h) and harvested.</sentence>
      <sentence id="59" pid="paragraph7">Total RNA was prepared and quantitative RT-PCR was performed.</sentence>
      <sentence id="60" pid="paragraph7">Data are representative of three independent experiments.</sentence>
      <sentence id="61" pid="paragraph7">* p≤ 0.05; ** p ≤0.03; *** p ≤0.02; **** p ≤0.02.</sentence>
      <sentence id="62" pid="paragraph7">( B ) MEF2KO cells were transfected with control or Ack1-specific siRNAs (40 nM) for 48 h and treated with EGF for 30 mins.</sentence>
      <sentence id="63" pid="paragraph7">Total RNA was prepared and quantitative RT-PCR was performed.</sentence>
      <sentence id="64" pid="paragraph7">* p ≤0.01; ** p ≤0.05; *** p ≤0.06; **** p≤ 0.05.</sentence>
      <sentence id="65" pid="paragraph7">( C ) Schematic representation of myr-AKT and myr-Y176F point mutants.</sentence>
      <sentence id="66" pid="paragraph7">SDM of myr-AKT was performed to generate the Y176F mutation.</sentence>
      <sentence id="67" pid="paragraph7">PH, Pleckstrin homology domain; Kinase, Kinase domain and CT, Carboxy Terminal regulatory region.</sentence>
      <sentence id="68" pid="paragraph7">( D ) AKT MEF1 2 KO cells were transfected with HA-tagged myr-AKT or myr-Y176F mutant and harvested 24 h and 48 h post-transfection.</sentence>
      <sentence id="69" pid="paragraph7">Cells were fixed and stained with anti-HA antibodies conjugated with Alexa 488 and anti-pSerine10-Histone3 conjugated with Alexa 647, a marker used to distinguish cells in late G2 and early M phase, and analyzed by flow cytometry.</sentence>
      <sentence id="70" pid="paragraph7">HA-myrAKT expressing cells showed 75% increase in the number of cells undergoing mitosis (upper right quadrant), while, HA-myrY176F-AKT expressing mitotic cells remain unchanged.</sentence>
      <sentence id="71" pid="paragraph8">( A ) Transgenic construct (Prob-Ack1) is shown.</sentence>
      <sentence id="72" pid="paragraph8">( B ) A 25 wk old Probasin-Ack1 transgenic (TG) and wild type [21] male mice prostate lysates were subjected to IP using anti-Myc antibodies followed by IB with pTyr antibodies (top panel).</sentence>
      <sentence id="73" pid="paragraph8">For bottom panels, lysates were subjected to IB with indicated antibodies.</sentence>
      <sentence id="74" pid="paragraph8">( C ) Prostate lysates from 21 and 25 wk old TG and the WT siblings were IB with respective antibodies.</sentence>
      <sentence id="75" pid="paragraph8">The bottom 2 panels represent tail-PCR of these mice.</sentence>
      <sentence id="76" pid="paragraph8">IL-2 was an internal control for PCR.</sentence>
      <sentence id="77" pid="paragraph8">( D–L ) Haematoxylin and eosin (H E) stained WT and TG mice prostates.</sentence>
      <sentence id="78" pid="paragraph8">Histological appearance of the prostate lateral lobe from a 22 wk old WT mouse ( D ), and corresponding lobe from age-matched TG mice with intraepithelial hyperplasia ( E ).</sentence>
      <sentence id="79" pid="paragraph8">The lateral prostate from 49 wk old TG mice exhibiting mPIN ( F ) is shown.</sentence>
      <sentence id="80" pid="paragraph8">Contrasting histological appearance of the lateral, ventral and dorsal lobes of the prostate glands from a WT mouse ( G–I ), and corresponding lobes from TG mice (49 week old) are shown ( J–L ).</sentence>
      <sentence id="81" pid="paragraph9">( A ) TMA sections representing different breast cancer stages stained with pTyr284-Ack1 and pTyr176-AKT antibodies.</sentence>
      <sentence id="82" pid="paragraph9">( B ) Box plots to summarize distributions of staining intensities for pTyr284-Ack1 in different stages of breast cancer.</sentence>
      <sentence id="83" pid="paragraph9">A significant increasing trend of intensity across progression stages was detected (Mantel-Haenszel test, p = 0.02).</sentence>
      <sentence id="84" pid="paragraph9">The box has lines at the lower quartile (25%), median (50%), and upper quartile values (75%) while the red-cross within the circle marks the mean value.</sentence>
      <sentence id="85" pid="paragraph9">Whiskers extend from each end of the box to the most extreme values within 1.5 times the interquartile range from the ends of the box.</sentence>
      <sentence id="86" pid="paragraph9">The data with values beyond the ends of the whiskers, displayed with black circles, are potential outliers.</sentence>
      <sentence id="87" pid="paragraph9">( C ) Box plots to summarize distributions of staining intensities for pTyr176-AKT in different stages of breast cancer.</sentence>
      <sentence id="88" pid="paragraph9">A significant increasing trend of intensity across progression stages was detected (Mantel-Haenszel test, p 0.0001).</sentence>
      <sentence id="89" pid="paragraph9">( D ) Kaplan–Meier analysis shows that individuals with breast cancer that have moderate to strong staining ( 4) of pTyr284-Ack1 have a lower probability of survival (log rank test, p = 0.08).</sentence>
      <sentence id="90" pid="paragraph9">( E ) Kaplan–Meier analysis of the breast cancer patients that have moderate to strong staining ( 4) of pTyr176-AKT have significantly lower probability of survival (log rank test, p = 0.02).</sentence>
      <sentence id="91" pid="paragraph10">We observed that EGF treatment of mouse embryonic fibroblasts (MEFs) resulted in rapid Tyr-phosphorylation of Ack1 as well as Akt1 at 5 and 10 mins respectively, suggesting that these two Tyr-phosphorylation events could be linked ( Fig. 1A ).</sentence>
      <sentence id="92" pid="paragraph10">To test this hypothesis, we examined whether Ack1 could bind and Tyr-phosphorylate AKT following RTK activation.</sentence>
      <sentence id="93" pid="paragraph10">Co-immunoprecipitation of lysates derived from Akt1, Akt2, and Akt1 2 knockout mouse embryo fibroblasts (MEF1KO, MEF2KO, and MEF1 2KO, respectively, Fig. S1A ) that were treated with EGF, either with or without pretreatment with LY294002, a PI3K inhibitor, revealed that endogenous Akt1 (AKT here onwards) and Ack1 formed a stable complex which was not abrogated by LY294002 ( Fig. 1B ).</sentence>
      <sentence id="94" pid="paragraph10">The bottom panel shows that upon LY294002 addition there was substantial decrease in AKT Ser473-phosphorylation, suggesting that LY294002 is functional.</sentence>
      <sentence id="95" pid="paragraph10">Akt2 interacted weakly with Ack1, while Akt3 present at low levels in the MEF1 2KO cells was not detectable in the complex.</sentence>
      <sentence id="96" pid="paragraph11">To test whether Ack1 directly phosphorylates AKT, in vitro binding assay was performed and AKT Tyr-phosphorylation was assessed.</sentence>
      <sentence id="97" pid="paragraph11">Myc-tagged Ack1 and HA-tagged AKT constructs were expressed and purified using respective antibody beads followed by elution, as described in methods section ( Fig. S1B ).</sentence>
      <sentence id="98" pid="paragraph11">In vitro binding assay revealed that purified Ack1 interacted directly with AKT resulting in AKT Tyr176-phosphorylation ( Fig. S1B –D ).</sentence>
      <sentence id="99" pid="paragraph11">Further, we generated GST-Ack construct that harbors kinase, SH3 and CRIB domain (schematic shown in Fig. S1E ) and expressed it in E. coli ( Fig. S1E ) [25] , [31] .</sentence>
      <sentence id="100" pid="paragraph11">Androgen-receptor (AR), another Ack1 substrate [26] was expressed as FLAG-tagged construct in HEK293 cells and purified using FLAG-beads ( Fig. S1E , left panel).</sentence>
      <sentence id="101" pid="paragraph11">GST-tagged Ack1 or GST (as control) bound to glutathione beads were incubated with purified AKT or Y176F mutant of AKT or AR  (shown in Fig. S1B and E ).</sentence>
      <sentence id="102" pid="paragraph11">GST-Ack1 bound to purified AKT and AR but not the Y176F mutant of AKT suggesting that AKT and AR are direct binding partners of Ack1 ( Fig. S1F ).</sentence>
      <sentence id="103" pid="paragraph12">Affinity purification of AKT coexpressed with Ack1 ( Fig. S2A ), followed by mass spectrometry analysis revealed that AKT was phosphorylated at Tyrosine 176 ( Fig. 1C–E ).</sentence>
      <sentence id="104" pid="paragraph12">Tyr176, located in the kinase domain, is evolutionarily conserved from unicellular eukaryotes to mammals and within all the three AKT isoforms ( Fig. 1F ).</sentence>
      <sentence id="105" pid="paragraph12">Two other phosphorylation events, Ser473 and Thr308 were also identified in the same preparation ( Fig. S2B –G ).</sentence>
      <sentence id="106" pid="paragraph12">In-silico analysis revealed that Tyr176 and Ser473 are located in regions with increased conformational flexibility and phosphorylation at Tyr176 is likely to induce substantial conformational change and thus affect the loop harboring Ser473 ( Fig. S3 ).</sentence>
      <sentence id="107" pid="paragraph12">To determine whether AKT Tyr176-phosphorylation is an upstream event that regulates AKT activation (or Ser473 phosphorylation, hereafter), site directed mutagenesis was performed to generate AKT phospho-tyrosine (Y176F) mutant ( Fig. S4A ).</sentence>
      <sentence id="108" pid="paragraph12">The Y176F mutant interacted poorly with Ack1 in the absence of ligand, and in the presence of ligand failed to interact with Ack1 resulting in decreased AKT Tyr/Ser-phosphorylations ( Fig. 1G , lane 6).</sentence>
      <sentence id="109" pid="paragraph12">Flow cytometric analysis of EGF treated cells revealed significant reduction in Ser473-phosphorylation in MEF1 2KO cells expressing Y176F as compared to AKT ( Fig. 1H and Fig. S4B ).</sentence>
      <sentence id="110" pid="paragraph12">These results imply that Ack1 mediated AKT Tyr-phosphorylation results in subsequent AKT activation.</sentence>
      <sentence id="111" pid="paragraph13">To identify domains involved in Ack1-AKT interaction, various deletions of Ack1 and AKT were generated ( Fig. S4A ).</sentence>
      <sentence id="112" pid="paragraph13">MEF1 2KO cells were co-transfected with HA-tagged AKT deletions and activated Ack1 or caAck.</sentence>
      <sentence id="113" pid="paragraph13">Immunoprecipitation using HA antibodies followed by immunoblotting with pTyr antibodies revealed Tyr-phosphorylation of full-length AKT and AKT lacking carboxy terminus (ΔCT-AKT), however, AKT deletion construct lacking the PH domain (ΔPH-AKT) exhibited significant decrease in Tyr-phosphorylation ( Fig. S4C , top panel).</sentence>
      <sentence id="114" pid="paragraph13">The decreased phosphorylation of AKT deletion construct lacking PH domain could be due to poor binding with activated Ack1.</sentence>
      <sentence id="115" pid="paragraph13">To assess this interaction in further detail, co-immunoprecipitation experiment was performed.</sentence>
      <sentence id="116" pid="paragraph13">It revealed that in contrast to AKT or ΔCT-AKT, ΔPH-AKT weakly binds Ack1 ( Fig. S4D , top panel).</sentence>
      <sentence id="117" pid="paragraph13">We have demonstrated that Tyr176 residue in AKT kinase domain is necessary for Ack1/AKT interaction, thus, collectively it indicates that the Ack1 need both the PH domain and tyrosine176 in AKT kinase domain for complex formation.</sentence>
      <sentence id="118" pid="paragraph14">To identify the region in Ack1 that recognize AKT, MEF1 2KO cells were transfected with Myc-tagged Ack1 deletions (shown in Fig. S4A ) and HA-tagged AKT.</sentence>
      <sentence id="119" pid="paragraph14">The lysates were immunoprecipitated using Myc antibodies followed by immunoblotting with AKT antibodies.</sentence>
      <sentence id="120" pid="paragraph14">The Ack1 construct expressing SAM and kinase domains (cAck) was able to bind AKT, however, construct lacking a part of kinase domain (dAck) bound poorly to endogeneous AKT ( Fig. S4E , top panel).</sentence>
      <sentence id="121" pid="paragraph14">GST-Ack1 that possess Kinase-SH3-CRIB domains but lacking SAM domain was able to bind AKT ( Fig. S1F ).</sentence>
      <sentence id="122" pid="paragraph14">Taken together it indicates that the kinase domain in Ack1 and tyrosine176 in the kinase domain along with AKT PH domain appear to be minimal domains required for efficient Ack1/AKT complex formation.</sentence>
      <sentence id="123" pid="paragraph15">While growth factor binding to RTK or amplification of the Ack1 gene causes Ack1 kinase activation [25] , [26] , [30] , somatic autoactivating mutations in Ack1 have not yet been identified.</sentence>
      <sentence id="124" pid="paragraph15">Recently, four point mutations in Ack1, i.e. R34L, R99Q, E346K, M409I have been identified in the COSMIC database.</sentence>
      <sentence id="125" pid="paragraph15">Using site-directed mutagenesis, we generated HA-tagged point mutants ( Fig. S5A ).</sentence>
      <sentence id="126" pid="paragraph15">We tested these mutants and observed that E346K mutant undergoes autoactivation and causes AKT Tyr/Ser/Thr-phosphorylation in serum starved cells ( Fig. S5B and C ).</sentence>
      <sentence id="127" pid="paragraph15">Earlier we and others have characterized a point mutant (L487F mutation) that leads to constitutive activation of Ack1, also called caAck [26] , [32] .</sentence>
      <sentence id="128" pid="paragraph15">Both caAck(L487F mutant) and E346K autoactivating mutant of Ack1 exhibited Tyr284-phosphorylation in the activation loop ( Fig. S5D ).</sentence>
      <sentence id="129" pid="paragraph15">We also measured the intrinsic kinase activity of the Y176F mutant and the wildtype AKT in the absence and presence of activated Ack1.</sentence>
      <sentence id="130" pid="paragraph15">The wildtype AKT displays significant increase in the kinase activity as compared to the Y176F mutant when coexpressed with either one of the Ack1 constructs, E346K and caAck ( Fig. S5E and F ).</sentence>
      <sentence id="131" pid="paragraph15">These results demonstrate that the somatic autoactivating mutations in Ack1 are sufficient to activate AKT.</sentence>
      <sentence id="132" pid="paragraph15">Taken together with the earlier evidence indicating direct Ack1-AKT interaction, it opens an intriguing possibility of RTK/PI3K-independent AKT activation in tumors that is mediated by (auto) activated Ack1.</sentence>
      <sentence id="133" pid="paragraph16">Mechanistically, targeting AKT to the plasma membrane is necessary for AKT activation [1] , [6] , [7] , [13] .</sentence>
      <sentence id="134" pid="paragraph16">Loss of the PH domain resulted in decrease in AKT Tyr-phosphorylation upon co-expression with activated Ack1 ( Fig. S4A , C and D ).</sentence>
      <sentence id="135" pid="paragraph16">Further, Ack1 interacts with RTKs which are located in the membrane [25] , [26] , [28] .</sentence>
      <sentence id="136" pid="paragraph16">These attributes suggest that activated Ack1 could engage AKT at the plasma membrane.</sentence>
      <sentence id="137" pid="paragraph16">To investigate the role of AKT Tyr176-phosphorylation on its cellular compartmentalization, we generated phospho-antibodies that specifically recognized Tyr176-phosphorylated AKT or pTyr176-AKT (details in SI methods ).</sentence>
      <sentence id="138" pid="paragraph16">The antibodies were extensively validated ( Fig. 2A , Fig. S6A , also see top panels of Fig. 2B, C and E , Fig. S6B ).</sentence>
      <sentence id="139" pid="paragraph16">Normal prostate epithelial cells, RWPE, exhibited pTyr176-AKT expression upon treatment with EGF and heregulin ligand ( Fig. 2A ).</sentence>
      <sentence id="140" pid="paragraph16">The pTyr176-AKT was detected when activated Ack1 was coexpressed with AKT but not the Y176F mutant.</sentence>
      <sentence id="141" pid="paragraph16">Further, incubation of the pTyr176-AKT-antibody with phosphoAKT-Y176-peptide resulted in loss of binding to Tyr176-phosphorylated AKT ( Fig. S6A ).</sentence>
      <sentence id="142" pid="paragraph16">Cell fractionation studies revealed that heregulin, insulin and EGF treatment resulted in a time-dependent accumulation of pTyr176-AKT at the plasma membrane that lead to AKT activation ( Fig. 2B, C and Fig. S6B , top panels).</sentence>
      <sentence id="143" pid="paragraph16">Optimal AKT Tyr-176 phosphorylation and plasma membrane accumulation was observed at 10, 30 and 40 mins upon EGF, insulin and heregulin ligand treatments, respectively ( Fig. S6B and Fig. 2B, C ).</sentence>
      <sentence id="144" pid="paragraph16">To assess whether EGF mediated AKT activation is dependent upon Tyr176-phosphorylation, MEF1 2KO cells expressing AKT or Y176F mutant were treated with EGF ligand.</sentence>
      <sentence id="145" pid="paragraph16">The Y176F mutant failed to translocate to the plasma membrane and become activated by EGF ( Fig. 2D ).</sentence>
      <sentence id="146" pid="paragraph16">The basal levels of pTyr176-AKT seen in cytosolic fraction ( Fig. 2D , panel 2, lanes 4–6) is likely to be Tyr-phosphorylated AKT3.</sentence>
      <sentence id="147" pid="paragraph16">Depletion of Ack1 by siRNA abrogated heregulin mediated AKT Tyr176-phosphorylation, plasma membrane localization and activation in MCF-7 cells ( Fig. 2E ) and MEFs (unpublished data).</sentence>
      <sentence id="148" pid="paragraph16">Further, GFP-E346K recruited dsRed-AKT but not the dsRed-Y176F mutant to the plasma membrane as assessed by immunofluorescence ( Fig. S6C –J ).</sentence>
      <sentence id="149" pid="paragraph16">Taken together, these data suggest that Ack1 is a key intermediate signaling entity necessary for RTK mediated AKT Tyr176-phosphorylation.</sentence>
      <sentence id="150" pid="paragraph17">Because Ack1/AKT interaction was unaffected by LY294002 treatment ( Fig. 1B ) we assessed whether AKT Tyr176-phosphorylation could occur upon inhibition of PI3K activity.</sentence>
      <sentence id="151" pid="paragraph17">First, LY294002 treatment neither affected endogenous AKT Tyr176-phosphorylation nor its membrane localization ( Fig. 3A ).</sentence>
      <sentence id="152" pid="paragraph17">Second, in contrast to Ack1 knockdown, depletion of PI3K 110α subunit by siRNA did not inhibit pTyr176-AKT levels in MCF7 cells treated with insulin ( Fig. 3B ).</sentence>
      <sentence id="153" pid="paragraph17">However, Ser473 phosphorylation of AKT was reduced upon knockdown of either Ack1 or PI3K, suggesting existence of two distinct pathways of AKT activation.</sentence>
      <sentence id="154" pid="paragraph17">Third, membrane fraction of AKT was phosphorylated at Ser473 even in the presence of LY294002 when coexpressed with activated Ack1 in serum starved MEF1 2KO cells ( Fig. S7A , panel 2).</sentence>
      <sentence id="155" pid="paragraph17">To determine whether Tyr-phosphorylated AKT can translocate to the plasma membrane in the absence of PIP3, AKT point mutant R25C that binds PIP3 inefficiently [4] was generated ( Fig. S7B ).</sentence>
      <sentence id="156" pid="paragraph17">The R25C mutant was Tyr-phosphorylated and recruited to membrane when coexpressed with activated Ack1, in the absence of ligand ( Fig. S7C and D ).</sentence>
      <sentence id="157" pid="paragraph17">Interestingly, in contrast to AKT which bound PIP3, Tyr-phosphorylated AKT bound another membrane phospholipid, phosphatidic acid (PA) ( Fig. S8 ).</sentence>
      <sentence id="158" pid="paragraph17">Combined together, our data indicates that RTK/Ack1 pathway could directly facilitate AKT plasma membrane localization and activation and a fraction of AKT that is Tyr176-phosphorylated can translocate to the membrane and undergo Ser473-phosphorylation even when PI3K is inhibited.</sentence>
      <sentence id="159" pid="paragraph18">Earlier we have observed that Ack1 translocates to the nucleus upon it's Tyr-phosphorylation [26] .</sentence>
      <sentence id="160" pid="paragraph18">We assessed the localization of pTyr176-AKT when Ack1 was activated.</sentence>
      <sentence id="161" pid="paragraph18">Ligand treatment facilitated nuclear translocation of both endogenous pTyr284-Ack1 and pTyr176-AKT ( Fig. S9A ).</sentence>
      <sentence id="162" pid="paragraph18">FoxO subgroup of transcription factors are phosphorylated by AKT leading to rapid relocalization of FoxO proteins from nucleus to cytoplasm, thus, preventing transactivation of target genes [1] , [11] , [12] .</sentence>
      <sentence id="163" pid="paragraph18">FoxO proteins regulate genes involved in cell cycle arrest ( e.g. p21 , p27KIP1 ), cell death ( e.g . Bim-1 ) and DNA repair (e.g. GADD45 ) [11] .</sentence>
      <sentence id="164" pid="paragraph18">Real time quantitative RT-PCR analysis revealed that in MEF1 2KO cells co-expressing caAck and AKT, expression of p21, p27, Bim-1 and GADD45 is down regulated as opposed to the activated Ack and Y176F mutant co-expressing cells ( Fig. 4A ).</sentence>
      <sentence id="165" pid="paragraph18">Consistent with this observation, depletion of Ack1 protein by siRNA resulted in increased FoxO-responsive gene expression ( Fig. 4B ).</sentence>
      <sentence id="166" pid="paragraph19">To further understand the molecular role of Tyr176 in cell growth, we generated a HA-tagged myristoylated Y176F or myr-Y176F ( Fig. 4C ).</sentence>
      <sentence id="167" pid="paragraph19">As the myristoylated version of AKT is constitutively anchored at the membrane, it exhibits high levels of AKT activation, as seen by Thr308-phosphorylation ( Fig. S9B ).</sentence>
      <sentence id="168" pid="paragraph19">MEF1 2KO cells expressing myr-Y176F exhibited significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation is an important event for subsequent AKT activation.</sentence>
      <sentence id="169" pid="paragraph19">Further, MEF1 2KO cells expressing myr-AKT grow exponentially as observed by an increase in the number of the double-positive HA and phospho-H3 (Ser10) stained cells, indicative of cells undergoing mitosis ( Fig. 4D ).</sentence>
      <sentence id="170" pid="paragraph19">In contrast, the number of double-positive myr-Y176F expressing cells remained unchanged after 24 hours ( Fig. 4D ).</sentence>
      <sentence id="171" pid="paragraph19">Thus, AKT Tyr176-phosphorylation can both suppress pro-apoptotic gene transcription and promote mitotic progression.</sentence>
      <sentence id="172" pid="paragraph20">We generated a transgenic mouse model in which Myc-tagged activated Ack1 was expressed under the control of modified Probasin (PB) promoter, ARR2PB ( Fig. 5A and B ).</sentence>
      <sentence id="173" pid="paragraph20">PB-Ack1 transgenic mice (TG) display significant increase in AKT Tyr176-phosphorylation leading to Ser473/Thr308-phosphorylation ( Fig. 5C , top 3 panels) and AKT substrate FOXO3a Ser318/321-phosphorylation ( Fig. 5B , panel 2) in the prostates.</sentence>
      <sentence id="174" pid="paragraph20">These mice developed intraepithelial hyperplasia by 22 weeks ( Fig. 5E ) and mPINs by 44 weeks ( Fig. 5F, J–L ).</sentence>
      <sentence id="175" pid="paragraph20">The prostate epithelium of TG mice was crowded with round to polygonal stratified nuclei, forming micropapillary projections and tufts ( Fig. 5E ).</sentence>
      <sentence id="176" pid="paragraph20">The acini were lined by a rim of basal cells ( Fig. 5F ).</sentence>
      <sentence id="177" pid="paragraph20">The areas of mPINs were easily identifiable and were characterized by prostatic acini containing intraluminal papillary structures lined by atypical cells with elongated nuclei exhibiting prominent nucleoli.</sentence>
      <sentence id="178" pid="paragraph20">Focally, the papillae merged into each other within the acini generating a cribiform pattern of growth ( Fig. 5J–L ).</sentence>
      <sentence id="179" pid="paragraph20">Dorsal lobe exhibited an increased number of small acini lined by cells containing nuclei exhibiting prominent nucleoli and the neoplastic acini were devoid of myoepithelial cells ( Fig. 5L ).</sentence>
      <sentence id="180" pid="paragraph20">We previously demonstrated that Ack1 regulates phosphorylation of androgen receptor [ 26 ] and tumor suppressor Wwox [25] in human prostate tumors.</sentence>
      <sentence id="181" pid="paragraph20">Neoplasia observed in PB-Ack1 mice could be due to the combined effect of Ack1 mediated AKT, AR and Wwox Tyr-phosphorylations.</sentence>
      <sentence id="182" pid="paragraph20">AR and Wwox Tyr-phosphorylations appear to be involved in late stage progression of prostate cancer to androgen-independence [26] .</sentence>
      <sentence id="183" pid="paragraph20">Ack1 mediated AKT Tyr176-phosphorylation and activation may be more proximal stage initiating processes in neoplastic progression that mimic or serve as an alternative to those of PTEN loss which has been prominently emphasized in other mouse models of prostate cancer [33] .</sentence>
      <sentence id="184" pid="paragraph21">To examine the role of pTyr284-Ack1 and pTyr176-AKT in breast tumor progression, we performed an extensive tissue microarray analysis (TMA) of clinically annotated breast (n = 476) tumor samples.</sentence>
      <sentence id="185" pid="paragraph21">Tyr284 is the primary autophosphorylation site in Ack1, hence, phospho-Ack1(Tyr284) antibodies were used to assess Ack1 activation [27] , [29] .</sentence>
      <sentence id="186" pid="paragraph21">Immunohistochemical analysis revealed that pTyr284-Ack1 and pTyr176-AKT were expressed in both membrane and nucleus ( Fig. S10A ,B ).</sentence>
      <sentence id="187" pid="paragraph21">A significant increase in expression of pTyr284-Ack1 and pTyr176-AKT was seen when breast cancers from progressive stages were examined, i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages ( Fig. 6A–C and Table 1 ).</sentence>
      <sentence id="188" pid="paragraph21">In contrast to pTyr284-Ack1, the total Ack1 levels remained unchanged between normal and tumor samples (compare Fig. S10D and E with F and G ).</sentence>
      <sentence id="189" pid="paragraph21">ANOVA results indicated that both pTyr284-Ack1 and pTyr176-AKT expression differed significantly among progression stages ( p 0.0001).</sentence>
      <sentence id="190" pid="paragraph21">When using Tukey-Kramer method to examine all pairwise differences between different stages, the expression levels of pTyr284-Ack1 and pTyr176-AKT in LNMM were significantly higher than those of all the earlier tumor stages; the expression levels were significantly lower in the normal samples when compared to those of all the later stages except for hyperplasia ( Tables 2 and 3 ).</sentence>
      <sentence id="191" pid="paragraph21">Kaplan-Meir analyses revealed that patients with high expression of pTyr284-Ack1 and pTyr176-AKT are at a higher risk for cancer-related deaths ( Fig. 6D, E and Table 4 ).</sentence>
      <sentence id="192" pid="paragraph21">Furthermore, expression of pTyr284-Ack1 was significantly correlated with pTyr176-AKT in situ (Spearman rank correlation coefficient ρ = 0.43, p 0.0001; Fig. S10C ).</sentence>
      <sentence id="193" pid="paragraph22">Our data demonstrates an alternate pathway of AKT activation wherein RTKs facilitate Ack1 phosphorylation at Tyr284 leading to its kinase activation.</sentence>
      <sentence id="194" pid="paragraph22">Ack1 could also be activated in some tumors by autoactivating somatic mutations, e.g. E346K.</sentence>
      <sentence id="195" pid="paragraph22">Activated Ack1 phosphorylates AKT at Tyr176 resulting in its binding to the anionic plasma membrane phospholipid PA. pTyr176-AKT localizes to the plasma membrane, where it is targeted by PDK1 and PDK2 (mTORC2 complex) for Thr308/Ser473 phosphorylations, respectively, leading to optimal AKT kinase activation.</sentence>
      <sentence id="196" pid="paragraph22">Activated AKT translocates to the nucleus, phosphorylates FoxO transcription factors to downregulate expression of FoxO target genes.</sentence>
      <sentence id="197" pid="paragraph23">Our study indicates that cells employ multiple and possibly mutually exclusive mechanisms to activate AKT ( Fig. 7 ).</sentence>
      <sentence id="198" pid="paragraph23">The reasons why RTKs would employ two distinct modes of AKT activation are not entirely clear.</sentence>
      <sentence id="199" pid="paragraph23">However, a fraction of AKT appears to utilize this alternative mode of activation in normal and prominently in cancerous cells.</sentence>
      <sentence id="200" pid="paragraph23">Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB-2 or EGFR activated Ack1 which in turn Tyr-phosphorylated and activated AKT.</sentence>
      <sentence id="201" pid="paragraph23">AKT is frequently activated in pancreatic cancer which has been shown to be highly correlated to HER-2/ neu overexpression [34] .</sentence>
      <sentence id="202" pid="paragraph23">Moreover, many of the pancreatic cell lines and tumors expressing activated AKT had retained wild-type PTEN [35] , [36] .</sentence>
      <sentence id="203" pid="paragraph23">We noticed that PanIN, pancreatic adenocarcinoma and breast tumors of MMTV- neu mice exhibit significantly higher levels of pTyr284-Ack1 and pTyr176-AKT (unpublished data).</sentence>
      <sentence id="204" pid="paragraph23">Taken collectively, our data may explain AKT activation in those tumors that display amplification/activation of RTKs but have normal PI3K/PTEN levels.</sentence>
      <sentence id="205" pid="paragraph23">We propose that other tumors that possess somatic autoactivating mutations or amplification in non-receptor tyrosine kinases could use similar mechanisms for AKT activation [37] .</sentence>
      <sentence id="206" pid="paragraph24">Are there conditions when Tyr176 modification is not needed for AKT activation?</sentence>
      <sentence id="207" pid="paragraph24">Some of the conditions when Tyr176 phosphorylation of AKT is not required for AKT activation could be; 1) Presence of constitutively active PIK3CA mutations, observed in colorectal, glioblastomas, gastric breast and lung cancers [38] .</sentence>
      <sentence id="208" pid="paragraph24">2) Loss of tumor suppressor PTEN resulting in increased levels of cellular PIP3, occur commonly in prostate cancer, endometrial cancer, and glioblastoma, among others [3] .</sentence>
      <sentence id="209" pid="paragraph24">3) A rare somatic activating mutation, E17K in the pH domain which facilitates AKT recruitment to the membrane in PIP3-independent manner [13] .</sentence>
      <sentence id="210" pid="paragraph25">We have used the term AKT ‘translocation’ to indicate emergence of (cytosolic) AKT in the plasma membrane in response to growth factors.</sentence>
      <sentence id="211" pid="paragraph25">Our data ( Fig. 2B and 2C ) demonstrate that AKT in the plasma membrane is phosphorylated at Tyr 176 and mutation of this site in AKT abrogates appearance of AKT in the plasma membrane ( Fig. 2D ).</sentence>
      <sentence id="212" pid="paragraph25">Based on the evidence, our model ( Fig. 7 ) suggests that as Ack1 signaling pathway is initiated at the plasma membrane by RTKs.</sentence>
      <sentence id="213" pid="paragraph25">Ack1 associates with growth factor-bound RTKs (via Mig6 homology domain in Ack1 carboxy terminal proline rich region) and is activated [25] , [26] , [39] .</sentence>
      <sentence id="214" pid="paragraph25">Ack1 is constitutively bound to AKT ( Fig. 1B and G ); Activated Ack1 directly phosphorylates AKT at Tyr176, thus facilitating accumulation of Tyr176-phosphorylated AKT at the plasma membrane.</sentence>
      <sentence id="215" pid="paragraph25">Tyr176-phosphorylated AKT preferentially binds PA, a plasma membrane phospholipid as opposed to unphosphorylated AKT (refer to Fig. S8 for details).</sentence>
      <sentence id="216" pid="paragraph25">PH domain in AKT is a lipid binding domain and thus might be involved in the membrane binding of Tyr176-phosphorylated AKT.</sentence>
      <sentence id="217" pid="paragraph25">Collectively, our data suggests that Ack1 mediated AKT Tyr176-phosphorylation is driving this translocation process.</sentence>
      <sentence id="218" pid="paragraph25">Thus, although AKT Tyr176-phosphorylation and its migration to the plasma membrane is PIP3 independent, the recruitment of Tyr176 AKT in the plasma membrane may require a functional PH domain.</sentence>
      <sentence id="219" pid="paragraph26">In contrast to AKT, pTyr176-AKT specifically binds the plasma membrane anionic phospholipid, PA ( Fig. S8 ).</sentence>
      <sentence id="220" pid="paragraph26">Tyr176-phosphorylation could induce conformational changes in the AKT PH domain to enable binding to PA. The PH domain of Son of sevenless (SOS) and PX domains of p47 phox have previously been shown to possess a phosphoinositide-binding pocket and a second anion binding pocket which enables them to interact with PA facilitating plasma membrane recruitment [40] , [41] .</sentence>
      <sentence id="221" pid="paragraph26">We speculate that AKT too might possess a masked anion binding pocket, and Tyr-phosphorylation induced conformational changes could unmask this pocket allowing it to bind PA.</sentence>
      <sentence id="222" pid="paragraph27">In endogenous systems Ack1 associates with AKT2 albeit weakly as compared to AKT1 ( Fig. 1B ).</sentence>
      <sentence id="223" pid="paragraph27">AKT isoforms are differentially distributed among different cellular compartments [42] with majority of AKT1 in the cytosol, and AKT2 in the mitochondria.</sentence>
      <sentence id="224" pid="paragraph27">Additionally AKT2 protein appears to be not as abundant as AKT1 in MCF-7 and MEFs ( Fig. S1A ).</sentence>
      <sentence id="225" pid="paragraph27">Thus, weak interaction with AKT2 could be a combined outcome of differential cellular distribution and lower protein levels.</sentence>
      <sentence id="226" pid="paragraph27">However, our unpublised data demonstrates significant tyrosine phosphorylation of AKT2 upon coexpression of Ack1 and AKT2 in HEK293T cells, suggesting that both AKT1 and 2 are Ack1 substrates.</sentence>
      <sentence id="227" pid="paragraph28">This study demonstrates that Tyr176-phosphorylation is sufficient for AKT membrane localization followed by PDK1/PDK2 mediated activation, defining the upstream Ack1 kinase activity as ‘PDK3’.</sentence>
      <sentence id="228" pid="paragraph28">We do not rule out the possibility that other tyrosine kinases may be able to target AKT for Tyr176-phosphorylation.</sentence>
      <sentence id="229" pid="paragraph28">Ack1 knockout mice are not currently available.</sentence>
      <sentence id="230" pid="paragraph28">However, when they are developed, they would allow us to investigate whether AKT can be phosphorylated at Tyr176 by other receptor or non-receptor tyrosine kinases in response to growth factors.</sentence>
      <sentence id="231" pid="paragraph28">Multiple non-receptor tyrosine kinases were earlier shown to increase AKT activity [43] , [44] , however, precise mechanism of AKT activation by any of the Tyr-modifications is not clear, nor is their role in initiation or progression of cancer.</sentence>
      <sentence id="232" pid="paragraph28">To our knowledge, this report provides the first demonstration for a role of Tyr-phosphorylated AKT in its compartmentalization, which allowed us to delineate its critical role in AKT kinase activation, its potential to initiate neoplasia in mouse prostates and promote disease progression in human breast cancers.</sentence>
      <sentence id="233" pid="paragraph28">Large numbers of tumors are reliant upon AKT activation for survival and growth making it an attractive target for molecular therapeutics [45] .</sentence>
      <sentence id="234" pid="paragraph28">The assay that was used during development of AKT inhibitors was primarily based on AKT Ser473-phosphorylation.</sentence>
      <sentence id="235" pid="paragraph28">Our data indicates that a new class of AKT inhibitors can be identified based on AKT Tyr176-phosphorylation.</sentence>
      <sentence id="236" pid="paragraph28">These novel inhibitors that block AKT membrane localization and activation could have major implications in cancer, diabetes and obesity research.</sentence>
    </sentences>
  </input>
  <EVENT end="90" id="V32061" paragraph="paragraph0" rule="-RULE10_AGENT_AFFECTED" start="15" uttnum="1">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="90" id="V32061" start="15">
      <type>ONT::MODULATE</type>
      <text>Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation</text>
    </predicate>
    <arg1 id="V32053" role=":AGENT"/>
    <arg2 id="V32070" role=":AFFECTED"/>
    <text>Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its Activation</text>
  </EVENT>
  <EVENT end="66" id="V32053" paragraph="paragraph0" rule="-RULE60_AGENT_AFFECTED-LOC6-AFFECTED" start="15" uttnum="1">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="66" id="V32053" start="15">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation</text>
    </predicate>
    <arg2 id="V32080" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000189"/>
    <site end="50" id="V32050" start="20">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Mediated AKT/PKB Tyrosine 176</text>
    </site>
    <text>Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation</text>
  </EVENT>
  <EVENT end="90" id="V32070" paragraph="paragraph0" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="76" uttnum="1">
    <type>ONT::ACTIVATE</type>
    <predicate end="90" id="V32070" start="76">
      <type>ONT::ACTIVATE</type>
      <text>Its Activation</text>
    </predicate>
    <arg2 id="V32067" role=":AFFECTED"/>
    <arg id="R000359" role=":RESULT"/>
    <text>Its Activation</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="20" id="V32032" paragraph="paragraph0" rule="-SIMPLE-REF" start="15" uttnum="1">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="50" id="V32050" paragraph="paragraph0" rule="-SIMPLE-REF" start="20" uttnum="1">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYROSINE-176</name>
    <text>Mediated AKT/PKB Tyrosine 176</text>
  </TERM>
  <TERM end="50" id="V32080" paragraph="paragraph0" rule="-INEVENT2B,-SIMPLE-REF" start="20" uttnum="1">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V32037"/>
      </inevent>
    </features>
    <name>AKT/PKB</name>
    <text>Mediated AKT/PKB Tyrosine 176</text>
    <not-features>
      <ptm event="V32053" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <EVENT end="50" id="V32037" paragraph="paragraph0" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="20" uttnum="1">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="50" id="V32037" start="20">
      <type>ONT::MODULATE</type>
      <text>Mediated AKT/PKB Tyrosine 176</text>
    </predicate>
    <arg2 id="V32080" role=":AFFECTED"/>
    <text>Mediated AKT/PKB Tyrosine 176</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="90" id="V32067" paragraph="paragraph0" rule="-SIMPLE-REF" start="76" uttnum="1">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Its Activation</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="GO:0016301" end="22" id="V35790" paragraph="paragraph1" rule="-SIMPLE-REF" start="3" uttnum="2">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>The AKT/PKB kinase</text>
  </TERM>
  <TERM end="110" id="V35869" paragraph="paragraph1" rule="-SIMPLE-REF" start="25" uttnum="2">
    <type>ONT::DEVICE-COMPONENT</type>
    <name>COMPONENT</name>
    <text>a key signaling component of one of the most frequently activated pathways in cancer</text>
  </TERM>
  <TERM end="15" id="V36102" paragraph="paragraph1" rule="-EXPLICIT-REF-SEQ0B,EKR:SequenceTermEquiv" start="7" uttnum="2" dbid="">
    <type>ONT::PROTEIN</type>
    <components type="ONT::EQUAL">
      <component id="V35738"/>
      <component id="V35746"/>
    </components>
    <text normalization="">AKT/PKB</text>
  </TERM>
  <TERM end="15" id="V35738" paragraph="paragraph1" rule="-EXPLICIT-REF-SEQ0B-TERM" start="7" uttnum="2">
    <type>ONT::PROTEIN</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT/PKB</text>
    <equals provenance="EKR:SequenceTermEquiv" id="V35738"/>
  </TERM>
  <TERM dbid="UP:P31749" end="15" id="V35746" paragraph="paragraph1" rule="-SIMPLE-REF" start="11" uttnum="2">
    <type>ONT::PROTEIN</type>
    <name>PKB</name>
    <text>PKB</text>
    <equals provenance="EKR:SequenceTermEquiv" id="V35738"/>
  </TERM>
  <TERM end="110" id="V35924" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="61" uttnum="2">
    <type>ONT::SIGNALING-PATHWAY</type>
    <features>
      <inevent>
        <event id="V35920"/>
      </inevent>
    </features>
    <name>PATHWAY</name>
    <text>the most frequently activated pathways in cancer</text>
  </TERM>
  <EVENT end="110" id="V35920" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="61" uttnum="2">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="110" id="V35920" start="61">
      <type>ONT::ACTIVATE</type>
      <text>the most frequently activated pathways in cancer</text>
    </predicate>
    <arg2 id="V35924" role=":AFFECTED"/>
    <text>the most frequently activated pathways in cancer</text>
  </EVENT>
  <TERM end="132" id="V36059" paragraph="paragraph1" rule="-SIMPLE-REF" start="117" uttnum="2">
    <type>ONT::GOAL</type>
    <name>TARGET</name>
    <text>a major target</text>
  </TERM>
  <TERM end="147" id="V36080" paragraph="paragraph1" rule="-SIMPLE-REF" start="135" uttnum="2">
    <type>ONT::MEDICATION</type>
    <name>CANCER-DRUG</name>
    <text>cancer drug</text>
  </TERM>
  <TERM dbid="GO:0004872" end="237" id="V48659" paragraph="paragraph1" rule="-EXPLICIT-REF1" start="207" uttnum="3">
    <type>ONT::PROTEIN</type>
    <name>RECEPTOR</name>
    <assoc-with id="V48649"/>
    <text>Receptor Tyrosine Kinase (RTK)</text>
  </TERM>
  <TERM dbid="GO:0004872" end="237" id="V48649" paragraph="paragraph1" rule="-SIMPLE-REF" start="207" uttnum="3">
    <type>ONT::PROTEIN</type>
    <name>RECEPTOR</name>
    <text>Receptor Tyrosine Kinase (RTK)</text>
  </TERM>
  <TERM end="225" id="V48654" paragraph="paragraph1" rule="-SIMPLE-REF" start="216" uttnum="3">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>Tyrosine</text>
  </TERM>
  <TERM dbid="CVCL:4W74" end="236" id="V48677" paragraph="paragraph1" rule="-SIMPLE-REF" start="233" uttnum="3">
    <type>ONT::CELL-LINE</type>
    <name>RTK</name>
    <text>RTK</text>
  </TERM>
  <TERM dbid="CHEBI:28874|CHEBI:18179|CHEBI:16749" end="267" id="V53925" paragraph="paragraph1" rule="-SIMPLE-REF" start="247" uttnum="3">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHATIDYLINOSITOL</name>
    <text>Phosphatidylinositol</text>
  </TERM>
  <EVENT end="298" id="V54007" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="273" uttnum="3">
    <type>ONT::ACTIVATE</type>
    <predicate end="298" id="V54007" start="273">
      <type>ONT::ACTIVATE</type>
      <text>kinase (PI3K) activation</text>
    </predicate>
    <arg2 id="V53958" role=":AFFECTED"/>
    <arg id="R000364" role=":RESULT"/>
    <text>kinase (PI3K) activation</text>
  </EVENT>
  <TERM dbid="GO:0016301" end="287" id="V53958" paragraph="paragraph1" rule="-SIMPLE-REF" start="273" uttnum="3">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase (PI3K)</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="285" id="V54001" paragraph="paragraph1" rule="-SIMPLE-REF" start="281" uttnum="3">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <TERM dbid="UP:P60484" end="346" id="V54072" paragraph="paragraph1" rule="-SIMPLE-REF" start="306" uttnum="3">
    <type>ONT::PROTEIN</type>
    <name>PHOSPHATASE-AND-TENSIN-HOMOLOG</name>
    <text>of Phosphatase and Tensin homolog (PTEN)</text>
  </TERM>
  <TERM dbid="UP:P60484" end="345" id="V54080" paragraph="paragraph1" rule="-SIMPLE-REF" start="341" uttnum="3">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>PTEN</text>
  </TERM>
  <TERM end="351" id="V67212" paragraph="paragraph1" rule="-ROBUSTPRO" start="348" uttnum="4">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM dbid="CHEBI:28874|CHEBI:18179|CHEBI:16749" end="371" id="V67249" paragraph="paragraph1" rule="-SIMPLE-REF" start="366" uttnum="4">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHATIDYLINOSITOL</name>
    <text>that</text>
  </TERM>
  <CC end="454" id="V67342" paragraph="paragraph1" rule="-RULE5B_AGENT_RESULT" start="371" uttnum="4">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V67269" role=":FACTOR"/>
    <arg id="V67381" role=":OUTCOME"/>
    <text>growth factors binding to RTKs lead to activation of a non-receptor tyrosine kinase</text>
  </CC>
  <TERM dbid="GO:0008083" end="402" id="V67269" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="371" uttnum="4">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V67279"/>
      </inevent>
    </features>
    <name>GROWTH-FACTORS</name>
    <text>growth factors binding to RTKs</text>
  </TERM>
  <EVENT end="454" id="V67381" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-LOC9-AFFECTED" start="407" uttnum="4">
    <type>ONT::ACTIVATE</type>
    <predicate end="454" id="V67381" start="407">
      <type>ONT::ACTIVATE</type>
      <text>to activation of a non-receptor tyrosine kinase</text>
    </predicate>
    <arg2 id="V67461" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000369"/>
    <site end="448" id="V67456" start="439">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">tyrosine</text>
    </site>
    <text>to activation of a non-receptor tyrosine kinase</text>
  </EVENT>
  <EVENT end="402" id="V67279" paragraph="paragraph1" rule="-RULE20C_AGENT_AFFECTED-ROBUST-AFFECTED" start="371" uttnum="4">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="402" id="V67279" start="371">
      <type>ONT::BIND</type>
      <text>growth factors binding to RTKs</text>
    </predicate>
    <arg1 id="V67269" role=":AGENT"/>
    <arg2 id="V67332" role=":AFFECTED"/>
    <text>growth factors binding to RTKs</text>
  </EVENT>
  <TERM end="402" id="V67332" paragraph="paragraph1" rule="-RULE20C_AGENT_AFFECTED-ROBUST-AFFECTED-TERM" start="371" uttnum="4">
    <type>ONT::REFERENTIAL-SEM</type>
    <name>RTKS</name>
    <text>growth factors binding to RTKs</text>
  </TERM>
  <TERM end="454" id="V67461" paragraph="paragraph1" rule="-EXPLICIT-REF1" start="421" uttnum="4">
    <type>ONT::PROTEIN</type>
    <name>TYROSINE</name>
    <assoc-with id="V67456"/>
    <text>of a non-receptor tyrosine kinase</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="448" id="V67456" paragraph="paragraph1" rule="-SIMPLE-REF" start="439" uttnum="4">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>tyrosine</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="461" id="V67484" paragraph="paragraph1" rule="-SIMPLE-REF" start="456" uttnum="4">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="487" id="V67560" paragraph="paragraph1" rule="-LOGICALOP-REF" start="476" uttnum="4">
    <type>ONT::GENE</type>
    <aggregate operator="OR">
      <member id="V67557"/>
      <member id="V67574"/>
    </aggregate>
    <text normalization="">ACK or TNK2</text>
  </TERM>
  <TERM dbid="HGNC:19297|UP:Q07912" end="480" id="V67557" paragraph="paragraph1" rule="-SIMPLE-REF" start="476" uttnum="4">
    <type>ONT::GENE</type>
    <name>ACK</name>
    <text>ACK</text>
  </TERM>
  <TERM dbid="HGNC:19297|UP:Q07912" end="487" id="V67574" paragraph="paragraph1" rule="-SIMPLE-REF" start="483" uttnum="4">
    <type>ONT::GENE</type>
    <name>TNK-2</name>
    <text>TNK2</text>
  </TERM>
  <EVENT end="524" id="V80041" paragraph="paragraph1" rule="-RULE60_AGENT_AFFECTED" start="490" uttnum="4">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="524" id="V80041" start="490">
      <type>ONT::PHOSPHORYLATION</type>
      <text>which directly phosphorylates AKT</text>
    </predicate>
    <arg1 id="V80029" role=":AGENT"/>
    <arg2 id="V80046" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000194"/>
    <text>which directly phosphorylates AKT</text>
  </EVENT>
  <TERM dbid="HGNC:19297|UP:Q07912" end="524" id="V80029" paragraph="paragraph1" rule="-SIMPLE-REF" start="490" uttnum="4">
    <type>ONT::GENE</type>
    <name>TNK-2</name>
    <text>which directly phosphorylates AKT</text>
  </TERM>
  <TERM end="524" id="V80046" paragraph="paragraph1" rule="-SIMPLE-REF" start="520" uttnum="4">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm event="V80041" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <EVENT end="588" id="V80080" paragraph="paragraph1" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="530" uttnum="4">
    <type>ONT::NO-CHANGE</type>
    <force>ONT::TRUE</force>
    <predicate end="588" id="V80080" start="530">
      <type>ONT::NO-CHANGE</type>
      <text>evolutionarily conserved tyrosine 176 in the kinase domain</text>
    </predicate>
    <arg2 id="V80093" role=":AFFECTED"/>
    <text>evolutionarily conserved tyrosine 176 in the kinase domain</text>
  </EVENT>
  <TERM end="568" id="V80093" paragraph="paragraph1" rule="-SIMPLE-REF" start="555" uttnum="4">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYROSINE-176</name>
    <text>tyrosine 176</text>
  </TERM>
  <TERM end="588" id="V80160" paragraph="paragraph1" rule="-SIMPLE-REF" start="571" uttnum="4">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>the kinase domain</text>
  </TERM>
  <TERM dbid="GO:0016301" end="582" id="V80157" paragraph="paragraph1" rule="-SIMPLE-REF" start="575" uttnum="4">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <EVENT end="717" id="V86211" paragraph="paragraph1" rule="-RULE30_AGENT_AFFECTED" start="590" uttnum="5">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="717" id="V86211" start="590">
      <type>ONT::STIMULATE</type>
      <text>Tyr176-phosphorylated AKT localizes to the plasma membrane and promotes Thr308/Ser473-phosphorylation leading to AKT activation</text>
    </predicate>
    <arg1 id="V86138" role=":AGENT"/>
    <text>Tyr176-phosphorylated AKT localizes to the plasma membrane and promotes Thr308/Ser473-phosphorylation leading to AKT activation</text>
  </EVENT>
  <TERM end="649" id="V86138" paragraph="paragraph1" rule="-INEVENT2B,-LOCATION1,-SIMPLE-REF" start="590" uttnum="5">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <location id="V86196"/>
      <ptm event="V86128" type="ONT::PHOSPHORYLATION"/>
    </features>
    <name>AKT</name>
    <text normalization="">Tyr176-phosphorylated AKT localizes to the plasma membrane</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="649" id="V86196" paragraph="paragraph1" rule="-SIMPLE-REF" start="626" uttnum="5">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>to the plasma membrane</text>
  </TERM>
  <EVENT end="649" id="V86128" paragraph="paragraph1" rule="-RULE60_AGENT_AFFECTED-A" start="590" uttnum="5">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="649" id="V86128" start="590">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr176-phosphorylated AKT localizes to the plasma membrane</text>
    </predicate>
    <arg2 id="V86138" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000013"/>
    <site end="612" id="V86120" start="590">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176-phosphorylated</text>
    </site>
    <text>Tyr176-phosphorylated AKT localizes to the plasma membrane</text>
  </EVENT>
  <TERM end="612" id="V86120" paragraph="paragraph1" rule="-SIMPLE-REF" start="590" uttnum="5">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176-phosphorylated</text>
  </TERM>
  <TERM end="668" id="V85723" paragraph="paragraph1" rule="-SIMPLE-REF" start="662" uttnum="5">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Threonine</name>
        <code>T</code>
        <pos>308</pos>
      </site>
    </features>
    <name>THR-308</name>
    <text>Thr308</text>
  </TERM>
  <EVENT end="692" id="V85742" paragraph="paragraph1" rule="-RULE60_AGENT_AFFECTED-LOC11-NONE" start="669" uttnum="5">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="692" id="V85742" start="669">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Ser473-phosphorylation</text>
    </predicate>
    <site end="692" id="V85736" start="669">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Ser473-phosphorylation</text>
    </site>
    <text>Ser473-phosphorylation</text>
  </EVENT>
  <TERM end="692" id="V85736" paragraph="paragraph1" rule="-SIMPLE-REF" start="669" uttnum="5">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473-phosphorylation</text>
  </TERM>
  <EVENT end="717" id="V86256" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="703" uttnum="5">
    <type>ONT::ACTIVATE</type>
    <predicate end="717" id="V86256" start="703">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V86252" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000374"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="707" id="V86252" paragraph="paragraph1" rule="-SIMPLE-REF" start="703" uttnum="5">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="779" id="V103108" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="719" uttnum="6">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>Mice expressing activated Ack1 specifically in the prostate</text>
  </TERM>
  <EVENT end="779" id="V103117" paragraph="paragraph1" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="724" uttnum="6">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="779" id="V103117" start="724">
      <type>ONT::EXPRESS</type>
      <text>expressing activated Ack1 specifically in the prostate</text>
    </predicate>
    <arg2 id="V103138" role=":AFFECTED-RESULT"/>
    <text>expressing activated Ack1 specifically in the prostate</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="750" id="V103138" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="735" uttnum="6">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="750" id="V103126" paragraph="paragraph1" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="735" uttnum="6">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="750" id="V103126" start="735">
      <type>ONT::ACTIVATE</type>
      <text>activated Ack1</text>
    </predicate>
    <arg2 id="V103138" role=":RESULT"/>
    <arg id="R000037" role=":AFFECTED"/>
    <text>activated Ack1</text>
  </EVENT>
  <TERM end="779" id="V103205" paragraph="paragraph1" rule="-SIMPLE-REF" start="766" uttnum="6">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>the prostate</text>
  </TERM>
  <EVENT end="826" id="V103210" paragraph="paragraph1" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="779" uttnum="6">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="826" id="V103210" start="779">
      <type>ONT::TRANSFORM</type>
      <text>exhibit AKT Tyr176-phosphorylation and develop</text>
    </predicate>
    <arg2 id="V103231" role=":FORMAL"/>
    <text>exhibit AKT Tyr176-phosphorylation and develop</text>
  </EVENT>
  <EVENT end="814" id="V103231" paragraph="paragraph1" rule="-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="787" uttnum="6">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="814" id="V103231" start="787">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg2 id="V103215" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000199"/>
    <site end="814" id="V103225" start="787">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">AKT Tyr176-phosphorylation</text>
    </site>
    <text>AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="814" id="V103225" paragraph="paragraph1" rule="-SIMPLE-REF" start="787" uttnum="6">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>AKT Tyr176-phosphorylation</text>
  </TERM>
  <TERM end="791" id="V103215" paragraph="paragraph1" rule="-SIMPLE-REF" start="787" uttnum="6">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V103231"/>
    </not-features>
  </TERM>
  <TERM dbid="XFAM:PF01221|UP:P63168" end="875" id="V103368" paragraph="paragraph1" rule="-SIMPLE-REF" start="870" uttnum="6">
    <type>ONT::PROTEIN</type>
    <name>MPINS</name>
    <text>mPINs</text>
  </TERM>
  <EVENT end="965" id="V117330" paragraph="paragraph1" rule="-RULE50_AGENT_AFFECTED-RESULT-LOC5-GD-NONE" start="887" uttnum="7">
    <type>ONT::EXPRESS</type>
    <predicate end="965" id="V117330" start="887">
      <type>ONT::EXPRESS</type>
      <text>expression levels of Tyr176-phosphorylated-AKT and Tyr284-phosphorylated-Ack1</text>
    </predicate>
    <site end="965" id="V117337" start="887">
      <type>ONT::LEVEL</type>
      <text normalization="LEVEL">expression levels of Tyr176-phosphorylated-AKT and Tyr284-phosphorylated-Ack1</text>
    </site>
    <text>expression levels of Tyr176-phosphorylated-AKT and Tyr284-phosphorylated-Ack1</text>
  </EVENT>
  <TERM end="965" id="V117389" paragraph="paragraph1" rule="-LOGICALOP-REF" start="908" uttnum="7">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V117380"/>
      <member id="V117426"/>
    </aggregate>
    <text normalization="">Tyr176-phosphorylated-AKT and Tyr284-phosphorylated-Ack1</text>
  </TERM>
  <TERM end="934" id="V117380" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="908" uttnum="7">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr176-phosphorylated-AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V117372"/>
    </features>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="965" id="V117426" paragraph="paragraph1" rule="-INEVENT2B,-SIMPLE-REF" start="938" uttnum="7">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <text>Tyr284-phosphorylated-Ack1</text>
    <features>
      <ptm event="V117413" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT end="934" id="V117372" paragraph="paragraph1" rule="-RULE60_AGENT_AFFECTED-A" start="908" uttnum="7">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="934" id="V117372" start="908">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr176-phosphorylated-AKT</text>
    </predicate>
    <arg2 id="V117380" role=":RESULT"/>
    <arg id="R000014" role=":AFFECTED"/>
    <site end="929" id="V117364" start="908">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176-phosphorylated</text>
    </site>
    <text>Tyr176-phosphorylated-AKT</text>
  </EVENT>
  <TERM end="929" id="V117364" paragraph="paragraph1" rule="-SIMPLE-REF" start="908" uttnum="7">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176-phosphorylated</text>
  </TERM>
  <EVENT end="965" id="V117413" paragraph="paragraph1" rule="-RULE60_AGENT_AFFECTED-A" start="938" uttnum="7">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="965" id="V117413" start="938">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr284-phosphorylated-Ack1</text>
    </predicate>
    <arg2 id="V117426" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000015"/>
    <site end="959" id="V117405" start="938">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr284-phosphorylated</text>
    </site>
    <text>Tyr284-phosphorylated-Ack1</text>
  </EVENT>
  <TERM end="959" id="V117405" paragraph="paragraph1" rule="-SIMPLE-REF" start="938" uttnum="7">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>284</pos>
      </site>
    </features>
    <name>TYR-284</name>
    <text>Tyr284-phosphorylated</text>
  </TERM>
  <TERM end="1102" id="V117573" paragraph="paragraph1" rule="-SIMPLE-REF" start="1077" uttnum="7">
    <type>ONT::PATIENT</type>
    <name>PATIENT</name>
    <text>of breast cancer patients</text>
  </TERM>
  <TERM end="1102" id="V117555" paragraph="paragraph1" rule="-SIMPLE-REF" start="1077" uttnum="7">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>BREAST</name>
    <text>of breast cancer patients</text>
  </TERM>
  <TERM end="1131" id="V134088" paragraph="paragraph1" rule="-SIMPLE-REF" start="1110" uttnum="8">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>RTK/Ack1/AKT pathway</text>
  </TERM>
  <TERM end="1173" id="V134145" paragraph="paragraph1" rule="-SIMPLE-REF" start="1140" uttnum="8">
    <type>ONT::GOAL</type>
    <name>TARGET</name>
    <text>a novel target for drug discovery</text>
  </TERM>
  <TERM dbid="CVCL:4W74" end="1113" id="V133974" paragraph="paragraph1" rule="-SIMPLE-REF" start="1110" uttnum="8">
    <type>ONT::CELL-LINE</type>
    <name>RTK</name>
    <text>RTK</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1118" id="V133987" paragraph="paragraph1" rule="-SIMPLE-REF" start="1114" uttnum="8">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="1123" id="V133995" paragraph="paragraph1" rule="-SIMPLE-REF" start="1119" uttnum="8">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1173" id="V134176" paragraph="paragraph1" rule="-SIMPLE-REF" start="1159" uttnum="8">
    <type>ONT::MEDICATION</type>
    <name>DRUG</name>
    <text>drug discovery</text>
  </TERM>
  <TERM end="22" id="V152181" paragraph="paragraph2" rule="-SIMPLE-REF" start="3" uttnum="9">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Protein kinase AKT</text>
  </TERM>
  <TERM dbid="GO:0004672|FA:03057" end="18" id="V152176" paragraph="paragraph2" rule="-SIMPLE-REF" start="3" uttnum="9">
    <type>ONT::GENE-PROTEIN</type>
    <name>PROTEIN-KINASE</name>
    <text>Protein kinase</text>
  </TERM>
  <TERM dbid="GO:0040007" end="52" id="V152293" paragraph="paragraph2" rule="-SIMPLE-REF" start="46" uttnum="9">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>GROWTH</name>
    <text>growth</text>
  </TERM>
  <TERM end="68" id="V152302" paragraph="paragraph2" rule="-SIMPLE-REF" start="54" uttnum="9">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>PROLIFERATION</name>
    <text>proliferation</text>
  </TERM>
  <TERM end="102" id="V152319" paragraph="paragraph2" rule="-SIMPLE-REF" start="72" uttnum="9">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cell survival [1]</text>
  </TERM>
  <EVENT end="155" id="V168231" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="140" uttnum="10">
    <type>ONT::ACTIVATE</type>
    <predicate end="155" id="V168231" start="140">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V168227" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000379"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="144" id="V168227" paragraph="paragraph2" rule="-SIMPLE-REF" start="140" uttnum="10">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="251" id="V168315" paragraph="paragraph2" rule="-RULE30_AGENT_AFFECTED" start="167" uttnum="10">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="251" id="V168315" start="167">
      <type>ONT::STIMULATE</type>
      <text>ligand binding to RTK facilitates translocation of AKT to the plasma membrane</text>
    </predicate>
    <arg1 id="V168254" role=":AGENT"/>
    <arg2 id="V168329" role=":AFFECTED"/>
    <text>ligand binding to RTK facilitates translocation of AKT to the plasma membrane</text>
  </EVENT>
  <TERM dbid="CHEBI:52214" end="189" id="V168254" paragraph="paragraph2" rule="-SIMPLE-REF" start="167" uttnum="10">
    <type>ONT::CHEMICAL</type>
    <name>LIGAND</name>
    <text>ligand binding to RTK</text>
  </TERM>
  <EVENT end="222" id="V168329" paragraph="paragraph2" rule="-RULE10C_AGENT_AFFECTED-AFFECTED" start="201" uttnum="10">
    <type>ONT::TRANSLOCATE</type>
    <predicate end="222" id="V168329" start="201">
      <type>ONT::TRANSLOCATE</type>
      <text>translocation of AKT</text>
    </predicate>
    <arg2 id="V168341" role=":AFFECTED"/>
    <text>translocation of AKT</text>
  </EVENT>
  <TERM dbid="CVCL:4W74" end="189" id="V168299" paragraph="paragraph2" rule="-SIMPLE-REF" start="182" uttnum="10">
    <type>ONT::CELL-LINE</type>
    <name>RTK</name>
    <text>to RTK</text>
  </TERM>
  <TERM end="222" id="V168341" paragraph="paragraph2" rule="-SIMPLE-REF" start="215" uttnum="10">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of AKT</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="251" id="V168391" paragraph="paragraph2" rule="-SIMPLE-REF" start="225" uttnum="10">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <TERM end="353" id="V168506" paragraph="paragraph2" rule="-SIMPLE-REF" start="346" uttnum="10">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Threonine</name>
        <code>T</code>
        <pos>308</pos>
      </site>
    </features>
    <name>THR-308</name>
    <text>Thr308</text>
  </TERM>
  <TERM dbid="UP:O15530" end="405" id="V168595" paragraph="paragraph2" rule="-SIMPLE-REF" start="401" uttnum="10">
    <type>ONT::PROTEIN</type>
    <name>PDK-1</name>
    <text>PDK1</text>
  </TERM>
  <TERM end="436" id="V182517" paragraph="paragraph2" rule="-SIMPLE-REF" start="414" uttnum="10">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473 by the ‘PDK2’,</text>
  </TERM>
  <TERM dbid="UP:Q15119|HGNC:8810" end="433" id="V182563" paragraph="paragraph2" rule="-SIMPLE-REF" start="429" uttnum="10">
    <type>ONT::GENE</type>
    <name>PDK-2</name>
    <text>PDK2</text>
  </TERM>
  <TERM end="536" id="V182741" paragraph="paragraph2" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="501" uttnum="10">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <location id="V182725"/>
    </features>
    <name>COMPLEX</name>
    <text>the mTORC2 complex [9]</text>
  </TERM>
  <TERM dbid="GO:0016301" end="491" id="V182652" paragraph="paragraph2" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="453" uttnum="10">
    <type>ONT::PROTEIN</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>DIFFERENT</value>
      </mod>
    </mods>
    <name>KINASES</name>
    <text>10 different kinases [8]</text>
  </TERM>
  <TERM dbid="GO:0031932" end="512" id="V182725" paragraph="paragraph2" rule="-SIMPLE-REF" start="505" uttnum="10">
    <type>ONT::CELL-PART</type>
    <name>MTORC-2</name>
    <text>mTORC2</text>
  </TERM>
  <CC end="630" id="V193568" paragraph="paragraph2" rule="-RULE5B_AGENT_RESULT" start="538" uttnum="11">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V193499" role=":FACTOR"/>
    <arg id="V193610" role=":OUTCOME"/>
    <text>Phosphorylation of AKT at Thr308 and Ser473 leads to its kinase activation [10]</text>
  </CC>
  <TERM dbid="GO:0016310" end="582" id="V193499" paragraph="paragraph2" rule="-SIMPLE-REF" start="538" uttnum="11">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>PHOSPHORYLATION</name>
    <text>Phosphorylation of AKT at Thr308 and Ser473</text>
  </TERM>
  <EVENT end="630" id="V193610" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED" start="588" uttnum="11">
    <type>ONT::ACTIVATE</type>
    <predicate end="630" id="V193610" start="588">
      <type>ONT::ACTIVATE</type>
      <text>to its kinase activation [10]</text>
    </predicate>
    <arg1 id="V193602" role=":AGENT"/>
    <arg2 id="V193607" role=":AFFECTED"/>
    <arg id="R000384" role=":RESULT"/>
    <text>to its kinase activation [10]</text>
  </EVENT>
  <TERM end="582" id="V193512" paragraph="paragraph2" rule="-SIMPLE-REF" start="554" uttnum="11">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of AKT at Thr308 and Ser473</text>
  </TERM>
  <TERM end="582" id="V193547" paragraph="paragraph2" rule="-LOGICALOP-REF" start="564" uttnum="11">
    <type>ONT::MOLECULAR-SITE</type>
    <aggregate operator="AND">
      <member id="V193543"/>
      <member id="V193563"/>
    </aggregate>
    <text normalization="">Thr308 and Ser473</text>
  </TERM>
  <TERM end="571" id="V193543" paragraph="paragraph2" rule="-SIMPLE-REF" start="564" uttnum="11">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Threonine</name>
        <code>T</code>
        <pos>308</pos>
      </site>
    </features>
    <name>THR-308</name>
    <text>Thr308</text>
  </TERM>
  <TERM end="582" id="V193563" paragraph="paragraph2" rule="-SIMPLE-REF" start="575" uttnum="11">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473</text>
  </TERM>
  <TERM end="630" id="V193602" paragraph="paragraph2" rule="-LOGICALOP-REF" start="588" uttnum="11">
    <type>ONT::MOLECULAR-SITE</type>
    <aggregate operator="AND">
      <member id="V193543"/>
      <member id="V193563"/>
    </aggregate>
    <text normalization="">to its kinase activation [10]</text>
  </TERM>
  <TERM dbid="GO:0016301" end="602" id="V193607" paragraph="paragraph2" rule="-SIMPLE-REF" start="595" uttnum="11">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="653" id="V206154" paragraph="paragraph2" rule="-SIMPLE-REF" start="649" uttnum="12">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="683" id="V206168" paragraph="paragraph2" rule="-SIMPLE-REF" start="668" uttnum="12">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATES</name>
    <text>its substrates</text>
  </TERM>
  <TERM end="683" id="V206161" paragraph="paragraph2" rule="-SIMPLE-REF" start="668" uttnum="12">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATES</name>
    <text>its substrates</text>
  </TERM>
  <EVENT end="808" id="V223399" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="794" uttnum="13">
    <type>ONT::ACTIVATE</type>
    <predicate end="808" id="V223399" start="794">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V223396" role=":AFFECTED"/>
    <arg id="R000389" role=":RESULT"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="798" id="V223396" paragraph="paragraph2" rule="-SIMPLE-REF" start="794" uttnum="13">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="901" id="V223597" paragraph="paragraph2" rule="-SIMPLE-REF" start="894" uttnum="13">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">by PI3K</text>
  </TERM>
  <TERM dbid="CHEBI:28874|CHEBI:18179|CHEBI:16749" end="867" id="V223488" paragraph="paragraph2" rule="-SIMPLE-REF" start="846" uttnum="13">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHATIDYLINOSITOL</name>
    <text>phosphatidylinositol</text>
  </TERM>
  <TERM dbid="CHEBI:16618" end="892" id="V223530" paragraph="paragraph2" rule="-SIMPLE-REF" start="888" uttnum="13">
    <type>ONT::MOLECULE</type>
    <name>PIP-3</name>
    <text>PIP3</text>
  </TERM>
  <EVENT end="964" id="V239353" paragraph="paragraph2" rule="-RULE20C_AGENT_AFFECTED" start="903" uttnum="14">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="964" id="V239353" start="903">
      <type>ONT::BIND</type>
      <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains</text>
    </predicate>
    <arg1 id="V239337" role=":AGENT"/>
    <arg2 id="V239383" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000119"/>
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains</text>
  </EVENT>
  <EVENT end="1004" id="V239446" paragraph="paragraph2" rule="-RULE20C_AGENT_AFFECTED-CELL_LOC3-GD-TO-AFFECTED" start="903" uttnum="14">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1004" id="V239446" start="903">
      <type>ONT::BIND</type>
      <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains and are recruited to the plasma membrane</text>
    </predicate>
    <arg2 id="V239337" role=":AFFECTED"/>
    <to-location end="1004" id="V239496" start="985">
      <type>ONT::CELL-PART</type>
      <text normalization="">the plasma membrane</text>
    </to-location>
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains and are recruited to the plasma membrane</text>
  </EVENT>
  <TERM end="916" id="V239337" paragraph="paragraph2" rule="-LOGICALOP-REF" start="903" uttnum="14">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V239333"/>
      <member id="V239348"/>
    </aggregate>
    <text normalization="">PDK1 and AKT</text>
    <not-features>
      <bound-to event="V239353" id="V239383"/>
    </not-features>
  </TERM>
  <TERM dbid="CHEBI:16618" end="943" id="V239383" paragraph="paragraph2" rule="-SIMPLE-REF" start="921" uttnum="14">
    <type>ONT::MOLECULE</type>
    <name>PIP-3</name>
    <text>the phospholipid PIP3</text>
    <not-features>
      <bound-to id="V239337" event="V239353"/>
    </not-features>
  </TERM>
  <TERM dbid="UP:O15530" end="908" id="V239333" paragraph="paragraph2" rule="-SIMPLE-REF" start="903" uttnum="14">
    <type>ONT::PROTEIN</type>
    <name>PDK-1</name>
    <text>PDK1</text>
  </TERM>
  <TERM end="916" id="V239348" paragraph="paragraph2" rule="-SIMPLE-REF" start="912" uttnum="14">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="CHEBI:16247" end="938" id="V239369" paragraph="paragraph2" rule="-SIMPLE-REF" start="925" uttnum="14">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHOLIPID</name>
    <text>phospholipid</text>
  </TERM>
  <TERM dbid="XFAM:PF14593.3" end="964" id="V239413" paragraph="paragraph2" rule="-SIMPLE-REF" start="947" uttnum="14">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>PH-DOMAINS</name>
    <text normalization="">their PH domains</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="1004" id="V239496" paragraph="paragraph2" rule="-SIMPLE-REF" start="985" uttnum="14">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <EVENT end="964" id="X245603" paragraph="paragraph2" rule="-VIA-A-GB" start="903" uttnum="14">
    <type>ONT::MODULATE</type>
    <predicate end="964" id="X245603" start="903">
      <type>ONT::MODULATE</type>
      <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains</text>
    </predicate>
    <arg1 id="V239337" role=":AGENT"/>
    <arg2 id="V239413" role=":AFFECTED"/>
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains</text>
  </EVENT>
  <EVENT end="964" id="X245604" paragraph="paragraph2" rule="-VIA-B-GB" start="903" uttnum="14">
    <type>ONT::MODULATE</type>
    <predicate end="964" id="X245604" start="903">
      <type>ONT::MODULATE</type>
      <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains</text>
    </predicate>
    <arg1 id="V239413" role=":AGENT"/>
    <arg2 id="V239383" role=":AFFECTED"/>
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains</text>
  </EVENT>
  <CC end="964" id="X245605" paragraph="paragraph2" rule="-VIA-C-GB" start="903" uttnum="14">
    <type>ONT::BY-MEANS-OF</type>
    <arg id="X245603" role=":FACTOR-SEQUENCE"/>
    <arg id="X245604" role=":FACTOR-SEQUENCE"/>
    <arg id="V239353" role=":OUTCOME"/>
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains</text>
  </CC>
  <EVENT end="1049" id="V242883" paragraph="paragraph2" rule="-RULE20C_AGENT_AFFECTED-LOC5-GD-NONE" start="1030" uttnum="15">
    <type>ONT::BIND</type>
    <predicate end="1049" id="V242883" start="1030">
      <type>ONT::BIND</type>
      <text>recruitment of AKT</text>
    </predicate>
    <site end="1049" id="V242883" start="1030">
      <type>ONT::BIND</type>
      <text normalization="">recruitment of AKT</text>
    </site>
    <text>recruitment of AKT</text>
  </EVENT>
  <TERM end="1049" id="V242895" paragraph="paragraph2" rule="-SIMPLE-REF" start="1045" uttnum="15">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="CVCL:4W74" end="1015" id="V242526" paragraph="paragraph2" rule="-SIMPLE-REF" start="1012" uttnum="15">
    <type>ONT::CELL-LINE</type>
    <name>RTK</name>
    <text>RTK</text>
  </TERM>
  <TERM end="1021" id="V242569" paragraph="paragraph2" rule="-SIMPLE-REF" start="1016" uttnum="15">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="1072" id="V242945" paragraph="paragraph2" rule="-SIMPLE-REF" start="1052" uttnum="15">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <TERM end="1105" id="V243038" paragraph="paragraph2" rule="-SIMPLE-REF" start="1096" uttnum="15">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>mechanism</text>
  </TERM>
  <TERM end="1125" id="V256833" paragraph="paragraph2" rule="-INEVENT2B,-SIMPLE-REF" start="1107" uttnum="15">
    <type>ONT::INFORMATION</type>
    <features>
      <inevent>
        <event id="V256829"/>
      </inevent>
    </features>
    <name>EVIDENCE</name>
    <text>mounting evidence</text>
  </TERM>
  <EVENT end="1116" id="V256829" paragraph="paragraph2" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="1107" uttnum="15">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="1116" id="V256829" start="1107">
      <type>ONT::TRANSFORM</type>
      <text>mounting</text>
    </predicate>
    <arg1 id="V256833" role=":AGENT"/>
    <text>mounting</text>
  </EVENT>
  <EVENT end="1154" id="V256862" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1139" uttnum="15">
    <type>ONT::ACTIVATE</type>
    <predicate end="1154" id="V256862" start="1139">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V256859" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000394"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="1143" id="V256859" paragraph="paragraph2" rule="-SIMPLE-REF" start="1139" uttnum="15">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="1186" id="V257015" paragraph="paragraph2" rule="-SIMPLE-REF" start="1169" uttnum="15">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K-independent</text>
  </TERM>
  <TERM end="1336" id="V270702" paragraph="paragraph2" rule="-SIMPLE-REF" start="1325" uttnum="16">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>BREAST</name>
    <text>the breast</text>
  </TERM>
  <TERM end="1356" id="V270715" paragraph="paragraph2" rule="-SIMPLE-REF" start="1340" uttnum="16">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>prostate tumors</text>
  </TERM>
  <EVENT end="1421" id="V270791" paragraph="paragraph2" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="1394" uttnum="16">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="1421" id="V270791" start="1394">
      <type>ONT::TRANSFORM</type>
      <text>that exhibit AKT activation</text>
    </predicate>
    <arg2 id="V270799" role=":FORMAL"/>
    <text>that exhibit AKT activation</text>
  </EVENT>
  <EVENT end="1421" id="V270799" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1407" uttnum="16">
    <type>ONT::ACTIVATE</type>
    <predicate end="1421" id="V270799" start="1407">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V270796" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000399"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="1411" id="V270796" paragraph="paragraph2" rule="-SIMPLE-REF" start="1407" uttnum="16">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="UP:P60484" end="1442" id="V278822" paragraph="paragraph2" rule="-SIMPLE-REF" start="1430" uttnum="16">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>normal PTEN</text>
  </TERM>
  <TERM end="1451" id="V278866" paragraph="paragraph2" rule="-SIMPLE-REF" start="1448" uttnum="16">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>3</pos>
      <aa-to>
        <aa>
          <name>Lysine</name>
          <code>K</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">3K</text>
  </TERM>
  <EVENT end="1579" id="V292851" paragraph="paragraph2" rule="-RULE50_AGENT_AFFECTED-RESULT-CELL_LOC1-GD-OTHERS-AFFECTED-RESULT" start="1531" uttnum="17">
    <type>ONT::EXPRESS</type>
    <predicate end="1579" id="V292851" start="1531">
      <type>ONT::EXPRESS</type>
      <text>normal PTEN expression was also seen in breast,</text>
    </predicate>
    <arg2 id="V292845" role=":AFFECTED-RESULT"/>
    <location end="1579" id="V292951" mod="null" start="1571">
      <type>ONT::EXTERNAL-BODY-PART</type>
      <text normalization="">breast,</text>
    </location>
    <text>normal PTEN expression was also seen in breast,</text>
  </EVENT>
  <TERM dbid="UP:P60484" end="1543" id="V292845" paragraph="paragraph2" rule="-SIMPLE-REF" start="1538" uttnum="17">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>PTEN</text>
  </TERM>
  <TERM end="1579" id="V292951" paragraph="paragraph2" rule="-SIMPLE-REF" start="1571" uttnum="17">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>BREAST</name>
    <text>breast,</text>
  </TERM>
  <TERM end="1651" id="V292975" paragraph="paragraph2" rule="-SIMPLE-REF" start="1591" uttnum="17">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>prostate tumors that exhibit activated AKT [15]</text>
  </TERM>
  <EVENT end="1651" id="V293001" paragraph="paragraph2" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="1607" uttnum="17">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="1651" id="V293001" start="1607">
      <type>ONT::TRANSFORM</type>
      <text>that exhibit activated AKT [15]</text>
    </predicate>
    <arg2 id="V293013" role=":FORMAL"/>
    <text>that exhibit activated AKT [15]</text>
  </EVENT>
  <TERM end="1651" id="V293013" paragraph="paragraph2" rule="-INEVENT2B,-SIMPLE-REF" start="1620" uttnum="17">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">activated AKT [15]</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="1651" id="V293007" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1620" uttnum="17">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1651" id="V293007" start="1620">
      <type>ONT::ACTIVATE</type>
      <text>activated AKT [15]</text>
    </predicate>
    <arg2 id="V293013" role=":RESULT"/>
    <arg id="R000042" role=":AFFECTED"/>
    <text>activated AKT [15]</text>
  </EVENT>
  <TERM dbid="CVCL:4W74" end="1703" id="V310950" paragraph="paragraph2" rule="-SIMPLE-REF" start="1653" uttnum="18">
    <type>ONT::CELL-LINE</type>
    <name>RTK</name>
    <text>While RTKs are suggested to be involved [21]</text>
  </TERM>
  <TERM end="1752" id="V315448" paragraph="paragraph2" rule="-SIMPLE-REF" start="1726" uttnum="18">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>mechanisms regulating RTK</text>
  </TERM>
  <EVENT end="1776" id="V315470" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1761" uttnum="18">
    <type>ONT::ACTIVATE</type>
    <predicate end="1776" id="V315470" start="1761">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V315467" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000404"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM dbid="CVCL:4W74" end="1752" id="V315457" paragraph="paragraph2" rule="-SIMPLE-REF" start="1748" uttnum="18">
    <type>ONT::CELL-LINE</type>
    <name>RTK</name>
    <text>RTK</text>
  </TERM>
  <TERM end="1765" id="V315467" paragraph="paragraph2" rule="-SIMPLE-REF" start="1761" uttnum="18">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="UP:P60484" end="1804" id="V315546" paragraph="paragraph2" rule="-SIMPLE-REF" start="1792" uttnum="18">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>normal PTEN</text>
  </TERM>
  <EVENT end="1822" id="V315600" paragraph="paragraph2" rule="-ACTIVITY1" start="1808" uttnum="18">
    <type>ONT::ACTIVITY</type>
    <predicate end="1822" id="V315600" start="1808">
      <type>ONT::ACTIVITY</type>
      <text>PI3K activity</text>
    </predicate>
    <arg1 id="V315596" role=":AGENT"/>
    <text>PI3K activity</text>
  </EVENT>
  <TERM end="1813" id="V315596" paragraph="paragraph2" rule="-SIMPLE-REF" start="1808" uttnum="18">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <EVENT end="1915" id="V331629" paragraph="paragraph2" rule="-INEVENT2B,-RULE5_AGENT_AFFECTED-AFFECTED" start="1879" uttnum="19">
    <type>ONT::TRANSFORM</type>
    <predicate end="1915" id="V331629" start="1879">
      <type>ONT::TRANSFORM</type>
      <text>PIK3CA activating mutation</text>
    </predicate>
    <arg2 id="V331620" role=":AFFECTED"/>
    <text>PIK3CA activating mutation</text>
  </EVENT>
  <TERM dbid="UP:P42336" end="1895" id="V331620" paragraph="paragraph2" rule="-SIMPLE-REF" start="1879" uttnum="19">
    <type>ONT::PROTEIN</type>
    <name>PIK-3-CA</name>
    <text>PIK3CA</text>
  </TERM>
  <EVENT end="1915" id="V331624" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AGENT" start="1879" uttnum="19">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1915" id="V331624" start="1879">
      <type>ONT::ACTIVATE</type>
      <text>PIK3CA activating mutation</text>
    </predicate>
    <arg1 id="V331629" role=":AGENT"/>
    <text>PIK3CA activating mutation</text>
  </EVENT>
  <EVENT end="2027" id="V331774" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1978" uttnum="19">
    <type>ONT::ACTIVATE</type>
    <predicate end="2027" id="V331774" start="1978">
      <type>ONT::ACTIVATE</type>
      <text>for full AKT activation in situ [23]</text>
    </predicate>
    <arg2 id="V331771" role=":AFFECTED"/>
    <arg id="R000409" role=":RESULT"/>
    <text>for full AKT activation in situ [23]</text>
  </EVENT>
  <TERM end="1991" id="V331771" paragraph="paragraph2" rule="-SIMPLE-REF" start="1987" uttnum="19">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="2059" id="V347465" paragraph="paragraph2" rule="-SIMPLE-REF" start="2048" uttnum="20">
    <type>ONT::INFORMATION</type>
    <name>DATUM</name>
    <text>these data</text>
  </TERM>
  <TERM end="2162" id="V347507" paragraph="paragraph2" rule="-INEVENT2B,-SIMPLE-REF" start="2081" uttnum="20">
    <type>ONT::SIGNALING-PATHWAY</type>
    <features>
      <inevent>
        <event id="V347526"/>
      </inevent>
    </features>
    <name>PATHWAY</name>
    <text>of additional pathways that regulate AKT activation in response to growth factors</text>
  </TERM>
  <EVENT end="2162" id="V347526" paragraph="paragraph2" rule="-RULE10_AGENT_AFFECTED" start="2081" uttnum="20">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="2162" id="V347526" start="2081">
      <type>ONT::MODULATE</type>
      <text>of additional pathways that regulate AKT activation in response to growth factors</text>
    </predicate>
    <arg1 id="V347507" role=":AGENT"/>
    <arg2 id="V347535" role=":AFFECTED"/>
    <text>of additional pathways that regulate AKT activation in response to growth factors</text>
  </EVENT>
  <EVENT end="2133" id="V347535" paragraph="paragraph2" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="2118" uttnum="20">
    <type>ONT::ACTIVATE</type>
    <predicate end="2133" id="V347535" start="2118">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V347531" role=":AFFECTED"/>
    <arg id="R000414" role=":RESULT"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="2122" id="V347531" paragraph="paragraph2" rule="-SIMPLE-REF" start="2118" uttnum="20">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="GO:0008083" end="2162" id="V347631" paragraph="paragraph2" rule="-SIMPLE-REF" start="2148" uttnum="20">
    <type>ONT::PROTEIN</type>
    <name>GROWTH-FACTORS</name>
    <text>growth factors</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="7" id="V361391" paragraph="paragraph3" rule="-SIMPLE-REF" start="3" uttnum="21">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="39" id="V361462" paragraph="paragraph3" rule="-EXPLICIT-REF1" start="11" uttnum="21">
    <type>ONT::PROTEIN</type>
    <name>TYROSINE</name>
    <assoc-with id="V361457"/>
    <text>nonreceptor tyrosine kinase</text>
  </TERM>
  <TERM end="32" id="V361457" paragraph="paragraph3" rule="-SIMPLE-REF" start="23" uttnum="21">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>tyrosine</text>
  </TERM>
  <TERM end="117" id="V361571" paragraph="paragraph3" rule="-SIMPLE-REF" start="65" uttnum="21">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>TRANSDUCER</name>
    <text>early transducer of variety of extracellular growth</text>
  </TERM>
  <TERM dbid="GO:0040007" end="117" id="V361598" paragraph="paragraph3" rule="-SIMPLE-REF" start="85" uttnum="21">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>GROWTH</name>
    <text>variety of extracellular growth</text>
  </TERM>
  <TERM dbid="GO:0005576" end="110" id="V361593" paragraph="paragraph3" rule="-SIMPLE-REF" start="93" uttnum="21">
    <type>ONT::CELL-PART</type>
    <name>EXTRACELLULAR</name>
    <text>of extracellular</text>
  </TERM>
  <TERM end="210" id="V361616" paragraph="paragraph3" rule="-SIMPLE-REF" start="117" uttnum="21">
    <type>ONT::MENTAL-OBJECT</type>
    <name>STIMULI</name>
    <text>factor stimuli including heregulin, insulin, EGF and PDGF signaling [24],</text>
  </TERM>
  <TERM dbid="UP:Q02297" end="151" id="V361635" paragraph="paragraph3" rule="-SIMPLE-REF" start="142" uttnum="21">
    <type>ONT::PROTEIN</type>
    <name>HEREGULIN</name>
    <text>heregulin</text>
  </TERM>
  <TERM dbid="UP:P01308" end="160" id="V361643" paragraph="paragraph3" rule="-SIMPLE-REF" start="153" uttnum="21">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>insulin</text>
  </TERM>
  <TERM dbid="UP:P01133" end="166" id="V361651" paragraph="paragraph3" rule="-SIMPLE-REF" start="162" uttnum="21">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <EVENT end="191" id="V361674" paragraph="paragraph3" rule="-RULE5_AGENT_AFFECTED-AGENT" start="170" uttnum="21">
    <type>ONT::SIGNALING</type>
    <predicate end="191" id="V361674" start="170">
      <type>ONT::SIGNALING</type>
      <text>PDGF signaling</text>
    </predicate>
    <arg1 id="V361666" role=":AGENT"/>
    <text>PDGF signaling</text>
  </EVENT>
  <TERM end="175" id="V361666" paragraph="paragraph3" rule="-SIMPLE-REF" start="170" uttnum="21">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P04085" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9GZP0" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9NRA1" type="ONT::PROTEIN"/>
      <member dbid="UP:P01127" type="ONT::PROTEIN"/>
    </members>
    <name>PDGF</name>
    <text normalization="">PDGF</text>
  </TERM>
  <EVENT end="389" id="V370562" paragraph="paragraph3" rule="-RULE60_AGENT_AFFECTED-LOC4-GD-AFFECTED" start="280" uttnum="22">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="389" id="V370562" start="280">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Ack1 is ubiquitously expressed and primarily phosphorylated at Tyr284 leading to its kinase activation</text>
    </predicate>
    <arg2 id="V370502" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000204"/>
    <site end="350" id="V370590" start="343">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr284</text>
    </site>
    <text>Ack1 is ubiquitously expressed and primarily phosphorylated at Tyr284 leading to its kinase activation</text>
  </EVENT>
  <EVENT end="389" id="V370540" paragraph="paragraph3" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="280" uttnum="22">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="389" id="V370540" start="280">
      <type>ONT::EXPRESS</type>
      <text>Ack1 is ubiquitously expressed and primarily phosphorylated at Tyr284 leading to its kinase activation</text>
    </predicate>
    <arg2 id="V370502" role=":AFFECTED-RESULT"/>
    <text>Ack1 is ubiquitously expressed and primarily phosphorylated at Tyr284 leading to its kinase activation</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="285" id="V370502" paragraph="paragraph3" rule="-SIMPLE-REF" start="280" uttnum="22">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V370562"/>
    </not-features>
  </TERM>
  <TERM end="350" id="V370590" paragraph="paragraph3" rule="-SIMPLE-REF" start="343" uttnum="22">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>284</pos>
      </site>
    </features>
    <name>TYR-284</name>
    <text>Tyr284</text>
  </TERM>
  <EVENT end="389" id="V370635" paragraph="paragraph3" rule="-RULE40A_AGENT_AFFECTED" start="358" uttnum="22">
    <type>ONT::ACTIVATE</type>
    <predicate end="389" id="V370635" start="358">
      <type>ONT::ACTIVATE</type>
      <text>to its kinase activation</text>
    </predicate>
    <arg1 id="V370627" role=":AGENT"/>
    <arg2 id="V370632" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000419"/>
    <text>to its kinase activation</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="389" id="V370627" paragraph="paragraph3" rule="-SIMPLE-REF" start="358" uttnum="22">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>to its kinase activation</text>
  </TERM>
  <TERM dbid="GO:0016301" end="372" id="V370632" paragraph="paragraph3" rule="-SIMPLE-REF" start="365" uttnum="22">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EPI end="590" id="V383503" paragraph="paragraph3" rule="-RULE50_0_NEUTRAL_FORMAL" start="421" uttnum="23">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V383537" role=":FORMAL"/>
    <text>Our earlier studies demonstrated that Ack1 regulates prostate cancer progression to androgen independence by positively regulating androgen receptor (AR) and negatively</text>
  </EPI>
  <EVENT end="590" id="V383537" paragraph="paragraph3" rule="-RULE50_0_NEUTRAL_FORMAL-EVENT,-RULE10_AGENT_AFFECTED-POLARITY1" start="421" uttnum="23">
    <type>ONT::MODULATE</type>
    <polarity>ONT::NEGATIVE</polarity>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V383503"/>
    <predicate end="590" id="V383537" start="421">
      <type>ONT::MODULATE</type>
      <text>Our earlier studies demonstrated that Ack1 regulates prostate cancer progression to androgen independence by positively regulating androgen receptor (AR) and negatively</text>
    </predicate>
    <arg1 id="V383533" role=":AGENT"/>
    <text>Our earlier studies demonstrated that Ack1 regulates prostate cancer progression to androgen independence by positively regulating androgen receptor (AR) and negatively</text>
  </EVENT>
  <TERM end="441" id="V383463" paragraph="paragraph3" rule="-ROBUSTPRO" start="421" uttnum="23">
    <type>ONT::PERSON</type>
    <text>Our earlier studies</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="464" id="V383533" paragraph="paragraph3" rule="-SIMPLE-REF" start="459" uttnum="23">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="CHEBI:50113" end="514" id="V383587" paragraph="paragraph3" rule="-SIMPLE-REF" start="505" uttnum="23">
    <type>ONT::CHEMICAL</type>
    <name>ANDROGEN</name>
    <text>androgen</text>
  </TERM>
  <EVENT end="575" id="V383628" paragraph="paragraph3" rule="-RULE10_AGENT_AFFECTED-POLARITY1-AFFECTED" start="530" uttnum="23">
    <type>ONT::MODULATE</type>
    <polarity>ONT::POSITIVE</polarity>
    <force>ONT::TRUE</force>
    <predicate end="575" id="V383628" start="530">
      <type>ONT::MODULATE</type>
      <text>positively regulating androgen receptor (AR)</text>
    </predicate>
    <arg2 id="V383638" role=":AFFECTED"/>
    <text>positively regulating androgen receptor (AR)</text>
  </EVENT>
  <TERM dbid="GO:0004872" end="575" id="V383638" paragraph="paragraph3" rule="-SIMPLE-REF" start="552" uttnum="23">
    <type>ONT::PROTEIN</type>
    <name>RECEPTOR</name>
    <text>androgen receptor (AR)</text>
  </TERM>
  <TERM dbid="CHEBI:50113" end="561" id="V383633" paragraph="paragraph3" rule="-SIMPLE-REF" start="552" uttnum="23">
    <type>ONT::CHEMICAL</type>
    <name>ANDROGEN</name>
    <text>androgen</text>
  </TERM>
  <TERM dbid="UP:P10275" end="573" id="V383651" paragraph="paragraph3" rule="-SIMPLE-REF" start="571" uttnum="23">
    <type>ONT::PROTEIN</type>
    <name>AR</name>
    <text>AR</text>
  </TERM>
  <TERM end="621" id="V383690" paragraph="paragraph3" rule="-SIMPLE-REF" start="611" uttnum="23">
    <type>ONT::PERSON</type>
    <name>SUPPRESSOR</name>
    <text>suppressor</text>
  </TERM>
  <TERM dbid="HGNC:12799|UP:Q9NZC7" end="664" id="V383704" paragraph="paragraph3" rule="-SIMPLE-REF" start="623" uttnum="23">
    <type>ONT::GENE</type>
    <name>WWOX</name>
    <text>Wwox [25], [26]</text>
  </TERM>
  <EPI end="742" id="V397386" paragraph="paragraph3" rule="-RULE50_0_AGENT_FORMAL-FORMAL" start="685" uttnum="24">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V397452" role=":FORMAL"/>
    <text>Ack1 gene is also shown to be amplified in primary lung,</text>
  </EPI>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="695" id="V397350" paragraph="paragraph3" rule="-EXPLICIT-REF1" start="685" uttnum="24">
    <type>ONT::GENE</type>
    <name>ACK-1</name>
    <assoc-with id="V397347"/>
    <text>Ack1 gene</text>
  </TERM>
  <EVENT end="742" id="V397452" paragraph="paragraph3" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE20_AGENT_AFFECTED-AFFECTED" start="685" uttnum="24">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V397386"/>
    <predicate end="742" id="V397452" start="685">
      <type>ONT::INCREASE</type>
      <text>Ack1 gene is also shown to be amplified in primary lung,</text>
    </predicate>
    <arg2 id="V397350" role=":AFFECTED"/>
    <text>Ack1 gene is also shown to be amplified in primary lung,</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="690" id="V397347" paragraph="paragraph3" rule="-SIMPLE-REF" start="685" uttnum="24">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="742" id="V397526" paragraph="paragraph3" rule="-SIMPLE-REF" start="728" uttnum="24">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>LUNG</name>
    <text>primary lung,</text>
  </TERM>
  <TERM end="763" id="V397547" paragraph="paragraph3" rule="-SIMPLE-REF" start="754" uttnum="24">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>prostate</text>
  </TERM>
  <TERM end="845" id="V411872" paragraph="paragraph3" rule="-ROBUSTPRO" start="842" uttnum="25">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="887" id="V411947" paragraph="paragraph3" rule="-SIMPLE-REF" start="861" uttnum="25">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>a novel mechanism of Ack1</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="887" id="V411964" paragraph="paragraph3" rule="-SIMPLE-REF" start="882" uttnum="25">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <EVENT end="911" id="V411978" paragraph="paragraph3" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="896" uttnum="25">
    <type>ONT::ACTIVATE</type>
    <predicate end="911" id="V411978" start="896">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V411974" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000424"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="900" id="V411974" paragraph="paragraph3" rule="-SIMPLE-REF" start="896" uttnum="25">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="969" id="V411990" paragraph="paragraph3" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="919" uttnum="25">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="969" id="V411990" start="919">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of Tyrosine 176 in the AKT kinase</text>
    </predicate>
    <site end="951" id="V412010" start="935">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">of Tyrosine 176</text>
    </site>
    <text>phosphorylation of Tyrosine 176 in the AKT kinase</text>
  </EVENT>
  <TERM end="951" id="V412010" paragraph="paragraph3" rule="-SIMPLE-REF" start="935" uttnum="25">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYROSINE-176</name>
    <text>of Tyrosine 176</text>
  </TERM>
  <TERM end="969" id="V412079" paragraph="paragraph3" rule="-EXPLICIT-REF1" start="954" uttnum="25">
    <type>ONT::PROTEIN</type>
    <name>AKT</name>
    <assoc-with id="V412074"/>
    <text>the AKT kinase</text>
  </TERM>
  <TERM end="962" id="V412074" paragraph="paragraph3" rule="-SIMPLE-REF" start="958" uttnum="25">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="976" id="V412082" paragraph="paragraph3" rule="-SIMPLE-REF" start="969" uttnum="25">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>domain</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="1028" id="V412200" paragraph="paragraph3" rule="-SIMPLE-REF" start="1008" uttnum="25">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <EVENT end="1060" id="V412222" paragraph="paragraph3" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1032" uttnum="25">
    <type>ONT::ACTIVATE</type>
    <predicate end="1060" id="V412222" start="1032">
      <type>ONT::ACTIVATE</type>
      <text>subsequent kinase activation</text>
    </predicate>
    <arg2 id="V412219" role=":AFFECTED"/>
    <arg id="R000429" role=":RESULT"/>
    <text>subsequent kinase activation</text>
  </EVENT>
  <TERM dbid="GO:0016301" end="1050" id="V412219" paragraph="paragraph3" rule="-SIMPLE-REF" start="1032" uttnum="25">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>subsequent kinase</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="33" id="V427938" paragraph="paragraph4" rule="-SIMPLE-REF" start="20" uttnum="26">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>MEF2KO cells</text>
  </TERM>
  <TERM end="44" id="V427963" paragraph="paragraph4" rule="-SIMPLE-REF" start="38" uttnum="26">
    <type>ONT::BODILY-FLUID</type>
    <name>SERUM</name>
    <text>serum</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="33" id="V427929" paragraph="paragraph4" rule="-SIMPLE-REF" start="20" uttnum="26">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>MEF2KO cells</text>
  </TERM>
  <TERM dbid="XFAM:PF00076|UP:Q9P2K5|UP:Q8C854|HGNC:17940|FA:02224" end="24" id="V427920" paragraph="paragraph4" rule="-SIMPLE-REF" start="20" uttnum="26">
    <type>ONT::GENE-PROTEIN</type>
    <name>MEF-2</name>
    <text>MEF2</text>
  </TERM>
  <TERM end="57" id="V427981" paragraph="paragraph4" rule="-SIMPLE-REF" start="53" uttnum="26">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>24 h</text>
  </TERM>
  <TERM dbid="UP:P01133" end="90" id="V428030" paragraph="paragraph4" rule="-SIMPLE-REF" start="76" uttnum="26">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF (10 ng/ml)</text>
  </TERM>
  <TERM dbid="UP:P43119|UP:Q9UII2|HGNC:871|HGNC:9602" end="200" id="V435570" paragraph="paragraph4" rule="-SIMPLE-REF" start="131" uttnum="27">
    <type>ONT::GENE</type>
    <name>IP</name>
    <text>IP with anti-Ack1 (top panel), anti-AKT (second panel) and anti-EGFR</text>
  </TERM>
  <TERM end="143" id="V435594" paragraph="paragraph4" rule="-SIMPLE-REF" start="139" uttnum="27">
    <type>ONT::PERSON</type>
    <name>ANTI</name>
    <text>anti</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="149" id="V435608" paragraph="paragraph4" rule="-SIMPLE-REF" start="144" uttnum="27">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="159" id="V435627" paragraph="paragraph4" rule="-SIMPLE-REF" start="150" uttnum="27">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panel</text>
  </TERM>
  <TERM end="171" id="V435646" paragraph="paragraph4" rule="-SIMPLE-REF" start="167" uttnum="27">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="184" id="V435666" paragraph="paragraph4" rule="-SIMPLE-REF" start="172" uttnum="27">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>second panel</text>
  </TERM>
  <TERM dbid="UP:P00533" end="200" id="V435692" paragraph="paragraph4" rule="-SIMPLE-REF" start="195" uttnum="27">
    <type>ONT::PROTEIN</type>
    <name>EGFR</name>
    <text>EGFR</text>
  </TERM>
  <TERM end="213" id="V435708" paragraph="paragraph4" rule="-SIMPLE-REF" start="208" uttnum="27">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>panel</text>
  </TERM>
  <TERM dbid="GO:0042571" end="284" id="V435715" paragraph="paragraph4" rule="-INEVENT2B,-SIMPLE-REF" start="215" uttnum="27">
    <type>ONT::CELL-PART</type>
    <features>
      <inevent>
        <event id="V435734"/>
      </inevent>
    </features>
    <name>ANTIBODIES</name>
    <text>antibodies followed by immunoblotting or IB with anti-pTyr antibodies</text>
  </TERM>
  <EVENT end="284" id="V435734" paragraph="paragraph4" rule="-RULE10C_AGENT_AFFECTED-LOC5-GD-NONE" start="226" uttnum="27">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="284" id="V435734" start="226">
      <type>ONT::TRANSLOCATE</type>
      <text>followed by immunoblotting or IB with anti-pTyr antibodies</text>
    </predicate>
    <arg2 id="V435715" role=":NEUTRAL"/>
    <site end="284" id="V435715" start="215">
      <type>ONT::CELL-PART</type>
      <text normalization="">antibodies followed by immunoblotting or IB with anti-pTyr antibodies</text>
    </site>
    <text>followed by immunoblotting or IB with anti-pTyr antibodies</text>
  </EVENT>
  <TERM dbid="GO:0042571" end="284" id="V435856" paragraph="paragraph4" rule="-SIMPLE-REF" start="264" uttnum="27">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>anti-pTyr antibodies</text>
  </TERM>
  <TERM end="302" id="V446293" paragraph="paragraph4" rule="-SIMPLE-REF" start="296" uttnum="28">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>panel</text>
  </TERM>
  <TERM dbid="GO:0042571" end="332" id="V446336" paragraph="paragraph4" rule="-SIMPLE-REF" start="321" uttnum="28">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="357" id="V450471" paragraph="paragraph4" rule="-SIMPLE-REF" start="349" uttnum="29">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="364" id="V450497" paragraph="paragraph4" rule="-SIMPLE-REF" start="359" uttnum="29">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs</text>
  </TERM>
  <TERM end="375" id="V450519" paragraph="paragraph4" rule="-SIMPLE-REF" start="369" uttnum="29">
    <type>ONT::BODILY-FLUID</type>
    <name>SERUM</name>
    <text>serum</text>
  </TERM>
  <TERM end="388" id="V450537" paragraph="paragraph4" rule="-SIMPLE-REF" start="384" uttnum="29">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>24 h</text>
  </TERM>
  <TERM dbid="UP:P01133" end="411" id="V450586" paragraph="paragraph4" rule="-SIMPLE-REF" start="407" uttnum="29">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <TERM end="485" id="V450848" paragraph="paragraph4" rule="-LOGICALOP-REF" start="453" uttnum="29">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="AND">
      <member id="V450754"/>
      <member id="V450859"/>
    </aggregate>
    <text normalization="">LY294002 (10 µM for 1 h) and EGF</text>
  </TERM>
  <TERM dbid="CHEBI:65329" end="478" id="V450754" paragraph="paragraph4" rule="-SIMPLE-REF" start="453" uttnum="29">
    <type>ONT::MOLECULE</type>
    <name>LY-294002</name>
    <text>LY294002 (10 µM for 1 h)</text>
  </TERM>
  <TERM dbid="UP:P01133" end="485" id="V450859" paragraph="paragraph4" rule="-SIMPLE-REF" start="482" uttnum="29">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <TERM end="476" id="V450838" paragraph="paragraph4" rule="-SIMPLE-REF" start="473" uttnum="29">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>1 h</text>
  </TERM>
  <TERM dbid="CVCL:F561" end="507" id="V463450" paragraph="paragraph4" rule="-SIMPLE-REF" start="504" uttnum="30">
    <type>ONT::CELL-LINE</type>
    <name>IP</name>
    <text>IP</text>
  </TERM>
  <TERM dbid="GO:0042571" end="578" id="V463497" paragraph="paragraph4" rule="-SIMPLE-REF" start="512" uttnum="30">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>Ack1 antibodies followed by IB with pan-AKT antibodies (top panel)</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="517" id="V463480" paragraph="paragraph4" rule="-SIMPLE-REF" start="512" uttnum="30">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="GO:0042571" end="578" id="V463596" paragraph="paragraph4" rule="-SIMPLE-REF" start="548" uttnum="30">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>pan-AKT antibodies (top panel)</text>
  </TERM>
  <TERM end="577" id="V463611" paragraph="paragraph4" rule="-SIMPLE-REF" start="568" uttnum="30">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panel</text>
  </TERM>
  <EVENT end="643" id="V478255" paragraph="paragraph4" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="597" uttnum="31">
    <type>ONT::PPEXPT</type>
    <force>ONT::TRUE</force>
    <predicate end="643" id="V478255" start="597">
      <type>ONT::PPEXPT</type>
      <text>HA-tagged Tyr-phosphorylated AKT was purified</text>
    </predicate>
    <arg2 id="V478233" role=":AFFECTED"/>
    <text>HA-tagged Tyr-phosphorylated AKT was purified</text>
  </EVENT>
  <TERM end="630" id="V478233" paragraph="paragraph4" rule="-INEVENT2B,-SIMPLE-REF" start="597" uttnum="31">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">HA-tagged Tyr-phosphorylated AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V478220"/>
    </features>
  </TERM>
  <EVENT end="630" id="V478220" paragraph="paragraph4" rule="-RULE60_AGENT_AFFECTED-A" start="597" uttnum="31">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="630" id="V478220" start="597">
      <type>ONT::PHOSPHORYLATION</type>
      <text>HA-tagged Tyr-phosphorylated AKT</text>
    </predicate>
    <arg2 id="V478233" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000016"/>
    <site end="626" id="V478212" start="607">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Tyr-phosphorylated</text>
    </site>
    <text>HA-tagged Tyr-phosphorylated AKT</text>
  </EVENT>
  <TERM end="626" id="V478212" paragraph="paragraph4" rule="-SIMPLE-REF" start="607" uttnum="31">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr-phosphorylated</text>
  </TERM>
  <TERM end="727" id="V478366" paragraph="paragraph4" rule="-SIMPLE-REF" start="717" uttnum="31">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S2A</text>
  </TERM>
  <EPI end="859" id="V492709" paragraph="paragraph4" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="773" uttnum="32">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg2 id="V492686" role=":FORMAL"/>
    <text>The peptide was detected at 13.83 mins in the total ion chromatogram (C)</text>
  </EPI>
  <TERM dbid="CHEBI:16670" end="785" id="V492686" paragraph="paragraph4" rule="-SIMPLE-REF" start="773" uttnum="32">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>The peptide</text>
  </TERM>
  <TERM dbid="CHEBI:24870" end="859" id="V492859" paragraph="paragraph4" rule="-SIMPLE-REF" start="815" uttnum="32">
    <type>ONT::MOLECULE</type>
    <name>ION</name>
    <text>the total ion chromatogram (C)</text>
  </TERM>
  <TERM end="955" id="V505955" paragraph="paragraph4" rule="-ROBUSTPRO" start="895" uttnum="32">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>which represents an error of 0.38 ppm (D)</text>
  </TERM>
  <TERM end="955" id="V505970" paragraph="paragraph4" rule="-SIMPLE-REF" start="912" uttnum="32">
    <type>ONT::PROBLEM</type>
    <name>ERROR</name>
    <text>an error of 0.38 ppm (D)</text>
  </TERM>
  <TERM end="948" id="V506018" paragraph="paragraph4" rule="-SIMPLE-REF" start="940" uttnum="32">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>D</text>
  </TERM>
  <TERM end="979" id="V508520" paragraph="paragraph4" rule="-SIMPLE-REF" start="971" uttnum="33">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>E</text>
  </TERM>
  <TERM end="1134" id="V511634" paragraph="paragraph4" rule="-INEVENT2B,-SIMPLE-REF" start="1028" uttnum="33">
    <type>ONT::SUBSTANCE</type>
    <features>
      <inevent>
        <event id="V511615"/>
      </inevent>
    </features>
    <name>Y</name>
    <text>VKEKATGRYpY indicating that the C-terminal tyrosine was phosphorylated</text>
  </TERM>
  <EVENT end="1134" id="V511615" paragraph="paragraph4" rule="-PHOSPHO" start="1028" uttnum="33">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1134" id="V511615" start="1028">
      <type>ONT::PHOSPHORYLATION</type>
      <text>VKEKATGRYpY indicating that the C-terminal tyrosine was phosphorylated</text>
    </predicate>
    <arg2 id="V511634" role=":AFFECTED"/>
    <text>VKEKATGRYpY indicating that the C-terminal tyrosine was phosphorylated</text>
  </EVENT>
  <TERM end="1116" id="V511742" paragraph="paragraph4" rule="-SIMPLE-REF" start="1092" uttnum="33">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>the C-terminal tyrosine</text>
    <not-features>
      <ptm event="V511764" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <EVENT end="1134" id="V511764" paragraph="paragraph4" rule="-RULE60_AGENT_AFFECTED-LOC9-AFFECTED" start="1092" uttnum="33">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1134" id="V511764" start="1092">
      <type>ONT::PHOSPHORYLATION</type>
      <text>the C-terminal tyrosine was phosphorylated</text>
    </predicate>
    <arg2 id="V511742" role=":AFFECTED"/>
    <arg id="R000209" role=":RESULT"/>
    <site end="1116" id="V511676" start="1092">
      <type>ONT::TERMINUS</type>
      <text normalization="">the C-terminal tyrosine</text>
    </site>
    <text>the C-terminal tyrosine was phosphorylated</text>
  </EVENT>
  <TERM end="1116" id="V511676" paragraph="paragraph4" rule="-SIMPLE-REF" start="1092" uttnum="33">
    <type>ONT::TERMINUS</type>
    <name>C-TERMINAL</name>
    <text>the C-terminal tyrosine</text>
  </TERM>
  <TERM end="1187" id="V522593" paragraph="paragraph4" rule="-SIMPLE-REF" start="1136" uttnum="33">
    <type>ONT::MENTAL-OBJECT</type>
    <name>DETECTION</name>
    <text>the detection of the phosphotyrosine y1</text>
  </TERM>
  <TERM dbid="CVCL:0585" end="1187" id="V522658" paragraph="paragraph4" rule="-SIMPLE-REF" start="1150" uttnum="33">
    <type>ONT::CELL-LINE</type>
    <name>Y-1</name>
    <text>of the phosphotyrosine y1</text>
  </TERM>
  <TERM dbid="CHEBI:37788|CHEBI:74956" end="1173" id="V522639" paragraph="paragraph4" rule="-SIMPLE-REF" start="1157" uttnum="33">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHOTYROSINE</name>
    <text>phosphotyrosine</text>
  </TERM>
  <TERM end="1286" id="V533870" paragraph="paragraph4" rule="-EXPLICIT-REF1" start="1252" uttnum="34">
    <type>ONT::PROTEIN</type>
    <name>AKT</name>
    <assoc-with id="V533865"/>
    <text>of AKT protein sequences revealed</text>
  </TERM>
  <TERM end="1259" id="V533865" paragraph="paragraph4" rule="-SIMPLE-REF" start="1255" uttnum="34">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1307" id="V533909" paragraph="paragraph4" rule="-SIMPLE-REF" start="1286" uttnum="34">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>that tyrosine at 176</text>
  </TERM>
  <TERM end="1331" id="V533972" paragraph="paragraph4" rule="-SIMPLE-REF" start="1325" uttnum="34">
    <type>ONT::SUBSTANCE</type>
    <name>YEAST</name>
    <text>yeast</text>
  </TERM>
  <TERM end="1341" id="V534000" paragraph="paragraph4" rule="-SIMPLE-REF" start="1334" uttnum="34">
    <type>ONT::PERSON</type>
    <name>HUMAN</name>
    <text>humans</text>
  </TERM>
  <TERM end="1375" id="V534068" paragraph="paragraph4" rule="-SIMPLE-REF" start="1371" uttnum="34">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1462" id="V546187" paragraph="paragraph4" rule="-SIMPLE-REF" start="1402" uttnum="35">
    <type>ONT::SHAPE-OBJECT</type>
    <name>CELL</name>
    <text>MEF1&amp;amp;2KO cells expressing HA-tagged AKT or Y176F mutant</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="1406" id="V546162" paragraph="paragraph4" rule="-SIMPLE-REF" start="1402" uttnum="35">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <TERM end="1446" id="V546228" paragraph="paragraph4" rule="-SIMPLE-REF" start="1432" uttnum="35">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">HA-tagged AKT</text>
  </TERM>
  <TERM end="1462" id="V546267" paragraph="paragraph4" rule="-SIMPLE-REF-MUTATION8" start="1449" uttnum="35">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>Y176F mutant</text>
  </TERM>
  <TERM end="1455" id="V546264" paragraph="paragraph4" rule="-SIMPLE-REF" start="1449" uttnum="35">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="1486" id="V546317" paragraph="paragraph4" rule="-SIMPLE-REF" start="1482" uttnum="35">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>24 h</text>
  </TERM>
  <TERM dbid="UP:P01133" end="1518" id="V556722" paragraph="paragraph4" rule="-SIMPLE-REF" start="1502" uttnum="35">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF for 15 mins</text>
  </TERM>
  <TERM dbid="CVCL:F561" end="1538" id="V556830" paragraph="paragraph4" rule="-SIMPLE-REF" start="1535" uttnum="35">
    <type>ONT::CELL-LINE</type>
    <name>IP</name>
    <text>IP</text>
  </TERM>
  <TERM end="1547" id="V556857" paragraph="paragraph4" rule="-SIMPLE-REF" start="1543" uttnum="35">
    <type>ONT::PERSON</type>
    <name>ANTI</name>
    <text>anti</text>
  </TERM>
  <TERM end="1608" id="V556879" paragraph="paragraph4" rule="-SIMPLE-REF" start="1548" uttnum="35">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>AB</name>
    <text>Ack1 Abs followed by IB with anti-AKT antibodies (top panel)</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1553" id="V556871" paragraph="paragraph4" rule="-SIMPLE-REF" start="1548" uttnum="35">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1608" id="V556956" paragraph="paragraph4" rule="-SIMPLE-REF" start="1577" uttnum="35">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>anti-AKT antibodies (top panel)</text>
  </TERM>
  <TERM end="1607" id="V556984" paragraph="paragraph4" rule="-SIMPLE-REF" start="1598" uttnum="35">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panel</text>
  </TERM>
  <TERM dbid="CVCL:F561" end="1635" id="V571016" paragraph="paragraph4" rule="-SIMPLE-REF" start="1632" uttnum="36">
    <type>ONT::CELL-LINE</type>
    <name>IP</name>
    <text>IP</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1706" id="V571079" paragraph="paragraph4" rule="-SIMPLE-REF" start="1640" uttnum="36">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>anti-Ack1 antibodies followed by IB with pTyr antibodies (panel 4)</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1650" id="V571057" paragraph="paragraph4" rule="-SIMPLE-REF" start="1645" uttnum="36">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1706" id="V571176" paragraph="paragraph4" rule="-SIMPLE-REF" start="1681" uttnum="36">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>pTyr antibodies (panel 4)</text>
  </TERM>
  <TERM end="1705" id="V571183" paragraph="paragraph4" rule="-SIMPLE-REF" start="1698" uttnum="36">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>panel 4</text>
  </TERM>
  <TERM end="1722" id="V584143" paragraph="paragraph4" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="1708" uttnum="37">
    <type>ONT::LOC-DEFINED-BY-CONTRAST</type>
    <mods>
      <mod>
        <type>ONT::SAME</type>
        <value>SAME</value>
      </mod>
    </mods>
    <name>BLOT</name>
    <text>The same blot</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1782" id="V584230" paragraph="paragraph4" rule="-SIMPLE-REF" start="1747" uttnum="37">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>anti-Ack1 antibodies (Bottom panel)</text>
  </TERM>
  <TERM end="1781" id="V584261" paragraph="paragraph4" rule="-SIMPLE-REF" start="1769" uttnum="37">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>Bottom panel</text>
  </TERM>
  <TERM dbid="CVCL:F561" end="1824" id="V593704" paragraph="paragraph4" rule="-SIMPLE-REF" start="1818" uttnum="38">
    <type>ONT::CELL-LINE</type>
    <name>IP</name>
    <text>to IP</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1848" id="V593750" paragraph="paragraph4" rule="-SIMPLE-REF" start="1829" uttnum="38">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>anti-HA antibodies</text>
  </TERM>
  <TERM end="1874" id="V593825" paragraph="paragraph4" rule="-SIMPLE-REF" start="1868" uttnum="38">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473</text>
  </TERM>
  <TERM end="1889" id="V593871" paragraph="paragraph4" rule="-SIMPLE-REF" start="1885" uttnum="38">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1900" id="V593875" paragraph="paragraph4" rule="-SIMPLE-REF" start="1889" uttnum="38">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="1918" id="V593895" paragraph="paragraph4" rule="-SIMPLE-REF" start="1901" uttnum="38">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>panels 2, 3 and 5</text>
  </TERM>
  <TERM end="1950" id="V607322" paragraph="paragraph4" rule="-SIMPLE-REF" start="1942" uttnum="39">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>H</text>
  </TERM>
  <TERM end="1991" id="V607406" paragraph="paragraph4" rule="-SIMPLE-REF-MUTATION8" start="1970" uttnum="39">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>AKT and Y176F mutant</text>
  </TERM>
  <TERM end="1974" id="V607364" paragraph="paragraph4" rule="-SIMPLE-REF" start="1970" uttnum="39">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1984" id="V607403" paragraph="paragraph4" rule="-SIMPLE-REF" start="1978" uttnum="39">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <EVENT end="2020" id="V607417" paragraph="paragraph4" rule="-RULE50_AGENT_AFFECTED-NONE" start="1991" uttnum="39">
    <type>ONT::EXPRESS</type>
    <predicate end="2020" id="V607417" start="1991">
      <type>ONT::EXPRESS</type>
      <text>expressing MEF1&amp;amp;2KO cells</text>
    </predicate>
    <arg2 id="V607460" role=":AFFECTED-RESULT"/>
    <text>expressing MEF1&amp;amp;2KO cells</text>
  </EVENT>
  <TERM end="2020" id="V607460" paragraph="paragraph4" rule="-SIMPLE-REF" start="2002" uttnum="39">
    <type>ONT::SHAPE-OBJECT</type>
    <name>CELL</name>
    <text>MEF1&amp;amp;2KO cells</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="2006" id="V607435" paragraph="paragraph4" rule="-SIMPLE-REF" start="2002" uttnum="39">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <TERM dbid="GO:0005623|CO:0000000" end="2028" id="V617490" paragraph="paragraph4" rule="-SIMPLE-REF" start="2022" uttnum="40">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Cells</text>
  </TERM>
  <TERM end="2039" id="V617515" paragraph="paragraph4" rule="-SIMPLE-REF" start="2033" uttnum="40">
    <type>ONT::BODILY-FLUID</type>
    <name>SERUM</name>
    <text>serum</text>
  </TERM>
  <EVENT end="2093" id="V617675" paragraph="paragraph4" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="2087" uttnum="40">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="2093" id="V617675" start="2087">
      <type>ONT::TRANSFORM</type>
      <text>fixed</text>
    </predicate>
    <arg1 id="V617568" role=":AGENT"/>
    <text>fixed</text>
  </EVENT>
  <EVENT end="2124" id="V617697" paragraph="paragraph4" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="2097" uttnum="40">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="2124" id="V617697" start="2097">
      <type>ONT::TRANSFORM</type>
      <text>stained with HA-antibodies</text>
    </predicate>
    <arg1 id="V617568" role=":AGENT"/>
    <text>stained with HA-antibodies</text>
  </EVENT>
  <TERM end="2057" id="V617568" paragraph="paragraph4" rule="-SIMPLE-REF" start="2054" uttnum="40">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>h,</text>
  </TERM>
  <TERM dbid="UP:P01133" end="2085" id="V617595" paragraph="paragraph4" rule="-SIMPLE-REF" start="2070" uttnum="40">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF for 15 mins</text>
  </TERM>
  <TERM dbid="GO:0042571" end="2124" id="V617723" paragraph="paragraph4" rule="-SIMPLE-REF" start="2110" uttnum="40">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>HA-antibodies</text>
  </TERM>
  <TERM dbid="GO:0042571" end="2176" id="V616678" paragraph="paragraph4" rule="-SIMPLE-REF" start="2165" uttnum="40">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="2222" id="V631827" paragraph="paragraph4" rule="-SIMPLE-REF" start="2201" uttnum="41">
    <type>ONT::GEO-OBJECT</type>
    <name>QUADRANT</name>
    <text>Upper right quadrant</text>
  </TERM>
  <TERM end="2288" id="V631837" paragraph="paragraph4" rule="-SIMPLE-REF" start="2233" uttnum="41">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells which express HA-tagged AKT or Y176F mutant that</text>
  </TERM>
  <TERM end="2255" id="V631868" paragraph="paragraph4" rule="-SIMPLE-REF" start="2253" uttnum="41">
    <type>ONT::GEO-OBJECT</type>
    <name>HA</name>
    <text>HA</text>
  </TERM>
  <TERM end="2283" id="V631925" paragraph="paragraph4" rule="-SIMPLE-REF-MUTATION8" start="2256" uttnum="41">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>tagged AKT or Y176F mutant</text>
  </TERM>
  <TERM end="2267" id="V631886" paragraph="paragraph4" rule="-SIMPLE-REF" start="2263" uttnum="41">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="2276" id="V631922" paragraph="paragraph4" rule="-SIMPLE-REF" start="2270" uttnum="41">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="2318" id="V631973" paragraph="paragraph4" rule="-SIMPLE-REF" start="2297" uttnum="41">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473-phosphorylated</text>
  </TERM>
  <EVENT end="133" id="V646144" paragraph="paragraph5" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="20" uttnum="42">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="133" id="V646144" start="20">
      <type>ONT::MODULATE</type>
      <text>RWPE, normal prostate epithelial cells were treated with EGF (10 ng/ml,10 mins) and heregulin (10 ng/ml, 35 mins)</text>
    </predicate>
    <arg2 id="V646107" role=":AFFECTED"/>
    <text>RWPE, normal prostate epithelial cells were treated with EGF (10 ng/ml,10 mins) and heregulin (10 ng/ml, 35 mins)</text>
  </EVENT>
  <TERM dbid="BTO:0000414|CO:0000066" end="59" id="V646107" paragraph="paragraph5" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="20" uttnum="42">
    <type>ONT::CELL</type>
    <features>
      <location id="V646091"/>
    </features>
    <name>EPITHELIAL-CELLS</name>
    <text>RWPE, normal prostate epithelial cells</text>
  </TERM>
  <TERM end="59" id="V646091" paragraph="paragraph5" rule="-SIMPLE-REF" start="20" uttnum="42">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>RWPE, normal prostate epithelial cells</text>
  </TERM>
  <TERM end="133" id="V646269" paragraph="paragraph5" rule="-LOGICALOP-REF" start="77" uttnum="42">
    <type>ONT::PROTEIN</type>
    <aggregate operator="AND">
      <member id="V646160"/>
      <member id="V646280"/>
    </aggregate>
    <text normalization="">EGF (10 ng/ml,10 mins) and heregulin (10 ng/ml, 35 mins)</text>
  </TERM>
  <TERM dbid="UP:P01133" end="100" id="V646160" paragraph="paragraph5" rule="-SIMPLE-REF" start="77" uttnum="42">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF (10 ng/ml,10 mins)</text>
  </TERM>
  <TERM dbid="UP:Q02297" end="114" id="V646280" paragraph="paragraph5" rule="-SIMPLE-REF" start="104" uttnum="42">
    <type>ONT::PROTEIN</type>
    <name>HEREGULIN</name>
    <text>heregulin</text>
  </TERM>
  <TERM dbid="GO:0042571" end="208" id="V662676" paragraph="paragraph5" rule="-SIMPLE-REF" start="135" uttnum="42">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>whole cell protein lysates were subjected to IB with indicated antibodies</text>
  </TERM>
  <TERM end="208" id="V662584" paragraph="paragraph5" rule="-SIMPLE-REF" start="135" uttnum="42">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>whole cell protein lysates were subjected to IB with indicated antibodies</text>
  </TERM>
  <TERM end="242" id="V677797" paragraph="paragraph5" rule="-SIMPLE-REF" start="217" uttnum="43">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>B, C) MCF-7 cells</text>
  </TERM>
  <TERM end="253" id="V677827" paragraph="paragraph5" rule="-SIMPLE-REF" start="247" uttnum="43">
    <type>ONT::BODILY-FLUID</type>
    <name>SERUM</name>
    <text>serum</text>
  </TERM>
  <TERM dbid="EFO:0001203|CVCL:0031" end="242" id="V677793" paragraph="paragraph5" rule="-SIMPLE-REF" start="217" uttnum="43">
    <type>ONT::CELL-LINE</type>
    <name>MCF-7</name>
    <text>B, C) MCF-7 cells</text>
  </TERM>
  <TERM end="266" id="V677845" paragraph="paragraph5" rule="-SIMPLE-REF" start="262" uttnum="43">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>24 h</text>
  </TERM>
  <TERM end="300" id="V677908" paragraph="paragraph5" rule="-SIMPLE-REF" start="292" uttnum="43">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM dbid="UP:P01308" end="310" id="V677918" paragraph="paragraph5" rule="-SIMPLE-REF" start="302" uttnum="43">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>insulin</text>
  </TERM>
  <TERM dbid="UP:Q02297" end="351" id="V678018" paragraph="paragraph5" rule="-SIMPLE-REF" start="341" uttnum="43">
    <type>ONT::PROTEIN</type>
    <name>HEREGULIN</name>
    <text>heregulin</text>
  </TERM>
  <TERM dbid="GO:0005623|CO:0000000" end="396" id="V684712" paragraph="paragraph5" rule="-SIMPLE-REF" start="383" uttnum="44">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Cell lysates</text>
  </TERM>
  <TERM dbid="GO:0042571" end="450" id="V684806" paragraph="paragraph5" rule="-SIMPLE-REF" start="440" uttnum="44">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="475" id="V685737" paragraph="paragraph5" rule="-SIMPLE-REF" start="452" uttnum="45">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Input panels pAck1(Tyr)</text>
  </TERM>
  <TERM dbid="UP:O00625|HGNC:30048" end="486" id="V685795" paragraph="paragraph5" rule="-SIMPLE-REF" start="477" uttnum="45">
    <type>ONT::GENE</type>
    <name>PIR</name>
    <text>pIR(Tyr)</text>
  </TERM>
  <TERM end="491" id="V685834" paragraph="paragraph5" rule="-SIMPLE-REF" start="490" uttnum="45">
    <type>ONT::SUBSTANCE</type>
    <name>P</name>
    <text>p</text>
  </TERM>
  <TERM end="475" id="V685693" paragraph="paragraph5" rule="-SIMPLE-REF" start="452" uttnum="45">
    <type>ONT::ICON</type>
    <name>P</name>
    <text>Input panels pAck1(Tyr)</text>
  </TERM>
  <TERM end="475" id="V685681" paragraph="paragraph5" rule="-SIMPLE-REF" start="452" uttnum="45">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>Input panels pAck1(Tyr)</text>
  </TERM>
  <TERM end="475" id="V685678" paragraph="paragraph5" rule="-SIMPLE-REF" start="452" uttnum="45">
    <type>ONT::INFORMATION</type>
    <name>INPUT</name>
    <text>Input panels pAck1(Tyr)</text>
  </TERM>
  <TERM end="474" id="V685758" paragraph="paragraph5" rule="-SIMPLE-REF" start="471" uttnum="45">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr</text>
  </TERM>
  <TERM end="484" id="V685807" paragraph="paragraph5" rule="-SIMPLE-REF" start="481" uttnum="45">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr</text>
  </TERM>
  <TERM dbid="HGNC:3430|UP:P04626" end="502" id="V685860" paragraph="paragraph5" rule="-SIMPLE-REF" start="491" uttnum="45">
    <type>ONT::GENE</type>
    <name>HER-2</name>
    <text>HER-2(Tyr)</text>
  </TERM>
  <TERM dbid="CVCL:F561" end="516" id="V685888" paragraph="paragraph5" rule="-SIMPLE-REF" start="513" uttnum="45">
    <type>ONT::CELL-LINE</type>
    <name>IP</name>
    <text>IP</text>
  </TERM>
  <TERM end="500" id="V685873" paragraph="paragraph5" rule="-SIMPLE-REF" start="497" uttnum="45">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr</text>
  </TERM>
  <TERM dbid="GO:0042571" end="543" id="V685928" paragraph="paragraph5" rule="-SIMPLE-REF" start="521" uttnum="45">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>respective antibodies</text>
  </TERM>
  <TERM dbid="GO:0042571" end="578" id="V686012" paragraph="paragraph5" rule="-SIMPLE-REF" start="568" uttnum="45">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="595" id="V698164" paragraph="paragraph5" rule="-SIMPLE-REF" start="587" uttnum="46">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>D</text>
  </TERM>
  <TERM dbid="CHEBI:28826" end="601" id="V698178" paragraph="paragraph5" rule="-SIMPLE-REF" start="597" uttnum="46">
    <type>ONT::MOLECULE</type>
    <name>MEF</name>
    <text>MEF</text>
  </TERM>
  <EVENT end="670" id="V698229" paragraph="paragraph5" rule="-RULE5_AFFECTED_AFFECTED1" start="607" uttnum="46">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="670" id="V698229" start="607">
      <type>ONT::TRANSFORM</type>
      <text>2KO cells were transfected with HA-tagged AKT or Y176F mutant,</text>
    </predicate>
    <arg1 id="V698204" role=":AFFECTED"/>
    <arg2 id="V698303" role=":AFFECTED1"/>
    <text>2KO cells were transfected with HA-tagged AKT or Y176F mutant,</text>
  </EVENT>
  <TERM end="617" id="V698204" paragraph="paragraph5" rule="-SIMPLE-REF" start="607" uttnum="46">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>2KO cells</text>
  </TERM>
  <TERM end="670" id="V698303" paragraph="paragraph5" rule="-SIMPLE-REF-MUTATION8" start="634" uttnum="46">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>with HA-tagged AKT or Y176F mutant,</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="611" id="V698195" paragraph="paragraph5" rule="-SIMPLE-REF" start="608" uttnum="46">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>KO</text>
  </TERM>
  <TERM end="653" id="V698264" paragraph="paragraph5" rule="-SIMPLE-REF" start="649" uttnum="46">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="662" id="V698300" paragraph="paragraph5" rule="-SIMPLE-REF" start="656" uttnum="46">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="676" id="V698313" paragraph="paragraph5" rule="-SIMPLE-REF" start="670" uttnum="46">
    <type>ONT::BODILY-FLUID</type>
    <name>SERUM</name>
    <text>serum</text>
  </TERM>
  <TERM end="689" id="V698331" paragraph="paragraph5" rule="-SIMPLE-REF" start="685" uttnum="46">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>24 h</text>
  </TERM>
  <TERM dbid="UP:P01133" end="723" id="V698380" paragraph="paragraph5" rule="-SIMPLE-REF" start="708" uttnum="46">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF for 15 mins</text>
  </TERM>
  <TERM dbid="GO:0005623|CO:0000000" end="738" id="V712985" paragraph="paragraph5" rule="-SIMPLE-REF" start="725" uttnum="47">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Cell lysates</text>
  </TERM>
  <TERM end="786" id="V713084" paragraph="paragraph5" rule="-SIMPLE-REF" start="777" uttnum="47">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panel</text>
  </TERM>
  <TERM dbid="GO:0042571" end="828" id="V713108" paragraph="paragraph5" rule="-SIMPLE-REF" start="802" uttnum="47">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>antibodies (bottom panels)</text>
  </TERM>
  <TERM end="827" id="V713136" paragraph="paragraph5" rule="-SIMPLE-REF" start="814" uttnum="47">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>bottom panels</text>
  </TERM>
  <TERM end="845" id="V723843" paragraph="paragraph5" rule="-SIMPLE-REF" start="837" uttnum="48">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>E</text>
  </TERM>
  <TERM dbid="EFO:0001203|BTO:0000093" end="858" id="V723870" paragraph="paragraph5" rule="-SIMPLE-REF" start="847" uttnum="48">
    <type>ONT::CELL-LINE</type>
    <name>MCF-7-CELLS</name>
    <text>MCF7 cells</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="905" id="V723929" paragraph="paragraph5" rule="-SIMPLE-REF" start="891" uttnum="48">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1-specific</text>
  </TERM>
  <TERM end="917" id="V724015" paragraph="paragraph5" rule="-SIMPLE-REF" start="913" uttnum="48">
    <type>ONT::CARDINAL-POINT</type>
    <name>N</name>
    <text>40 n</text>
  </TERM>
  <TERM end="929" id="V724103" paragraph="paragraph5" rule="-SIMPLE-REF" start="927" uttnum="48">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>h</text>
  </TERM>
  <TERM dbid="UP:Q02297" end="967" id="V724137" paragraph="paragraph5" rule="-SIMPLE-REF" start="946" uttnum="48">
    <type>ONT::PROTEIN</type>
    <name>HEREGULIN</name>
    <text>heregulin for 40 mins</text>
  </TERM>
  <TERM dbid="GO:0005623|CO:0000000" end="982" id="V739602" paragraph="paragraph5" rule="-SIMPLE-REF" start="969" uttnum="49">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Cell lysates</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1032" id="V739689" paragraph="paragraph5" rule="-SIMPLE-REF" start="1022" uttnum="49">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="1056" id="V740539" paragraph="paragraph5" rule="-ROBUSTPRO" start="1053" uttnum="50">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="1090" id="V740588" paragraph="paragraph5" rule="-SIMPLE-REF" start="1071" uttnum="50">
    <type>ONT::INTERNAL-COMPUTER-STORAGE</type>
    <name>BUFFER</name>
    <text>the volumes buffer</text>
  </TERM>
  <TERM end="1053" id="V740536" paragraph="paragraph5" rule="-SIMPLE-REF" start="1037" uttnum="50">
    <type>ONT::PROCEDURE</type>
    <name>EXPERIMENT</name>
    <text>this experiment</text>
  </TERM>
  <EVENT end="1126" id="V740617" paragraph="paragraph5" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="1094" uttnum="50">
    <type>ONT::INHIBIT</type>
    <predicate end="1126" id="V740617" start="1094">
      <type>ONT::INHIBIT</type>
      <text>extraction of cytosolic proteins</text>
    </predicate>
    <arg2 id="V740632" role=":AFFECTED"/>
    <text>extraction of cytosolic proteins</text>
  </EVENT>
  <TERM end="1126" id="V740632" paragraph="paragraph5" rule="-SIMPLE-REF" start="1105" uttnum="50">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>of cytosolic proteins</text>
  </TERM>
  <TERM end="1157" id="V756150" paragraph="paragraph5" rule="-SIMPLE-REF" start="1134" uttnum="51">
    <type>ONT::LIQUID-SUBSTANCE</type>
    <name>EXTRACT</name>
    <text>the cytosolic extracts</text>
  </TERM>
  <TERM end="1164" id="V756194" paragraph="paragraph5" rule="-SIMPLE-REF" start="1161" uttnum="51">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Unspecified or unknown amino acid</name>
          <code>X</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2X</text>
  </TERM>
  <TERM dbid="UP:SL-0091|GO:0005829" end="1295" id="V761639" paragraph="paragraph5" rule="-SIMPLE-REF" start="1287" uttnum="51">
    <type>ONT::CELL-PART</type>
    <name>CYTOSOL</name>
    <text>cytosol</text>
  </TERM>
  <TERM end="1279" id="V761128" paragraph="paragraph5" rule="-SIMPLE-REF" start="1275" uttnum="51">
    <type>ONT::SUBSTANCE</type>
    <name>P</name>
    <text>p176</text>
  </TERM>
  <TERM end="1284" id="V761143" paragraph="paragraph5" rule="-SIMPLE-REF" start="1280" uttnum="51">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="1329" id="V761671" paragraph="paragraph5" rule="-SIMPLE-REF" start="1313" uttnum="51">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>plasma membrane</text>
  </TERM>
  <TERM dbid="EFO:0001203|BTO:0000093" end="32" id="V764945" paragraph="paragraph6" rule="-SIMPLE-REF" start="20" uttnum="52">
    <type>ONT::CELL-LINE</type>
    <name>MCF-7-CELLS</name>
    <text>MCF-7 cells</text>
  </TERM>
  <TERM dbid="CHEBI:65329" end="61" id="V765001" paragraph="paragraph6" rule="-SIMPLE-REF" start="53" uttnum="52">
    <type>ONT::MOLECULE</type>
    <name>LY-294002</name>
    <text>LY294002</text>
  </TERM>
  <TERM end="73" id="V781093" paragraph="paragraph6" rule="-SIMPLE-REF" start="70" uttnum="52">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>1 h</text>
  </TERM>
  <TERM dbid="UP:Q02297" end="108" id="V781135" paragraph="paragraph6" rule="-SIMPLE-REF" start="84" uttnum="52">
    <type>ONT::PROTEIN</type>
    <name>HEREGULIN</name>
    <text>by heregulin for 40 mins</text>
  </TERM>
  <TERM dbid="GO:0005623|CO:0000000" end="123" id="V795235" paragraph="paragraph6" rule="-SIMPLE-REF" start="110" uttnum="53">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Cell lysates</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="154" id="V795283" paragraph="paragraph6" rule="-SIMPLE-REF" start="145" uttnum="53">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>membrane</text>
  </TERM>
  <TERM dbid="GO:0042571" end="208" id="V795386" paragraph="paragraph6" rule="-SIMPLE-REF" start="198" uttnum="53">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="225" id="V809007" paragraph="paragraph6" rule="-SIMPLE-REF" start="217" uttnum="54">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM dbid="EFO:0001203|BTO:0000093" end="239" id="V809037" paragraph="paragraph6" rule="-SIMPLE-REF" start="227" uttnum="54">
    <type>ONT::CELL-LINE</type>
    <name>MCF-7-CELLS</name>
    <text>MCF-7 cells</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="295" id="V809114" paragraph="paragraph6" rule="-SIMPLE-REF" start="290" uttnum="54">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="304" id="V809164" paragraph="paragraph6" rule="-SIMPLE-REF" start="299" uttnum="54">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <EVENT end="353" id="V809254" paragraph="paragraph6" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="324" uttnum="54">
    <type>ONT::MODULATE</type>
    <predicate end="353" id="V809254" start="324">
      <type>ONT::MODULATE</type>
      <text>insulin treatment for 30 mins</text>
    </predicate>
    <arg1 id="V809251" role=":AFFECTED"/>
    <text>insulin treatment for 30 mins</text>
  </EVENT>
  <TERM dbid="UP:P01308" end="332" id="V809251" paragraph="paragraph6" rule="-SIMPLE-REF" start="324" uttnum="54">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>insulin</text>
  </TERM>
  <TERM dbid="CVCL:F561" end="389" id="V823006" paragraph="paragraph6" rule="-SIMPLE-REF" start="383" uttnum="55">
    <type>ONT::CELL-LINE</type>
    <name>IP</name>
    <text>to IP</text>
  </TERM>
  <TERM dbid="GO:0005623|CO:0000000" end="368" id="V822934" paragraph="paragraph6" rule="-SIMPLE-REF" start="355" uttnum="55">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Cell lysates</text>
  </TERM>
  <TERM dbid="GO:0042571" end="411" id="V823061" paragraph="paragraph6" rule="-SIMPLE-REF" start="394" uttnum="55">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>pTyr-antibodies,</text>
  </TERM>
  <TERM end="443" id="V822607" paragraph="paragraph6" rule="-SIMPLE-REF" start="439" uttnum="55">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="GO:0042571" end="465" id="V823152" paragraph="paragraph6" rule="-SIMPLE-REF" start="443" uttnum="55">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies (top panel)</text>
  </TERM>
  <TERM end="464" id="V823167" paragraph="paragraph6" rule="-SIMPLE-REF" start="455" uttnum="55">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panel</text>
  </TERM>
  <TERM end="480" id="V837327" paragraph="paragraph6" rule="-SIMPLE-REF" start="467" uttnum="56">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>Lower panels</text>
  </TERM>
  <TERM dbid="GO:0042571" end="513" id="V837391" paragraph="paragraph6" rule="-SIMPLE-REF" start="503" uttnum="56">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="530" id="V839721" paragraph="paragraph6" rule="-SIMPLE-REF" start="515" uttnum="57">
    <type>ONT::PROCEDURE</type>
    <name>EXPERIMENT</name>
    <text>The experiment</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="568" id="V839770" paragraph="paragraph6" rule="-SIMPLE-REF" start="563" uttnum="57">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="39" id="V844386" paragraph="paragraph7" rule="-SIMPLE-REF" start="20" uttnum="58">
    <type>ONT::DEVICE</type>
    <name>CELL</name>
    <text>MEF1&amp;amp;2KO cells</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="24" id="V844359" paragraph="paragraph7" rule="-SIMPLE-REF" start="20" uttnum="58">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <TERM end="85" id="V844470" paragraph="paragraph7" rule="-SIMPLE-REF" start="44" uttnum="58">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">transfected with caAck and HA-tagged AKT</text>
  </TERM>
  <TERM end="95" id="V844506" paragraph="paragraph7" rule="-SIMPLE-REF" start="88" uttnum="58">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F,</text>
  </TERM>
  <EVENT end="85" id="V844410" paragraph="paragraph7" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="44" uttnum="58">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="85" id="V844410" start="44">
      <type>ONT::TRANSFORM</type>
      <text>transfected with caAck and HA-tagged AKT</text>
    </predicate>
    <arg1 id="V844470" role=":AFFECTED"/>
    <text>transfected with caAck and HA-tagged AKT</text>
  </EVENT>
  <TERM end="101" id="V844514" paragraph="paragraph7" rule="-SIMPLE-REF" start="95" uttnum="58">
    <type>ONT::BODILY-FLUID</type>
    <name>SERUM</name>
    <text>serum</text>
  </TERM>
  <TERM end="114" id="V844532" paragraph="paragraph7" rule="-SIMPLE-REF" start="110" uttnum="58">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>24 h</text>
  </TERM>
  <TERM dbid="CHEBI:33697" end="141" id="V858876" paragraph="paragraph7" rule="-SIMPLE-REF" start="131" uttnum="59">
    <type>ONT::CELL-PART</type>
    <name>RNA</name>
    <text>Total RNA</text>
  </TERM>
  <TERM end="198" id="V859637" paragraph="paragraph7" rule="-SIMPLE-REF" start="193" uttnum="60">
    <type>ONT::INFORMATION</type>
    <name>DATUM</name>
    <text>Data</text>
  </TERM>
  <TERM end="249" id="V859676" paragraph="paragraph7" rule="-SIMPLE-REF" start="220" uttnum="60">
    <type>ONT::PROCEDURE</type>
    <name>EXPERIMENT</name>
    <text>three independent experiments</text>
  </TERM>
  <TERM end="297" id="V860056" paragraph="paragraph7" rule="-SIMPLE-REF" start="260" uttnum="61">
    <type>ONT::SUBSTANCE</type>
    <name>P</name>
    <text>p≤0.05; **p</text>
  </TERM>
  <TERM end="326" id="V860116" paragraph="paragraph7" rule="-SIMPLE-REF" start="297" uttnum="61">
    <type>ONT::ICON</type>
    <name>P</name>
    <text>≤0.03; ***p≤</text>
  </TERM>
  <TERM end="359" id="V860185" paragraph="paragraph7" rule="-SIMPLE-REF" start="326" uttnum="61">
    <type>ONT::SUBSTANCE</type>
    <name>P</name>
    <text>0.02; ****p≤0.02</text>
  </TERM>
  <TERM end="376" id="V870095" paragraph="paragraph7" rule="-SIMPLE-REF" start="368" uttnum="62">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <EVENT end="453" id="V870157" paragraph="paragraph7" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="378" uttnum="62">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="453" id="V870157" start="378">
      <type>ONT::TRANSFORM</type>
      <text>MEF2KO cells were transfected with control or Ack1-specific siRNAs (40 nM)</text>
    </predicate>
    <arg2 id="V870132" role=":AFFECTED"/>
    <text>MEF2KO cells were transfected with control or Ack1-specific siRNAs (40 nM)</text>
  </EVENT>
  <TERM end="391" id="V870132" paragraph="paragraph7" rule="-SIMPLE-REF" start="378" uttnum="62">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>MEF2KO cells</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="391" id="V870123" paragraph="paragraph7" rule="-SIMPLE-REF" start="378" uttnum="62">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>MEF2KO cells</text>
  </TERM>
  <TERM dbid="XFAM:PF00076|UP:Q9P2K5|UP:Q8C854|HGNC:17940|FA:02224" end="382" id="V870114" paragraph="paragraph7" rule="-SIMPLE-REF" start="378" uttnum="62">
    <type>ONT::GENE-PROTEIN</type>
    <name>MEF-2</name>
    <text>MEF2</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="438" id="V870194" paragraph="paragraph7" rule="-SIMPLE-REF" start="424" uttnum="62">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1-specific</text>
  </TERM>
  <TERM end="450" id="V870280" paragraph="paragraph7" rule="-SIMPLE-REF" start="446" uttnum="62">
    <type>ONT::CARDINAL-POINT</type>
    <name>N</name>
    <text>40 n</text>
  </TERM>
  <TERM end="462" id="V870356" paragraph="paragraph7" rule="-SIMPLE-REF" start="457" uttnum="62">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>48 h</text>
  </TERM>
  <TERM dbid="UP:P01133" end="494" id="V870402" paragraph="paragraph7" rule="-SIMPLE-REF" start="479" uttnum="62">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF for 30 mins</text>
  </TERM>
  <TERM dbid="CHEBI:33697" end="506" id="V885039" paragraph="paragraph7" rule="-SIMPLE-REF" start="496" uttnum="63">
    <type>ONT::CELL-PART</type>
    <name>RNA</name>
    <text>Total RNA</text>
  </TERM>
  <TERM end="605" id="V885872" paragraph="paragraph7" rule="-SIMPLE-REF" start="567" uttnum="64">
    <type>ONT::ICON</type>
    <name>P</name>
    <text>p≤0.01; **p≤</text>
  </TERM>
  <TERM end="748" id="V896033" paragraph="paragraph7" rule="-SIMPLE-REF-MUTATION8" start="685" uttnum="65">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>Schematic representation of myr-AKT and myr-Y176F point mutants</text>
  </TERM>
  <TERM end="748" id="V895981" paragraph="paragraph7" rule="-SIMPLE-REF" start="685" uttnum="65">
    <type>ONT::INFO-HOLDER</type>
    <name>REPRESENTATION</name>
    <text>Schematic representation of myr-AKT and myr-Y176F point mutants</text>
  </TERM>
  <TERM dbid="CHEBI:25456" end="716" id="V895994" paragraph="paragraph7" rule="-SIMPLE-REF" start="713" uttnum="65">
    <type>ONT::MOLECULE</type>
    <name>MYR</name>
    <text>myr</text>
  </TERM>
  <TERM end="721" id="V896002" paragraph="paragraph7" rule="-SIMPLE-REF" start="717" uttnum="65">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="CHEBI:25456" end="728" id="V895757" paragraph="paragraph7" rule="-SIMPLE-REF" start="725" uttnum="65">
    <type>ONT::MOLECULE</type>
    <name>MYR</name>
    <text>myr</text>
  </TERM>
  <TERM end="735" id="V895789" paragraph="paragraph7" rule="-SIMPLE-REF" start="729" uttnum="65">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="765" id="V899809" paragraph="paragraph7" rule="-SIMPLE-REF" start="757" uttnum="66">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">myr-AKT</text>
  </TERM>
  <TERM dbid="CHEBI:25456" end="765" id="V899801" paragraph="paragraph7" rule="-SIMPLE-REF" start="757" uttnum="66">
    <type>ONT::MOLECULE</type>
    <name>MYR</name>
    <text>myr-AKT</text>
  </TERM>
  <EVENT end="809" id="V899865" paragraph="paragraph7" rule="-RULE40A_AGENT_AFFECTED-LOC5-GD-NONE" start="754" uttnum="66">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="809" id="V899865" start="754">
      <type>ONT::PRODUCE</type>
      <text>of myr-AKT was performed to generate the Y176F mutation</text>
    </predicate>
    <arg2 id="V899904" role=":AFFECTED-RESULT"/>
    <site end="765" id="V899788" start="750">
      <type>ONT::REFERENTIAL-SEM</type>
      <text normalization="SDM">SDM of myr-AKT</text>
    </site>
    <text>of myr-AKT was performed to generate the Y176F mutation</text>
  </EVENT>
  <EVENT end="809" id="V899904" paragraph="paragraph7" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="791" uttnum="66">
    <type>ONT::TRANSFORM</type>
    <predicate end="809" id="V899904" start="791">
      <type>ONT::TRANSFORM</type>
      <text>the Y176F mutation</text>
    </predicate>
    <arg2 id="V899901" role=":AFFECTED"/>
    <text>the Y176F mutation</text>
  </EVENT>
  <TERM end="801" id="V899901" paragraph="paragraph7" rule="-SIMPLE-REF" start="795" uttnum="66">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="873" id="V902740" paragraph="paragraph7" rule="-LOGICALOP-REF" start="811" uttnum="67">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="AND">
      <member id="V902736"/>
      <member id="V902753"/>
    </aggregate>
    <text normalization="">PH, Pleckstrin homology domain; Kinase, Kinase domain and CT,</text>
  </TERM>
  <TERM dbid="XFAM:PF00169.26" end="865" id="V902736" paragraph="paragraph7" rule="-EXPLICIT-REF1" start="811" uttnum="67">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PH</name>
    <assoc-with id="V902686"/>
    <text>PH, Pleckstrin homology domain; Kinase, Kinase domain</text>
  </TERM>
  <TERM dbid="UP:P49585|HGNC:8754" end="873" id="V902753" paragraph="paragraph7" rule="-SIMPLE-REF" start="869" uttnum="67">
    <type>ONT::GENE</type>
    <name>CT</name>
    <text>CT,</text>
  </TERM>
  <TERM dbid="GO:0016301" end="865" id="V902733" paragraph="paragraph7" rule="-SIMPLE-REF" start="811" uttnum="67">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>PH, Pleckstrin homology domain; Kinase, Kinase domain</text>
  </TERM>
  <TERM dbid="XFAM:PF15404.3|XFAM:PF15405.3|XFAM:PF03703.11|XFAM:PF15406.3|XFAM:PF16457.2|XFAM:PF15413.3|XFAM:PF00169.26|XFAM:PF16652.2|XFAM:PF15409.3|XFAM:PF10882.5|XFAM:PF06713.8|XFAM:PF15410.3|XFAM:PF15411.3|XFAM:PF08000.8" end="865" id="V902717" paragraph="paragraph7" rule="-SIMPLE-REF" start="811" uttnum="67">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PLECKSTRIN-HOMOLOGY-DOMAIN</name>
    <text>PH, Pleckstrin homology domain; Kinase, Kinase domain</text>
  </TERM>
  <TERM dbid="XFAM:PF00169.26" end="815" id="V902686" paragraph="paragraph7" rule="-SIMPLE-REF" start="811" uttnum="67">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PH</name>
    <text>PH,</text>
  </TERM>
  <TERM dbid="GO:0016301" end="851" id="V902725" paragraph="paragraph7" rule="-SIMPLE-REF" start="843" uttnum="67">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>Kinase,</text>
  </TERM>
  <TERM end="907" id="V902764" paragraph="paragraph7" rule="-SIMPLE-REF" start="873" uttnum="67">
    <type>ONT::TERMINUS</type>
    <name>TERMINAL</name>
    <text>Carboxy Terminal regulatory region</text>
  </TERM>
  <TERM dbid="CHEBI:46883" end="881" id="V902761" paragraph="paragraph7" rule="-SIMPLE-REF" start="873" uttnum="67">
    <type>ONT::MOLECULE</type>
    <name>CARBOXY</name>
    <text>Carboxy</text>
  </TERM>
  <TERM end="924" id="V913371" paragraph="paragraph7" rule="-SIMPLE-REF" start="916" uttnum="68">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>D</text>
  </TERM>
  <TERM end="939" id="V913382" paragraph="paragraph7" rule="-SIMPLE-REF" start="926" uttnum="68">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT MEF1&amp;amp;</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="934" id="V913396" paragraph="paragraph7" rule="-SIMPLE-REF" start="930" uttnum="68">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <EVENT end="1010" id="V913442" paragraph="paragraph7" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="939" uttnum="68">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="1010" id="V913442" start="939">
      <type>ONT::TRANSFORM</type>
      <text>2 KO cells were transfected with HA-tagged myr-AKT or myr-Y176F mutant</text>
    </predicate>
    <arg1 id="V913417" role=":AFFECTED"/>
    <text>2 KO cells were transfected with HA-tagged myr-AKT or myr-Y176F mutant</text>
  </EVENT>
  <TERM end="950" id="V913417" paragraph="paragraph7" rule="-SIMPLE-REF" start="939" uttnum="68">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>2 KO cells</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="944" id="V913413" paragraph="paragraph7" rule="-SIMPLE-REF" start="941" uttnum="68">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>KO</text>
  </TERM>
  <TERM dbid="CHEBI:25456" end="985" id="V913478" paragraph="paragraph7" rule="-SIMPLE-REF" start="972" uttnum="68">
    <type>ONT::MOLECULE</type>
    <name>MYR</name>
    <text>HA-tagged myr</text>
  </TERM>
  <TERM end="1010" id="V913501" paragraph="paragraph7" rule="-SIMPLE-REF-MUTATION8" start="986" uttnum="68">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>AKT or myr-Y176F mutant</text>
  </TERM>
  <TERM end="990" id="V913486" paragraph="paragraph7" rule="-SIMPLE-REF" start="986" uttnum="68">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="CHEBI:25456" end="996" id="V913093" paragraph="paragraph7" rule="-SIMPLE-REF" start="993" uttnum="68">
    <type>ONT::MOLECULE</type>
    <name>MYR</name>
    <text>myr</text>
  </TERM>
  <TERM end="1003" id="V913125" paragraph="paragraph7" rule="-SIMPLE-REF" start="997" uttnum="68">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="1029" id="V913522" paragraph="paragraph7" rule="-SIMPLE-REF" start="1024" uttnum="68">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>24 h</text>
  </TERM>
  <TERM end="1038" id="V913551" paragraph="paragraph7" rule="-SIMPLE-REF" start="1033" uttnum="68">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>48 h</text>
  </TERM>
  <EVENT end="1110" id="V927571" paragraph="paragraph7" rule="-RULE5_AGENT_AFFECTED-AGENT" start="1057" uttnum="69">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="1110" id="V927571" start="1057">
      <type>ONT::TRANSFORM</type>
      <text>Cells were fixed and stained with anti-HA antibodies</text>
    </predicate>
    <arg1 id="V927522" role=":AGENT"/>
    <text>Cells were fixed and stained with anti-HA antibodies</text>
  </EVENT>
  <TERM dbid="GO:0005623|CO:0000000" end="1063" id="V927522" paragraph="paragraph7" rule="-SIMPLE-REF" start="1057" uttnum="69">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Cells</text>
  </TERM>
  <EVENT end="1074" id="V927549" paragraph="paragraph7" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="1057" uttnum="69">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="1074" id="V927549" start="1057">
      <type>ONT::TRANSFORM</type>
      <text>Cells were fixed</text>
    </predicate>
    <arg2 id="V927522" role=":AFFECTED"/>
    <text>Cells were fixed</text>
  </EVENT>
  <TERM dbid="GO:0042571" end="1110" id="V927609" paragraph="paragraph7" rule="-SIMPLE-REF" start="1091" uttnum="69">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>anti-HA antibodies</text>
  </TERM>
  <TERM end="1200" id="V927833" paragraph="paragraph7" rule="-SIMPLE-REF" start="1191" uttnum="69">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>MARKER</name>
    <text>a marker</text>
  </TERM>
  <TERM end="1226" id="V927890" paragraph="paragraph7" rule="-SIMPLE-REF" start="1220" uttnum="69">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells</text>
  </TERM>
  <TERM end="1237" id="V927965" paragraph="paragraph7" rule="-SIMPLE-REF" start="1229" uttnum="69">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Glycine</name>
        <code>G</code>
        <pos>2</pos>
      </site>
    </features>
    <name>G-2</name>
    <text>late G2</text>
  </TERM>
  <TERM end="1315" id="V944439" paragraph="paragraph7" rule="-SIMPLE-REF" start="1309" uttnum="70">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells</text>
  </TERM>
  <TERM end="1358" id="V944558" paragraph="paragraph7" rule="-SIMPLE-REF" start="1349" uttnum="70">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>of cells</text>
  </TERM>
  <EVENT end="1399" id="V944569" paragraph="paragraph7" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="1358" uttnum="70">
    <type>ONT::TRANSFORM</type>
    <predicate end="1399" id="V944569" start="1358">
      <type>ONT::TRANSFORM</type>
      <text>undergoing mitosis (upper right quadrant)</text>
    </predicate>
    <arg2 id="V944575" role=":AFFECTED"/>
    <text>undergoing mitosis (upper right quadrant)</text>
  </EVENT>
  <TERM dbid="GO:0007067" end="1399" id="V944575" paragraph="paragraph7" rule="-SIMPLE-REF" start="1369" uttnum="70">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>MITOSIS</name>
    <text>mitosis (upper right quadrant)</text>
  </TERM>
  <TERM end="1398" id="V944601" paragraph="paragraph7" rule="-SIMPLE-REF" start="1378" uttnum="70">
    <type>ONT::GEO-OBJECT</type>
    <name>QUADRANT</name>
    <text>upper right quadrant</text>
  </TERM>
  <TERM end="1410" id="V958135" paragraph="paragraph7" rule="-SIMPLE-REF" start="1408" uttnum="70">
    <type>ONT::GEO-OBJECT</type>
    <name>HA</name>
    <text>HA</text>
  </TERM>
  <TERM dbid="CHEBI:25456" end="1419" id="V958145" paragraph="paragraph7" rule="-SIMPLE-REF" start="1411" uttnum="70">
    <type>ONT::MOLECULE</type>
    <name>MYR</name>
    <text>myrY176F</text>
  </TERM>
  <TERM dbid="BTO:0001476" end="1449" id="V958287" paragraph="paragraph7" rule="-INEVENT2B,-SIMPLE-REF" start="1420" uttnum="70">
    <type>ONT::INTERNAL-BODY-PART</type>
    <features>
      <inevent>
        <event id="V958218"/>
      </inevent>
    </features>
    <name>MITOTIC-CELLS</name>
    <text>AKT expressing mitotic cells</text>
  </TERM>
  <TERM end="1424" id="V958203" paragraph="paragraph7" rule="-SIMPLE-REF" start="1420" uttnum="70">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <EVENT end="1449" id="V958218" paragraph="paragraph7" rule="-RULE50_AGENT_AFFECTED-AFFECTED" start="1420" uttnum="70">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="1449" id="V958218" start="1420">
      <type>ONT::EXPRESS</type>
      <text>AKT expressing mitotic cells</text>
    </predicate>
    <arg2 id="V958287" role=":AFFECTED"/>
    <text>AKT expressing mitotic cells</text>
  </EVENT>
  <TERM end="53" id="V969571" paragraph="paragraph8" rule="-SIMPLE-REF" start="20" uttnum="71">
    <type>ONT::MENTAL-OBJECT</type>
    <name>CONSTRUCT</name>
    <text>Transgenic construct (Prob-Ack1)</text>
  </TERM>
  <TERM dbid="EFO:0004020" end="31" id="V969559" paragraph="paragraph8" rule="-SIMPLE-REF" start="20" uttnum="71">
    <type>ONT::PROCESS</type>
    <name>TRANSGENIC</name>
    <text>Transgenic</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="51" id="V969604" paragraph="paragraph8" rule="-SIMPLE-REF" start="42" uttnum="71">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Prob-Ack1</text>
  </TERM>
  <TERM end="78" id="V984977" paragraph="paragraph8" rule="-SIMPLE-REF" start="70" uttnum="72">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="195" id="V985074" paragraph="paragraph8" rule="-SIMPLE-REF" start="85" uttnum="72">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>wk old Probasin-Ack1 transgenic (TG) and wild type [21]</text>
  </TERM>
  <TERM dbid="XFAM:PF00061|UP:O08976" end="195" id="V985047" paragraph="paragraph8" rule="-SIMPLE-REF" start="85" uttnum="72">
    <type>ONT::PROTEIN</type>
    <name>PROBASIN</name>
    <text>wk old Probasin-Ack1 transgenic (TG) and wild type [21]</text>
  </TERM>
  <TERM dbid="EFO:0004020" end="122" id="V985096" paragraph="paragraph8" rule="-SIMPLE-REF" start="106" uttnum="72">
    <type>ONT::PROCESS</type>
    <name>TRANSGENIC</name>
    <text>transgenic (TG)</text>
  </TERM>
  <TERM end="183" id="V985160" paragraph="paragraph8" rule="-SIMPLE-REF-MUTATION7" start="126" uttnum="72">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILD-TYPE</name>
    <text>wild type</text>
  </TERM>
  <TERM dbid="HGNC:11764|UP:P01266" end="120" id="V985104" paragraph="paragraph8" rule="-SIMPLE-REF" start="118" uttnum="72">
    <type>ONT::GENE</type>
    <name>TG</name>
    <text>TG</text>
  </TERM>
  <TERM end="200" id="V985205" paragraph="paragraph8" rule="-SIMPLE-REF" start="195" uttnum="72">
    <type>ONT::MALE-PERSON</type>
    <name>MALE</name>
    <text>male</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="205" id="V985213" paragraph="paragraph8" rule="-SIMPLE-REF" start="200" uttnum="72">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>mice</text>
  </TERM>
  <TERM end="214" id="V985216" paragraph="paragraph8" rule="-SIMPLE-REF" start="205" uttnum="72">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>prostate</text>
  </TERM>
  <CC end="258" id="V985297" paragraph="paragraph8" rule="-RULE5B_AGENT_RESULT-NONE" start="227" uttnum="72">
    <type>ONT::CAUSE</type>
    <text>subjected to IP using anti-Myc</text>
  </CC>
  <EVENT end="258" id="V985248" paragraph="paragraph8" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="227" uttnum="72">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="258" id="V985248" start="227">
      <type>ONT::MODULATE</type>
      <text>subjected to IP using anti-Myc</text>
    </predicate>
    <arg2 id="V985297" role=":AFFECTED"/>
    <text>subjected to IP using anti-Myc</text>
  </EVENT>
  <TERM dbid="CVCL:F561" end="243" id="V985283" paragraph="paragraph8" rule="-SIMPLE-REF" start="237" uttnum="72">
    <type>ONT::CELL-LINE</type>
    <name>IP</name>
    <text>to IP</text>
  </TERM>
  <TERM dbid="GO:0042571" end="269" id="V985319" paragraph="paragraph8" rule="-SIMPLE-REF" start="258" uttnum="72">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM dbid="GO:0042571" end="316" id="V985429" paragraph="paragraph8" rule="-SIMPLE-REF" start="294" uttnum="72">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies (top panel)</text>
  </TERM>
  <TERM end="315" id="V985444" paragraph="paragraph8" rule="-SIMPLE-REF" start="306" uttnum="72">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panel</text>
  </TERM>
  <TERM end="335" id="V995884" paragraph="paragraph8" rule="-SIMPLE-REF" start="322" uttnum="73">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>bottom panels</text>
  </TERM>
  <TERM dbid="GO:0042571" end="391" id="V995992" paragraph="paragraph8" rule="-SIMPLE-REF" start="381" uttnum="73">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="452" id="V1012916" paragraph="paragraph8" rule="-SIMPLE-REF" start="410" uttnum="74">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>Prostate lysates from 21 and 25 wk old TG</text>
  </TERM>
  <TERM dbid="HGNC:11764|UP:P01266" end="452" id="V1012967" paragraph="paragraph8" rule="-SIMPLE-REF" start="439" uttnum="74">
    <type>ONT::GENE</type>
    <name>TG</name>
    <text>25 wk old TG</text>
  </TERM>
  <TERM end="472" id="V1013007" paragraph="paragraph8" rule="-SIMPLE-REF" start="456" uttnum="74">
    <type>ONT::FAMILY-RELATION</type>
    <name>SIBLING</name>
    <text>the WT siblings</text>
  </TERM>
  <TERM dbid="GO:0042571" end="506" id="V1013064" paragraph="paragraph8" rule="-SIMPLE-REF" start="485" uttnum="74">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>respective antibodies</text>
  </TERM>
  <TERM end="528" id="V1027814" paragraph="paragraph8" rule="-SIMPLE-REF" start="508" uttnum="75">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>The bottom 2 panels</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="560" id="V1027866" paragraph="paragraph8" rule="-SIMPLE-REF" start="556" uttnum="75">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>mice</text>
  </TERM>
  <TERM dbid="GO:0042571" end="556" id="V1027860" paragraph="paragraph8" rule="-SIMPLE-REF" start="550" uttnum="75">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>these</text>
  </TERM>
  <TERM dbid="FA:01824|HGNC:6001|UP:P04351|XFAM:PF00715|UP:P60568" end="567" id="V1032508" paragraph="paragraph8" rule="-SIMPLE-REF" start="562" uttnum="76">
    <type>ONT::GENE-PROTEIN</type>
    <name>IL-2</name>
    <text>IL-2</text>
  </TERM>
  <TERM dbid="CHEBI:51686|CHEBI:5601" end="632" id="V1033115" paragraph="paragraph8" rule="-SIMPLE-REF" start="619" uttnum="77">
    <type>ONT::MOLECULE</type>
    <name>HAEMATOXYLIN</name>
    <text>Haematoxylin</text>
  </TERM>
  <TERM end="642" id="V1033130" paragraph="paragraph8" rule="-SIMPLE-REF" start="636" uttnum="77">
    <type>ONT::MATERIAL</type>
    <name>EOSIN</name>
    <text>eosin</text>
  </TERM>
  <TERM end="650" id="V1033146" paragraph="paragraph8" rule="-SIMPLE-REF" start="643" uttnum="77">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>H</name>
    <text>H&amp;amp;E</text>
  </TERM>
  <TERM end="663" id="V1033178" paragraph="paragraph8" rule="-SIMPLE-REF-MUTATION7" start="660" uttnum="77">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILDTYPE</name>
    <text>WT</text>
  </TERM>
  <TERM end="684" id="V1033218" paragraph="paragraph8" rule="-SIMPLE-REF" start="667" uttnum="77">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>TG mice prostates</text>
  </TERM>
  <TERM dbid="HGNC:11764|UP:P01266" end="684" id="V1033198" paragraph="paragraph8" rule="-SIMPLE-REF" start="667" uttnum="77">
    <type>ONT::GENE</type>
    <name>TG</name>
    <text>TG mice prostates</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="675" id="V1033215" paragraph="paragraph8" rule="-SIMPLE-REF" start="670" uttnum="77">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>mice</text>
  </TERM>
  <TERM dbid="UP:Q96B36|HGNC:28426" end="781" id="V1049422" paragraph="paragraph8" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="710" uttnum="78">
    <type>ONT::GENE</type>
    <features>
      <location id="V1049413"/>
    </features>
    <name>LOBE</name>
    <text>of the prostate lateral lobe from a 22 wk old WT mouse (D)</text>
  </TERM>
  <TERM end="781" id="V1049413" paragraph="paragraph8" rule="-SIMPLE-REF" start="710" uttnum="78">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>of the prostate lateral lobe from a 22 wk old WT mouse (D)</text>
  </TERM>
  <TERM end="781" id="V1049500" paragraph="paragraph8" rule="-SIMPLE-REF" start="744" uttnum="78">
    <type>ONT::COMPUTER-INPUT-DEVICE</type>
    <name>MOUSE</name>
    <text>a 22 wk old WT mouse (D)</text>
  </TERM>
  <TERM end="780" id="V1049521" paragraph="paragraph8" rule="-SIMPLE-REF" start="772" uttnum="78">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>D</text>
  </TERM>
  <TERM dbid="UP:Q96B36|HGNC:28426" end="826" id="V1049554" paragraph="paragraph8" rule="-SIMPLE-REF" start="787" uttnum="78">
    <type>ONT::GENE</type>
    <name>LOBE</name>
    <text>corresponding lobe from age-matched TG</text>
  </TERM>
  <TERM dbid="HGNC:11764|UP:P01266" end="826" id="V1049602" paragraph="paragraph8" rule="-SIMPLE-REF" start="811" uttnum="78">
    <type>ONT::GENE</type>
    <name>TG</name>
    <text>age-matched TG</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="884" id="V1049619" paragraph="paragraph8" rule="-SIMPLE-REF" start="826" uttnum="78">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>mice with intraepithelial hyperplasia (E)</text>
  </TERM>
  <TERM end="883" id="V1049662" paragraph="paragraph8" rule="-SIMPLE-REF" start="873" uttnum="78">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>E</text>
  </TERM>
  <TERM end="907" id="V1058213" paragraph="paragraph8" rule="-SIMPLE-REF" start="886" uttnum="79">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>The lateral prostate</text>
  </TERM>
  <TERM dbid="XFAM:PF01221|UP:P63168" end="963" id="V1058311" paragraph="paragraph8" rule="-SIMPLE-REF" start="941" uttnum="79">
    <type>ONT::PROTEIN</type>
    <name>MPIN</name>
    <text>mPIN (F)</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="941" id="V1058265" paragraph="paragraph8" rule="-SIMPLE-REF" start="912" uttnum="79">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>49 wk old TG mice exhibiting</text>
  </TERM>
  <TERM dbid="HGNC:11764|UP:P01266" end="925" id="V1058248" paragraph="paragraph8" rule="-SIMPLE-REF" start="922" uttnum="79">
    <type>ONT::GENE</type>
    <name>TG</name>
    <text>TG</text>
  </TERM>
  <EPI end="1009" id="V1070394" paragraph="paragraph8" rule="-RULE50_0_NEUTRAL_FORMAL-NONE" start="973" uttnum="80">
    <type>ONT::SEEM</type>
    <text>Contrasting histological appearance</text>
  </EPI>
  <EPI end="1009" id="V1070380" paragraph="paragraph8" rule="-RULE50_0_AGENT_NEUTRAL-AGENT" start="973" uttnum="80">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg1 id="V1070394" role=":AGENT"/>
    <text>Contrasting histological appearance</text>
  </EPI>
  <TERM dbid="UP:Q96B36|HGNC:28426" end="1160" id="V1070446" paragraph="paragraph8" rule="-SIMPLE-REF" start="1044" uttnum="80">
    <type>ONT::GENE</type>
    <name>LOBES</name>
    <text>lobes of the prostate glands from a WT mouse (G–I), and corresponding lobes from TG mice (49 week old)</text>
  </TERM>
  <TERM end="1073" id="V1070471" paragraph="paragraph8" rule="-SIMPLE-REF" start="1053" uttnum="80">
    <type>ONT::BODY-PART</type>
    <name>PROSTATE-GLANDS</name>
    <text>the prostate glands</text>
  </TERM>
  <TERM end="1109" id="V1070535" paragraph="paragraph8" rule="-SIMPLE-REF" start="1078" uttnum="80">
    <type>ONT::COMPUTER-INPUT-DEVICE</type>
    <name>MOUSE</name>
    <text>a WT mouse (G–I),</text>
  </TERM>
  <TERM dbid="UP:Q96B36|HGNC:28426" end="1146" id="V1070616" paragraph="paragraph8" rule="-SIMPLE-REF" start="1113" uttnum="80">
    <type>ONT::GENE</type>
    <name>LOBES</name>
    <text>corresponding lobes from TG mice</text>
  </TERM>
  <TERM end="1106" id="V1070582" paragraph="paragraph8" rule="-SIMPLE-REF" start="1096" uttnum="80">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31871" type="ONT::PROTEIN"/>
      <member dbid="UP:P09471" type="ONT::PROTEIN"/>
      <member dbid="UP:P19086" type="ONT::PROTEIN"/>
      <member dbid="UP:P08754" type="ONT::PROTEIN"/>
      <member dbid="UP:P04899" type="ONT::PROTEIN"/>
    </members>
    <name>G-I</name>
    <text normalization="">G–I</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="1146" id="V1070649" paragraph="paragraph8" rule="-SIMPLE-REF" start="1138" uttnum="80">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>TG mice</text>
  </TERM>
  <TERM dbid="HGNC:11764|UP:P01266" end="1141" id="V1070632" paragraph="paragraph8" rule="-SIMPLE-REF" start="1138" uttnum="80">
    <type>ONT::GENE</type>
    <name>TG</name>
    <text>TG</text>
  </TERM>
  <TERM dbid="CVCL:F563" end="1187" id="V1070742" paragraph="paragraph8" rule="-SIMPLE-REF" start="1177" uttnum="80">
    <type>ONT::CELL-LINE</type>
    <name>J-L</name>
    <text>J–L</text>
  </TERM>
  <TERM dbid="CHEBI:18139|CHEBI:60567|CHEBI:60610|CHEBI:166055|CHEBI:53050" end="24" id="V1079751" paragraph="paragraph9" rule="-SIMPLE-REF" start="20" uttnum="81">
    <type>ONT::MOLECULE</type>
    <name>TMA</name>
    <text>TMA</text>
  </TERM>
  <TERM dbid="GO:0042571" end="129" id="V1079840" paragraph="paragraph9" rule="-SIMPLE-REF" start="107" uttnum="81">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>pTyr176-AKT antibodies</text>
  </TERM>
  <TERM end="119" id="V1079295" paragraph="paragraph9" rule="-SIMPLE-REF" start="115" uttnum="81">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="103" id="V1079513" paragraph="paragraph9" rule="-SIMPLE-REF" start="98" uttnum="81">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="146" id="V1091728" paragraph="paragraph9" rule="-SIMPLE-REF" start="138" uttnum="82">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM end="152" id="V1091737" paragraph="paragraph9" rule="-SIMPLE-REF" start="148" uttnum="82">
    <type>ONT::BOX</type>
    <name>BOX</name>
    <text>Box</text>
  </TERM>
  <EPI end="262" id="V1091776" paragraph="paragraph9" rule="-RULE50_0_AGENT_FORMAL-FORMAL" start="161" uttnum="82">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1091789" role=":FORMAL"/>
    <text>summarize distributions of staining intensities for pTyr284-Ack1 in different stages of breast cancer</text>
  </EPI>
  <EVENT end="262" id="V1091789" paragraph="paragraph9" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE10_AGENT_AFFECTED-AFFECTED" start="161" uttnum="82">
    <type>ONT::MODULATE</type>
    <epistemic-modality id="V1091776"/>
    <predicate end="262" id="V1091789" start="161">
      <type>ONT::MODULATE</type>
      <text>summarize distributions of staining intensities for pTyr284-Ack1 in different stages of breast cancer</text>
    </predicate>
    <text>summarize distributions of staining intensities for pTyr284-Ack1 in different stages of breast cancer</text>
  </EVENT>
  <EPI end="347" id="V1106114" paragraph="paragraph9" rule="-RULE50_0_AGENT_FORMAL-FORMAL" start="264" uttnum="83">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1106062" role=":FORMAL"/>
    <text>A significant increasing trend of intensity across progression stages was detected</text>
  </EPI>
  <EVENT end="347" id="V1106062" paragraph="paragraph9" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE20_AGENT_AFFECTED-NONE" start="264" uttnum="83">
    <type>ONT::INCREASE</type>
    <epistemic-modality id="V1106114"/>
    <predicate end="347" id="V1106062" start="264">
      <type>ONT::INCREASE</type>
      <text>A significant increasing trend of intensity across progression stages was detected</text>
    </predicate>
    <text>A significant increasing trend of intensity across progression stages was detected</text>
  </EVENT>
  <TERM end="308" id="V1106067" paragraph="paragraph9" rule="-SIMPLE-REF" start="289" uttnum="83">
    <type>ONT::GEO-OBJECT</type>
    <name>TREND</name>
    <text>trend of intensity</text>
  </TERM>
  <TERM end="509" id="V1117631" paragraph="paragraph9" rule="-SIMPLE-REF" start="501" uttnum="84">
    <type>ONT::BOX</type>
    <name>BOX</name>
    <text>The box</text>
  </TERM>
  <TERM end="560" id="V1117726" paragraph="paragraph9" rule="-SIMPLE-REF" start="548" uttnum="84">
    <type>ONT::MENTAL-OBJECT</type>
    <name>MEDIAN</name>
    <text>median (50%)</text>
  </TERM>
  <TERM end="546" id="V1117693" paragraph="paragraph9" rule="-SIMPLE-REF" start="522" uttnum="84">
    <type>ONT::MENTAL-OBJECT</type>
    <name>QUARTILE</name>
    <text>the lower quartile (25%)</text>
  </TERM>
  <TERM end="581" id="V1117773" paragraph="paragraph9" rule="-SIMPLE-REF" start="572" uttnum="84">
    <type>ONT::MENTAL-OBJECT</type>
    <name>QUARTILE</name>
    <text>quartile</text>
  </TERM>
  <TERM end="652" id="V1134437" paragraph="paragraph9" rule="-SIMPLE-REF" start="638" uttnum="84">
    <type>ONT::MENTAL-OBJECT</type>
    <name>MEAN-VALUE</name>
    <text>the mean value</text>
  </TERM>
  <TERM end="632" id="V1134375" paragraph="paragraph9" rule="-SIMPLE-REF" start="621" uttnum="84">
    <type>ONT::SHAPE-OBJECT</type>
    <name>CIRCLE</name>
    <text>the circle</text>
  </TERM>
  <TERM end="663" id="V1149690" paragraph="paragraph9" rule="-SIMPLE-REF" start="654" uttnum="85">
    <type>ONT::NATURAL-OBJECT</type>
    <name>WHISKERS</name>
    <text>Whiskers</text>
  </TERM>
  <EVENT end="722" id="V1149721" paragraph="paragraph9" rule="-RULE30_AGENT_FORMAL-NONE" start="675" uttnum="85">
    <type>ONT::INHIBIT</type>
    <predicate end="722" id="V1149721" start="675">
      <type>ONT::INHIBIT</type>
      <text>each end of the box to the most extreme values</text>
    </predicate>
    <arg2 id="V1149755" role=":AFFECTED"/>
    <text>each end of the box to the most extreme values</text>
  </EVENT>
  <TERM end="695" id="V1149755" paragraph="paragraph9" rule="-SIMPLE-REF" start="684" uttnum="85">
    <type>ONT::BOX</type>
    <name>BOX</name>
    <text>of the box</text>
  </TERM>
  <TERM end="787" id="V1149932" paragraph="paragraph9" rule="-SIMPLE-REF" start="777" uttnum="85">
    <type>ONT::BOX</type>
    <name>BOX</name>
    <text>of the box</text>
  </TERM>
  <EVENT end="873" id="V1163327" paragraph="paragraph9" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="789" uttnum="86">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="873" id="V1163327" start="789">
      <type>ONT::TRANSFORM</type>
      <text>The data with values beyond the ends of the whiskers, displayed with black circles,</text>
    </predicate>
    <arg1 id="V1163249" role=":AGENT"/>
    <text>The data with values beyond the ends of the whiskers, displayed with black circles,</text>
  </EVENT>
  <TERM end="798" id="V1163249" paragraph="paragraph9" rule="-SIMPLE-REF" start="789" uttnum="86">
    <type>ONT::INFORMATION</type>
    <name>DATA</name>
    <text>The data</text>
  </TERM>
  <TERM end="873" id="V1163348" paragraph="paragraph9" rule="-SIMPLE-REF" start="858" uttnum="86">
    <type>ONT::SHAPE-OBJECT</type>
    <name>CIRCLE</name>
    <text>black circles,</text>
  </TERM>
  <TERM end="895" id="V1163386" paragraph="paragraph9" rule="-SIMPLE-REF" start="877" uttnum="86">
    <type>ONT::INHABITANT</type>
    <name>OUTLIERS</name>
    <text>potential outliers</text>
  </TERM>
  <TERM end="918" id="V1175201" paragraph="paragraph9" rule="-SIMPLE-REF" start="914" uttnum="87">
    <type>ONT::BOX</type>
    <name>BOX</name>
    <text>Box</text>
  </TERM>
  <EPI end="1027" id="V1175240" paragraph="paragraph9" rule="-RULE50_0_AGENT_FORMAL-FORMAL" start="927" uttnum="87">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1175248" role=":FORMAL"/>
    <text>summarize distributions of staining intensities for pTyr176-AKT in different stages of breast cancer</text>
  </EPI>
  <EVENT end="1027" id="V1175248" paragraph="paragraph9" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE10_AGENT_AFFECTED-NONE" start="927" uttnum="87">
    <type>ONT::MODULATE</type>
    <epistemic-modality id="V1175240"/>
    <predicate end="1027" id="V1175248" start="927">
      <type>ONT::MODULATE</type>
      <text>summarize distributions of staining intensities for pTyr176-AKT in different stages of breast cancer</text>
    </predicate>
    <text>summarize distributions of staining intensities for pTyr176-AKT in different stages of breast cancer</text>
  </EVENT>
  <TERM end="991" id="V1174995" paragraph="paragraph9" rule="-SIMPLE-REF" start="987" uttnum="87">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <EPI end="1112" id="V1188436" paragraph="paragraph9" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="1029" uttnum="88">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1188389" role=":FORMAL"/>
    <text>A significant increasing trend of intensity across progression stages was detected</text>
  </EPI>
  <TERM end="1099" id="V1188389" paragraph="paragraph9" rule="-SIMPLE-REF" start="1029" uttnum="88">
    <type>ONT::GEO-OBJECT</type>
    <name>TREND</name>
    <text>A significant increasing trend of intensity across progression stages</text>
  </TERM>
  <TERM end="1284" id="V1201722" paragraph="paragraph9" rule="-SIMPLE-REF" start="1276" uttnum="89">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>D</text>
  </TERM>
  <TERM end="1350" id="V1201766" paragraph="paragraph9" rule="-SIMPLE-REF" start="1319" uttnum="89">
    <type>ONT::PERSON</type>
    <name>INDIVIDUAL</name>
    <text>individuals with breast cancer</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1412" id="V1200706" paragraph="paragraph9" rule="-SIMPLE-REF" start="1407" uttnum="89">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="1486" id="V1202033" paragraph="paragraph9" rule="-SIMPLE-REF" start="1473" uttnum="89">
    <type>ONT::SUBSTANCE</type>
    <name>P</name>
    <text>p = </text>
  </TERM>
  <TERM end="1508" id="V1215685" paragraph="paragraph9" rule="-SIMPLE-REF" start="1500" uttnum="90">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>E</text>
  </TERM>
  <TERM end="1562" id="V1215728" paragraph="paragraph9" rule="-SIMPLE-REF" start="1510" uttnum="90">
    <type>ONT::PATIENT</type>
    <name>PATIENT</name>
    <text>Kaplan–Meier analysis of the breast cancer patients</text>
  </TERM>
  <TERM end="1546" id="V1215710" paragraph="paragraph9" rule="-SIMPLE-REF" start="1532" uttnum="90">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>BREAST</name>
    <text>of the breast</text>
  </TERM>
  <TERM end="1567" id="V1215737" paragraph="paragraph9" rule="-SIMPLE-REF" start="1562" uttnum="90">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>BREAST</name>
    <text>that</text>
  </TERM>
  <TERM end="1623" id="V1219607" paragraph="paragraph9" rule="-SIMPLE-REF" start="1619" uttnum="90">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="6" id="V1233233" paragraph="paragraph10" rule="-ROBUSTPRO" start="3" uttnum="91">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="20" id="V1233252" paragraph="paragraph10" rule="-ROBUSTPRO" start="15" uttnum="91">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>that</text>
  </TERM>
  <EVENT end="34" id="V1233266" paragraph="paragraph10" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="20" uttnum="91">
    <type>ONT::MODULATE</type>
    <predicate end="34" id="V1233266" start="20">
      <type>ONT::MODULATE</type>
      <text>EGF treatment</text>
    </predicate>
    <arg2 id="V1233263" role=":AFFECTED"/>
    <text>EGF treatment</text>
  </EVENT>
  <TERM dbid="UP:P01133" end="24" id="V1233263" paragraph="paragraph10" rule="-SIMPLE-REF" start="20" uttnum="91">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <TERM end="43" id="V1233276" paragraph="paragraph10" rule="-SIMPLE-REF" start="37" uttnum="91">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>MOUSE</name>
    <text>mouse</text>
  </TERM>
  <CC end="134" id="V1233337" paragraph="paragraph10" rule="-RULE5B_AGENT_AFFECTED" start="43" uttnum="91">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1233305" role=":FACTOR"/>
    <arg id="V1233407" role=":OUTCOME"/>
    <text>embryonic fibroblasts (MEFs) resulted in rapid Tyr-phosphorylation of Ack1 as well as Akt1</text>
  </CC>
  <TERM dbid="CO:2000042" end="72" id="V1233305" paragraph="paragraph10" rule="-SIMPLE-REF" start="43" uttnum="91">
    <type>ONT::CELL</type>
    <name>EMBRYONIC-FIBROBLASTS</name>
    <text>embryonic fibroblasts (MEFs)</text>
  </TERM>
  <EVENT end="134" id="V1233407" paragraph="paragraph10" rule="-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="81" uttnum="91">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="134" id="V1233407" start="81">
      <type>ONT::PHOSPHORYLATION</type>
      <text>in rapid Tyr-phosphorylation of Ack1 as well as Akt1</text>
    </predicate>
    <arg2 id="V1233432" role=":AFFECTED"/>
    <arg id="R000214" role=":RESULT"/>
    <site end="134" id="V1233401" start="81">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">in rapid Tyr-phosphorylation of Ack1 as well as Akt1</text>
    </site>
    <text>in rapid Tyr-phosphorylation of Ack1 as well as Akt1</text>
  </EVENT>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="70" id="V1233329" paragraph="paragraph10" rule="-SIMPLE-REF" start="66" uttnum="91">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs</text>
  </TERM>
  <TERM end="134" id="V1233401" paragraph="paragraph10" rule="-SIMPLE-REF" start="81" uttnum="91">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>in rapid Tyr-phosphorylation of Ack1 as well as Akt1</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="118" id="V1233432" paragraph="paragraph10" rule="-SIMPLE-REF" start="110" uttnum="91">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <text>of Ack1</text>
    <not-features>
      <ptm event="V1233407" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM dbid="UP:P31749" end="134" id="V1233540" paragraph="paragraph10" rule="-SIMPLE-REF" start="129" uttnum="91">
    <type>ONT::PROTEIN</type>
    <name>AKT-1</name>
    <text>Akt1</text>
  </TERM>
  <TERM end="194" id="V1248587" paragraph="paragraph10" rule="-SIMPLE-REF" start="191" uttnum="91">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr</text>
  </TERM>
  <TERM end="268" id="V1248708" paragraph="paragraph10" rule="-SIMPLE-REF" start="252" uttnum="91">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">1A</text>
  </TERM>
  <TERM end="332" id="V1256388" paragraph="paragraph10" rule="-SIMPLE-REF" start="279" uttnum="92">
    <type>ONT::HYPOTHESIZE</type>
    <name>HYPOTHESIS</name>
    <text>this hypothesis, we examined whether Ack1 could bind</text>
  </TERM>
  <TERM end="299" id="V1256397" paragraph="paragraph10" rule="-ROBUSTPRO" start="296" uttnum="92">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="332" id="V1256430" paragraph="paragraph10" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="316" uttnum="92">
    <type>ONT::BIND</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::COULD</modality>
    <predicate end="332" id="V1256430" start="316">
      <type>ONT::BIND</type>
      <text>Ack1 could bind</text>
    </predicate>
    <arg1 id="V1256416" role=":AGENT"/>
    <text>Ack1 could bind</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="321" id="V1256416" paragraph="paragraph10" rule="-SIMPLE-REF" start="316" uttnum="92">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="358" id="V1256468" paragraph="paragraph10" rule="-SIMPLE-REF" start="336" uttnum="92">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr-phosphorylate AKT</text>
  </TERM>
  <TERM dbid="CVCL:4W74" end="372" id="V1256481" paragraph="paragraph10" rule="-SIMPLE-REF" start="368" uttnum="92">
    <type>ONT::CELL-LINE</type>
    <name>RTK</name>
    <text>RTK</text>
  </TERM>
  <TERM end="451" id="V1270902" paragraph="paragraph10" rule="-LOGICALOP-REF" start="431" uttnum="93">
    <type>ONT::PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1270918"/>
      <member id="V1270882"/>
      <member id="V1270895"/>
    </aggregate>
    <text normalization="">Akt1, Akt2, and Akt1</text>
  </TERM>
  <TERM dbid="UP:P31749" end="435" id="V1270882" paragraph="paragraph10" rule="-SIMPLE-REF" start="431" uttnum="93">
    <type>ONT::PROTEIN</type>
    <name>AKT-1</name>
    <text>Akt1</text>
  </TERM>
  <TERM dbid="UP:P31751" end="441" id="V1270895" paragraph="paragraph10" rule="-SIMPLE-REF" start="437" uttnum="93">
    <type>ONT::PROTEIN</type>
    <name>AKT-2</name>
    <text>Akt2</text>
  </TERM>
  <TERM dbid="UP:P31749" end="451" id="V1270918" paragraph="paragraph10" rule="-SIMPLE-REF" start="447" uttnum="93">
    <type>ONT::PROTEIN</type>
    <name>AKT-1</name>
    <text>Akt1</text>
  </TERM>
  <TERM dbid="CO:0000057" end="493" id="V1270962" paragraph="paragraph10" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="468" uttnum="93">
    <type>ONT::CELL</type>
    <features>
      <location id="V1270940"/>
    </features>
    <name>FIBROBLASTS</name>
    <text>mouse embryo fibroblasts</text>
  </TERM>
  <TERM end="493" id="V1270934" paragraph="paragraph10" rule="-SIMPLE-REF" start="468" uttnum="93">
    <type>ONT::COMPUTER-INPUT-DEVICE</type>
    <name>MOUSE</name>
    <text>mouse embryo fibroblasts</text>
  </TERM>
  <TERM dbid="BTO:0001233|BTO:0000379" end="481" id="V1270940" paragraph="paragraph10" rule="-SIMPLE-REF" start="474" uttnum="93">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>EMBRYO</name>
    <text>embryo</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="502" id="V1271000" paragraph="paragraph10" rule="-SIMPLE-REF" start="494" uttnum="93">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>MEF1KO,</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="498" id="V1270991" paragraph="paragraph10" rule="-SIMPLE-REF" start="494" uttnum="93">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="510" id="V1271031" paragraph="paragraph10" rule="-SIMPLE-REF" start="502" uttnum="93">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>MEF2KO,</text>
  </TERM>
  <TERM dbid="XFAM:PF00076|UP:Q9P2K5|UP:Q8C854|HGNC:17940|FA:02224" end="506" id="V1271022" paragraph="paragraph10" rule="-SIMPLE-REF" start="502" uttnum="93">
    <type>ONT::GENE-PROTEIN</type>
    <name>MEF-2</name>
    <text>MEF2</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="518" id="V1271063" paragraph="paragraph10" rule="-SIMPLE-REF" start="514" uttnum="93">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="526" id="V1271080" paragraph="paragraph10" rule="-SIMPLE-REF" start="524" uttnum="93">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>KO</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="557" id="V1271101" paragraph="paragraph10" rule="-SIMPLE-REF" start="554" uttnum="93">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM dbid="CVCL:U609|CVCL:4Y48" end="576" id="V1271181" paragraph="paragraph10" rule="-SIMPLE-REF" start="559" uttnum="93">
    <type>ONT::CELL-LINE</type>
    <name>S-1-A</name>
    <text>S1A</text>
  </TERM>
  <TERM dbid="CVCL:U609|CVCL:4Y48" end="642" id="V1280234" paragraph="paragraph10" rule="-SIMPLE-REF" start="578" uttnum="93">
    <type>ONT::CELL-LINE</type>
    <name>S-1-A</name>
    <text>that were treated with EGF, either with or without pretreatment</text>
  </TERM>
  <TERM dbid="UP:P01133" end="606" id="V1280279" paragraph="paragraph10" rule="-SIMPLE-REF" start="601" uttnum="93">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF,</text>
  </TERM>
  <TERM dbid="CHEBI:65329" end="674" id="V1280344" paragraph="paragraph10" rule="-SIMPLE-REF" start="647" uttnum="93">
    <type>ONT::MOLECULE</type>
    <name>LY-294002</name>
    <text>LY294002, a PI3K inhibitor,</text>
  </TERM>
  <TERM dbid="CHEBI:35222" end="673" id="V1280437" paragraph="paragraph10" rule="-SIMPLE-REF" start="657" uttnum="93">
    <type>ONT::CHEMICAL</type>
    <name>INHIBITOR</name>
    <text>a PI3K inhibitor</text>
  </TERM>
  <TERM end="673" id="V1280432" paragraph="paragraph10" rule="-SIMPLE-REF" start="657" uttnum="93">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">a PI3K inhibitor</text>
  </TERM>
  <TERM dbid="UP:P31749" end="705" id="V1291338" paragraph="paragraph10" rule="-SIMPLE-REF" start="684" uttnum="93">
    <type>ONT::PROTEIN</type>
    <name>AKT-1</name>
    <text>that endogenous Akt1</text>
  </TERM>
  <TERM end="715" id="V1291346" paragraph="paragraph10" rule="-SIMPLE-REF" start="706" uttnum="93">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT here</text>
  </TERM>
  <EVENT end="828" id="V1291390" paragraph="paragraph10" rule="-RULE40_AGENT_AFFECTED-RESULT" start="728" uttnum="93">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="828" id="V1291390" start="728">
      <type>ONT::PRODUCE</type>
      <text>Ack1 formed a stable complex which was not abrogated by LY294002 (Fig. 1B)</text>
    </predicate>
    <arg1 id="V1291385" role=":AGENT"/>
    <arg2 id="V1291446" role=":AFFECTED-RESULT"/>
    <text>Ack1 formed a stable complex which was not abrogated by LY294002 (Fig. 1B)</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="733" id="V1291385" paragraph="paragraph10" rule="-SIMPLE-REF" start="728" uttnum="93">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="828" id="V1291446" paragraph="paragraph10" rule="-INEVENT2B,-SIMPLE-REF" start="740" uttnum="93">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <features>
      <inevent>
        <event id="V1291496"/>
      </inevent>
    </features>
    <name>COMPLEX</name>
    <text>a stable complex which was not abrogated by LY294002 (Fig. 1B)</text>
  </TERM>
  <EVENT end="828" id="V1291496" paragraph="paragraph10" rule="-RULE30_AGENT_AFFECTED" start="740" uttnum="93">
    <type>ONT::INHIBIT</type>
    <negation>+</negation>
    <force>ONT::FALSE</force>
    <predicate end="828" id="V1291496" start="740">
      <type>ONT::INHIBIT</type>
      <text>a stable complex which was not abrogated by LY294002 (Fig. 1B)</text>
    </predicate>
    <arg1 id="V1291530" role=":AGENT"/>
    <arg2 id="V1291446" role=":AFFECTED"/>
    <text>a stable complex which was not abrogated by LY294002 (Fig. 1B)</text>
  </EVENT>
  <TERM dbid="CHEBI:65329" end="828" id="V1291530" paragraph="paragraph10" rule="-SIMPLE-REF" start="781" uttnum="93">
    <type>ONT::MOLECULE</type>
    <name>LY-294002</name>
    <text>by LY294002 (Fig. 1B)</text>
  </TERM>
  <TERM end="827" id="V1291584" paragraph="paragraph10" rule="-SIMPLE-REF" start="811" uttnum="93">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">1B</text>
  </TERM>
  <EVENT end="943" id="V1304917" paragraph="paragraph10" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="891" uttnum="94">
    <type>ONT::DECREASE</type>
    <predicate end="943" id="V1304917" start="891">
      <type>ONT::DECREASE</type>
      <text>substantial decrease in AKT Ser473-phosphorylation,</text>
    </predicate>
    <arg2 id="V1304998" role=":AFFECTED"/>
    <text>substantial decrease in AKT Ser473-phosphorylation,</text>
  </EVENT>
  <EVENT end="881" id="V1304882" paragraph="paragraph10" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="863" uttnum="94">
    <type>ONT::INCREASE</type>
    <predicate end="881" id="V1304882" start="863">
      <type>ONT::INCREASE</type>
      <text>LY294002 addition</text>
    </predicate>
    <arg2 id="V1304874" role=":AFFECTED"/>
    <text>LY294002 addition</text>
  </EVENT>
  <TERM dbid="CHEBI:65329" end="872" id="V1304874" paragraph="paragraph10" rule="-SIMPLE-REF" start="863" uttnum="94">
    <type>ONT::MOLECULE</type>
    <name>LY-294002</name>
    <text>LY294002</text>
  </TERM>
  <EVENT end="943" id="V1304998" paragraph="paragraph10" rule="-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="912" uttnum="94">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="943" id="V1304998" start="912">
      <type>ONT::PHOSPHORYLATION</type>
      <text>in AKT Ser473-phosphorylation,</text>
    </predicate>
    <arg2 id="V1304982" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000219"/>
    <site end="943" id="V1304992" start="912">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">in AKT Ser473-phosphorylation,</text>
    </site>
    <text>in AKT Ser473-phosphorylation,</text>
  </EVENT>
  <TERM end="943" id="V1304992" paragraph="paragraph10" rule="-SIMPLE-REF" start="912" uttnum="94">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>in AKT Ser473-phosphorylation,</text>
  </TERM>
  <TERM end="919" id="V1304982" paragraph="paragraph10" rule="-SIMPLE-REF" start="915" uttnum="94">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm event="V1304998" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM dbid="CHEBI:65329" end="981" id="V1305040" paragraph="paragraph10" rule="-ACTIVE3,-SIMPLE-REF" start="954" uttnum="94">
    <type>ONT::MOLECULE</type>
    <features>
      <active>TRUE</active>
    </features>
    <name>LY-294002</name>
    <text>that LY294002 is functional</text>
  </TERM>
  <EVENT end="1015" id="V1319619" paragraph="paragraph10" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="983" uttnum="95">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1015" id="V1319619" start="983">
      <type>ONT::BIND</type>
      <text>Akt2 interacted weakly with Ack1</text>
    </predicate>
    <arg1 id="V1319610" role=":AGENT"/>
    <text>Akt2 interacted weakly with Ack1</text>
  </EVENT>
  <TERM dbid="UP:P31751" end="988" id="V1319610" paragraph="paragraph10" rule="-SIMPLE-REF" start="983" uttnum="95">
    <type>ONT::PROTEIN</type>
    <name>AKT-2</name>
    <text>Akt2</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1015" id="V1319646" paragraph="paragraph10" rule="-SIMPLE-REF" start="1011" uttnum="95">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="UP:Q9Y243" end="1028" id="V1319968" paragraph="paragraph10" rule="-SIMPLE-REF" start="1017" uttnum="95">
    <type>ONT::PROTEIN</type>
    <name>AKT-3</name>
    <text>while Akt3</text>
  </TERM>
  <TERM end="1076" id="V1320108" paragraph="paragraph10" rule="-SIMPLE-REF" start="1053" uttnum="95">
    <type>ONT::SHAPE-OBJECT</type>
    <name>CELL</name>
    <text>the MEF1&amp;amp;2KO cells</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="1061" id="V1320083" paragraph="paragraph10" rule="-SIMPLE-REF" start="1057" uttnum="95">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <TERM end="1109" id="V1320217" paragraph="paragraph10" rule="-SIMPLE-REF" start="1098" uttnum="95">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>the complex</text>
  </TERM>
  <EPI end="147" id="V1331420" paragraph="paragraph11" rule="-RULE50_0_AGENT_NEUTRAL-NEUTRAL" start="111" uttnum="96">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1331389" role=":NEUTRAL"/>
    <text>AKT Tyr-phosphorylation was assessed</text>
  </EPI>
  <EVENT end="87" id="V1331147" paragraph="paragraph11" rule="-RULE60_AGENT_AFFECTED" start="19" uttnum="96">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="87" id="V1331147" start="19">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Ack1 directly phosphorylates AKT, in vitro binding</text>
    </predicate>
    <arg1 id="V1331138" role=":AGENT"/>
    <arg2 id="V1331152" role=":AFFECTED"/>
    <arg id="R000224" role=":RESULT"/>
    <text>Ack1 directly phosphorylates AKT, in vitro binding</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="24" id="V1331138" paragraph="paragraph11" rule="-SIMPLE-REF" start="19" uttnum="96">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="61" id="V1331152" paragraph="paragraph11" rule="-SIMPLE-REF" start="48" uttnum="96">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT,</text>
    <not-features>
      <ptm event="V1331147" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <EVENT end="87" id="V1331270" paragraph="paragraph11" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="48" uttnum="96">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="87" id="V1331270" start="48">
      <type>ONT::BIND</type>
      <text>AKT, in vitro binding</text>
    </predicate>
    <arg1 id="V1331152" role=":AGENT"/>
    <text>AKT, in vitro binding</text>
  </EVENT>
  <TERM end="93" id="V1331289" paragraph="paragraph11" rule="-SIMPLE-REF" start="87" uttnum="96">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAY</name>
    <text>assay</text>
  </TERM>
  <EVENT end="147" id="V1331389" paragraph="paragraph11" rule="-RULE50_0_AGENT_NEUTRAL-EVENT,-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="111" uttnum="96">
    <type>ONT::PHOSPHORYLATION</type>
    <epistemic-modality id="V1331420"/>
    <predicate end="147" id="V1331389" start="111">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT Tyr-phosphorylation was assessed</text>
    </predicate>
    <arg2 id="V1331378" role=":AFFECTED"/>
    <arg id="R000229" role=":RESULT"/>
    <site end="135" id="V1331383" start="111">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">AKT Tyr-phosphorylation</text>
    </site>
    <text>AKT Tyr-phosphorylation was assessed</text>
  </EVENT>
  <TERM end="135" id="V1331383" paragraph="paragraph11" rule="-SIMPLE-REF" start="111" uttnum="96">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>AKT Tyr-phosphorylation</text>
  </TERM>
  <TERM end="115" id="V1331378" paragraph="paragraph11" rule="-SIMPLE-REF" start="111" uttnum="96">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm event="V1331389" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="183" id="V1344743" paragraph="paragraph11" rule="-LOGICALOP-REF" start="149" uttnum="97">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1344739"/>
      <member id="V1344773"/>
    </aggregate>
    <text normalization="">Myc-tagged Ack1 and HA-tagged AKT</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="165" id="V1344739" paragraph="paragraph11" rule="-SIMPLE-REF" start="149" uttnum="97">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Myc-tagged Ack1</text>
  </TERM>
  <TERM end="183" id="V1344773" paragraph="paragraph11" rule="-SIMPLE-REF" start="169" uttnum="97">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">HA-tagged AKT</text>
  </TERM>
  <TERM end="194" id="V1344779" paragraph="paragraph11" rule="-SIMPLE-REF" start="183" uttnum="97">
    <type>ONT::MENTAL-OBJECT</type>
    <name>CONSTRUCTS</name>
    <text>constructs</text>
  </TERM>
  <TERM dbid="GO:0042571" end="248" id="V1344856" paragraph="paragraph11" rule="-SIMPLE-REF" start="239" uttnum="97">
    <type>ONT::PROTEIN</type>
    <name>ANTIBODY</name>
    <text>antibody</text>
  </TERM>
  <TERM end="312" id="V1345002" paragraph="paragraph11" rule="-SIMPLE-REF" start="297" uttnum="97">
    <type>ONT::METHOD</type>
    <name>METHOD</name>
    <text>methods</text>
  </TERM>
  <TERM end="355" id="V1345071" paragraph="paragraph11" rule="-SIMPLE-REF" start="338" uttnum="97">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S1B</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="426" id="V1359288" paragraph="paragraph11" rule="-INEVENT2B,-SIMPLE-REF" start="407" uttnum="98">
    <type>ONT::GENE-PROTEIN</type>
    <features>
      <inevent>
        <event id="V1359274"/>
      </inevent>
    </features>
    <name>ACK-1</name>
    <text>that purified Ack1</text>
  </TERM>
  <EVENT end="426" id="V1359274" paragraph="paragraph11" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="407" uttnum="98">
    <type>ONT::PPEXPT</type>
    <force>ONT::TRUE</force>
    <predicate end="426" id="V1359274" start="407">
      <type>ONT::PPEXPT</type>
      <text>that purified Ack1</text>
    </predicate>
    <arg2 id="V1359288" role=":AFFECTED"/>
    <text>that purified Ack1</text>
  </EVENT>
  <EVENT end="495" id="V1359404" paragraph="paragraph11" rule="-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="465" uttnum="98">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="495" id="V1359404" start="465">
      <type>ONT::PHOSPHORYLATION</type>
      <text>in AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg2 id="V1359388" role=":AFFECTED"/>
    <arg id="R000234" role=":RESULT"/>
    <site end="495" id="V1359398" start="465">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">in AKT Tyr176-phosphorylation</text>
    </site>
    <text>in AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="455" id="V1359321" paragraph="paragraph11" rule="-SIMPLE-REF" start="451" uttnum="98">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="495" id="V1359398" paragraph="paragraph11" rule="-SIMPLE-REF" start="465" uttnum="98">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>in AKT Tyr176-phosphorylation</text>
  </TERM>
  <TERM end="472" id="V1359388" paragraph="paragraph11" rule="-SIMPLE-REF" start="468" uttnum="98">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1359404"/>
    </not-features>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="511" id="V1359419" paragraph="paragraph11" rule="-SIMPLE-REF" start="508" uttnum="98">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="523" id="V1359473" paragraph="paragraph11" rule="-SIMPLE-REF" start="513" uttnum="98">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S1B</text>
  </TERM>
  <TERM end="547" id="V1372846" paragraph="paragraph11" rule="-ROBUSTPRO" start="544" uttnum="99">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="616" id="V1372881" paragraph="paragraph11" rule="-SIMPLE-REF" start="557" uttnum="99">
    <type>ONT::MENTAL-OBJECT</type>
    <name>CONSTRUCT</name>
    <text>GST-Ack construct that harbors kinase, SH3 and CRIB domain</text>
  </TERM>
  <TERM end="565" id="V1373928" paragraph="paragraph11" rule="-EXPLICIT-REF-SEQ0B" start="557" uttnum="99">
    <type>ONT::GENE-PROTEIN</type>
    <components>
      <component id="V1372856"/>
      <component id="V1372864"/>
    </components>
    <text normalization="">GST-Ack</text>
  </TERM>
  <TERM dbid="HGNC:23613|XFAM:PF07648|FA:01669|UP:Q86UG4|XFAM:PF03137" end="565" id="V1372856" paragraph="paragraph11" rule="-EXPLICIT-REF-SEQ0B-TERM" start="557" uttnum="99">
    <type>ONT::GENE-PROTEIN</type>
    <name>GST</name>
    <text>GST-Ack</text>
  </TERM>
  <TERM dbid="HGNC:19297|UP:Q07912" end="565" id="V1372864" paragraph="paragraph11" rule="-SIMPLE-REF" start="561" uttnum="99">
    <type>ONT::GENE</type>
    <name>ACK</name>
    <text>Ack</text>
  </TERM>
  <TERM end="616" id="V1372960" paragraph="paragraph11" rule="-SIMPLE-REF" start="588" uttnum="99">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>kinase, SH3 and CRIB domain</text>
  </TERM>
  <TERM dbid="GO:0016301" end="594" id="V1372925" paragraph="paragraph11" rule="-SIMPLE-REF" start="588" uttnum="99">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM dbid="CVCL:7701|CVCL:M383" end="600" id="V1372938" paragraph="paragraph11" rule="-SIMPLE-REF" start="596" uttnum="99">
    <type>ONT::CELL-LINE</type>
    <name>SH-3</name>
    <text>SH3</text>
  </TERM>
  <TERM end="670" id="V1373089" paragraph="paragraph11" rule="-SIMPLE-REF" start="653" uttnum="99">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S1E</text>
  </TERM>
  <TERM end="689" id="V1373120" paragraph="paragraph11" rule="-SIMPLE-REF" start="686" uttnum="99">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">it</text>
  </TERM>
  <TERM end="760" id="V1373223" paragraph="paragraph11" rule="-SIMPLE-REF" start="700" uttnum="99">
    <type>ONT::BACTERIUM</type>
    <name>E.COLI</name>
    <text>E. coli (Fig. S1E)</text>
  </TERM>
  <TERM end="752" id="V1373280" paragraph="paragraph11" rule="-SIMPLE-REF" start="735" uttnum="99">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S1E</text>
  </TERM>
  <TERM end="857" id="V1386798" paragraph="paragraph11" rule="-SIMPLE-REF" start="792" uttnum="100">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATE</name>
    <text>Androgen-receptor (AR), another Ack1 substrate [26]</text>
  </TERM>
  <EVENT end="871" id="V1386837" paragraph="paragraph11" rule="-RULE50_AGENT_AFFECTED-RESULT-NONE" start="861" uttnum="100">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="871" id="V1386837" start="861">
      <type>ONT::EXPRESS</type>
      <text>expressed</text>
    </predicate>
    <arg2 id="V1386798" role=":AFFECTED"/>
    <text>expressed</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="829" id="V1386791" paragraph="paragraph11" rule="-SIMPLE-REF" start="824" uttnum="100">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="CHEBI:50113" end="800" id="V1386750" paragraph="paragraph11" rule="-SIMPLE-REF" start="792" uttnum="100">
    <type>ONT::CHEMICAL</type>
    <name>ANDROGEN</name>
    <text>Androgen</text>
  </TERM>
  <TERM dbid="GO:0004872" end="810" id="V1386758" paragraph="paragraph11" rule="-SIMPLE-REF" start="801" uttnum="100">
    <type>ONT::PROTEIN</type>
    <name>RECEPTOR</name>
    <text>receptor</text>
  </TERM>
  <TERM dbid="UP:P10275" end="813" id="V1386771" paragraph="paragraph11" rule="-SIMPLE-REF" start="811" uttnum="100">
    <type>ONT::PROTEIN</type>
    <name>AR</name>
    <text>AR</text>
  </TERM>
  <TERM end="912" id="V1386911" paragraph="paragraph11" rule="-SIMPLE-REF" start="874" uttnum="100">
    <type>ONT::MENTAL-OBJECT</type>
    <name>CONSTRUCT</name>
    <text>FLAG-tagged construct in HEK293 cells</text>
  </TERM>
  <TERM dbid="BTO:0000007" end="912" id="V1386998" paragraph="paragraph11" rule="-SIMPLE-REF" start="896" uttnum="100">
    <type>ONT::CELL-LINE</type>
    <name>HEK-293-CELLS</name>
    <text>in HEK293 cells</text>
  </TERM>
  <TERM end="935" id="V1387028" paragraph="paragraph11" rule="-SIMPLE-REF" start="931" uttnum="100">
    <type>ONT::FLAG</type>
    <name>FLAG</name>
    <text>FLAG</text>
  </TERM>
  <TERM end="942" id="V1387046" paragraph="paragraph11" rule="-SIMPLE-REF" start="936" uttnum="100">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>BEADS</name>
    <text>beads</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="958" id="V1387073" paragraph="paragraph11" rule="-SIMPLE-REF" start="955" uttnum="100">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="990" id="V1387120" paragraph="paragraph11" rule="-SIMPLE-REF" start="960" uttnum="100">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S1E, left panel)</text>
  </TERM>
  <TERM end="989" id="V1387157" paragraph="paragraph11" rule="-SIMPLE-REF" start="984" uttnum="100">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>panel</text>
  </TERM>
  <TERM end="1028" id="V1400756" paragraph="paragraph11" rule="-LOGICALOP-REF" start="992" uttnum="101">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="OR">
      <member id="V1400753"/>
      <member id="V1400765"/>
    </aggregate>
    <text normalization="">GST-tagged Ack1 or GST (as control)</text>
  </TERM>
  <TERM end="1055" id="V1400865" paragraph="paragraph11" rule="-SIMPLE-REF" start="1034" uttnum="101">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>BEADS</name>
    <text>to glutathione beads</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1008" id="V1400753" paragraph="paragraph11" rule="-SIMPLE-REF" start="992" uttnum="101">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>GST-tagged Ack1</text>
  </TERM>
  <TERM dbid="HGNC:23613|XFAM:PF07648|FA:01669|UP:Q86UG4|XFAM:PF03137" end="1015" id="V1400765" paragraph="paragraph11" rule="-SIMPLE-REF" start="1011" uttnum="101">
    <type>ONT::GENE-PROTEIN</type>
    <name>GST</name>
    <text>GST</text>
  </TERM>
  <TERM dbid="MESH:D005978" end="1049" id="V1400861" paragraph="paragraph11" rule="-SIMPLE-REF" start="1037" uttnum="101">
    <type>ONT::MOLECULE</type>
    <name>GLUTATHIONE</name>
    <text>glutathione</text>
  </TERM>
  <TERM end="1104" id="V1400961" paragraph="paragraph11" rule="-INEVENT2B,-SIMPLE-REF-MUTATION8" start="1075" uttnum="101">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
      <inevent>
        <event id="V1400915"/>
      </inevent>
    </features>
    <name>MUTANT</name>
    <text>purified AKT or Y176F mutant</text>
  </TERM>
  <EVENT end="1104" id="V1400915" paragraph="paragraph11" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="1075" uttnum="101">
    <type>ONT::PPEXPT</type>
    <force>ONT::TRUE</force>
    <predicate end="1104" id="V1400915" start="1075">
      <type>ONT::PPEXPT</type>
      <text>purified AKT or Y176F mutant</text>
    </predicate>
    <arg2 id="V1400961" role=":AFFECTED"/>
    <text>purified AKT or Y176F mutant</text>
  </EVENT>
  <TERM end="1088" id="V1400922" paragraph="paragraph11" rule="-SIMPLE-REF" start="1084" uttnum="101">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1097" id="V1400958" paragraph="paragraph11" rule="-SIMPLE-REF" start="1091" uttnum="101">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="1116" id="V1400978" paragraph="paragraph11" rule="-LOGICALOP-REF" start="1107" uttnum="101">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="OR">
      <member id="V1400975"/>
      <member id="V1400987"/>
    </aggregate>
    <text normalization="">AKT or AR</text>
  </TERM>
  <TERM end="1111" id="V1400975" paragraph="paragraph11" rule="-SIMPLE-REF" start="1107" uttnum="101">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="UP:P10275" end="1116" id="V1400987" paragraph="paragraph11" rule="-SIMPLE-REF" start="1114" uttnum="101">
    <type>ONT::PROTEIN</type>
    <name>AR</name>
    <text>AR</text>
  </TERM>
  <TERM end="1162" id="V1415616" paragraph="paragraph11" rule="-SIMPLE-REF" start="1144" uttnum="101">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S1B</text>
  </TERM>
  <TERM end="1180" id="V1415635" paragraph="paragraph11" rule="-SIMPLE-REF" start="1172" uttnum="101">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>E</text>
  </TERM>
  <EVENT end="1253" id="V1429412" paragraph="paragraph11" rule="-RULE20C_AGENT_AFFECTED" start="1183" uttnum="102">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1253" id="V1429412" start="1183">
      <type>ONT::BIND</type>
      <text>GST-Ack1 bound to purified AKT and AR but not the Y176F mutant of AKT</text>
    </predicate>
    <arg1 id="V1429393" role=":AGENT"/>
    <arg2 id="V1429462" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000128"/>
    <text>GST-Ack1 bound to purified AKT and AR but not the Y176F mutant of AKT</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1192" id="V1429393" paragraph="paragraph11" rule="-SIMPLE-REF" start="1183" uttnum="102">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>GST-Ack1</text>
    <not-features>
      <bound-to id="V1429462" event="V1429412"/>
    </not-features>
  </TERM>
  <TERM end="1253" id="V1429462" paragraph="paragraph11" rule="-LOGICALOP-REF" start="1198" uttnum="102">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1429458"/>
      <member id="V1429473"/>
    </aggregate>
    <text normalization="">to purified AKT and AR but not the Y176F mutant of AKT</text>
    <not-features>
      <bound-to id="V1429393" event="V1429412"/>
    </not-features>
  </TERM>
  <TERM dbid="HGNC:23613|XFAM:PF07648|FA:01669|UP:Q86UG4|XFAM:PF03137" end="1192" id="V1429380" paragraph="paragraph11" rule="-SIMPLE-REF" start="1183" uttnum="102">
    <type>ONT::GENE-PROTEIN</type>
    <name>GST</name>
    <text>GST-Ack1</text>
  </TERM>
  <TERM end="1214" id="V1429458" paragraph="paragraph11" rule="-INEVENT2B,-SIMPLE-REF" start="1201" uttnum="102">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <inevent>
        <event id="V1429451"/>
      </inevent>
    </features>
    <name>AKT</name>
    <text normalization="">purified AKT</text>
  </TERM>
  <TERM dbid="UP:P10275" end="1253" id="V1429473" paragraph="paragraph11" rule="-SIMPLE-REF" start="1218" uttnum="102">
    <type>ONT::PROTEIN</type>
    <name>AR</name>
    <text>AR but not the Y176F mutant of AKT</text>
  </TERM>
  <EVENT end="1214" id="V1429451" paragraph="paragraph11" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="1201" uttnum="102">
    <type>ONT::PPEXPT</type>
    <force>ONT::TRUE</force>
    <predicate end="1214" id="V1429451" start="1201">
      <type>ONT::PPEXPT</type>
      <text>purified AKT</text>
    </predicate>
    <arg2 id="V1429458" role=":AFFECTED"/>
    <text>purified AKT</text>
  </EVENT>
  <TERM end="1253" id="V1429535" paragraph="paragraph11" rule="-SIMPLE-REF-MUTATION8" start="1229" uttnum="102">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>the Y176F mutant of AKT</text>
  </TERM>
  <TERM end="1239" id="V1429532" paragraph="paragraph11" rule="-SIMPLE-REF" start="1233" uttnum="102">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="1253" id="V1429549" paragraph="paragraph11" rule="-SIMPLE-REF" start="1249" uttnum="102">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1280" id="V1429582" paragraph="paragraph11" rule="-LOGICALOP-REF" start="1269" uttnum="102">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1429578"/>
      <member id="V1429593"/>
    </aggregate>
    <text normalization="">AKT and AR</text>
  </TERM>
  <TERM end="1299" id="V1429629" paragraph="paragraph11" rule="-SIMPLE-REF" start="1284" uttnum="102">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>BINDING</name>
    <text>direct binding</text>
  </TERM>
  <TERM end="1273" id="V1429578" paragraph="paragraph11" rule="-SIMPLE-REF" start="1269" uttnum="102">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="UP:P10275" end="1280" id="V1429593" paragraph="paragraph11" rule="-SIMPLE-REF" start="1277" uttnum="102">
    <type>ONT::PROTEIN</type>
    <name>AR</name>
    <text>AR</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1316" id="V1429663" paragraph="paragraph11" rule="-SIMPLE-REF" start="1311" uttnum="102">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="1332" id="V1429673" paragraph="paragraph11" rule="-SIMPLE-REF" start="1329" uttnum="102">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="1351" id="V1429722" paragraph="paragraph11" rule="-SIMPLE-REF" start="1334" uttnum="102">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S1F</text>
  </TERM>
  <EVENT end="54" id="V1441239" paragraph="paragraph12" rule="-RULE20_AGENT_AFFECTED" start="3" uttnum="103">
    <type>ONT::PPEXPT</type>
    <predicate end="54" id="V1441239" start="3">
      <type>ONT::PPEXPT</type>
      <text>Affinity purification of AKT coexpressed with Ack1</text>
    </predicate>
    <arg1 id="V1441236" role=":AGENT"/>
    <arg2 id="V1441255" role=":AFFECTED"/>
    <text>Affinity purification of AKT coexpressed with Ack1</text>
  </EVENT>
  <EVENT end="54" id="V1441236" paragraph="paragraph12" rule="-RULE20C_AFFECTED_AFFECTED1-LOC5-GD-NONE" start="3" uttnum="103">
    <type>ONT::BIND</type>
    <predicate end="54" id="V1441236" start="3">
      <type>ONT::BIND</type>
      <text>Affinity purification of AKT coexpressed with Ack1</text>
    </predicate>
    <site end="54" id="V1441255" start="25">
      <type>ONT::PROTEIN-FAMILY</type>
      <text normalization="">of AKT coexpressed with Ack1</text>
    </site>
    <text>Affinity purification of AKT coexpressed with Ack1</text>
  </EVENT>
  <TERM end="54" id="V1441255" paragraph="paragraph12" rule="-INEVENT2B,-SIMPLE-REF" start="25" uttnum="103">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <inevent>
        <event id="V1441267"/>
      </inevent>
    </features>
    <name>AKT</name>
    <text normalization="">of AKT coexpressed with Ack1</text>
  </TERM>
  <EVENT end="54" id="V1441267" paragraph="paragraph12" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="25" uttnum="103">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="54" id="V1441267" start="25">
      <type>ONT::EXPRESS</type>
      <text>of AKT coexpressed with Ack1</text>
    </predicate>
    <arg2 id="V1441255" role=":AFFECTED-RESULT"/>
    <site end="54" id="V1441255" start="25">
      <type>ONT::PROTEIN-FAMILY</type>
      <text normalization="">of AKT coexpressed with Ack1</text>
    </site>
    <text>of AKT coexpressed with Ack1</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="54" id="V1441306" paragraph="paragraph12" rule="-SIMPLE-REF" start="49" uttnum="103">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="89" id="V1441393" paragraph="paragraph12" rule="-SIMPLE-REF" start="72" uttnum="103">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S2A</text>
  </TERM>
  <EVENT end="131" id="V1441404" paragraph="paragraph12" rule="-RULE10C_AGENT_AFFECTED-AGENT" start="92" uttnum="103">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="131" id="V1441404" start="92">
      <type>ONT::TRANSLOCATE</type>
      <text>followed by mass spectrometry analysis</text>
    </predicate>
    <arg1 id="V1441469" role=":AGENT"/>
    <text>followed by mass spectrometry analysis</text>
  </EVENT>
  <EPI end="131" id="V1441469" paragraph="paragraph12" rule="-RULE50_0_AGENT_FORMAL-NONE" start="101" uttnum="103">
    <type>ONT::TEST</type>
    <text>by mass spectrometry analysis</text>
  </EPI>
  <EVENT end="221" id="V1441519" paragraph="paragraph12" rule="-RULE60_AGENT_AFFECTED-LOC4-GD-AFFECTED" start="140" uttnum="103">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="221" id="V1441519" start="140">
      <type>ONT::PHOSPHORYLATION</type>
      <text>that AKT was phosphorylated at Tyrosine 176 (Fig. 1C–E)</text>
    </predicate>
    <arg2 id="V1441497" role=":AFFECTED"/>
    <arg id="R000239" role=":RESULT"/>
    <site end="221" id="V1441550" start="171">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyrosine 176 (Fig. 1C–E)</text>
    </site>
    <text>that AKT was phosphorylated at Tyrosine 176 (Fig. 1C–E)</text>
  </EVENT>
  <TERM end="149" id="V1441497" paragraph="paragraph12" rule="-SIMPLE-REF" start="145" uttnum="103">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1441519"/>
    </not-features>
  </TERM>
  <TERM end="221" id="V1441550" paragraph="paragraph12" rule="-SIMPLE-REF" start="171" uttnum="103">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYROSINE-176</name>
    <text>Tyrosine 176 (Fig. 1C–E)</text>
  </TERM>
  <TERM end="204" id="V1440942" paragraph="paragraph12" rule="-SIMPLE-REF" start="202" uttnum="103">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-to>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">1C</text>
  </TERM>
  <TERM end="261" id="V1454355" paragraph="paragraph12" rule="-SIMPLE-REF" start="223" uttnum="104">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176, located in the kinase domain,</text>
  </TERM>
  <TERM end="261" id="V1454435" paragraph="paragraph12" rule="-SIMPLE-REF" start="242" uttnum="104">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>the kinase domain,</text>
  </TERM>
  <TERM dbid="GO:0016301" end="253" id="V1454432" paragraph="paragraph12" rule="-SIMPLE-REF" start="246" uttnum="104">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="401" id="V1454490" paragraph="paragraph12" rule="-SIMPLE-REF" start="294" uttnum="104">
    <type>ONT::ORGANISM</type>
    <name>EUKARYOTES</name>
    <text>unicellular eukaryotes to mammals and within all the three AKT isoforms (Fig. 1F)</text>
  </TERM>
  <TERM end="328" id="V1454517" paragraph="paragraph12" rule="-SIMPLE-REF" start="320" uttnum="104">
    <type>ONT::ANIMAL</type>
    <name>MAMMAL</name>
    <text>mammals</text>
  </TERM>
  <TERM end="357" id="V1454569" paragraph="paragraph12" rule="-SIMPLE-REF" start="353" uttnum="104">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="400" id="V1454632" paragraph="paragraph12" rule="-SIMPLE-REF" start="384" uttnum="104">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">1F</text>
  </TERM>
  <TERM end="444" id="V1467537" paragraph="paragraph12" rule="-SIMPLE-REF" start="403" uttnum="105">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Two other phosphorylation events, Ser473</text>
  </TERM>
  <TERM end="528" id="V1467729" paragraph="paragraph12" rule="-SIMPLE-REF" start="518" uttnum="105">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S2B</text>
  </TERM>
  <TERM end="608" id="V1484243" paragraph="paragraph12" rule="-LOGICALOP-REF" start="585" uttnum="106">
    <type>ONT::MOLECULAR-SITE</type>
    <aggregate operator="AND">
      <member id="V1484239"/>
      <member id="V1484259"/>
    </aggregate>
    <text normalization="">that Tyr176 and Ser473</text>
  </TERM>
  <TERM end="597" id="V1484239" paragraph="paragraph12" rule="-SIMPLE-REF" start="585" uttnum="106">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>that Tyr176</text>
  </TERM>
  <TERM end="608" id="V1484259" paragraph="paragraph12" rule="-SIMPLE-REF" start="601" uttnum="106">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473</text>
  </TERM>
  <TERM end="631" id="V1484341" paragraph="paragraph12" rule="-SIMPLE-REF" start="623" uttnum="106">
    <type>ONT::AREA-DEF-BY-USE</type>
    <name>REGION</name>
    <text>regions</text>
  </TERM>
  <EVENT end="703" id="V1484380" paragraph="paragraph12" rule="-RULE60_AGENT_AFFECTED-LOC7-GD-NONE" start="677" uttnum="106">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="703" id="V1484380" start="677">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation at Tyr176</text>
    </predicate>
    <site end="703" id="V1484408" start="696">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176</text>
    </site>
    <text>phosphorylation at Tyr176</text>
  </EVENT>
  <TERM end="703" id="V1484408" paragraph="paragraph12" rule="-SIMPLE-REF" start="696" uttnum="106">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <TERM end="782" id="V1484522" paragraph="paragraph12" rule="-SIMPLE-REF" start="773" uttnum="106">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the loop</text>
  </TERM>
  <TERM end="799" id="V1484549" paragraph="paragraph12" rule="-SIMPLE-REF" start="792" uttnum="106">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473</text>
  </TERM>
  <EVENT end="757" id="V1484479" paragraph="paragraph12" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="723" uttnum="106">
    <type>ONT::TRANSFORM</type>
    <predicate end="757" id="V1484479" start="723">
      <type>ONT::TRANSFORM</type>
      <text>substantial conformational change</text>
    </predicate>
    <text>substantial conformational change</text>
  </EVENT>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="815" id="V1484559" paragraph="paragraph12" rule="-SIMPLE-REF" start="812" uttnum="106">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM dbid="EFO:0005838|CVCL:Z233" end="833" id="V1484590" paragraph="paragraph12" rule="-SIMPLE-REF" start="817" uttnum="106">
    <type>ONT::CELL-LINE</type>
    <name>S-3</name>
    <text>S3</text>
  </TERM>
  <TERM dbid="EFO:0005838|CVCL:Z233" end="910" id="V1499670" paragraph="paragraph12" rule="-SIMPLE-REF" start="905" uttnum="107">
    <type>ONT::CELL-LINE</type>
    <name>S-3</name>
    <text>that</text>
  </TERM>
  <EVENT end="963" id="V1499687" paragraph="paragraph12" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="920" uttnum="107">
    <type>ONT::ACTIVATE</type>
    <predicate end="963" id="V1499687" start="920">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation (or Ser473 phosphorylation,</text>
    </predicate>
    <arg2 id="V1499684" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000434"/>
    <text>AKT activation (or Ser473 phosphorylation,</text>
  </EVENT>
  <EVENT end="884" id="V1499625" paragraph="paragraph12" rule="-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="857" uttnum="107">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="884" id="V1499625" start="857">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg2 id="V1499609" role=":AFFECTED"/>
    <arg id="R000244" role=":RESULT"/>
    <site end="884" id="V1499619" start="857">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">AKT Tyr176-phosphorylation</text>
    </site>
    <text>AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="884" id="V1499619" paragraph="paragraph12" rule="-SIMPLE-REF" start="857" uttnum="107">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>AKT Tyr176-phosphorylation</text>
  </TERM>
  <TERM end="861" id="V1499609" paragraph="paragraph12" rule="-SIMPLE-REF" start="857" uttnum="107">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm event="V1499625" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="924" id="V1499684" paragraph="paragraph12" rule="-SIMPLE-REF" start="920" uttnum="107">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="961" id="V1499712" paragraph="paragraph12" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="939" uttnum="107">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="961" id="V1499712" start="939">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Ser473 phosphorylation</text>
    </predicate>
    <site end="946" id="V1499709" start="939">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Ser473</text>
    </site>
    <text>Ser473 phosphorylation</text>
  </EVENT>
  <TERM end="946" id="V1499709" paragraph="paragraph12" rule="-SIMPLE-REF" start="939" uttnum="107">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473</text>
  </TERM>
  <EVENT end="1099" id="V1514028" paragraph="paragraph12" rule="-RULE40_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="1018" uttnum="107">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="1099" id="V1514028" start="1018">
      <type>ONT::PRODUCE</type>
      <text>generate AKT phospho-tyrosine (Y176F) mutant (Fig. S4A)</text>
    </predicate>
    <arg2 id="V1514092" role=":AFFECTED-RESULT"/>
    <text>generate AKT phospho-tyrosine (Y176F) mutant (Fig. S4A)</text>
  </EVENT>
  <TERM end="1099" id="V1514092" paragraph="paragraph12" rule="-EXPLICIT-REF4" start="1027" uttnum="107">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>AKT</name>
    <text normalization="">AKT phospho-tyrosine (Y176F) mutant (Fig. S4A)</text>
  </TERM>
  <TERM end="1054" id="V1514086" paragraph="paragraph12" rule="-SIMPLE-REF" start="1049" uttnum="107">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="1098" id="V1514183" paragraph="paragraph12" rule="-SIMPLE-REF" start="1081" uttnum="107">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S4A</text>
  </TERM>
  <TERM end="1111" id="V1529021" paragraph="paragraph12" rule="-SIMPLE-REF" start="1105" uttnum="108">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <EVENT end="1231" id="V1529278" paragraph="paragraph12" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="1209" uttnum="108">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1231" id="V1529278" start="1209">
      <type>ONT::BIND</type>
      <text>to interact with Ack1</text>
    </predicate>
    <arg2 id="V1529303" role=":AFFECTED"/>
    <text>to interact with Ack1</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1146" id="V1529064" paragraph="paragraph12" rule="-SIMPLE-REF" start="1141" uttnum="108">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="CHEBI:52214" end="1170" id="V1529138" paragraph="paragraph12" rule="-SIMPLE-REF" start="1161" uttnum="108">
    <type>ONT::CHEMICAL</type>
    <name>LIGAND</name>
    <text>of ligand</text>
  </TERM>
  <TERM dbid="CHEBI:52214" end="1202" id="V1529231" paragraph="paragraph12" rule="-SIMPLE-REF" start="1195" uttnum="108">
    <type>ONT::CHEMICAL</type>
    <name>LIGAND</name>
    <text>ligand</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1231" id="V1529303" paragraph="paragraph12" rule="-SIMPLE-REF" start="1221" uttnum="108">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>with Ack1</text>
  </TERM>
  <EVENT end="1258" id="V1529370" paragraph="paragraph12" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="1244" uttnum="108">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="1258" id="V1529370" start="1244">
      <type>ONT::DECREASE</type>
      <text>decreased AKT</text>
    </predicate>
    <arg2 id="V1529377" role=":AFFECTED"/>
    <text>decreased AKT</text>
  </EVENT>
  <TERM end="1258" id="V1529377" paragraph="paragraph12" rule="-SIMPLE-REF" start="1254" uttnum="108">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1261" id="V1528869" paragraph="paragraph12" rule="-SIMPLE-REF" start="1258" uttnum="108">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr</text>
  </TERM>
  <TERM dbid="GO:0016310" end="1283" id="V1528885" paragraph="paragraph12" rule="-SIMPLE-REF" start="1262" uttnum="108">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>PHOSPHORYLATIONS</name>
    <text>Ser-phosphorylations</text>
  </TERM>
  <TERM end="1283" id="V1528877" paragraph="paragraph12" rule="-SIMPLE-REF" start="1262" uttnum="108">
    <type>ONT::AMINO-ACID</type>
    <name>SER</name>
    <text>Ser-phosphorylations</text>
  </TERM>
  <TERM end="1317" id="V1529416" paragraph="paragraph12" rule="-SIMPLE-REF" start="1301" uttnum="108">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-to>
        <aa>
          <name>Glycine</name>
          <code>G</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">1G</text>
  </TERM>
  <TERM end="1324" id="V1529422" paragraph="paragraph12" rule="-SIMPLE-REF" start="1319" uttnum="108">
    <type>ONT::LANE</type>
    <name>LANE</name>
    <text>lane</text>
  </TERM>
  <EPI end="1374" id="V1543994" paragraph="paragraph12" rule="-RULE50_0_AGENT_FORMAL-NONE" start="1328" uttnum="109">
    <type>ONT::TEST</type>
    <arg2 id="V1544015" role=":NEUTRAL"/>
    <text>Flow cytometric analysis of EGF treated cells</text>
  </EPI>
  <TERM end="1374" id="V1544015" paragraph="paragraph12" rule="-INEVENT2B,-SIMPLE-REF" start="1353" uttnum="109">
    <type>ONT::CELL</type>
    <features>
      <inevent>
        <event id="V1544011"/>
      </inevent>
    </features>
    <name>CELL</name>
    <text>of EGF treated cells</text>
  </TERM>
  <TERM dbid="UP:P01133" end="1360" id="V1544006" paragraph="paragraph12" rule="-SIMPLE-REF" start="1356" uttnum="109">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <EVENT end="1374" id="V1544011" paragraph="paragraph12" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1353" uttnum="109">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1374" id="V1544011" start="1353">
      <type>ONT::MODULATE</type>
      <text>of EGF treated cells</text>
    </predicate>
    <arg2 id="V1544015" role=":AFFECTED"/>
    <text>of EGF treated cells</text>
  </EVENT>
  <EVENT end="1443" id="V1544109" paragraph="paragraph12" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="1408" uttnum="109">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1443" id="V1544109" start="1408">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Ser473-phosphorylation in MEF1&amp;amp;</text>
    </predicate>
    <site end="1414" id="V1544103" start="1408">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Ser473</text>
    </site>
    <text>Ser473-phosphorylation in MEF1&amp;amp;</text>
  </EVENT>
  <TERM end="1414" id="V1544103" paragraph="paragraph12" rule="-SIMPLE-REF" start="1408" uttnum="109">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="1438" id="V1544180" paragraph="paragraph12" rule="-SIMPLE-REF" start="1434" uttnum="109">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <TERM end="1453" id="V1544206" paragraph="paragraph12" rule="-SIMPLE-REF" start="1443" uttnum="109">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>2KO cells</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="1447" id="V1544197" paragraph="paragraph12" rule="-SIMPLE-REF" start="1444" uttnum="109">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>KO</text>
  </TERM>
  <TERM end="1470" id="V1544251" paragraph="paragraph12" rule="-SIMPLE-REF" start="1464" uttnum="109">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="1489" id="V1544323" paragraph="paragraph12" rule="-SIMPLE-REF" start="1485" uttnum="109">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="1505" id="V1544334" paragraph="paragraph12" rule="-SIMPLE-REF" start="1502" uttnum="109">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM dbid="CVCL:J416" end="1524" id="V1544374" paragraph="paragraph12" rule="-SIMPLE-REF" start="1507" uttnum="109">
    <type>ONT::CELL-LINE</type>
    <name>|1-H|</name>
    <text>1H</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="1543" id="V1544396" paragraph="paragraph12" rule="-SIMPLE-REF" start="1540" uttnum="109">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="1562" id="V1544450" paragraph="paragraph12" rule="-SIMPLE-REF" start="1545" uttnum="109">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S4B</text>
  </TERM>
  <TERM end="1579" id="V1557161" paragraph="paragraph12" rule="-SIMPLE-REF" start="1565" uttnum="110">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>These results</text>
  </TERM>
  <CC end="1664" id="V1557228" paragraph="paragraph12" rule="-RULE5B_AGENT_AFFECTED" start="1585" uttnum="110">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1557216" role=":FACTOR"/>
    <arg id="V1557298" role=":OUTCOME"/>
    <text>that Ack1 mediated AKT Tyr-phosphorylation results in subsequent AKT activation</text>
  </CC>
  <EVENT end="1628" id="V1557216" paragraph="paragraph12" rule="-INEVENT2B,-RULE60_AGENT_AFFECTED-LOC11" start="1590" uttnum="110">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1628" id="V1557216" start="1590">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Ack1 mediated AKT Tyr-phosphorylation</text>
    </predicate>
    <arg1 id="V1557195" role=":AGENT"/>
    <arg2 id="V1557205" role=":AFFECTED"/>
    <arg id="R000249" role=":RESULT"/>
    <site end="1628" id="V1557210" start="1590">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Ack1 mediated AKT Tyr-phosphorylation</text>
    </site>
    <text>Ack1 mediated AKT Tyr-phosphorylation</text>
  </EVENT>
  <EVENT end="1664" id="V1557298" paragraph="paragraph12" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1636" uttnum="110">
    <type>ONT::ACTIVATE</type>
    <predicate end="1664" id="V1557298" start="1636">
      <type>ONT::ACTIVATE</type>
      <text>in subsequent AKT activation</text>
    </predicate>
    <arg2 id="V1557294" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000439"/>
    <text>in subsequent AKT activation</text>
  </EVENT>
  <TERM end="1628" id="V1557210" paragraph="paragraph12" rule="-SIMPLE-REF" start="1590" uttnum="110">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Ack1 mediated AKT Tyr-phosphorylation</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1595" id="V1557195" paragraph="paragraph12" rule="-SIMPLE-REF" start="1590" uttnum="110">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <EVENT end="1628" id="V1557200" paragraph="paragraph12" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1590" uttnum="110">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1628" id="V1557200" start="1590">
      <type>ONT::MODULATE</type>
      <text>Ack1 mediated AKT Tyr-phosphorylation</text>
    </predicate>
    <arg2 id="V1557216" role=":AFFECTED"/>
    <text>Ack1 mediated AKT Tyr-phosphorylation</text>
  </EVENT>
  <TERM end="1608" id="V1557205" paragraph="paragraph12" rule="-SIMPLE-REF" start="1604" uttnum="110">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm event="V1557216" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="1654" id="V1557294" paragraph="paragraph12" rule="-SIMPLE-REF" start="1650" uttnum="110">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="56" id="V1574318" paragraph="paragraph13" rule="-SIMPLE-REF" start="15" uttnum="111">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>domains involved in Ack1-AKT interaction,</text>
  </TERM>
  <EVENT end="55" id="V1574406" paragraph="paragraph13" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="32" uttnum="111">
    <type>ONT::BIND</type>
    <predicate end="55" id="V1574406" start="32">
      <type>ONT::BIND</type>
      <text>in Ack1-AKT interaction</text>
    </predicate>
    <arg1 id="V1574395" role=":AGENT"/>
    <text>in Ack1-AKT interaction</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="55" id="V1574387" paragraph="paragraph13" rule="-SIMPLE-REF" start="32" uttnum="111">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>in Ack1-AKT interaction</text>
  </TERM>
  <TERM end="44" id="V1574395" paragraph="paragraph13" rule="-SIMPLE-REF" start="40" uttnum="111">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="EFO:0004014" end="142" id="V1587616" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF" start="57" uttnum="111">
    <type>ONT::PROCESS</type>
    <features>
      <inevent>
        <event id="V1587670"/>
      </inevent>
    </features>
    <name>DELETIONS</name>
    <text>various deletions of Ack1 and AKT were generated (Fig. S4A)</text>
  </TERM>
  <EVENT end="106" id="V1587670" paragraph="paragraph13" rule="-RULE40A_AGENT_AFFECTED-NONE" start="96" uttnum="111">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="106" id="V1587670" start="96">
      <type>ONT::PRODUCE</type>
      <text>generated</text>
    </predicate>
    <arg2 id="V1587616" role=":AFFECTED-RESULT"/>
    <text>generated</text>
  </EVENT>
  <TERM end="91" id="V1587637" paragraph="paragraph13" rule="-LOGICALOP-REF" start="78" uttnum="111">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1587633"/>
      <member id="V1587648"/>
    </aggregate>
    <text normalization="">Ack1 and AKT</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="83" id="V1587633" paragraph="paragraph13" rule="-SIMPLE-REF" start="78" uttnum="111">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="91" id="V1587648" paragraph="paragraph13" rule="-SIMPLE-REF" start="87" uttnum="111">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="141" id="V1587757" paragraph="paragraph13" rule="-SIMPLE-REF" start="124" uttnum="111">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S4A</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="148" id="V1591168" paragraph="paragraph13" rule="-SIMPLE-REF" start="144" uttnum="112">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <EVENT end="231" id="V1591229" paragraph="paragraph13" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="153" uttnum="112">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="231" id="V1591229" start="153">
      <type>ONT::TRANSFORM</type>
      <text>2KO cells were co-transfected with HA-tagged AKT deletions and activated Ack1</text>
    </predicate>
    <arg1 id="V1591194" role=":AFFECTED"/>
    <text>2KO cells were co-transfected with HA-tagged AKT deletions and activated Ack1</text>
  </EVENT>
  <TERM end="163" id="V1591194" paragraph="paragraph13" rule="-SIMPLE-REF" start="153" uttnum="112">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>2KO cells</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="157" id="V1591185" paragraph="paragraph13" rule="-SIMPLE-REF" start="154" uttnum="112">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>KO</text>
  </TERM>
  <TERM dbid="EFO:0004014" end="212" id="V1591286" paragraph="paragraph13" rule="-SIMPLE-REF" start="188" uttnum="112">
    <type>ONT::PROCESS</type>
    <name>DELETIONS</name>
    <text>HA-tagged AKT deletions</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="231" id="V1591313" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF" start="216" uttnum="112">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <TERM end="202" id="V1591269" paragraph="paragraph13" rule="-SIMPLE-REF" start="198" uttnum="112">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <EVENT end="231" id="V1591301" paragraph="paragraph13" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="216" uttnum="112">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="231" id="V1591301" start="216">
      <type>ONT::ACTIVATE</type>
      <text>activated Ack1</text>
    </predicate>
    <arg2 id="V1591313" role=":RESULT"/>
    <arg id="R000047" role=":AFFECTED"/>
    <text>activated Ack1</text>
  </EVENT>
  <EVENT end="281" id="V1606821" paragraph="paragraph13" rule="-INEVENT2B,-RULE20_AFFECTED_AFFECTED1-NONE" start="241" uttnum="113">
    <type>ONT::PPEXPT</type>
    <predicate end="281" id="V1606821" start="241">
      <type>ONT::PPEXPT</type>
      <text>Immunoprecipitation using HA antibodies</text>
    </predicate>
    <text>Immunoprecipitation using HA antibodies</text>
  </EVENT>
  <CC end="281" id="V1606838" paragraph="paragraph13" rule="-RULE5B_AGENT_AFFECTED" start="241" uttnum="113">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1606821" role=":FACTOR"/>
    <arg id="V1606855" role=":OUTCOME"/>
    <text>Immunoprecipitation using HA antibodies</text>
  </CC>
  <TERM dbid="GO:0042571" end="281" id="V1606855" paragraph="paragraph13" rule="-SIMPLE-REF" start="267" uttnum="113">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>HA antibodies</text>
  </TERM>
  <TERM dbid="XFAM:PF03457.11" end="270" id="V1606843" paragraph="paragraph13" rule="-SIMPLE-REF" start="267" uttnum="113">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>HA</name>
    <text>HA</text>
  </TERM>
  <TERM dbid="GO:0042571" end="329" id="V1606962" paragraph="paragraph13" rule="-SIMPLE-REF" start="318" uttnum="113">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>antibodies</text>
  </TERM>
  <TERM end="341" id="V1606990" paragraph="paragraph13" rule="-SIMPLE-REF" start="338" uttnum="113">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr</text>
  </TERM>
  <EVENT end="419" id="V1606996" paragraph="paragraph13" rule="-RULE60_AGENT_AFFECTED-LOC5-GD-NONE" start="342" uttnum="113">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="419" id="V1606996" start="342">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of full-length AKT and AKT lacking carboxy terminus (ΔCT-AKT)</text>
    </predicate>
    <site end="358" id="V1607500" start="338">
      <type>ONT::REFERENTIAL-SEM</type>
      <text normalization="">Tyr-phosphorylation</text>
    </site>
    <text>phosphorylation of full-length AKT and AKT lacking carboxy terminus (ΔCT-AKT)</text>
  </EVENT>
  <TERM end="419" id="V1607055" paragraph="paragraph13" rule="-LOGICALOP-REF" start="361" uttnum="113">
    <type>ONT::PROTEIN-FAMILY</type>
    <aggregate operator="AND">
      <member id="V1607051"/>
      <member id="V1607066"/>
    </aggregate>
    <text normalization="AKT">full-length AKT and AKT lacking carboxy terminus (ΔCT-AKT)</text>
  </TERM>
  <TERM end="377" id="V1607051" paragraph="paragraph13" rule="-SIMPLE-REF" start="361" uttnum="113">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">full-length AKT</text>
  </TERM>
  <TERM end="419" id="V1607066" paragraph="paragraph13" rule="-SIMPLE-REF" start="381" uttnum="113">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT lacking carboxy terminus (ΔCT-AKT)</text>
  </TERM>
  <TERM end="419" id="V1607078" paragraph="paragraph13" rule="-SIMPLE-REF" start="393" uttnum="113">
    <type>ONT::TERMINUS</type>
    <name>TERMINUS</name>
    <text>carboxy terminus (ΔCT-AKT)</text>
  </TERM>
  <TERM dbid="CHEBI:46883" end="401" id="V1607075" paragraph="paragraph13" rule="-SIMPLE-REF" start="393" uttnum="113">
    <type>ONT::MOLECULE</type>
    <name>CARBOXY</name>
    <text>carboxy</text>
  </TERM>
  <TERM end="418" id="V1607113" paragraph="paragraph13" rule="-SIMPLE-REF" start="411" uttnum="113">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">ΔCT-AKT</text>
  </TERM>
  <TERM end="539" id="V1618030" paragraph="paragraph13" rule="-SIMPLE-REF" start="430" uttnum="113">
    <type>ONT::MENTAL-OBJECT</type>
    <name>CONSTRUCT</name>
    <text>AKT deletion construct lacking the PH domain (ΔPH-AKT) exhibited significant decrease in Tyr-phosphorylation</text>
  </TERM>
  <EVENT end="539" id="V1618017" paragraph="paragraph13" rule="-RULE10_AGENT_AFFECTED-AGENT" start="430" uttnum="113">
    <type>ONT::MODULATE</type>
    <predicate end="539" id="V1618017" start="430">
      <type>ONT::MODULATE</type>
      <text>AKT deletion construct lacking the PH domain (ΔPH-AKT) exhibited significant decrease in Tyr-phosphorylation</text>
    </predicate>
    <arg1 id="V1618013" role=":AGENT"/>
    <text>AKT deletion construct lacking the PH domain (ΔPH-AKT) exhibited significant decrease in Tyr-phosphorylation</text>
  </EVENT>
  <EVENT end="539" id="V1618120" paragraph="paragraph13" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="453" uttnum="113">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="539" id="V1618120" start="453">
      <type>ONT::TRANSFORM</type>
      <text>lacking the PH domain (ΔPH-AKT) exhibited significant decrease in Tyr-phosphorylation</text>
    </predicate>
    <arg2 id="V1618128" role=":FORMAL"/>
    <text>lacking the PH domain (ΔPH-AKT) exhibited significant decrease in Tyr-phosphorylation</text>
  </EVENT>
  <TERM end="434" id="V1618013" paragraph="paragraph13" rule="-SIMPLE-REF" start="430" uttnum="113">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <EVENT end="516" id="V1618128" paragraph="paragraph13" rule="-RULE20_AGENT_AFFECTED-NONE" start="495" uttnum="113">
    <type>ONT::DECREASE</type>
    <predicate end="516" id="V1618128" start="495">
      <type>ONT::DECREASE</type>
      <text>significant decrease</text>
    </predicate>
    <text>significant decrease</text>
  </EVENT>
  <TERM dbid="XFAM:PF14593.3" end="485" id="V1618069" paragraph="paragraph13" rule="-SIMPLE-REF" start="461" uttnum="113">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>PH-DOMAIN</name>
    <text normalization="">the PH domain (ΔPH-AKT)</text>
  </TERM>
  <TERM end="483" id="V1618099" paragraph="paragraph13" rule="-SIMPLE-REF" start="476" uttnum="113">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">ΔPH-AKT</text>
  </TERM>
  <EVENT end="539" id="V1618199" paragraph="paragraph13" rule="-RULE60_AGENT_AFFECTED-LOC11-NONE" start="519" uttnum="113">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="539" id="V1618199" start="519">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr-phosphorylation</text>
    </predicate>
    <site end="539" id="V1618193" start="519">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Tyr-phosphorylation</text>
    </site>
    <text>Tyr-phosphorylation</text>
  </EVENT>
  <TERM end="539" id="V1618193" paragraph="paragraph13" rule="-SIMPLE-REF" start="519" uttnum="113">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr-phosphorylation</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="555" id="V1618217" paragraph="paragraph13" rule="-SIMPLE-REF" start="552" uttnum="113">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="586" id="V1618285" paragraph="paragraph13" rule="-SIMPLE-REF" start="557" uttnum="113">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S4C, top panel)</text>
  </TERM>
  <TERM end="585" id="V1618299" paragraph="paragraph13" rule="-SIMPLE-REF" start="576" uttnum="113">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panel</text>
  </TERM>
  <EVENT end="618" id="V1627938" paragraph="paragraph13" rule="-INEVENT2B,-RULE60_AGENT_AFFECTED-NONE" start="588" uttnum="114">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="618" id="V1627938" start="588">
      <type>ONT::PHOSPHORYLATION</type>
      <text>The decreased phosphorylation</text>
    </predicate>
    <text>The decreased phosphorylation</text>
  </EVENT>
  <EVENT end="618" id="V1627933" paragraph="paragraph13" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="588" uttnum="114">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="618" id="V1627933" start="588">
      <type>ONT::DECREASE</type>
      <text>The decreased phosphorylation</text>
    </predicate>
    <arg2 id="V1627938" role=":AFFECTED"/>
    <text>The decreased phosphorylation</text>
  </EVENT>
  <EVENT end="710" id="V1627954" paragraph="paragraph13" rule="-RULE10_AGENT_AFFECTED-AGENT" start="621" uttnum="114">
    <type>ONT::MODULATE</type>
    <predicate end="710" id="V1627954" start="621">
      <type>ONT::MODULATE</type>
      <text>AKT deletion construct lacking PH domain could be due to poor binding with activated Ack1</text>
    </predicate>
    <arg1 id="V1627950" role=":AGENT"/>
    <text>AKT deletion construct lacking PH domain could be due to poor binding with activated Ack1</text>
  </EVENT>
  <TERM end="625" id="V1627950" paragraph="paragraph13" rule="-SIMPLE-REF" start="621" uttnum="114">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="662" id="V1627970" paragraph="paragraph13" rule="-SIMPLE-REF" start="634" uttnum="114">
    <type>ONT::MENTAL-OBJECT</type>
    <name>CONSTRUCT</name>
    <text>construct lacking PH domain</text>
  </TERM>
  <TERM dbid="XFAM:PF14593.3" end="662" id="V1627999" paragraph="paragraph13" rule="-SIMPLE-REF" start="652" uttnum="114">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>PH-DOMAIN</name>
    <text normalization="">PH domain</text>
  </TERM>
  <EVENT end="710" id="V1628078" paragraph="paragraph13" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="678" uttnum="114">
    <type>ONT::BIND</type>
    <predicate end="710" id="V1628078" start="678">
      <type>ONT::BIND</type>
      <text>poor binding with activated Ack1</text>
    </predicate>
    <arg2 id="V1628112" role=":AFFECTED"/>
    <text>poor binding with activated Ack1</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="710" id="V1628112" paragraph="paragraph13" rule="-INEVENT2B,-SIMPLE-REF" start="691" uttnum="114">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>with activated Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="710" id="V1628101" paragraph="paragraph13" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="691" uttnum="114">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="710" id="V1628101" start="691">
      <type>ONT::ACTIVATE</type>
      <text>with activated Ack1</text>
    </predicate>
    <arg2 id="V1628112" role=":RESULT"/>
    <arg id="R000052" role=":AFFECTED"/>
    <text>with activated Ack1</text>
  </EVENT>
  <EPI end="757" id="V1639315" paragraph="paragraph13" rule="-RULE50_0_AGENT_NEUTRAL-NEUTRAL" start="712" uttnum="115">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1639327" role=":NEUTRAL"/>
    <text>To assess this interaction in further detail,</text>
  </EPI>
  <EVENT end="757" id="V1639327" paragraph="paragraph13" rule="-RULE50_0_AGENT_NEUTRAL-EVENT,-RULE20C_AFFECTED_AFFECTED1-NONE" start="712" uttnum="115">
    <type>ONT::BIND</type>
    <epistemic-modality id="V1639315"/>
    <predicate end="757" id="V1639327" start="712">
      <type>ONT::BIND</type>
      <text>To assess this interaction in further detail,</text>
    </predicate>
    <text>To assess this interaction in further detail,</text>
  </EVENT>
  <TERM end="756" id="V1639393" paragraph="paragraph13" rule="-SIMPLE-REF" start="742" uttnum="115">
    <type>ONT::INFORMATION-FUNCTION-OBJECT</type>
    <name>DETAIL</name>
    <text>further detail</text>
  </TERM>
  <TERM end="792" id="V1653180" paragraph="paragraph13" rule="-SIMPLE-REF" start="758" uttnum="115">
    <type>ONT::PROCEDURE</type>
    <name>EXPERIMENT</name>
    <text>co-immunoprecipitation experiment</text>
  </TERM>
  <EVENT end="881" id="V1654138" paragraph="paragraph13" rule="-RULE20C_AGENT_AFFECTED" start="824" uttnum="116">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="881" id="V1654138" start="824">
      <type>ONT::BIND</type>
      <text>in contrast to AKT or ΔCT-AKT, ΔPH-AKT weakly binds Ack1</text>
    </predicate>
    <arg1 id="V1654117" role=":AGENT"/>
    <arg2 id="V1654152" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000137"/>
    <text>in contrast to AKT or ΔCT-AKT, ΔPH-AKT weakly binds Ack1</text>
  </EVENT>
  <TERM end="863" id="V1654117" paragraph="paragraph13" rule="-SIMPLE-REF" start="855" uttnum="116">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">ΔPH-AKT</text>
    <not-features>
      <bound-to id="V1654152" event="V1654138"/>
    </not-features>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="881" id="V1654152" paragraph="paragraph13" rule="-SIMPLE-REF" start="876" uttnum="116">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <not-features>
      <bound-to id="V1654117" event="V1654138"/>
    </not-features>
  </TERM>
  <TERM end="853" id="V1654043" paragraph="paragraph13" rule="-LOGICALOP-REF" start="839" uttnum="116">
    <type>ONT::PROTEIN-FAMILY</type>
    <aggregate operator="OR">
      <member id="V1654040"/>
      <member id="V1654074"/>
    </aggregate>
    <text normalization="AKT">AKT or ΔCT-AKT</text>
  </TERM>
  <TERM end="843" id="V1654040" paragraph="paragraph13" rule="-SIMPLE-REF" start="839" uttnum="116">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="853" id="V1654074" paragraph="paragraph13" rule="-SIMPLE-REF" start="846" uttnum="116">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">ΔCT-AKT</text>
  </TERM>
  <TERM end="928" id="V1654226" paragraph="paragraph13" rule="-SIMPLE-REF" start="899" uttnum="116">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S4D, top panel)</text>
  </TERM>
  <TERM end="927" id="V1654240" paragraph="paragraph13" rule="-SIMPLE-REF" start="918" uttnum="116">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panel</text>
  </TERM>
  <TERM end="933" id="V1668239" paragraph="paragraph13" rule="-ROBUSTPRO" start="930" uttnum="117">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="971" id="V1668299" paragraph="paragraph13" rule="-SIMPLE-REF" start="956" uttnum="117">
    <type>ONT::RESIDUE</type>
    <name>RESIDUE</name>
    <text>Tyr176 residue</text>
  </TERM>
  <CC end="1031" id="V1668386" paragraph="paragraph13" rule="-NECESSARY1" start="956" uttnum="117">
    <type>ONT::DEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V1668299" role=":FACTOR"/>
    <arg id="V1668420" role=":OUTCOME"/>
    <text>Tyr176 residue in AKT kinase domain is necessary for Ack1/AKT interaction,</text>
  </CC>
  <TERM end="963" id="V1668296" paragraph="paragraph13" rule="-SIMPLE-REF" start="956" uttnum="117">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <TERM end="992" id="V1668364" paragraph="paragraph13" rule="-EXPLICIT-REF1" start="974" uttnum="117">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>AKT</name>
    <assoc-with id="V1668356"/>
    <text>AKT kinase domain</text>
  </TERM>
  <TERM dbid="GO:0016301" end="992" id="V1668361" paragraph="paragraph13" rule="-SIMPLE-REF" start="974" uttnum="117">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>AKT kinase domain</text>
  </TERM>
  <TERM end="978" id="V1668356" paragraph="paragraph13" rule="-SIMPLE-REF" start="974" uttnum="117">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <EVENT end="1031" id="V1668420" paragraph="paragraph13" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="1005" uttnum="117">
    <type>ONT::BIND</type>
    <predicate end="1031" id="V1668420" start="1005">
      <type>ONT::BIND</type>
      <text>for Ack1/AKT interaction,</text>
    </predicate>
    <arg1 id="V1668442" role=":AGENT"/>
    <text>for Ack1/AKT interaction,</text>
  </EVENT>
  <TERM end="1018" id="V1668442" paragraph="paragraph13" rule="-EXPLICIT-REF-SEQ0B" start="1009" uttnum="117">
    <type>ONT::GENE-PROTEIN</type>
    <components>
      <component id="V1668184"/>
      <component id="V1668192"/>
    </components>
    <text normalization="">Ack1/AKT</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1018" id="V1668184" paragraph="paragraph13" rule="-EXPLICIT-REF-SEQ0B-TERM" start="1009" uttnum="117">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1/AKT</text>
  </TERM>
  <TERM end="1018" id="V1668192" paragraph="paragraph13" rule="-SIMPLE-REF" start="1014" uttnum="117">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1053" id="V1682878" paragraph="paragraph13" rule="-SIMPLE-REF" start="1050" uttnum="117">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>it</text>
  </TERM>
  <TERM dbid="XFAM:PF14593.3" end="1101" id="V1682968" paragraph="paragraph13" rule="-SIMPLE-REF" start="1087" uttnum="117">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>PH-DOMAIN</name>
    <text normalization="">the PH domain</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1077" id="V1682917" paragraph="paragraph13" rule="-SIMPLE-REF" start="1068" uttnum="117">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>the Ack1</text>
  </TERM>
  <TERM end="1150" id="V1682983" paragraph="paragraph13" rule="-SIMPLE-REF" start="1105" uttnum="117">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>tyrosine176 in AKT kinase domain for complex</text>
  </TERM>
  <TERM end="1138" id="V1683056" paragraph="paragraph13" rule="-EXPLICIT-REF1" start="1120" uttnum="117">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>AKT</name>
    <assoc-with id="V1683048"/>
    <text>AKT kinase domain</text>
  </TERM>
  <TERM dbid="GO:0016301" end="1138" id="V1683053" paragraph="paragraph13" rule="-SIMPLE-REF" start="1120" uttnum="117">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>AKT kinase domain</text>
  </TERM>
  <TERM end="1124" id="V1683048" paragraph="paragraph13" rule="-SIMPLE-REF" start="1120" uttnum="117">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1150" id="V1683092" paragraph="paragraph13" rule="-SIMPLE-REF" start="1142" uttnum="117">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complex</text>
  </TERM>
  <TERM end="26" id="V1696737" paragraph="paragraph14" rule="-SIMPLE-REF" start="15" uttnum="118">
    <type>ONT::AREA-DEF-BY-USE</type>
    <name>REGION</name>
    <text>the region</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="34" id="V1696799" paragraph="paragraph14" rule="-SIMPLE-REF" start="29" uttnum="118">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="53" id="V1696806" paragraph="paragraph14" rule="-SIMPLE-REF" start="34" uttnum="118">
    <type>ONT::AREA-DEF-BY-USE</type>
    <name>REGION</name>
    <text>that recognize AKT,</text>
  </TERM>
  <TERM end="53" id="V1696825" paragraph="paragraph14" rule="-SIMPLE-REF" start="49" uttnum="118">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT,</text>
  </TERM>
  <TERM dbid="XFAM:PF08824|XFAM:PF12026|XFAM:PF14604|UP:O35177" end="58" id="V1699341" paragraph="paragraph14" rule="-SIMPLE-REF" start="54" uttnum="118">
    <type>ONT::PROTEIN</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <EVENT end="121" id="V1699389" paragraph="paragraph14" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="63" uttnum="118">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="121" id="V1699389" start="63">
      <type>ONT::TRANSFORM</type>
      <text>2KO cells were transfected with Myc-tagged Ack1 deletions</text>
    </predicate>
    <arg1 id="V1699364" role=":AFFECTED"/>
    <text>2KO cells were transfected with Myc-tagged Ack1 deletions</text>
  </EVENT>
  <TERM end="73" id="V1699364" paragraph="paragraph14" rule="-SIMPLE-REF" start="63" uttnum="118">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>2KO cells</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="67" id="V1699355" paragraph="paragraph14" rule="-SIMPLE-REF" start="64" uttnum="118">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>KO</text>
  </TERM>
  <TERM dbid="UP:P01106" end="98" id="V1699405" paragraph="paragraph14" rule="-SIMPLE-REF" start="95" uttnum="118">
    <type>ONT::PROTEIN</type>
    <name>MYC</name>
    <text>Myc</text>
  </TERM>
  <TERM dbid="EFO:0004014" end="121" id="V1699447" paragraph="paragraph14" rule="-SIMPLE-REF" start="99" uttnum="118">
    <type>ONT::PROCESS</type>
    <name>DELETIONS</name>
    <text>tagged Ack1 deletions</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="111" id="V1699430" paragraph="paragraph14" rule="-SIMPLE-REF" start="106" uttnum="118">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="165" id="V1699602" paragraph="paragraph14" rule="-SIMPLE-REF" start="148" uttnum="118">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S4A</text>
  </TERM>
  <TERM end="184" id="V1699639" paragraph="paragraph14" rule="-SIMPLE-REF" start="171" uttnum="118">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">HA-tagged AKT</text>
  </TERM>
  <TERM dbid="GO:0042571" end="289" id="V1714826" paragraph="paragraph14" rule="-SIMPLE-REF" start="228" uttnum="119">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>Myc antibodies followed by immunoblotting with AKT antibodies</text>
  </TERM>
  <TERM dbid="UP:P01106" end="232" id="V1714809" paragraph="paragraph14" rule="-SIMPLE-REF" start="228" uttnum="119">
    <type>ONT::PROTEIN</type>
    <name>MYC</name>
    <text>Myc</text>
  </TERM>
  <TERM dbid="GO:0042571" end="289" id="V1714897" paragraph="paragraph14" rule="-SIMPLE-REF" start="275" uttnum="119">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>AKT antibodies</text>
  </TERM>
  <TERM end="279" id="V1714893" paragraph="paragraph14" rule="-SIMPLE-REF" start="275" uttnum="119">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="372" id="V1729005" paragraph="paragraph14" rule="-SIMPLE-REF" start="291" uttnum="120">
    <type>ONT::MENTAL-OBJECT</type>
    <name>CONSTRUCT</name>
    <text>The Ack1 construct expressing SAM and kinase domains (cAck) was able to bind AKT,</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="300" id="V1728993" paragraph="paragraph14" rule="-SIMPLE-REF" start="295" uttnum="120">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <EVENT end="351" id="V1729022" paragraph="paragraph14" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="310" uttnum="120">
    <type>ONT::EXPRESS</type>
    <predicate end="351" id="V1729022" start="310">
      <type>ONT::EXPRESS</type>
      <text>expressing SAM and kinase domains (cAck)</text>
    </predicate>
    <arg2 id="V1729035" role=":AFFECTED-RESULT"/>
    <text>expressing SAM and kinase domains (cAck)</text>
  </EVENT>
  <TERM end="351" id="V1729035" paragraph="paragraph14" rule="-LOGICALOP-REF" start="321" uttnum="120">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="AND">
      <member id="V1729031"/>
      <member id="V1729049"/>
    </aggregate>
    <text normalization="">SAM and kinase domains (cAck)</text>
  </TERM>
  <TERM dbid="CHEBI:67040|CHEBI:15414" end="325" id="V1729031" paragraph="paragraph14" rule="-SIMPLE-REF" start="321" uttnum="120">
    <type>ONT::MOLECULE</type>
    <name>SAM</name>
    <text>SAM</text>
  </TERM>
  <TERM end="351" id="V1729049" paragraph="paragraph14" rule="-SIMPLE-REF" start="329" uttnum="120">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>kinase domains (cAck)</text>
  </TERM>
  <TERM dbid="GO:0016301" end="336" id="V1729046" paragraph="paragraph14" rule="-SIMPLE-REF" start="329" uttnum="120">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <EVENT end="371" id="V1729146" paragraph="paragraph14" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="360" uttnum="120">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="371" id="V1729146" start="360">
      <type>ONT::BIND</type>
      <text>to bind AKT</text>
    </predicate>
    <arg2 id="V1729155" role=":AFFECTED"/>
    <text>to bind AKT</text>
  </EVENT>
  <TERM end="371" id="V1729155" paragraph="paragraph14" rule="-SIMPLE-REF" start="368" uttnum="120">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="431" id="V1732280" paragraph="paragraph14" rule="-SIMPLE-REF" start="382" uttnum="120">
    <type>ONT::MENTAL-OBJECT</type>
    <name>CONSTRUCT</name>
    <text>construct lacking a part of kinase domain (dAck)</text>
  </TERM>
  <TERM end="431" id="V1732360" paragraph="paragraph14" rule="-SIMPLE-REF" start="410" uttnum="120">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>kinase domain (dAck)</text>
  </TERM>
  <TERM dbid="GO:0016301" end="417" id="V1732357" paragraph="paragraph14" rule="-SIMPLE-REF" start="410" uttnum="120">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM end="500" id="V1732460" paragraph="paragraph14" rule="-SIMPLE-REF" start="447" uttnum="120">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">endogeneous AKT (Fig. S4E,</text>
  </TERM>
  <TERM end="498" id="V1732517" paragraph="paragraph14" rule="-SIMPLE-REF" start="481" uttnum="120">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S4E</text>
  </TERM>
  <TERM end="509" id="V1732531" paragraph="paragraph14" rule="-SIMPLE-REF" start="500" uttnum="120">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panel</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="521" id="V1743473" paragraph="paragraph14" rule="-SIMPLE-REF" start="512" uttnum="121">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>GST-Ack1</text>
  </TERM>
  <TERM dbid="HGNC:23613|XFAM:PF07648|FA:01669|UP:Q86UG4|XFAM:PF03137" end="521" id="V1743460" paragraph="paragraph14" rule="-SIMPLE-REF" start="512" uttnum="121">
    <type>ONT::GENE-PROTEIN</type>
    <name>GST</name>
    <text>GST-Ack1</text>
  </TERM>
  <TERM end="581" id="V1743500" paragraph="paragraph14" rule="-SIMPLE-REF" start="534" uttnum="121">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>Kinase-SH3-CRIB domains but lacking SAM domain</text>
  </TERM>
  <TERM dbid="CHEBI:67040|CHEBI:15414" end="581" id="V1743520" paragraph="paragraph14" rule="-EXPLICIT-REF1" start="570" uttnum="121">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>SAM</name>
    <assoc-with id="V1743517"/>
    <text>SAM domain</text>
  </TERM>
  <TERM dbid="CHEBI:67040|CHEBI:15414" end="574" id="V1743517" paragraph="paragraph14" rule="-SIMPLE-REF" start="570" uttnum="121">
    <type>ONT::MOLECULE</type>
    <name>SAM</name>
    <text>SAM</text>
  </TERM>
  <TERM dbid="GO:0016301" end="540" id="V1743233" paragraph="paragraph14" rule="-SIMPLE-REF" start="534" uttnum="121">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>Kinase</text>
  </TERM>
  <TERM dbid="CVCL:7701|CVCL:M383" end="544" id="V1743246" paragraph="paragraph14" rule="-SIMPLE-REF" start="541" uttnum="121">
    <type>ONT::CELL-LINE</type>
    <name>SH-3</name>
    <text>SH3</text>
  </TERM>
  <TERM end="550" id="V1743258" paragraph="paragraph14" rule="-SIMPLE-REF" start="545" uttnum="121">
    <type>ONT::FURNISHINGS</type>
    <name>CRIB</name>
    <text>CRIB</text>
  </TERM>
  <EVENT end="638" id="V1743569" paragraph="paragraph14" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="590" uttnum="121">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="638" id="V1743569" start="590">
      <type>ONT::BIND</type>
      <text>to bind AKT (Fig. S1F)</text>
    </predicate>
    <arg2 id="V1743578" role=":AFFECTED"/>
    <text>to bind AKT (Fig. S1F)</text>
  </EVENT>
  <TERM end="638" id="V1743578" paragraph="paragraph14" rule="-SIMPLE-REF" start="598" uttnum="121">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT (Fig. S1F)</text>
  </TERM>
  <TERM end="637" id="V1743638" paragraph="paragraph14" rule="-SIMPLE-REF" start="620" uttnum="121">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S1F</text>
  </TERM>
  <TERM end="658" id="V1759115" paragraph="paragraph14" rule="-SIMPLE-REF" start="655" uttnum="122">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">it</text>
  </TERM>
  <TERM end="673" id="V1759131" paragraph="paragraph14" rule="-SIMPLE-REF" start="668" uttnum="122">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">that</text>
  </TERM>
  <TERM end="715" id="V1759152" paragraph="paragraph14" rule="-SIMPLE-REF" start="673" uttnum="122">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>the kinase domain in Ack1 and tyrosine176</text>
  </TERM>
  <TERM dbid="GO:0016301" end="684" id="V1759149" paragraph="paragraph14" rule="-SIMPLE-REF" start="677" uttnum="122">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="699" id="V1759214" paragraph="paragraph14" rule="-SIMPLE-REF" start="694" uttnum="122">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="715" id="V1759228" paragraph="paragraph14" rule="-SIMPLE-REF" start="703" uttnum="122">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>tyrosine176</text>
  </TERM>
  <TERM end="761" id="V1759326" paragraph="paragraph14" rule="-LOGICALOP-REF" start="729" uttnum="122">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="AND">
      <member id="V1759303"/>
      <member id="V1759353"/>
    </aggregate>
    <text normalization="">domain along with AKT PH domain</text>
  </TERM>
  <TERM dbid="GO:0016301" end="729" id="V1759300" paragraph="paragraph14" rule="-SIMPLE-REF" start="718" uttnum="122">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>the kinase</text>
  </TERM>
  <TERM end="736" id="V1759303" paragraph="paragraph14" rule="-SIMPLE-REF" start="729" uttnum="122">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>domain</text>
  </TERM>
  <TERM dbid="XFAM:PF14593.3" end="761" id="V1759353" paragraph="paragraph14" rule="-SIMPLE-REF" start="747" uttnum="122">
    <type>ONT::PROTEIN-FAMILY</type>
    <name>PH-DOMAIN</name>
    <text normalization="">AKT PH domain</text>
  </TERM>
  <TERM end="751" id="V1759333" paragraph="paragraph14" rule="-SIMPLE-REF" start="747" uttnum="122">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="790" id="V1759413" paragraph="paragraph14" rule="-SIMPLE-REF" start="774" uttnum="122">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>minimal domains</text>
  </TERM>
  <TERM end="830" id="V1759476" paragraph="paragraph14" rule="-SIMPLE-REF" start="813" uttnum="122">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1/AKT</name>
    <text>Ack1/AKT complex</text>
  </TERM>
  <CC end="119" id="V1773097" paragraph="paragraph15" rule="-RULE5B_AGENT_AFFECTED" start="3" uttnum="123">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1773016" role=":FACTOR"/>
    <arg id="V1773117" role=":OUTCOME"/>
    <text>While growth factor binding to RTK or amplification of the Ack1 gene causes Ack1 kinase activation [25]</text>
  </CC>
  <TERM dbid="GO:0019838" end="31" id="V1773016" paragraph="paragraph15" rule="-SIMPLE-REF" start="3" uttnum="123">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>GROWTH-FACTOR-BINDING</name>
    <text>While growth factor binding</text>
  </TERM>
  <EVENT end="119" id="V1773117" paragraph="paragraph15" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="79" uttnum="123">
    <type>ONT::ACTIVATE</type>
    <predicate end="119" id="V1773117" start="79">
      <type>ONT::ACTIVATE</type>
      <text>Ack1 kinase activation [25]</text>
    </predicate>
    <arg2 id="V1773114" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000444"/>
    <text>Ack1 kinase activation [25]</text>
  </EVENT>
  <TERM dbid="CVCL:4W74" end="38" id="V1773045" paragraph="paragraph15" rule="-SIMPLE-REF" start="34" uttnum="123">
    <type>ONT::CELL-LINE</type>
    <name>RTK</name>
    <text>RTK</text>
  </TERM>
  <EVENT end="72" id="V1773062" paragraph="paragraph15" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="41" uttnum="123">
    <type>ONT::TRANSFORM</type>
    <predicate end="72" id="V1773062" start="41">
      <type>ONT::TRANSFORM</type>
      <text>amplification of the Ack1 gene</text>
    </predicate>
    <arg2 id="V1773091" role=":AFFECTED"/>
    <text>amplification of the Ack1 gene</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="72" id="V1773091" paragraph="paragraph15" rule="-EXPLICIT-REF1" start="55" uttnum="123">
    <type>ONT::GENE</type>
    <name>ACK-1</name>
    <assoc-with id="V1773088"/>
    <text>of the Ack1 gene</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="67" id="V1773088" paragraph="paragraph15" rule="-SIMPLE-REF" start="62" uttnum="123">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="91" id="V1773114" paragraph="paragraph15" rule="-EXPLICIT-REF1" start="79" uttnum="123">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <assoc-with id="V1773109"/>
    <text>Ack1 kinase</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="84" id="V1773109" paragraph="paragraph15" rule="-SIMPLE-REF" start="79" uttnum="123">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="200" id="V1788926" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="159" uttnum="123">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTATIONS</name>
    <text>somatic autoactivating mutations in Ack1</text>
  </TERM>
  <EVENT end="200" id="V1788910" paragraph="paragraph15" rule="-RULE40A_AGENT_AFFECTED-MODA1_2-AGENT" start="159" uttnum="123">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <mods>
      <mod>
        <type>ONT::MANNER-REFL</type>
        <value>AUTO-</value>
      </mod>
    </mods>
    <predicate end="200" id="V1788910" start="159">
      <type>ONT::ACTIVATE</type>
      <text>somatic autoactivating mutations in Ack1</text>
    </predicate>
    <arg1 id="V1788926" role=":AGENT"/>
    <text>somatic autoactivating mutations in Ack1</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="200" id="V1788989" paragraph="paragraph15" rule="-SIMPLE-REF" start="195" uttnum="123">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="261" id="V1802385" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="251" uttnum="124">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTATIONS</name>
    <text>mutations</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="281" id="V1802459" paragraph="paragraph15" rule="-SIMPLE-REF" start="264" uttnum="124">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1, i.e. R34L,</text>
  </TERM>
  <TERM end="279" id="V1802575" paragraph="paragraph15" rule="-SIMPLE-REF" start="275" uttnum="124">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>34</pos>
      <aa-from>
        <aa>
          <name>Arginine</name>
          <code>R</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Leucine</name>
          <code>L</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">R34L</text>
  </TERM>
  <TERM end="294" id="V1802607" paragraph="paragraph15" rule="-SIMPLE-REF" start="281" uttnum="124">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>99</pos>
      <aa-from>
        <aa>
          <name>Arginine</name>
          <code>R</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Glutamine</name>
          <code>Q</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">R99Q, E346K,</text>
  </TERM>
  <TERM end="292" id="V1802635" paragraph="paragraph15" rule="-SIMPLE-REF" start="287" uttnum="124">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>346</pos>
      <aa-from>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Lysine</name>
          <code>K</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">E346K</text>
  </TERM>
  <TERM end="300" id="V1802703" paragraph="paragraph15" rule="-SIMPLE-REF" start="294" uttnum="124">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>409</pos>
      <aa-from>
        <aa>
          <name>Methionine</name>
          <code>M</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Isoleucine</name>
          <code>I</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">M409I</text>
  </TERM>
  <TERM end="343" id="V1802817" paragraph="paragraph15" rule="-SIMPLE-REF" start="324" uttnum="124">
    <type>ONT::DATABASE</type>
    <name>DATABASE</name>
    <text>the COSMIC database</text>
  </TERM>
  <TERM end="381" id="V1813783" paragraph="paragraph15" rule="-ROBUSTPRO" start="378" uttnum="125">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="451" id="V1813823" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="391" uttnum="125">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>HA-tagged point mutants (Fig. S5A)</text>
  </TERM>
  <TERM end="376" id="V1813770" paragraph="paragraph15" rule="-SIMPLE-REF" start="351" uttnum="125">
    <type>ONT::PHYSICAL-PHENOMENON</type>
    <name>MUTAGENESIS</name>
    <text>site-directed mutagenesis</text>
  </TERM>
  <TERM end="365" id="V1813735" paragraph="paragraph15" rule="-SIMPLE-REF" start="351" uttnum="125">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>site-directed</text>
  </TERM>
  <TERM end="451" id="V1813815" paragraph="paragraph15" rule="-SIMPLE-REF" start="391" uttnum="125">
    <type>ONT::SHAPE</type>
    <name>POINT</name>
    <text>HA-tagged point mutants (Fig. S5A)</text>
  </TERM>
  <TERM end="450" id="V1813910" paragraph="paragraph15" rule="-SIMPLE-REF" start="433" uttnum="125">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S5A</text>
  </TERM>
  <TERM end="456" id="V1829063" paragraph="paragraph15" rule="-ROBUSTPRO" start="453" uttnum="126">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="477" id="V1829078" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="463" uttnum="126">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>these mutants</text>
  </TERM>
  <EVENT end="533" id="V1829151" paragraph="paragraph15" rule="-RULE5_AGENT_AFFECTED" start="495" uttnum="126">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="533" id="V1829151" start="495">
      <type>ONT::TRANSFORM</type>
      <text>E346K mutant undergoes autoactivation</text>
    </predicate>
    <arg1 id="V1829141" role=":AGENT"/>
    <arg2 id="V1829163" role=":AFFECTED"/>
    <text>E346K mutant undergoes autoactivation</text>
  </EVENT>
  <EVENT end="585" id="V1829183" paragraph="paragraph15" rule="-RULE40A_AGENT_AFFECTED-ROBUST-AFFECTED" start="495" uttnum="126">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="585" id="V1829183" start="495">
      <type>ONT::PRODUCE</type>
      <text>E346K mutant undergoes autoactivation and causes AKT Tyr/Ser/Thr-phosphorylation in serum</text>
    </predicate>
    <arg1 id="V1829141" role=":AGENT"/>
    <arg2 id="V1829388" role=":AFFECTED"/>
    <text>E346K mutant undergoes autoactivation and causes AKT Tyr/Ser/Thr-phosphorylation in serum</text>
  </EVENT>
  <TERM end="508" id="V1829141" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="495" uttnum="126">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>E346K mutant</text>
  </TERM>
  <EVENT end="533" id="V1829163" paragraph="paragraph15" rule="-RULE40A_AGENT_AFFECTED-MODA1_2-NONE" start="518" uttnum="126">
    <type>ONT::ACTIVATE</type>
    <mods>
      <mod>
        <type>ONT::MANNER-REFL</type>
        <value>AUTO-</value>
      </mod>
    </mods>
    <predicate end="533" id="V1829163" start="518">
      <type>ONT::ACTIVATE</type>
      <text>autoactivation</text>
    </predicate>
    <text>autoactivation</text>
  </EVENT>
  <TERM end="501" id="V1829138" paragraph="paragraph15" rule="-SIMPLE-REF" start="495" uttnum="126">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>346</pos>
      <aa-from>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Lysine</name>
          <code>K</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">E346K</text>
  </TERM>
  <TERM end="585" id="V1829388" paragraph="paragraph15" rule="-RULE40A_AGENT_AFFECTED-ROBUST-AFFECTED-TERM" start="495" uttnum="126">
    <type>ONT::REFERENTIAL-SEM</type>
    <name>TYR/SER/THR-PHOSPHORYLATION</name>
    <text>E346K mutant undergoes autoactivation and causes AKT Tyr/Ser/Thr-phosphorylation in serum</text>
  </TERM>
  <TERM end="548" id="V1829190" paragraph="paragraph15" rule="-SIMPLE-REF" start="544" uttnum="126">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="585" id="V1829247" paragraph="paragraph15" rule="-SIMPLE-REF" start="579" uttnum="126">
    <type>ONT::BODILY-FLUID</type>
    <name>SERUM</name>
    <text>serum</text>
  </TERM>
  <TERM end="599" id="V1829262" paragraph="paragraph15" rule="-SIMPLE-REF" start="585" uttnum="126">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>starved cells</text>
  </TERM>
  <TERM end="635" id="V1829329" paragraph="paragraph15" rule="-SIMPLE-REF" start="617" uttnum="126">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S5B</text>
  </TERM>
  <TERM end="728" id="V1844813" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="697" uttnum="127">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>a point mutant (L487F mutation)</text>
  </TERM>
  <TERM end="667" id="V1844716" paragraph="paragraph15" rule="-ROBUSTPRO" start="664" uttnum="127">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="728" id="V1844805" paragraph="paragraph15" rule="-SIMPLE-REF" start="697" uttnum="127">
    <type>ONT::SHAPE</type>
    <name>POINT</name>
    <text>a point mutant (L487F mutation)</text>
  </TERM>
  <EVENT end="727" id="V1844861" paragraph="paragraph15" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="713" uttnum="127">
    <type>ONT::TRANSFORM</type>
    <predicate end="727" id="V1844861" start="713">
      <type>ONT::TRANSFORM</type>
      <text>L487F mutation</text>
    </predicate>
    <arg2 id="V1844858" role=":AFFECTED"/>
    <text>L487F mutation</text>
  </EVENT>
  <TERM end="719" id="V1844858" paragraph="paragraph15" rule="-SIMPLE-REF" start="713" uttnum="127">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Leucine</name>
          <code>L</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">L487F</text>
  </TERM>
  <CC end="775" id="V1845734" paragraph="paragraph15" rule="-RULE5B_AGENT_RESULT" start="729" uttnum="127">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V1845724" role=":FACTOR"/>
    <arg id="V1845772" role=":OUTCOME"/>
    <text>that leads to constitutive activation of Ack1,</text>
  </CC>
  <TERM end="734" id="V1845724" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="729" uttnum="127">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>that</text>
  </TERM>
  <EVENT end="775" id="V1845772" paragraph="paragraph15" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="740" uttnum="127">
    <type>ONT::ACTIVATE</type>
    <predicate end="775" id="V1845772" start="740">
      <type>ONT::ACTIVATE</type>
      <text>to constitutive activation of Ack1,</text>
    </predicate>
    <arg2 id="V1845791" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000449"/>
    <text>to constitutive activation of Ack1,</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="774" id="V1845791" paragraph="paragraph15" rule="-SIMPLE-REF" start="767" uttnum="127">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>of Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="913" id="V1847557" paragraph="paragraph15" rule="-INEVENT2B,-SIMPLE-REF" start="861" uttnum="128">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>346</pos>
      <aa-from>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Lysine</name>
          <code>K</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">E346K autoactivating mutant of Ack1 exhibited Tyr284</text>
  </TERM>
  <TERM end="855" id="V1847517" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="843" uttnum="128">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>L487F mutant</text>
  </TERM>
  <TERM end="849" id="V1847514" paragraph="paragraph15" rule="-SIMPLE-REF" start="843" uttnum="128">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>487</pos>
      <aa-from>
        <aa>
          <name>Leucine</name>
          <code>L</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">L487F</text>
  </TERM>
  <EVENT end="913" id="V1847568" paragraph="paragraph15" rule="-RULE40A_AGENT_AFFECTED-MODA1_2" start="861" uttnum="128">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <mods>
      <mod>
        <type>ONT::MANNER-REFL</type>
        <value>AUTO-</value>
      </mod>
    </mods>
    <predicate end="913" id="V1847568" start="861">
      <type>ONT::ACTIVATE</type>
      <text>E346K autoactivating mutant of Ack1 exhibited Tyr284</text>
    </predicate>
    <arg1 id="V1847557" role=":AGENT"/>
    <arg2 id="V1847581" role=":AFFECTED"/>
    <text>E346K autoactivating mutant of Ack1 exhibited Tyr284</text>
  </EVENT>
  <TERM end="889" id="V1847581" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="882" uttnum="128">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>mutant</text>
  </TERM>
  <TERM end="913" id="V1847615" paragraph="paragraph15" rule="-INEVENT2B,-SIMPLE-REF" start="892" uttnum="128">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>284</pos>
      </site>
      <inevent>
        <event id="V1847605"/>
      </inevent>
    </features>
    <name>TYR-284</name>
    <text>Ack1 exhibited Tyr284</text>
  </TERM>
  <EVENT end="907" id="V1847605" paragraph="paragraph15" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="892" uttnum="128">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="907" id="V1847605" start="892">
      <type>ONT::TRANSFORM</type>
      <text>Ack1 exhibited</text>
    </predicate>
    <arg1 id="V1847600" role=":AGENT"/>
    <arg2 id="V1847615" role=":FORMAL"/>
    <text>Ack1 exhibited</text>
  </EVENT>
  <TERM end="907" id="V1847600" paragraph="paragraph15" rule="-SIMPLE-REF" start="892" uttnum="128">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1 exhibited</text>
  </TERM>
  <TERM end="953" id="V1847695" paragraph="paragraph15" rule="-SIMPLE-REF" start="933" uttnum="128">
    <type>ONT::GRAPHIC-SYMBOL</type>
    <name>LOOP</name>
    <text>the activation loop</text>
  </TERM>
  <TERM end="988" id="V1847765" paragraph="paragraph15" rule="-SIMPLE-REF" start="971" uttnum="128">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S5D</text>
  </TERM>
  <TERM end="994" id="V1860567" paragraph="paragraph15" rule="-ROBUSTPRO" start="991" uttnum="129">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="1029" id="V1860595" paragraph="paragraph15" rule="-SIMPLE-REF" start="1008" uttnum="129">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>the intrinsic kinase</text>
  </TERM>
  <TERM end="1058" id="V1860650" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="1041" uttnum="129">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>the Y176F mutant</text>
  </TERM>
  <TERM end="1079" id="V1860679" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="1062" uttnum="129">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>AKT</name>
    <text normalization="">the wildtype AKT</text>
  </TERM>
  <TERM end="1051" id="V1860647" paragraph="paragraph15" rule="-SIMPLE-REF" start="1045" uttnum="129">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1124" id="V1860784" paragraph="paragraph15" rule="-INEVENT2B,-SIMPLE-REF" start="1107" uttnum="129">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>of activated Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="1124" id="V1860772" paragraph="paragraph15" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1107" uttnum="129">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1124" id="V1860772" start="1107">
      <type>ONT::ACTIVATE</type>
      <text>of activated Ack1</text>
    </predicate>
    <arg2 id="V1860784" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000057"/>
    <text>of activated Ack1</text>
  </EVENT>
  <TERM end="1199" id="V1869844" paragraph="paragraph15" rule="-INEVENT2B,-SIMPLE-REF-MUTATION7" start="1126" uttnum="130">
    <type>ONT::WILDTYPE-OBJ</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>WILDTYPE</name>
    <text>The wildtype AKT displays significant increase in the kinase activity as</text>
  </TERM>
  <EVENT end="1199" id="V1869855" paragraph="paragraph15" rule="-RULE10_AGENT_AFFECTED" start="1139" uttnum="130">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1199" id="V1869855" start="1139">
      <type>ONT::MODULATE</type>
      <text>AKT displays significant increase in the kinase activity as</text>
    </predicate>
    <arg1 id="V1869851" role=":AGENT"/>
    <arg2 id="V1869867" role=":AFFECTED"/>
    <text>AKT displays significant increase in the kinase activity as</text>
  </EVENT>
  <TERM end="1143" id="V1869851" paragraph="paragraph15" rule="-SIMPLE-REF" start="1139" uttnum="130">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <EVENT end="1196" id="V1869867" paragraph="paragraph15" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="1152" uttnum="130">
    <type>ONT::INCREASE</type>
    <predicate end="1196" id="V1869867" start="1152">
      <type>ONT::INCREASE</type>
      <text>significant increase in the kinase activity</text>
    </predicate>
    <arg2 id="V1869944" role=":AFFECTED"/>
    <text>significant increase in the kinase activity</text>
  </EVENT>
  <EVENT end="1196" id="V1869944" paragraph="paragraph15" rule="-ACTIVITY1" start="1173" uttnum="130">
    <type>ONT::ACTIVITY</type>
    <predicate end="1196" id="V1869944" start="1173">
      <type>ONT::ACTIVITY</type>
      <text>in the kinase activity</text>
    </predicate>
    <arg1 id="V1869940" role=":AGENT"/>
    <text>in the kinase activity</text>
  </EVENT>
  <TERM end="1187" id="V1869940" paragraph="paragraph15" rule="-SIMPLE-REF" start="1176" uttnum="130">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>the kinase</text>
  </TERM>
  <TERM end="1228" id="V1870055" paragraph="paragraph15" rule="-SIMPLE-REF-MUTATION8" start="1208" uttnum="130">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>to the Y176F mutant</text>
  </TERM>
  <TERM end="1221" id="V1870052" paragraph="paragraph15" rule="-SIMPLE-REF" start="1215" uttnum="130">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1273" id="V1870152" paragraph="paragraph15" rule="-SIMPLE-REF" start="1264" uttnum="130">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>the Ack1</text>
  </TERM>
  <TERM end="1291" id="V1870199" paragraph="paragraph15" rule="-SIMPLE-REF" start="1285" uttnum="130">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>346</pos>
      <aa-from>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Lysine</name>
          <code>K</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">E346K</text>
  </TERM>
  <TERM end="1317" id="V1870232" paragraph="paragraph15" rule="-SIMPLE-REF" start="1314" uttnum="130">
    <type>ONT::FRUIT</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="1337" id="V1870281" paragraph="paragraph15" rule="-SIMPLE-REF" start="1319" uttnum="130">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S5E</text>
  </TERM>
  <TERM end="1355" id="V1870299" paragraph="paragraph15" rule="-SIMPLE-REF" start="1347" uttnum="130">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>F</name>
    <text>F</text>
  </TERM>
  <TERM end="1372" id="V1884084" paragraph="paragraph15" rule="-SIMPLE-REF" start="1358" uttnum="131">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>These results</text>
  </TERM>
  <TERM end="1426" id="V1884154" paragraph="paragraph15" rule="-INEVENT2B,-SIMPLE-REF-MUTATION8" start="1389" uttnum="131">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
      <inevent>
        <event id="V1884138"/>
      </inevent>
    </features>
    <name>MUTATIONS</name>
    <text>the somatic autoactivating mutations</text>
  </TERM>
  <EVENT end="1426" id="V1884138" paragraph="paragraph15" rule="-RULE40A_AGENT_AFFECTED-MODA1_2-AGENT" start="1389" uttnum="131">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <mods>
      <mod>
        <type>ONT::MANNER-REFL</type>
        <value>AUTO-</value>
      </mod>
    </mods>
    <predicate end="1426" id="V1884138" start="1389">
      <type>ONT::ACTIVATE</type>
      <text>the somatic autoactivating mutations</text>
    </predicate>
    <arg1 id="V1884154" role=":AGENT"/>
    <text>the somatic autoactivating mutations</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1434" id="V1884217" paragraph="paragraph15" rule="-SIMPLE-REF" start="1429" uttnum="131">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <EVENT end="1464" id="V1884266" paragraph="paragraph15" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1449" uttnum="131">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1464" id="V1884266" start="1449">
      <type>ONT::ACTIVATE</type>
      <text>to activate AKT</text>
    </predicate>
    <arg2 id="V1884273" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000454"/>
    <text>to activate AKT</text>
  </EVENT>
  <TERM end="1464" id="V1884273" paragraph="paragraph15" rule="-SIMPLE-REF" start="1461" uttnum="131">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="1545" id="V1898259" paragraph="paragraph15" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="1486" uttnum="132">
    <type>ONT::BIND</type>
    <predicate end="1545" id="V1898259" start="1486">
      <type>ONT::BIND</type>
      <text>the earlier evidence indicating direct Ack1-AKT interaction</text>
    </predicate>
    <arg1 id="V1898247" role=":AGENT"/>
    <text>the earlier evidence indicating direct Ack1-AKT interaction</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1545" id="V1898239" paragraph="paragraph15" rule="-SIMPLE-REF" start="1486" uttnum="132">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>the earlier evidence indicating direct Ack1-AKT interaction</text>
  </TERM>
  <TERM end="1545" id="V1898212" paragraph="paragraph15" rule="-SIMPLE-REF" start="1486" uttnum="132">
    <type>ONT::INFORMATION</type>
    <name>EVIDENCE</name>
    <text>the earlier evidence indicating direct Ack1-AKT interaction</text>
  </TERM>
  <TERM end="1534" id="V1898247" paragraph="paragraph15" rule="-SIMPLE-REF" start="1530" uttnum="132">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1610" id="V1911129" paragraph="paragraph15" rule="-SIMPLE-REF" start="1585" uttnum="132">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">RTK/PI3K-independent AKT</text>
  </TERM>
  <TERM dbid="CVCL:4W74" end="1588" id="V1910083" paragraph="paragraph15" rule="-SIMPLE-REF" start="1585" uttnum="132">
    <type>ONT::CELL-LINE</type>
    <name>RTK</name>
    <text>RTK</text>
  </TERM>
  <TERM end="1606" id="V1910134" paragraph="paragraph15" rule="-SIMPLE-REF" start="1589" uttnum="132">
    <type>ONT::PERSON</type>
    <name>INDEPENDENT</name>
    <text>PI3K-independent</text>
  </TERM>
  <TERM end="1606" id="V1910126" paragraph="paragraph15" rule="-SIMPLE-REF" start="1589" uttnum="132">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K-independent</text>
  </TERM>
  <TERM end="1656" id="V1911266" paragraph="paragraph15" rule="-SIMPLE-REF" start="1652" uttnum="132">
    <type>ONT::LAND-VEHICLE</type>
    <name>AUTO</name>
    <text>auto</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1672" id="V1911287" paragraph="paragraph15" rule="-SIMPLE-REF" start="1668" uttnum="132">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <EVENT end="57" id="V1921824" paragraph="paragraph16" rule="-RULE10C_AGENT_AFFECTED-CELL_LOC3-GD-TO-AFFECTED" start="20" uttnum="133">
    <type>ONT::TRANSLOCATE</type>
    <predicate end="57" id="V1921824" start="20">
      <type>ONT::TRANSLOCATE</type>
      <text>targeting AKT to the plasma membrane</text>
    </predicate>
    <arg2 id="V1921831" role=":AFFECTED"/>
    <to-location end="57" id="V1921881" start="37">
      <type>ONT::CELL-PART</type>
      <text normalization="">the plasma membrane</text>
    </to-location>
    <text>targeting AKT to the plasma membrane</text>
  </EVENT>
  <CC end="105" id="V1921904" paragraph="paragraph16" rule="-NECESSARY1" start="20" uttnum="133">
    <type>ONT::DEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V1921824" role=":FACTOR"/>
    <arg id="V1921940" role=":OUTCOME"/>
    <text>targeting AKT to the plasma membrane is necessary for AKT activation [1]</text>
  </CC>
  <TERM end="34" id="V1921831" paragraph="paragraph16" rule="-SIMPLE-REF" start="30" uttnum="133">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="57" id="V1921881" paragraph="paragraph16" rule="-SIMPLE-REF" start="37" uttnum="133">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <EVENT end="105" id="V1921940" paragraph="paragraph16" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="70" uttnum="133">
    <type>ONT::ACTIVATE</type>
    <predicate end="105" id="V1921940" start="70">
      <type>ONT::ACTIVATE</type>
      <text>for AKT activation [1]</text>
    </predicate>
    <arg2 id="V1921937" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000459"/>
    <text>for AKT activation [1]</text>
  </EVENT>
  <TERM end="78" id="V1921937" paragraph="paragraph16" rule="-SIMPLE-REF" start="74" uttnum="133">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="205" id="V1938820" paragraph="paragraph16" rule="-RULE20_AGENT_AFFECTED-NONE" start="193" uttnum="134">
    <type>ONT::DECREASE</type>
    <predicate end="205" id="V1938820" start="193">
      <type>ONT::DECREASE</type>
      <text>in decrease</text>
    </predicate>
    <text>in decrease</text>
  </EVENT>
  <TERM dbid="XFAM:PF16453.2|XFAM:PF00169.26" end="184" id="V1938752" paragraph="paragraph16" rule="-SIMPLE-REF" start="167" uttnum="134">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PH-DOMAIN</name>
    <text>of the PH domain</text>
  </TERM>
  <EVENT end="232" id="V1938898" paragraph="paragraph16" rule="-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="208" uttnum="134">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="232" id="V1938898" start="208">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT Tyr-phosphorylation</text>
    </predicate>
    <arg2 id="V1938887" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000254"/>
    <site end="232" id="V1938892" start="208">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">AKT Tyr-phosphorylation</text>
    </site>
    <text>AKT Tyr-phosphorylation</text>
  </EVENT>
  <TERM end="232" id="V1938892" paragraph="paragraph16" rule="-SIMPLE-REF" start="208" uttnum="134">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>AKT Tyr-phosphorylation</text>
  </TERM>
  <TERM end="212" id="V1938887" paragraph="paragraph16" rule="-SIMPLE-REF" start="208" uttnum="134">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1938898"/>
    </not-features>
  </TERM>
  <EVENT end="271" id="V1938928" paragraph="paragraph16" rule="-RULE50_AGENT_AFFECTED-RESULT-LOC5-GD-NONE" start="237" uttnum="134">
    <type>ONT::EXPRESS</type>
    <predicate end="271" id="V1938928" start="237">
      <type>ONT::EXPRESS</type>
      <text>co-expression with activated Ack1</text>
    </predicate>
    <site end="271" id="V1938928" start="237">
      <type>ONT::EXPRESS</type>
      <text normalization="">co-expression with activated Ack1</text>
    </site>
    <text>co-expression with activated Ack1</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="271" id="V1938965" paragraph="paragraph16" rule="-INEVENT2B,-SIMPLE-REF" start="256" uttnum="134">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="271" id="V1938953" paragraph="paragraph16" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="256" uttnum="134">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="271" id="V1938953" start="256">
      <type>ONT::ACTIVATE</type>
      <text>activated Ack1</text>
    </predicate>
    <arg2 id="V1938965" role=":RESULT"/>
    <arg id="R000062" role=":AFFECTED"/>
    <text>activated Ack1</text>
  </EVENT>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="287" id="V1938975" paragraph="paragraph16" rule="-SIMPLE-REF" start="284" uttnum="134">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="329" id="V1939052" paragraph="paragraph16" rule="-SIMPLE-REF" start="289" uttnum="134">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S4A, C and D)</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="345" id="V1953627" paragraph="paragraph16" rule="-SIMPLE-REF" start="340" uttnum="135">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="454" id="V1953764" paragraph="paragraph16" rule="-SIMPLE-REF" start="386" uttnum="135">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>the membrane [25], [26], [28]</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="501" id="V1970493" paragraph="paragraph16" rule="-INEVENT2B,-SIMPLE-REF" start="486" uttnum="136">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <TERM end="540" id="V1970510" paragraph="paragraph16" rule="-SIMPLE-REF-MODBP4-GD,-SIMPLE-REF" start="514" uttnum="136">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <location id="V1970554"/>
    </features>
    <name>AKT</name>
    <text normalization="">AKT at the plasma membrane</text>
  </TERM>
  <EVENT end="501" id="V1970481" paragraph="paragraph16" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="486" uttnum="136">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="501" id="V1970481" start="486">
      <type>ONT::ACTIVATE</type>
      <text>activated Ack1</text>
    </predicate>
    <arg2 id="V1970493" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000067"/>
    <text>activated Ack1</text>
  </EVENT>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="540" id="V1970554" paragraph="paragraph16" rule="-SIMPLE-REF" start="521" uttnum="136">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <EVENT end="596" id="V1971332" paragraph="paragraph16" rule="-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="566" uttnum="137">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="596" id="V1971332" start="566">
      <type>ONT::PHOSPHORYLATION</type>
      <text>of AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg2 id="V1971316" role=":AFFECTED"/>
    <arg id="R000259" role=":RESULT"/>
    <site end="596" id="V1971326" start="566">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">of AKT Tyr176-phosphorylation</text>
    </site>
    <text>of AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="596" id="V1971326" paragraph="paragraph16" rule="-SIMPLE-REF" start="566" uttnum="137">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>of AKT Tyr176-phosphorylation</text>
  </TERM>
  <TERM end="573" id="V1971316" paragraph="paragraph16" rule="-SIMPLE-REF" start="569" uttnum="137">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1971332"/>
    </not-features>
  </TERM>
  <TERM end="637" id="V1983818" paragraph="paragraph16" rule="-ROBUSTPRO" start="634" uttnum="137">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM dbid="GO:0042571" end="772" id="V1983837" paragraph="paragraph16" rule="-SIMPLE-REF" start="647" uttnum="137">
    <type>ONT::CELL-PART</type>
    <name>ANTIBODIES</name>
    <text>phospho-antibodies that specifically recognized Tyr176-phosphorylated AKT or pTyr176-AKT (details in SI methods)</text>
  </TERM>
  <TERM end="721" id="V1983911" paragraph="paragraph16" rule="-INEVENT2B,-SIMPLE-REF" start="695" uttnum="137">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr176-phosphorylated AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1983901"/>
    </features>
  </TERM>
  <EVENT end="721" id="V1983901" paragraph="paragraph16" rule="-RULE60_AGENT_AFFECTED-A" start="695" uttnum="137">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="721" id="V1983901" start="695">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr176-phosphorylated AKT</text>
    </predicate>
    <arg2 id="V1983911" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000017"/>
    <site end="717" id="V1983893" start="695">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176-phosphorylated</text>
    </site>
    <text>Tyr176-phosphorylated AKT</text>
  </EVENT>
  <TERM end="717" id="V1983893" paragraph="paragraph16" rule="-SIMPLE-REF" start="695" uttnum="137">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176-phosphorylated</text>
  </TERM>
  <TERM end="771" id="V1983924" paragraph="paragraph16" rule="-SIMPLE-REF" start="737" uttnum="137">
    <type>ONT::INFORMATION-FUNCTION-OBJECT</type>
    <name>DETAIL</name>
    <text>details in SI methods</text>
  </TERM>
  <TERM end="771" id="V1983984" paragraph="paragraph16" rule="-SIMPLE-REF" start="748" uttnum="137">
    <type>ONT::METHOD</type>
    <name>METHOD</name>
    <text>SI methods</text>
  </TERM>
  <TERM dbid="UP:P14410|HGNC:10856|HGNC:10880|UP:P40967" end="757" id="V1983981" paragraph="paragraph16" rule="-SIMPLE-REF" start="748" uttnum="137">
    <type>ONT::GENE</type>
    <name>SI</name>
    <text>SI</text>
  </TERM>
  <EPI end="816" id="V1997588" paragraph="paragraph16" rule="-RULE50_0_AGENT_FORMAL-NONE" start="774" uttnum="138">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V1997562" role=":NEUTRAL"/>
    <text>The antibodies were extensively validated</text>
  </EPI>
  <TERM dbid="GO:0042571" end="789" id="V1997562" paragraph="paragraph16" rule="-SIMPLE-REF" start="774" uttnum="138">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ANTIBODIES</name>
    <text>The antibodies</text>
  </TERM>
  <TERM end="850" id="V1997661" paragraph="paragraph16" rule="-SIMPLE-REF" start="834" uttnum="138">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2A</text>
  </TERM>
  <TERM end="886" id="V1997744" paragraph="paragraph16" rule="-SIMPLE-REF" start="869" uttnum="138">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>6</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S6A</text>
  </TERM>
  <TERM end="908" id="V1997783" paragraph="paragraph16" rule="-SIMPLE-REF" start="897" uttnum="138">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panels</text>
  </TERM>
  <TERM end="930" id="V1997837" paragraph="paragraph16" rule="-SIMPLE-REF" start="928" uttnum="138">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2B</text>
  </TERM>
  <TERM end="953" id="V1997889" paragraph="paragraph16" rule="-SIMPLE-REF" start="938" uttnum="138">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>E</text>
  </TERM>
  <TERM end="989" id="V1997947" paragraph="paragraph16" rule="-SIMPLE-REF" start="972" uttnum="138">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>6</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S6B</text>
  </TERM>
  <TERM dbid="BTO:0000414|CO:0000066" end="1024" id="V2009416" paragraph="paragraph16" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="992" uttnum="139">
    <type>ONT::CELL</type>
    <features>
      <location id="V2009400"/>
    </features>
    <name>EPITHELIAL-CELLS</name>
    <text>Normal prostate epithelial cells</text>
  </TERM>
  <TERM end="1024" id="V2009400" paragraph="paragraph16" rule="-SIMPLE-REF" start="992" uttnum="139">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>Normal prostate epithelial cells</text>
  </TERM>
  <TERM end="1054" id="V2008570" paragraph="paragraph16" rule="-SIMPLE-REF" start="1050" uttnum="139">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="UP:P01133" end="1089" id="V2009486" paragraph="paragraph16" rule="-SIMPLE-REF" start="1085" uttnum="139">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <TERM dbid="CHEBI:52214" end="1110" id="V2009506" paragraph="paragraph16" rule="-SIMPLE-REF" start="1093" uttnum="139">
    <type>ONT::CHEMICAL</type>
    <name>LIGAND</name>
    <text>heregulin ligand</text>
  </TERM>
  <TERM dbid="UP:Q02297" end="1103" id="V2009501" paragraph="paragraph16" rule="-SIMPLE-REF" start="1093" uttnum="139">
    <type>ONT::PROTEIN</type>
    <name>HEREGULIN</name>
    <text>heregulin</text>
  </TERM>
  <TERM end="1144" id="V2009579" paragraph="paragraph16" rule="-SIMPLE-REF" start="1128" uttnum="139">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2A</text>
  </TERM>
  <EVENT end="1245" id="V2024005" paragraph="paragraph16" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="1181" uttnum="140">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="1245" id="V2024005" start="1181">
      <type>ONT::EXPRESS</type>
      <text>activated Ack1 was coexpressed with AKT but not the Y176F mutant</text>
    </predicate>
    <arg2 id="V2023976" role=":AFFECTED-RESULT"/>
    <text>activated Ack1 was coexpressed with AKT but not the Y176F mutant</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1196" id="V2023976" paragraph="paragraph16" rule="-INEVENT2B,-SIMPLE-REF" start="1181" uttnum="140">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="1196" id="V2023965" paragraph="paragraph16" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1181" uttnum="140">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1196" id="V2023965" start="1181">
      <type>ONT::ACTIVATE</type>
      <text>activated Ack1</text>
    </predicate>
    <arg2 id="V2023976" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000072"/>
    <text>activated Ack1</text>
  </EVENT>
  <TERM end="1245" id="V2024039" paragraph="paragraph16" rule="-SIMPLE-REF" start="1217" uttnum="140">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT but not the Y176F mutant</text>
  </TERM>
  <TERM end="1245" id="V2024101" paragraph="paragraph16" rule="-SIMPLE-REF-MUTATION8" start="1229" uttnum="140">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>the Y176F mutant</text>
  </TERM>
  <TERM end="1239" id="V2024098" paragraph="paragraph16" rule="-SIMPLE-REF" start="1233" uttnum="140">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="1163" id="V2023095" paragraph="paragraph16" rule="-SIMPLE-REF" start="1159" uttnum="140">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1295" id="V2040708" paragraph="paragraph16" rule="-SIMPLE-REF" start="1256" uttnum="141">
    <type>ONT::TREATMENT</type>
    <name>INCUBATION</name>
    <text>incubation of the pTyr176-AKT-antibody</text>
  </TERM>
  <TERM dbid="CHEBI:16670" end="1324" id="V2040774" paragraph="paragraph16" rule="-SIMPLE-REF" start="1300" uttnum="141">
    <type>ONT::MOLECULE</type>
    <name>PEPTIDE</name>
    <text>phosphoAKT-Y176-peptide</text>
  </TERM>
  <TERM end="1324" id="V2040766" paragraph="paragraph16" rule="-INEVENT2B,-SIMPLE-REF" start="1300" uttnum="141">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
      <ptm type="ONT::PHOSPHORYLATION" event="V2040737"/>
    </features>
    <name>Y-176</name>
    <text>phosphoAKT-Y176-peptide</text>
  </TERM>
  <TERM dbid="HGNC:391|UP:P31749" end="1324" id="V2040742" paragraph="paragraph16" rule="-SIMPLE-REF" start="1300" uttnum="141">
    <type>ONT::GENE</type>
    <name>AKT</name>
    <text>phosphoAKT-Y176-peptide</text>
  </TERM>
  <EVENT end="1324" id="V2040737" paragraph="paragraph16" rule="-PHOSPHO" start="1300" uttnum="141">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1324" id="V2040737" start="1300">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphoAKT-Y176-peptide</text>
    </predicate>
    <arg2 id="V2040766" role=":RESULT"/>
    <arg id="R000018" role=":AFFECTED"/>
    <text>phosphoAKT-Y176-peptide</text>
  </EVENT>
  <TERM end="1285" id="V2039804" paragraph="paragraph16" rule="-SIMPLE-REF" start="1282" uttnum="141">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="GO:0042571" end="1295" id="V2039812" paragraph="paragraph16" rule="-SIMPLE-REF" start="1286" uttnum="141">
    <type>ONT::PROTEIN</type>
    <name>ANTIBODY</name>
    <text>antibody</text>
  </TERM>
  <EVENT end="1381" id="V2040855" paragraph="paragraph16" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="1341" uttnum="141">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1381" id="V2040855" start="1341">
      <type>ONT::BIND</type>
      <text>of binding to Tyr176-phosphorylated AKT</text>
    </predicate>
    <arg2 id="V2040910" role=":AFFECTED"/>
    <text>of binding to Tyr176-phosphorylated AKT</text>
  </EVENT>
  <TERM end="1381" id="V2040910" paragraph="paragraph16" rule="-INEVENT2B,-SIMPLE-REF" start="1352" uttnum="141">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">to Tyr176-phosphorylated AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2040900"/>
    </features>
  </TERM>
  <EVENT end="1381" id="V2040900" paragraph="paragraph16" rule="-RULE60_AGENT_AFFECTED-A" start="1352" uttnum="141">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1381" id="V2040900" start="1352">
      <type>ONT::PHOSPHORYLATION</type>
      <text>to Tyr176-phosphorylated AKT</text>
    </predicate>
    <arg2 id="V2040910" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000019"/>
    <site end="1377" id="V2040892" start="1355">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176-phosphorylated</text>
    </site>
    <text>to Tyr176-phosphorylated AKT</text>
  </EVENT>
  <TERM end="1377" id="V2040892" paragraph="paragraph16" rule="-SIMPLE-REF" start="1355" uttnum="141">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176-phosphorylated</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="1397" id="V2040920" paragraph="paragraph16" rule="-SIMPLE-REF" start="1394" uttnum="141">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="1416" id="V2040989" paragraph="paragraph16" rule="-SIMPLE-REF" start="1399" uttnum="141">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>6</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S6A</text>
  </TERM>
  <TERM end="1460" id="V2056520" paragraph="paragraph16" rule="-SIMPLE-REF" start="1455" uttnum="142">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>6</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">that</text>
  </TERM>
  <EVENT end="1438" id="V2056473" paragraph="paragraph16" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="1419" uttnum="142">
    <type>ONT::TRANSFORM</type>
    <predicate end="1438" id="V2056473" start="1419">
      <type>ONT::TRANSFORM</type>
      <text>Cell fractionation</text>
    </predicate>
    <arg2 id="V2056462" role=":AFFECTED"/>
    <text>Cell fractionation</text>
  </EVENT>
  <TERM dbid="GO:0005623|CO:0000000" end="1424" id="V2056462" paragraph="paragraph16" rule="-SIMPLE-REF" start="1419" uttnum="142">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Cell</text>
  </TERM>
  <TERM dbid="UP:Q02297" end="1469" id="V2056531" paragraph="paragraph16" rule="-SIMPLE-REF" start="1460" uttnum="142">
    <type>ONT::PROTEIN</type>
    <name>HEREGULIN</name>
    <text>heregulin</text>
  </TERM>
  <TERM dbid="UP:P01308" end="1479" id="V2056539" paragraph="paragraph16" rule="-SIMPLE-REF" start="1471" uttnum="142">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>insulin</text>
  </TERM>
  <EVENT end="1497" id="V2056557" paragraph="paragraph16" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1483" uttnum="142">
    <type>ONT::MODULATE</type>
    <predicate end="1497" id="V2056557" start="1483">
      <type>ONT::MODULATE</type>
      <text>EGF treatment</text>
    </predicate>
    <arg2 id="V2056554" role=":AFFECTED"/>
    <text>EGF treatment</text>
  </EVENT>
  <TERM dbid="UP:P01133" end="1487" id="V2056554" paragraph="paragraph16" rule="-SIMPLE-REF" start="1483" uttnum="142">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <TERM end="1554" id="V2055636" paragraph="paragraph16" rule="-SIMPLE-REF" start="1550" uttnum="142">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="1577" id="V2056750" paragraph="paragraph16" rule="-SIMPLE-REF" start="1557" uttnum="142">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <CC end="1627" id="V2056775" paragraph="paragraph16" rule="-RULE5B_AGENT_RESULT" start="1577" uttnum="142">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2056758" role=":FACTOR"/>
    <arg id="V2056818" role=":OUTCOME"/>
    <text>that lead to AKT activation (Fig. 2B,</text>
  </CC>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="1627" id="V2056758" paragraph="paragraph16" rule="-SIMPLE-REF" start="1577" uttnum="142">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>that lead to AKT activation (Fig. 2B,</text>
  </TERM>
  <EVENT end="1627" id="V2056818" paragraph="paragraph16" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1587" uttnum="142">
    <type>ONT::ACTIVATE</type>
    <predicate end="1627" id="V2056818" start="1587">
      <type>ONT::ACTIVATE</type>
      <text>to AKT activation (Fig. 2B,</text>
    </predicate>
    <arg2 id="V2056815" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000464"/>
    <text>to AKT activation (Fig. 2B,</text>
  </EVENT>
  <TERM end="1594" id="V2056815" paragraph="paragraph16" rule="-SIMPLE-REF" start="1590" uttnum="142">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="1625" id="V2056870" paragraph="paragraph16" rule="-SIMPLE-REF" start="1623" uttnum="142">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2B</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="1662" id="V2056920" paragraph="paragraph16" rule="-SIMPLE-REF" start="1659" uttnum="142">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="1694" id="V2056966" paragraph="paragraph16" rule="-SIMPLE-REF" start="1664" uttnum="142">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>6</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S6B, top panels)</text>
  </TERM>
  <TERM end="1693" id="V2056980" paragraph="paragraph16" rule="-SIMPLE-REF" start="1683" uttnum="142">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>top panels</text>
  </TERM>
  <EVENT end="1732" id="V2071425" paragraph="paragraph16" rule="-RULE60_AGENT_AFFECTED-LOC10-AFFECTED" start="1704" uttnum="143">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1732" id="V2071425" start="1704">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT Tyr-176 phosphorylation</text>
    </predicate>
    <arg2 id="V2071409" role=":AFFECTED"/>
    <arg id="R000264" role=":RESULT"/>
    <site end="1716" id="V2071422" start="1708">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr-176</text>
    </site>
    <text>AKT Tyr-176 phosphorylation</text>
  </EVENT>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="1752" id="V2071454" paragraph="paragraph16" rule="-SIMPLE-REF" start="1736" uttnum="143">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>plasma membrane</text>
  </TERM>
  <TERM end="1732" id="V2071409" paragraph="paragraph16" rule="-SIMPLE-REF" start="1704" uttnum="143">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT Tyr-176 phosphorylation</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2071425"/>
    </not-features>
  </TERM>
  <TERM end="1716" id="V2071422" paragraph="paragraph16" rule="-SIMPLE-REF" start="1708" uttnum="143">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr-176</text>
  </TERM>
  <EPI end="1849" id="V2071482" paragraph="paragraph16" rule="-RULE50_0_AGENT_NEUTRAL-NEUTRAL" start="1752" uttnum="143">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg2 id="V2071459" role=":NEUTRAL"/>
    <text>accumulation was observed at 10, 30 and 40 mins upon EGF, insulin and heregulin ligand treatments</text>
  </EPI>
  <EVENT end="1849" id="V2071459" paragraph="paragraph16" rule="-RULE50_0_AGENT_NEUTRAL-EVENT,-RULE20C_AGENT_AFFECTED-NONE" start="1752" uttnum="143">
    <type>ONT::BIND</type>
    <epistemic-modality id="V2071482"/>
    <predicate end="1849" id="V2071459" start="1752">
      <type>ONT::BIND</type>
      <text>accumulation was observed at 10, 30 and 40 mins upon EGF, insulin and heregulin ligand treatments</text>
    </predicate>
    <text>accumulation was observed at 10, 30 and 40 mins upon EGF, insulin and heregulin ligand treatments</text>
  </EVENT>
  <TERM dbid="UP:P01133" end="1808" id="V2071595" paragraph="paragraph16" rule="-SIMPLE-REF" start="1805" uttnum="143">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <TERM dbid="UP:P01308" end="1818" id="V2071603" paragraph="paragraph16" rule="-SIMPLE-REF" start="1810" uttnum="143">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>insulin</text>
  </TERM>
  <TERM dbid="EFO:0000727" end="1849" id="V2071640" paragraph="paragraph16" rule="-SIMPLE-REF" start="1822" uttnum="143">
    <type>ONT::PROCESS</type>
    <name>TREATMENTS</name>
    <text>heregulin ligand treatments</text>
  </TERM>
  <TERM dbid="CHEBI:52214" end="1849" id="V2071623" paragraph="paragraph16" rule="-SIMPLE-REF" start="1822" uttnum="143">
    <type>ONT::CHEMICAL</type>
    <name>LIGAND</name>
    <text>heregulin ligand treatments</text>
  </TERM>
  <TERM dbid="UP:Q02297" end="1849" id="V2071618" paragraph="paragraph16" rule="-SIMPLE-REF" start="1822" uttnum="143">
    <type>ONT::PROTEIN</type>
    <name>HEREGULIN</name>
    <text>heregulin ligand treatments</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="1880" id="V2071656" paragraph="paragraph16" rule="-SIMPLE-REF" start="1877" uttnum="143">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="1900" id="V2071702" paragraph="paragraph16" rule="-SIMPLE-REF" start="1882" uttnum="143">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>6</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S6B</text>
  </TERM>
  <TERM end="1923" id="V2071759" paragraph="paragraph16" rule="-SIMPLE-REF" start="1921" uttnum="143">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2B</text>
  </TERM>
  <EVENT end="1989" id="V2083022" paragraph="paragraph16" rule="-INEVENT2B,-RULE40A_AGENT_AFFECTED" start="1961" uttnum="144">
    <type>ONT::ACTIVATE</type>
    <predicate end="1989" id="V2083022" start="1961">
      <type>ONT::ACTIVATE</type>
      <text>EGF mediated AKT activation</text>
    </predicate>
    <arg1 id="V2083009" role=":AGENT"/>
    <arg2 id="V2083019" role=":AFFECTED"/>
    <arg id="R000469" role=":RESULT"/>
    <text>EGF mediated AKT activation</text>
  </EVENT>
  <CC end="2029" id="V2083046" paragraph="paragraph16" rule="-RULE5B_NEUTRAL1_NEUTRAL" start="1961" uttnum="144">
    <type>ONT::DEPENDENT</type>
    <force>ONT::TRUE</force>
    <arg id="V2083072" role=":FACTOR"/>
    <arg id="V2083022" role=":OUTCOME"/>
    <text>EGF mediated AKT activation is dependent upon Tyr176-phosphorylation</text>
  </CC>
  <TERM dbid="UP:P01133" end="1965" id="V2083009" paragraph="paragraph16" rule="-SIMPLE-REF" start="1961" uttnum="144">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <EVENT end="1989" id="V2083014" paragraph="paragraph16" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1961" uttnum="144">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1989" id="V2083014" start="1961">
      <type>ONT::MODULATE</type>
      <text>EGF mediated AKT activation</text>
    </predicate>
    <arg2 id="V2083022" role=":AFFECTED"/>
    <text>EGF mediated AKT activation</text>
  </EVENT>
  <TERM end="1978" id="V2083019" paragraph="paragraph16" rule="-SIMPLE-REF" start="1974" uttnum="144">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="2029" id="V2083072" paragraph="paragraph16" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="2002" uttnum="144">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="2029" id="V2083072" start="2002">
      <type>ONT::PHOSPHORYLATION</type>
      <text>upon Tyr176-phosphorylation</text>
    </predicate>
    <site end="2013" id="V2083066" start="2007">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176</text>
    </site>
    <text>upon Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="2013" id="V2083066" paragraph="paragraph16" rule="-SIMPLE-REF" start="2007" uttnum="144">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <TERM end="2081" id="V2097256" paragraph="paragraph16" rule="-SIMPLE-REF" start="2031" uttnum="144">
    <type>ONT::DEVICE</type>
    <name>CELL</name>
    <text>MEF1&amp;amp;2KO cells expressing AKT or Y176F mutant</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="2035" id="V2097229" paragraph="paragraph16" rule="-SIMPLE-REF" start="2031" uttnum="144">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <TERM end="2065" id="V2097276" paragraph="paragraph16" rule="-SIMPLE-REF" start="2061" uttnum="144">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="2081" id="V2097315" paragraph="paragraph16" rule="-SIMPLE-REF-MUTATION8" start="2068" uttnum="144">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>Y176F mutant</text>
  </TERM>
  <TERM end="2074" id="V2097312" paragraph="paragraph16" rule="-SIMPLE-REF" start="2068" uttnum="144">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM dbid="CHEBI:52214" end="2109" id="V2097360" paragraph="paragraph16" rule="-SIMPLE-REF" start="2099" uttnum="144">
    <type>ONT::CHEMICAL</type>
    <name>LIGAND</name>
    <text>EGF ligand</text>
  </TERM>
  <TERM dbid="UP:P01133" end="2103" id="V2097355" paragraph="paragraph16" rule="-SIMPLE-REF" start="2099" uttnum="144">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>EGF</text>
  </TERM>
  <TERM end="2128" id="V2110892" paragraph="paragraph16" rule="-SIMPLE-REF-MUTATION8" start="2111" uttnum="145">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>The Y176F mutant</text>
  </TERM>
  <TERM end="2121" id="V2110889" paragraph="paragraph16" rule="-SIMPLE-REF" start="2115" uttnum="145">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <EVENT end="2201" id="V2110938" paragraph="paragraph16" rule="-RULE10C_AGENT_AFFECTED-CELL_LOC3-GD-TO-AGENT" start="2111" uttnum="145">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="2201" id="V2110938" start="2111">
      <type>ONT::TRANSLOCATE</type>
      <text>The Y176F mutant failed to translocate to the plasma membrane and become activated by EGF</text>
    </predicate>
    <arg1 id="V2110892" role=":AGENT"/>
    <to-location end="2173" id="V2110988" start="2153">
      <type>ONT::CELL-PART</type>
      <text normalization="">the plasma membrane</text>
    </to-location>
    <text>The Y176F mutant failed to translocate to the plasma membrane and become activated by EGF</text>
  </EVENT>
  <EVENT end="2201" id="V2111016" paragraph="paragraph16" rule="-RULE40A_AGENT_AFFECTED-LOC9" start="2111" uttnum="145">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="2201" id="V2111016" start="2111">
      <type>ONT::ACTIVATE</type>
      <text>The Y176F mutant failed to translocate to the plasma membrane and become activated by EGF</text>
    </predicate>
    <arg1 id="V2111047" role=":AGENT"/>
    <arg2 id="V2110892" role=":AFFECTED"/>
    <site end="2121" id="V2110889" start="2115">
      <type>ONT::MUTATION</type>
      <text normalization="">Y176F</text>
    </site>
    <text>The Y176F mutant failed to translocate to the plasma membrane and become activated by EGF</text>
  </EVENT>
  <TERM dbid="UP:P01133" end="2201" id="V2111047" paragraph="paragraph16" rule="-SIMPLE-REF" start="2194" uttnum="145">
    <type>ONT::PROTEIN</type>
    <name>EGF</name>
    <text>by EGF</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="2173" id="V2110988" paragraph="paragraph16" rule="-SIMPLE-REF" start="2153" uttnum="145">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="2217" id="V2111058" paragraph="paragraph16" rule="-SIMPLE-REF" start="2214" uttnum="145">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="2235" id="V2111102" paragraph="paragraph16" rule="-SIMPLE-REF" start="2219" uttnum="145">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2D</text>
  </TERM>
  <TERM end="2353" id="V2126230" paragraph="paragraph16" rule="-SIMPLE-REF" start="2333" uttnum="146">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>panel 2, lanes 4–6)</text>
  </TERM>
  <TERM end="2331" id="V2126224" paragraph="paragraph16" rule="-SIMPLE-REF" start="2315" uttnum="146">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2D</text>
  </TERM>
  <TERM dbid="UP:Q9Y243" end="2392" id="V2126338" paragraph="paragraph16" rule="-INEVENT2B,-SIMPLE-REF" start="2369" uttnum="146">
    <type>ONT::PROTEIN</type>
    <name>AKT-3</name>
    <text>Tyr-phosphorylated AKT3</text>
    <features>
      <ptm event="V2126320" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT end="2392" id="V2126320" paragraph="paragraph16" rule="-RULE60_AGENT_AFFECTED-A" start="2369" uttnum="146">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="2392" id="V2126320" start="2369">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr-phosphorylated AKT3</text>
    </predicate>
    <arg2 id="V2126338" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000020"/>
    <site end="2388" id="V2126312" start="2369">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Tyr-phosphorylated</text>
    </site>
    <text>Tyr-phosphorylated AKT3</text>
  </EVENT>
  <TERM end="2388" id="V2126312" paragraph="paragraph16" rule="-SIMPLE-REF" start="2369" uttnum="146">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr-phosphorylated</text>
  </TERM>
  <EVENT end="2412" id="V2139968" paragraph="paragraph16" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="2394" uttnum="147">
    <type>ONT::TRANSFORM</type>
    <predicate end="2412" id="V2139968" start="2394">
      <type>ONT::TRANSFORM</type>
      <text>Depletion of Ack1</text>
    </predicate>
    <arg2 id="V2139988" role=":AFFECTED"/>
    <text>Depletion of Ack1</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="2412" id="V2139988" paragraph="paragraph16" rule="-SIMPLE-REF" start="2404" uttnum="147">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>of Ack1</text>
  </TERM>
  <TERM end="2417" id="V2140025" paragraph="paragraph16" rule="-SIMPLE-REF" start="2412" uttnum="147">
    <type>ONT::SUBSTANCE</type>
    <name>SI</name>
    <text>by si</text>
  </TERM>
  <TERM dbid="CHEBI:18273" end="2421" id="V2140035" paragraph="paragraph16" rule="-SIMPLE-REF" start="2417" uttnum="147">
    <type>ONT::CHEMICAL</type>
    <name>RNA</name>
    <text>RNA</text>
  </TERM>
  <TERM dbid="UP:Q02297" end="2441" id="V2140054" paragraph="paragraph16" rule="-INEVENT2B,-SIMPLE-REF" start="2421" uttnum="147">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V2140049"/>
      </inevent>
    </features>
    <name>HEREGULIN</name>
    <text>abrogated heregulin</text>
  </TERM>
  <EVENT end="2441" id="V2140049" paragraph="paragraph16" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="2421" uttnum="147">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="2441" id="V2140049" start="2421">
      <type>ONT::INHIBIT</type>
      <text>abrogated heregulin</text>
    </predicate>
    <arg2 id="V2140054" role=":AFFECTED"/>
    <text>abrogated heregulin</text>
  </EVENT>
  <EVENT end="2476" id="V2140080" paragraph="paragraph16" rule="-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="2450" uttnum="147">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="2476" id="V2140080" start="2450">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg2 id="V2140064" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000269"/>
    <site end="2476" id="V2140074" start="2450">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">AKT Tyr176-phosphorylation</text>
    </site>
    <text>AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="2476" id="V2140074" paragraph="paragraph16" rule="-SIMPLE-REF" start="2450" uttnum="147">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>AKT Tyr176-phosphorylation</text>
  </TERM>
  <TERM end="2454" id="V2140064" paragraph="paragraph16" rule="-SIMPLE-REF" start="2450" uttnum="147">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2140080"/>
    </not-features>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="2494" id="V2140107" paragraph="paragraph16" rule="-SIMPLE-REF" start="2478" uttnum="147">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>plasma membrane</text>
  </TERM>
  <TERM dbid="EFO:0001203|BTO:0000093" end="2537" id="V2140207" paragraph="paragraph16" rule="-SIMPLE-REF" start="2525" uttnum="147">
    <type>ONT::CELL-LINE</type>
    <name>MCF-7-CELLS</name>
    <text>MCF-7 cells</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="2553" id="V2140218" paragraph="paragraph16" rule="-SIMPLE-REF" start="2550" uttnum="147">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="2571" id="V2140250" paragraph="paragraph16" rule="-SIMPLE-REF" start="2555" uttnum="147">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2E</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="2582" id="V2140284" paragraph="paragraph16" rule="-SIMPLE-REF" start="2577" uttnum="147">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs</text>
  </TERM>
  <TERM end="2599" id="V2140295" paragraph="paragraph16" rule="-SIMPLE-REF" start="2595" uttnum="147">
    <type>ONT::INFORMATION</type>
    <name>DATA</name>
    <text>data</text>
  </TERM>
  <TERM end="2633" id="V2157628" paragraph="paragraph16" rule="-SIMPLE-REF" start="2602" uttnum="148">
    <type>ONT::SUBSTANCE</type>
    <name>DS</name>
    <text>Further, GFP-E346K recruited ds</text>
  </TERM>
  <TERM end="2695" id="V2157653" paragraph="paragraph16" rule="-SIMPLE-REF" start="2633" uttnum="148">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Red-AKT but not the dsRed-Y176F mutant to the plasma membrane</text>
  </TERM>
  <TERM dbid="UP:O43781|HGNC:3094|FA:03256" end="2695" id="V2157639" paragraph="paragraph16" rule="-SIMPLE-REF" start="2633" uttnum="148">
    <type>ONT::GENE-PROTEIN</type>
    <name>RED</name>
    <text>Red-AKT but not the dsRed-Y176F mutant to the plasma membrane</text>
  </TERM>
  <TERM end="2695" id="V2157695" paragraph="paragraph16" rule="-SIMPLE-REF" start="2649" uttnum="148">
    <type>ONT::SUBSTANCE</type>
    <name>DS</name>
    <text>the dsRed-Y176F mutant to the plasma membrane</text>
  </TERM>
  <TERM dbid="UP:O43781|HGNC:3094|FA:03256" end="2658" id="V2157706" paragraph="paragraph16" rule="-SIMPLE-REF" start="2655" uttnum="148">
    <type>ONT::GENE-PROTEIN</type>
    <name>RED</name>
    <text>Red</text>
  </TERM>
  <TERM end="2672" id="V2157762" paragraph="paragraph16" rule="-SIMPLE-REF-MUTATION8" start="2659" uttnum="148">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>Y176F mutant</text>
  </TERM>
  <TERM end="2665" id="V2157754" paragraph="paragraph16" rule="-SIMPLE-REF" start="2659" uttnum="148">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="2695" id="V2157814" paragraph="paragraph16" rule="-SIMPLE-REF" start="2675" uttnum="148">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <TERM end="2767" id="V2157880" paragraph="paragraph16" rule="-SIMPLE-REF" start="2710" uttnum="148">
    <type>ONT::METHOD</type>
    <name>IMMUNOFLUORESCENCE</name>
    <text>immunofluorescence (Fig. S6C–J)</text>
  </TERM>
  <TERM end="2757" id="V2157950" paragraph="paragraph16" rule="-SIMPLE-REF" start="2747" uttnum="148">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>6</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S6C</text>
  </TERM>
  <TERM end="2796" id="V2170565" paragraph="paragraph16" rule="-SIMPLE-REF" start="2785" uttnum="149">
    <type>ONT::INFORMATION</type>
    <name>DATUM</name>
    <text>these data</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="2814" id="V2170602" paragraph="paragraph16" rule="-SIMPLE-REF" start="2809" uttnum="149">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="2906" id="V2170741" paragraph="paragraph16" rule="-SIMPLE-REF" start="2817" uttnum="149">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>a key intermediate signaling entity necessary for RTK mediated AKT Tyr176-phosphorylation</text>
  </TERM>
  <TERM end="2823" id="V2170665" paragraph="paragraph16" rule="-SIMPLE-REF" start="2817" uttnum="149">
    <type>ONT::IDENTIFICATION</type>
    <name>KEY</name>
    <text>a key</text>
  </TERM>
  <TERM end="2884" id="V2170731" paragraph="paragraph16" rule="-SIMPLE-REF" start="2880" uttnum="149">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="CVCL:4W74" end="2871" id="V2170721" paragraph="paragraph16" rule="-SIMPLE-REF" start="2867" uttnum="149">
    <type>ONT::CELL-LINE</type>
    <name>RTK</name>
    <text>RTK</text>
  </TERM>
  <EVENT end="32" id="V2182875" paragraph="paragraph17" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="11" uttnum="150">
    <type>ONT::BIND</type>
    <predicate end="32" id="V2182875" start="11">
      <type>ONT::BIND</type>
      <text>Ack1/AKT interaction</text>
    </predicate>
    <arg1 id="V2182998" role=":AGENT"/>
    <text>Ack1/AKT interaction</text>
  </EVENT>
  <TERM end="20" id="V2182998" paragraph="paragraph17" rule="-EXPLICIT-REF-SEQ0B" start="11" uttnum="150">
    <type>ONT::GENE-PROTEIN</type>
    <components>
      <component id="V2182809"/>
      <component id="V2182817"/>
    </components>
    <text normalization="">Ack1/AKT</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="20" id="V2182809" paragraph="paragraph17" rule="-EXPLICIT-REF-SEQ0B-TERM" start="11" uttnum="150">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1/AKT</text>
  </TERM>
  <TERM end="20" id="V2182817" paragraph="paragraph17" rule="-SIMPLE-REF" start="16" uttnum="150">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <EVENT end="104" id="V2182940" paragraph="paragraph17" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="50" uttnum="150">
    <type>ONT::MODULATE</type>
    <predicate end="104" id="V2182940" start="50">
      <type>ONT::MODULATE</type>
      <text>LY294002 treatment (Fig. 1B)</text>
    </predicate>
    <arg2 id="V2182933" role=":AFFECTED"/>
    <text>LY294002 treatment (Fig. 1B)</text>
  </EVENT>
  <TERM dbid="CHEBI:65329" end="59" id="V2182933" paragraph="paragraph17" rule="-SIMPLE-REF" start="50" uttnum="150">
    <type>ONT::MOLECULE</type>
    <name>LY-294002</name>
    <text>LY294002</text>
  </TERM>
  <TERM end="103" id="V2182990" paragraph="paragraph17" rule="-SIMPLE-REF" start="87" uttnum="150">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">1B</text>
  </TERM>
  <EPI end="196" id="V2196677" paragraph="paragraph17" rule="-RULE50_0_AGENT_NEUTRAL-AGENT" start="105" uttnum="150">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg1 id="V2196671" role=":AGENT"/>
    <text>we assessed whether AKT Tyr176-phosphorylation could occur upon inhibition of PI3K activity</text>
  </EPI>
  <TERM end="108" id="V2196671" paragraph="paragraph17" rule="-ROBUSTPRO" start="105" uttnum="150">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="152" id="V2196703" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="125" uttnum="150">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="152" id="V2196703" start="125">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg2 id="V2196687" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000274"/>
    <site end="152" id="V2196697" start="125">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">AKT Tyr176-phosphorylation</text>
    </site>
    <text>AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="152" id="V2196697" paragraph="paragraph17" rule="-SIMPLE-REF" start="125" uttnum="150">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>AKT Tyr176-phosphorylation</text>
  </TERM>
  <TERM end="129" id="V2196687" paragraph="paragraph17" rule="-SIMPLE-REF" start="125" uttnum="150">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2196703"/>
    </not-features>
  </TERM>
  <EVENT end="196" id="V2196728" paragraph="paragraph17" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="169" uttnum="150">
    <type>ONT::INHIBIT</type>
    <predicate end="196" id="V2196728" start="169">
      <type>ONT::INHIBIT</type>
      <text>inhibition of PI3K activity</text>
    </predicate>
    <arg2 id="V2196781" role=":AFFECTED"/>
    <text>inhibition of PI3K activity</text>
  </EVENT>
  <EVENT end="196" id="V2196781" paragraph="paragraph17" rule="-ACTIVITY1" start="180" uttnum="150">
    <type>ONT::ACTIVITY</type>
    <predicate end="196" id="V2196781" start="180">
      <type>ONT::ACTIVITY</type>
      <text>of PI3K activity</text>
    </predicate>
    <arg1 id="V2196777" role=":AGENT"/>
    <text>of PI3K activity</text>
  </EVENT>
  <TERM end="188" id="V2196777" paragraph="paragraph17" rule="-SIMPLE-REF" start="183" uttnum="150">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <EVENT end="224" id="V2210612" paragraph="paragraph17" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="205" uttnum="151">
    <type>ONT::MODULATE</type>
    <predicate end="224" id="V2210612" start="205">
      <type>ONT::MODULATE</type>
      <text>LY294002 treatment</text>
    </predicate>
    <arg2 id="V2210605" role=":AFFECTED"/>
    <text>LY294002 treatment</text>
  </EVENT>
  <EVENT end="279" id="V2210646" paragraph="paragraph17" rule="-INEVENT2B,-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="232" uttnum="151">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="279" id="V2210646" start="232">
      <type>ONT::PHOSPHORYLATION</type>
      <text>affected endogenous AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg2 id="V2210630" role=":AFFECTED"/>
    <arg id="R000279" role=":RESULT"/>
    <site end="279" id="V2210640" start="232">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">affected endogenous AKT Tyr176-phosphorylation</text>
    </site>
    <text>affected endogenous AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM dbid="CHEBI:65329" end="214" id="V2210605" paragraph="paragraph17" rule="-SIMPLE-REF" start="205" uttnum="151">
    <type>ONT::MOLECULE</type>
    <name>LY-294002</name>
    <text>LY294002</text>
  </TERM>
  <TERM end="279" id="V2210640" paragraph="paragraph17" rule="-SIMPLE-REF" start="232" uttnum="151">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>affected endogenous AKT Tyr176-phosphorylation</text>
  </TERM>
  <EVENT end="279" id="V2210620" paragraph="paragraph17" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="232" uttnum="151">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="279" id="V2210620" start="232">
      <type>ONT::MODULATE</type>
      <text>affected endogenous AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg2 id="V2210646" role=":AFFECTED"/>
    <text>affected endogenous AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="256" id="V2210630" paragraph="paragraph17" rule="-SIMPLE-REF" start="241" uttnum="151">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">endogenous AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2210646"/>
    </not-features>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="296" id="V2210662" paragraph="paragraph17" rule="-SIMPLE-REF" start="287" uttnum="151">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>membrane</text>
  </TERM>
  <TERM end="343" id="V2210742" paragraph="paragraph17" rule="-SIMPLE-REF" start="327" uttnum="151">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>3</pos>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">3A</text>
  </TERM>
  <EVENT end="385" id="V2222080" paragraph="paragraph17" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="369" uttnum="152">
    <type>ONT::TRANSFORM</type>
    <predicate end="385" id="V2222080" start="369">
      <type>ONT::TRANSFORM</type>
      <text>Ack1 knockdown,</text>
    </predicate>
    <arg2 id="V2222074" role=":AFFECTED"/>
    <text>Ack1 knockdown,</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="374" id="V2222074" paragraph="paragraph17" rule="-SIMPLE-REF" start="369" uttnum="152">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="403" id="V2222143" paragraph="paragraph17" rule="-SIMPLE-REF" start="398" uttnum="152">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <TERM end="453" id="V2221749" paragraph="paragraph17" rule="-SIMPLE-REF" start="449" uttnum="152">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="EFO:0001203|BTO:0000093" end="474" id="V2222338" paragraph="paragraph17" rule="-SIMPLE-REF" start="463" uttnum="152">
    <type>ONT::CELL-LINE</type>
    <name>MCF-7-CELLS</name>
    <text>MCF7 cells</text>
  </TERM>
  <TERM dbid="UP:P01308" end="495" id="V2222359" paragraph="paragraph17" rule="-SIMPLE-REF" start="487" uttnum="152">
    <type>ONT::PROTEIN</type>
    <name>INSULIN</name>
    <text>insulin</text>
  </TERM>
  <TERM end="529" id="V2222409" paragraph="paragraph17" rule="-SIMPLE-REF" start="513" uttnum="152">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>3</pos>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">3B</text>
  </TERM>
  <EVENT end="621" id="V2231398" paragraph="paragraph17" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="541" uttnum="153">
    <type>ONT::DECREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="621" id="V2231398" start="541">
      <type>ONT::DECREASE</type>
      <text>Ser473 phosphorylation of AKT was reduced upon knockdown of either Ack1 or PI3K,</text>
    </predicate>
    <arg2 id="V2231364" role=":AFFECTED"/>
    <text>Ser473 phosphorylation of AKT was reduced upon knockdown of either Ack1 or PI3K,</text>
  </EVENT>
  <EVENT end="571" id="V2231364" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-A" start="541" uttnum="153">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="571" id="V2231364" start="541">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Ser473 phosphorylation of AKT</text>
    </predicate>
    <arg2 id="V2231376" role=":AFFECTED"/>
    <arg id="R000284" role=":RESULT"/>
    <site end="548" id="V2231361" start="541">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Ser473</text>
    </site>
    <text>Ser473 phosphorylation of AKT</text>
  </EVENT>
  <TERM end="548" id="V2231361" paragraph="paragraph17" rule="-SIMPLE-REF" start="541" uttnum="153">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473</text>
  </TERM>
  <TERM end="571" id="V2231376" paragraph="paragraph17" rule="-SIMPLE-REF" start="564" uttnum="153">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of AKT</text>
    <not-features>
      <ptm event="V2231364" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <EVENT end="621" id="V2231413" paragraph="paragraph17" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="588" uttnum="153">
    <type>ONT::TRANSFORM</type>
    <predicate end="621" id="V2231413" start="588">
      <type>ONT::TRANSFORM</type>
      <text>knockdown of either Ack1 or PI3K,</text>
    </predicate>
    <arg2 id="V2231425" role=":AFFECTED"/>
    <text>knockdown of either Ack1 or PI3K,</text>
  </EVENT>
  <TERM end="620" id="V2231425" paragraph="paragraph17" rule="-LOGICALOP-REF" start="598" uttnum="153">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="ONE-OF">
      <member id="V2231436"/>
      <member id="V2231483"/>
    </aggregate>
    <text normalization="">of either Ack1 or PI3K</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="613" id="V2231436" paragraph="paragraph17" rule="-SIMPLE-REF" start="608" uttnum="153">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="620" id="V2231483" paragraph="paragraph17" rule="-SIMPLE-REF" start="616" uttnum="153">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <TERM end="685" id="V2233835" paragraph="paragraph17" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="643" uttnum="153">
    <type>ONT::SIGNALING-PATHWAY</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>DISTINCT</value>
      </mod>
    </mods>
    <name>PATHWAY</name>
    <text>of two distinct pathways of AKT activation</text>
  </TERM>
  <EVENT end="685" id="V2233851" paragraph="paragraph17" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="671" uttnum="153">
    <type>ONT::ACTIVATE</type>
    <predicate end="685" id="V2233851" start="671">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V2233847" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000474"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="675" id="V2233847" paragraph="paragraph17" rule="-SIMPLE-REF" start="671" uttnum="153">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="703" id="V2235354" paragraph="paragraph17" rule="-SIMPLE-REF" start="694" uttnum="154">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>membrane</text>
  </TERM>
  <EVENT end="818" id="V2235391" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-LOC4-GD-AFFECTED" start="715" uttnum="154">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="818" id="V2235391" start="715">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT was phosphorylated at Ser473 even in the presence of LY294002 when coexpressed with activated Ack1</text>
    </predicate>
    <arg2 id="V2235369" role=":AFFECTED"/>
    <arg id="R000289" role=":RESULT"/>
    <site end="748" id="V2235419" start="741">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Ser473</text>
    </site>
    <text>AKT was phosphorylated at Ser473 even in the presence of LY294002 when coexpressed with activated Ack1</text>
  </EVENT>
  <TERM end="719" id="V2235369" paragraph="paragraph17" rule="-SIMPLE-REF" start="715" uttnum="154">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm event="V2235391" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="748" id="V2235419" paragraph="paragraph17" rule="-SIMPLE-REF" start="741" uttnum="154">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473</text>
  </TERM>
  <TERM dbid="CHEBI:65329" end="781" id="V2235512" paragraph="paragraph17" rule="-SIMPLE-REF" start="769" uttnum="154">
    <type>ONT::MOLECULE</type>
    <name>LY-294002</name>
    <text>of LY294002</text>
  </TERM>
  <EVENT end="818" id="V2235542" paragraph="paragraph17" rule="-RULE50_AGENT_AFFECTED-RESULT-LOC5-GD-NONE" start="786" uttnum="154">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="818" id="V2235542" start="786">
      <type>ONT::EXPRESS</type>
      <text>coexpressed with activated Ack1</text>
    </predicate>
    <site end="818" id="V2235492" start="756">
      <type>ONT::STATUS</type>
      <text normalization="PRESENCE">the presence of LY294002 when coexpressed with activated Ack1</text>
    </site>
    <text>coexpressed with activated Ack1</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="818" id="V2235587" paragraph="paragraph17" rule="-INEVENT2B,-SIMPLE-REF" start="803" uttnum="154">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="818" id="V2235575" paragraph="paragraph17" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="803" uttnum="154">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="818" id="V2235575" start="803">
      <type>ONT::ACTIVATE</type>
      <text>activated Ack1</text>
    </predicate>
    <arg2 id="V2235587" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000077"/>
    <text>activated Ack1</text>
  </EVENT>
  <TERM end="827" id="V2235644" paragraph="paragraph17" rule="-SIMPLE-REF" start="821" uttnum="154">
    <type>ONT::BODILY-FLUID</type>
    <name>SERUM</name>
    <text>serum</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="839" id="V2235669" paragraph="paragraph17" rule="-SIMPLE-REF" start="835" uttnum="154">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <TERM end="854" id="V2235695" paragraph="paragraph17" rule="-SIMPLE-REF" start="845" uttnum="154">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>KO cells</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="848" id="V2235686" paragraph="paragraph17" rule="-SIMPLE-REF" start="845" uttnum="154">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>KO</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="870" id="V2235708" paragraph="paragraph17" rule="-SIMPLE-REF" start="867" uttnum="154">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="891" id="V2235777" paragraph="paragraph17" rule="-SIMPLE-REF" start="872" uttnum="154">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>7</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S7A,</text>
  </TERM>
  <TERM end="898" id="V2235783" paragraph="paragraph17" rule="-SIMPLE-REF" start="891" uttnum="154">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>panel 2</text>
  </TERM>
  <EVENT end="1008" id="V2249408" paragraph="paragraph17" rule="-RULE10C_AGENT_AFFECTED-CELL_LOC1-GD-TO-AGENT" start="922" uttnum="155">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::CAN</modality>
    <predicate end="1008" id="V2249408" start="922">
      <type>ONT::TRANSLOCATE</type>
      <text>Tyr-phosphorylated AKT can translocate to the plasma membrane in the absence of PIP3,</text>
    </predicate>
    <arg1 id="V2249390" role=":AGENT"/>
    <to-location end="984" id="V2249458" start="964">
      <type>ONT::CELL-PART</type>
      <text normalization="">the plasma membrane</text>
    </to-location>
    <text>Tyr-phosphorylated AKT can translocate to the plasma membrane in the absence of PIP3,</text>
  </EVENT>
  <TERM end="945" id="V2249390" paragraph="paragraph17" rule="-INEVENT2B,-SIMPLE-REF" start="922" uttnum="155">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr-phosphorylated AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2249377"/>
    </features>
  </TERM>
  <EVENT end="945" id="V2249377" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-A" start="922" uttnum="155">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="945" id="V2249377" start="922">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr-phosphorylated AKT</text>
    </predicate>
    <arg2 id="V2249390" role=":RESULT"/>
    <arg id="R000021" role=":AFFECTED"/>
    <site end="941" id="V2249369" start="922">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Tyr-phosphorylated</text>
    </site>
    <text>Tyr-phosphorylated AKT</text>
  </EVENT>
  <TERM end="941" id="V2249369" paragraph="paragraph17" rule="-SIMPLE-REF" start="922" uttnum="155">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr-phosphorylated</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="984" id="V2249458" paragraph="paragraph17" rule="-SIMPLE-REF" start="964" uttnum="155">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <TERM dbid="CHEBI:16618" end="1008" id="V2249542" paragraph="paragraph17" rule="-SIMPLE-REF" start="999" uttnum="155">
    <type>ONT::MOLECULE</type>
    <name>PIP-3</name>
    <text>of PIP3,</text>
  </TERM>
  <TERM end="1012" id="V2249550" paragraph="paragraph17" rule="-SIMPLE-REF" start="1008" uttnum="155">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1030" id="V2249629" paragraph="paragraph17" rule="-SIMPLE-REF" start="1025" uttnum="155">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>25</pos>
      <aa-from>
        <aa>
          <name>Arginine</name>
          <code>R</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">R25C</text>
  </TERM>
  <EVENT end="1041" id="V2249649" paragraph="paragraph17" rule="-RULE20C_AGENT_AFFECTED-AGENT" start="1030" uttnum="155">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1041" id="V2249649" start="1030">
      <type>ONT::BIND</type>
      <text>that binds</text>
    </predicate>
    <arg1 id="V2249636" role=":AGENT"/>
    <text>that binds</text>
  </EVENT>
  <TERM end="1041" id="V2249636" paragraph="paragraph17" rule="-SIMPLE-REF" start="1030" uttnum="155">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>25</pos>
      <aa-from>
        <aa>
          <name>Arginine</name>
          <code>R</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">that binds</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="1107" id="V2249714" paragraph="paragraph17" rule="-SIMPLE-REF" start="1104" uttnum="155">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="1126" id="V2249760" paragraph="paragraph17" rule="-SIMPLE-REF" start="1109" uttnum="155">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>7</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S7B</text>
  </TERM>
  <TERM end="1145" id="V2263403" paragraph="paragraph17" rule="-SIMPLE-REF-MUTATION8" start="1129" uttnum="156">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>The R25C mutant</text>
  </TERM>
  <TERM end="1138" id="V2263400" paragraph="paragraph17" rule="-SIMPLE-REF" start="1133" uttnum="156">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>25</pos>
      <aa-from>
        <aa>
          <name>Arginine</name>
          <code>R</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">R25C</text>
  </TERM>
  <TERM end="1168" id="V2263427" paragraph="paragraph17" rule="-SIMPLE-REF" start="1149" uttnum="156">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr-phosphorylated</text>
  </TERM>
  <EVENT end="1199" id="V2263455" paragraph="paragraph17" rule="-RULE20C_AGENT_AFFECTED-CELL_LOC3-GD-TO-NONE" start="1172" uttnum="156">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1199" id="V2263455" start="1172">
      <type>ONT::BIND</type>
      <text>recruited to membrane when</text>
    </predicate>
    <to-location end="1194" id="V2263484" start="1185">
      <type>ONT::CELL-PART</type>
      <text normalization="">membrane</text>
    </to-location>
    <text>recruited to membrane when</text>
  </EVENT>
  <TERM dbid="GO:0016020|UP:SL-0162" end="1194" id="V2263484" paragraph="paragraph17" rule="-SIMPLE-REF" start="1185" uttnum="156">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>membrane</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1257" id="V2263555" paragraph="paragraph17" rule="-INEVENT2B,-SIMPLE-REF" start="1216" uttnum="156">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1, in the absence of ligand</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="1257" id="V2263543" paragraph="paragraph17" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1216" uttnum="156">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1257" id="V2263543" start="1216">
      <type>ONT::ACTIVATE</type>
      <text>activated Ack1, in the absence of ligand</text>
    </predicate>
    <arg2 id="V2263555" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000082"/>
    <text>activated Ack1, in the absence of ligand</text>
  </EVENT>
  <TERM dbid="CHEBI:52214" end="1257" id="V2263632" paragraph="paragraph17" rule="-SIMPLE-REF" start="1247" uttnum="156">
    <type>ONT::CHEMICAL</type>
    <name>LIGAND</name>
    <text>of ligand</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="1273" id="V2263642" paragraph="paragraph17" rule="-SIMPLE-REF" start="1270" uttnum="156">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="1293" id="V2263702" paragraph="paragraph17" rule="-SIMPLE-REF" start="1275" uttnum="156">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>7</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S7C</text>
  </TERM>
  <TERM end="1311" id="V2263729" paragraph="paragraph17" rule="-SIMPLE-REF" start="1303" uttnum="156">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>D</name>
    <text>D</text>
  </TERM>
  <EVENT end="1426" id="V2277092" paragraph="paragraph17" rule="-RULE20C_AGENT_AFFECTED" start="1314" uttnum="157">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1426" id="V2277092" start="1314">
      <type>ONT::BIND</type>
      <text>Interestingly, in contrast to AKT which bound PIP3, Tyr-phosphorylated AKT bound another membrane phospholipid,</text>
    </predicate>
    <arg1 id="V2277079" role=":AGENT"/>
    <arg2 id="V2277115" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000146"/>
    <text>Interestingly, in contrast to AKT which bound PIP3, Tyr-phosphorylated AKT bound another membrane phospholipid,</text>
  </EVENT>
  <TERM end="1389" id="V2277079" paragraph="paragraph17" rule="-INEVENT2B,-SIMPLE-REF" start="1366" uttnum="157">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr-phosphorylated AKT</text>
    <features>
      <ptm event="V2277066" type="ONT::PHOSPHORYLATION"/>
    </features>
    <not-features>
      <bound-to event="V2277092" id="V2277115"/>
    </not-features>
  </TERM>
  <TERM dbid="CHEBI:16247" end="1426" id="V2277115" paragraph="paragraph17" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="1395" uttnum="157">
    <type>ONT::MOLECULE</type>
    <features>
      <location id="V2277110"/>
    </features>
    <name>PHOSPHOLIPID</name>
    <text>another membrane phospholipid,</text>
    <not-features>
      <bound-to id="V2277079" event="V2277092"/>
    </not-features>
  </TERM>
  <TERM end="1364" id="V2277007" paragraph="paragraph17" rule="-INEVENT2B,-SIMPLE-REF" start="1344" uttnum="157">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT which bound PIP3</text>
    <features>
      <bound-to event="V2277027" id="R000029"/>
    </features>
  </TERM>
  <EVENT end="1364" id="V2277027" paragraph="paragraph17" rule="-RULE20C_AGENT_AFFECTED" start="1344" uttnum="157">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1364" id="V2277027" start="1344">
      <type>ONT::BIND</type>
      <text>AKT which bound PIP3</text>
    </predicate>
    <arg1 id="R000028" role=":AGENT"/>
    <arg2 id="V2277050" role=":AFFECTED"/>
    <arg id="R000030" role=":RESULT"/>
    <text>AKT which bound PIP3</text>
  </EVENT>
  <TERM dbid="CHEBI:16618" end="1364" id="V2277050" paragraph="paragraph17" rule="-SIMPLE-REF" start="1360" uttnum="157">
    <type>ONT::MOLECULE</type>
    <name>PIP-3</name>
    <text>PIP3</text>
    <not-features>
      <bound-to event="V2277027" id="R000028"/>
    </not-features>
  </TERM>
  <EVENT end="1389" id="V2277066" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-A" start="1366" uttnum="157">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1389" id="V2277066" start="1366">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr-phosphorylated AKT</text>
    </predicate>
    <arg2 id="V2277079" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000022"/>
    <site end="1385" id="V2277058" start="1366">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Tyr-phosphorylated</text>
    </site>
    <text>Tyr-phosphorylated AKT</text>
  </EVENT>
  <TERM end="1385" id="V2277058" paragraph="paragraph17" rule="-SIMPLE-REF" start="1366" uttnum="157">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr-phosphorylated</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="1412" id="V2277110" paragraph="paragraph17" rule="-SIMPLE-REF" start="1403" uttnum="157">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>membrane</text>
  </TERM>
  <TERM dbid="CHEBI:16337" end="1449" id="V2277132" paragraph="paragraph17" rule="-SIMPLE-REF" start="1426" uttnum="157">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHATIDIC-ACID</name>
    <text>phosphatidic acid (PA)</text>
  </TERM>
  <TERM dbid="CVCL:E800" end="1447" id="V2277140" paragraph="paragraph17" rule="-SIMPLE-REF" start="1445" uttnum="157">
    <type>ONT::CELL-LINE</type>
    <name>PA</name>
    <text>PA</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="1465" id="V2277161" paragraph="paragraph17" rule="-SIMPLE-REF" start="1462" uttnum="157">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="1483" id="V2277189" paragraph="paragraph17" rule="-SIMPLE-REF" start="1467" uttnum="157">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>8</pos>
      </site>
    </features>
    <name>S-8</name>
    <text>S8</text>
  </TERM>
  <TERM end="1514" id="V2290738" paragraph="paragraph17" rule="-SIMPLE-REF" start="1505" uttnum="158">
    <type>ONT::INFORMATION</type>
    <name>DATA</name>
    <text>our data</text>
  </TERM>
  <TERM end="1514" id="V2290734" paragraph="paragraph17" rule="-ROBUSTPRO" start="1505" uttnum="158">
    <type>ONT::PERSON</type>
    <text>our data</text>
  </TERM>
  <TERM end="1546" id="V2290762" paragraph="paragraph17" rule="-SIMPLE-REF" start="1529" uttnum="158">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>RTK/Ack1 pathway</text>
  </TERM>
  <TERM dbid="CVCL:4W74" end="1532" id="V2290651" paragraph="paragraph17" rule="-SIMPLE-REF" start="1529" uttnum="158">
    <type>ONT::CELL-LINE</type>
    <name>RTK</name>
    <text>RTK</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1538" id="V2290664" paragraph="paragraph17" rule="-SIMPLE-REF" start="1533" uttnum="158">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="1605" id="V2290806" paragraph="paragraph17" rule="-SIMPLE-REF" start="1572" uttnum="158">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT plasma membrane localization</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="1592" id="V2290825" paragraph="paragraph17" rule="-SIMPLE-REF" start="1576" uttnum="158">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>plasma membrane</text>
  </TERM>
  <TERM end="1672" id="V2290914" paragraph="paragraph17" rule="-SIMPLE-REF" start="1638" uttnum="158">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT that is Tyr176-phosphorylated</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2290965"/>
    </not-features>
  </TERM>
  <EVENT end="1672" id="V2290965" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-A" start="1638" uttnum="158">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1672" id="V2290965" start="1638">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT that is Tyr176-phosphorylated</text>
    </predicate>
    <arg2 id="V2290914" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000294"/>
    <site end="1672" id="V2290957" start="1650">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176-phosphorylated</text>
    </site>
    <text>AKT that is Tyr176-phosphorylated</text>
  </EVENT>
  <TERM end="1672" id="V2290957" paragraph="paragraph17" rule="-SIMPLE-REF" start="1650" uttnum="158">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176-phosphorylated</text>
  </TERM>
  <EVENT end="1739" id="V2291062" paragraph="paragraph17" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="1716" uttnum="158">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1739" id="V2291062" start="1716">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Ser473-phosphorylation</text>
    </predicate>
    <site end="1722" id="V2291056" start="1716">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Ser473</text>
    </site>
    <text>Ser473-phosphorylation</text>
  </EVENT>
  <TERM end="1722" id="V2291056" paragraph="paragraph17" rule="-SIMPLE-REF" start="1716" uttnum="158">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="1704" id="V2291024" paragraph="paragraph17" rule="-SIMPLE-REF" start="1691" uttnum="158">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>the membrane</text>
  </TERM>
  <EVENT end="1766" id="V2291152" paragraph="paragraph17" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="1744" uttnum="158">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="1766" id="V2291152" start="1744">
      <type>ONT::INHIBIT</type>
      <text>when PI3K is inhibited</text>
    </predicate>
    <arg2 id="V2291128" role=":AFFECTED"/>
    <text>when PI3K is inhibited</text>
  </EVENT>
  <TERM end="1754" id="V2291128" paragraph="paragraph17" rule="-SIMPLE-REF" start="1749" uttnum="158">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <EPI end="73" id="V2307472" paragraph="paragraph18" rule="-RULE50_0_AGENT_FORMAL" start="3" uttnum="159">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg1 id="V2307448" role=":AGENT"/>
    <arg2 id="V2307505" role=":FORMAL"/>
    <text>Earlier we have observed that Ack1 translocates to the nucleus upon it</text>
  </EPI>
  <TERM end="14" id="V2307448" paragraph="paragraph18" rule="-ROBUSTPRO" start="11" uttnum="159">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <EVENT end="73" id="V2307505" paragraph="paragraph18" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE10C_AGENT_AFFECTED-CELL_LOC1-GD-TO-AGENT" start="3" uttnum="159">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V2307472"/>
    <predicate end="73" id="V2307505" start="3">
      <type>ONT::TRANSLOCATE</type>
      <text>Earlier we have observed that Ack1 translocates to the nucleus upon it</text>
    </predicate>
    <arg1 id="V2307501" role=":AGENT"/>
    <to-location end="66" id="V2307541" start="54">
      <type>ONT::CELL-PART</type>
      <text normalization="">the nucleus</text>
    </to-location>
    <text>Earlier we have observed that Ack1 translocates to the nucleus upon it</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="38" id="V2307501" paragraph="paragraph18" rule="-SIMPLE-REF" start="33" uttnum="159">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="UP:SL-0191|GO:0005634" end="66" id="V2307541" paragraph="paragraph18" rule="-SIMPLE-REF" start="54" uttnum="159">
    <type>ONT::CELL-PART</type>
    <name>NUCLEUS</name>
    <text>the nucleus</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="73" id="V2307578" paragraph="paragraph18" rule="-SIMPLE-REF" start="71" uttnum="159">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>it</text>
  </TERM>
  <EVENT end="113" id="V2307612" paragraph="paragraph18" rule="-RULE60_AGENT_AFFECTED-LOC11-NONE" start="76" uttnum="159">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="113" id="V2307612" start="76">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr-phosphorylation [26]</text>
    </predicate>
    <site end="113" id="V2307606" start="76">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Tyr-phosphorylation [26]</text>
    </site>
    <text>Tyr-phosphorylation [26]</text>
  </EVENT>
  <TERM end="113" id="V2307606" paragraph="paragraph18" rule="-SIMPLE-REF" start="76" uttnum="159">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr-phosphorylation [26]</text>
  </TERM>
  <TERM end="118" id="V2322276" paragraph="paragraph18" rule="-ROBUSTPRO" start="115" uttnum="160">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <EVENT end="182" id="V2322349" paragraph="paragraph18" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="159" uttnum="160">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="182" id="V2322349" start="159">
      <type>ONT::ACTIVATE</type>
      <text>when Ack1 was activated</text>
    </predicate>
    <arg2 id="V2322327" role=":AFFECTED"/>
    <arg id="R000479" role=":RESULT"/>
    <text>when Ack1 was activated</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="169" id="V2322327" paragraph="paragraph18" rule="-SIMPLE-REF" start="164" uttnum="160">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="319" id="V2324291" paragraph="paragraph18" rule="-RULE30_AGENT_AFFECTED" start="184" uttnum="161">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="319" id="V2324291" start="184">
      <type>ONT::STIMULATE</type>
      <text>Ligand treatment facilitated nuclear translocation of both endogenous pTyr284-Ack1 and pTyr176-AKT (Fig. S9A)</text>
    </predicate>
    <arg1 id="V2324275" role=":AGENT"/>
    <text>Ligand treatment facilitated nuclear translocation of both endogenous pTyr284-Ack1 and pTyr176-AKT (Fig. S9A)</text>
  </EVENT>
  <EVENT end="201" id="V2324275" paragraph="paragraph18" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="184" uttnum="161">
    <type>ONT::MODULATE</type>
    <predicate end="201" id="V2324275" start="184">
      <type>ONT::MODULATE</type>
      <text>Ligand treatment</text>
    </predicate>
    <arg2 id="V2324272" role=":AFFECTED"/>
    <text>Ligand treatment</text>
  </EVENT>
  <TERM dbid="CHEBI:52214" end="191" id="V2324272" paragraph="paragraph18" rule="-SIMPLE-REF" start="184" uttnum="161">
    <type>ONT::CHEMICAL</type>
    <name>LIGAND</name>
    <text>Ligand</text>
  </TERM>
  <TERM end="318" id="V2324423" paragraph="paragraph18" rule="-SIMPLE-REF" start="301" uttnum="161">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>9</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S9A</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="267" id="V2324081" paragraph="paragraph18" rule="-SIMPLE-REF" start="262" uttnum="161">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="283" id="V2323863" paragraph="paragraph18" rule="-SIMPLE-REF" start="279" uttnum="161">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="GO:0001071|GO:0001070" end="360" id="V2340814" paragraph="paragraph18" rule="-SIMPLE-REF" start="335" uttnum="162">
    <type>ONT::PROTEIN</type>
    <name>TRANSCRIPTION-FACTORS</name>
    <text>of transcription factors</text>
  </TERM>
  <TERM end="426" id="V2340869" paragraph="paragraph18" rule="-INEVENT2B,-SIMPLE-REF" start="379" uttnum="162">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <inevent>
        <event id="V2340874"/>
      </inevent>
    </features>
    <name>AKT</name>
    <text normalization="">by AKT leading to rapid relocalization of FoxO</text>
  </TERM>
  <CC end="426" id="V2340874" paragraph="paragraph18" rule="-RULE5B_AGENT_RESULT-AGENT" start="379" uttnum="162">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2340869" role=":FACTOR"/>
    <text>by AKT leading to rapid relocalization of FoxO</text>
  </CC>
  <TERM end="426" id="V2340957" paragraph="paragraph18" rule="-SIMPLE-REF" start="418" uttnum="162">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>O</name>
    <text>of FoxO</text>
  </TERM>
  <TERM end="426" id="V2340933" paragraph="paragraph18" rule="-SIMPLE-REF" start="418" uttnum="162">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>FOX</name>
    <text>of FoxO</text>
  </TERM>
  <TERM end="460" id="V2340971" paragraph="paragraph18" rule="-SIMPLE-REF" start="426" uttnum="162">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>proteins from nucleus to cytoplasm</text>
  </TERM>
  <TERM dbid="UP:SL-0191|GO:0005634" end="448" id="V2340987" paragraph="paragraph18" rule="-SIMPLE-REF" start="440" uttnum="162">
    <type>ONT::CELL-PART</type>
    <name>NUCLEUS</name>
    <text>nucleus</text>
  </TERM>
  <TERM dbid="GO:0005737|UP:SL-0086" end="460" id="V2341016" paragraph="paragraph18" rule="-SIMPLE-REF" start="451" uttnum="162">
    <type>ONT::CELL-PART</type>
    <name>CYTOPLASM</name>
    <text>cytoplasm</text>
  </TERM>
  <EVENT end="565" id="V2354187" paragraph="paragraph18" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="468" uttnum="162">
    <type>ONT::INHIBIT</type>
    <predicate end="565" id="V2354187" start="468">
      <type>ONT::INHIBIT</type>
      <text>preventing transactivation of target genes [1], [11], [12]</text>
    </predicate>
    <arg2 id="V2354199" role=":AFFECTED"/>
    <text>preventing transactivation of target genes [1], [11], [12]</text>
  </EVENT>
  <EVENT end="565" id="V2354199" paragraph="paragraph18" rule="-RULE40A_AGENT_AFFECTED-MODA1_1-AFFECTED" start="479" uttnum="162">
    <type>ONT::ACTIVATE</type>
    <mods>
      <mod>
        <type>ONT::ACROSS</type>
        <value>TRANS-</value>
      </mod>
    </mods>
    <predicate end="565" id="V2354199" start="479">
      <type>ONT::ACTIVATE</type>
      <text>transactivation of target genes [1], [11], [12]</text>
    </predicate>
    <arg2 id="V2354225" role=":AFFECTED"/>
    <arg id="R000484" role=":RESULT"/>
    <text>transactivation of target genes [1], [11], [12]</text>
  </EVENT>
  <TERM end="565" id="V2354225" paragraph="paragraph18" rule="-SIMPLE-REF" start="495" uttnum="162">
    <type>ONT::GENE</type>
    <name>GENE</name>
    <text>of target genes [1], [11], [12]</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="565" id="V2354220" paragraph="paragraph18" rule="-SIMPLE-REF" start="495" uttnum="162">
    <type>ONT::GOAL</type>
    <name>TARGET</name>
    <text>of target genes [1], [11], [12]</text>
  </TERM>
  <EVENT end="678" id="V2359304" paragraph="paragraph18" rule="-RULE10_AGENT_AFFECTED" start="572" uttnum="163">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="678" id="V2359304" start="572">
      <type>ONT::MODULATE</type>
      <text>proteins regulate genes involved in cell cycle arrest (e.g. p21, p27KIP1</text>
    </predicate>
    <arg1 id="V2359299" role=":AGENT"/>
    <arg2 id="V2359307" role=":AFFECTED"/>
    <text>proteins regulate genes involved in cell cycle arrest (e.g. p21, p27KIP1</text>
  </EVENT>
  <TERM end="581" id="V2359299" paragraph="paragraph18" rule="-SIMPLE-REF" start="572" uttnum="163">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>proteins</text>
  </TERM>
  <TERM end="678" id="V2359307" paragraph="paragraph18" rule="-SIMPLE-REF" start="590" uttnum="163">
    <type>ONT::GENE</type>
    <name>GENE</name>
    <text>genes involved in cell cycle arrest (e.g. p21, p27KIP1</text>
  </TERM>
  <TERM dbid="UP:P46527" end="678" id="V2359547" paragraph="paragraph18" rule="-SIMPLE-REF" start="605" uttnum="163">
    <type>ONT::PROTEIN</type>
    <name>P-27-KIP-1</name>
    <text>in cell cycle arrest (e.g. p21, p27KIP1</text>
  </TERM>
  <TERM dbid="GO:0007050" end="662" id="V2359426" paragraph="paragraph18" rule="-SIMPLE-REF" start="608" uttnum="163">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELL-CYCLE-ARREST</name>
    <text>cell cycle arrest (e.g. p21,</text>
  </TERM>
  <TERM dbid="UP:Q15170|XFAM:PF02234|UP:Q62092|HGNC:11616|UP:P38936|XFAM:PF06387|UP:P63028|HGNC:1784|UP:P39689|XFAM:PF00838" end="652" id="V2359490" paragraph="paragraph18" rule="-SIMPLE-REF" start="640" uttnum="163">
    <type>ONT::GENE-PROTEIN</type>
    <name>P-21</name>
    <text>p21</text>
  </TERM>
  <TERM dbid="GO:0008219" end="692" id="V2359582" paragraph="paragraph18" rule="-SIMPLE-REF" start="681" uttnum="163">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELL-DEATH</name>
    <text>cell death</text>
  </TERM>
  <TERM dbid="GO:0006281" end="791" id="V2359659" paragraph="paragraph18" rule="-SIMPLE-REF" start="743" uttnum="163">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>DNA-REPAIR</name>
    <text>DNA repair (e.g. GADD45)</text>
  </TERM>
  <TERM dbid="FA:01442|HGNC:4095|UP:P24522" end="783" id="V2359702" paragraph="paragraph18" rule="-SIMPLE-REF" start="768" uttnum="163">
    <type>ONT::GENE-PROTEIN</type>
    <name>GADD-45</name>
    <text>GADD45</text>
  </TERM>
  <TERM end="906" id="V2373609" paragraph="paragraph18" rule="-SIMPLE-REF" start="860" uttnum="164">
    <type>ONT::DEVICE</type>
    <name>CELL</name>
    <text>MEF1&amp;amp;2KO cells co-expressing caAck and AKT</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="864" id="V2373582" paragraph="paragraph18" rule="-SIMPLE-REF" start="860" uttnum="164">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <TERM end="906" id="V2373669" paragraph="paragraph18" rule="-SIMPLE-REF" start="903" uttnum="164">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <EVENT end="940" id="V2387156" paragraph="paragraph18" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="908" uttnum="164">
    <type>ONT::EXPRESS</type>
    <predicate end="940" id="V2387156" start="908">
      <type>ONT::EXPRESS</type>
      <text>expression of p21, p27,</text>
    </predicate>
    <arg2 id="V2387199" role=":AFFECTED-RESULT"/>
    <text>expression of p21, p27,</text>
  </EVENT>
  <TERM dbid="UP:Q15170|XFAM:PF02234|UP:Q62092|HGNC:11616|UP:P38936|XFAM:PF06387|UP:P63028|HGNC:1784|UP:P39689|XFAM:PF00838" end="940" id="V2387199" paragraph="paragraph18" rule="-SIMPLE-REF" start="919" uttnum="164">
    <type>ONT::GENE-PROTEIN</type>
    <name>P-21</name>
    <text>of p21, p27,</text>
  </TERM>
  <TERM dbid="UP:Q13177" end="938" id="V2387235" paragraph="paragraph18" rule="-SIMPLE-REF" start="935" uttnum="164">
    <type>ONT::PROTEIN</type>
    <name>P-27</name>
    <text>p27</text>
  </TERM>
  <TERM dbid="UP:O43521|HGNC:994" end="943" id="V2387008" paragraph="paragraph18" rule="-SIMPLE-REF" start="940" uttnum="164">
    <type>ONT::GENE</type>
    <name>BIM</name>
    <text>Bim</text>
  </TERM>
  <EVENT end="1070" id="V2387295" paragraph="paragraph18" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="967" uttnum="164">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="1070" id="V2387295" start="967">
      <type>ONT::INHIBIT</type>
      <text>GADD45 is down regulated as opposed to the activated Ack and Y176F mutant co-expressing cells</text>
    </predicate>
    <arg2 id="V2387258" role=":AFFECTED"/>
    <text>GADD45 is down regulated as opposed to the activated Ack and Y176F mutant co-expressing cells</text>
  </EVENT>
  <TERM dbid="FA:01442|HGNC:4095|UP:P24522" end="983" id="V2387258" paragraph="paragraph18" rule="-SIMPLE-REF" start="967" uttnum="164">
    <type>ONT::GENE-PROTEIN</type>
    <name>GADD-45</name>
    <text>GADD45</text>
  </TERM>
  <TERM dbid="HGNC:19297|UP:Q07912" end="1033" id="V2387403" paragraph="paragraph18" rule="-INEVENT2B,-SIMPLE-REF" start="1015" uttnum="164">
    <type>ONT::GENE</type>
    <name>ACK</name>
    <text>the activated Ack</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <TERM end="1070" id="V2387479" paragraph="paragraph18" rule="-SIMPLE-REF" start="1037" uttnum="164">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>Y176F mutant co-expressing cells</text>
  </TERM>
  <EVENT end="1033" id="V2387396" paragraph="paragraph18" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1015" uttnum="164">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1033" id="V2387396" start="1015">
      <type>ONT::ACTIVATE</type>
      <text>the activated Ack</text>
    </predicate>
    <arg2 id="V2387403" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000087"/>
    <text>the activated Ack</text>
  </EVENT>
  <TERM end="1070" id="V2387445" paragraph="paragraph18" rule="-SIMPLE-REF-MUTATION8" start="1037" uttnum="164">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTANT</name>
    <text>Y176F mutant co-expressing cells</text>
  </TERM>
  <TERM end="1043" id="V2387442" paragraph="paragraph18" rule="-SIMPLE-REF" start="1037" uttnum="164">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="1086" id="V2387493" paragraph="paragraph18" rule="-SIMPLE-REF" start="1083" uttnum="164">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="1104" id="V2387555" paragraph="paragraph18" rule="-SIMPLE-REF" start="1088" uttnum="164">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">4A</text>
  </TERM>
  <EVENT end="1214" id="V2401189" paragraph="paragraph18" rule="-RULE40A_AGENT_AFFECTED-ROBUST-AFFECTED" start="1107" uttnum="165">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="1214" id="V2401189" start="1107">
      <type>ONT::PRODUCE</type>
      <text>Consistent with this observation, depletion of Ack1 protein by siRNA resulted in increased FoxO-responsive</text>
    </predicate>
    <arg2 id="V2401306" role=":AFFECTED"/>
    <text>Consistent with this observation, depletion of Ack1 protein by siRNA resulted in increased FoxO-responsive</text>
  </EVENT>
  <TERM end="1214" id="V2401306" paragraph="paragraph18" rule="-RULE40A_AGENT_AFFECTED-ROBUST-AFFECTED-TERM" start="1107" uttnum="165">
    <type>ONT::REFERENTIAL-SEM</type>
    <name>FOXO-RESPONSIVE</name>
    <text>Consistent with this observation, depletion of Ack1 protein by siRNA resulted in increased FoxO-responsive</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1167" id="V2401128" paragraph="paragraph18" rule="-EXPLICIT-REF1" start="1151" uttnum="165">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <assoc-with id="V2401123"/>
    <text>of Ack1 protein</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1159" id="V2401123" paragraph="paragraph18" rule="-SIMPLE-REF" start="1154" uttnum="165">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="1264" id="V2401378" paragraph="paragraph18" rule="-SIMPLE-REF" start="1248" uttnum="165">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">4B</text>
  </TERM>
  <TERM end="68" id="V2416026" paragraph="paragraph19" rule="-SIMPLE-REF" start="44" uttnum="166">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>of Tyr176 in cell growth</text>
  </TERM>
  <TERM dbid="GO:0016049" end="68" id="V2416106" paragraph="paragraph19" rule="-SIMPLE-REF" start="57" uttnum="166">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>CELL-GROWTH</name>
    <text>cell growth</text>
  </TERM>
  <TERM end="73" id="V2428668" paragraph="paragraph19" rule="-ROBUSTPRO" start="70" uttnum="166">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="109" id="V2428720" paragraph="paragraph19" rule="-SIMPLE-REF" start="83" uttnum="166">
    <type>ONT::GEO-OBJECT</type>
    <name>HA</name>
    <text>a HA-tagged myristoylated</text>
  </TERM>
  <TERM end="115" id="V2428767" paragraph="paragraph19" rule="-SIMPLE-REF" start="109" uttnum="166">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="162" id="V2428838" paragraph="paragraph19" rule="-SIMPLE-REF" start="146" uttnum="166">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-to>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">4C</text>
  </TERM>
  <TERM dbid="CHEBI:25456" end="121" id="V2428407" paragraph="paragraph19" rule="-SIMPLE-REF" start="118" uttnum="166">
    <type>ONT::MOLECULE</type>
    <name>MYR</name>
    <text>myr</text>
  </TERM>
  <TERM end="128" id="V2428439" paragraph="paragraph19" rule="-SIMPLE-REF" start="122" uttnum="166">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <EVENT end="243" id="V2443794" paragraph="paragraph19" rule="-RULE20C_AFFECTED_AFFECTED1-CELL_LOC2-GD-OTHERS-NONE" start="165" uttnum="167">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="243" id="V2443794" start="165">
      <type>ONT::BIND</type>
      <text>As the myristoylated version of AKT is constitutively anchored at the membrane</text>
    </predicate>
    <location end="243" id="V2443830" mod="null" start="231">
      <type>ONT::CELL-PART</type>
      <text normalization="">the membrane</text>
    </location>
    <text>As the myristoylated version of AKT is constitutively anchored at the membrane</text>
  </EVENT>
  <TERM end="201" id="V2443748" paragraph="paragraph19" rule="-SIMPLE-REF" start="194" uttnum="167">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of AKT</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="243" id="V2443830" paragraph="paragraph19" rule="-SIMPLE-REF" start="231" uttnum="167">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>the membrane</text>
  </TERM>
  <EVENT end="288" id="V2453500" paragraph="paragraph19" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="272" uttnum="167">
    <type>ONT::ACTIVATE</type>
    <predicate end="288" id="V2453500" start="272">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation,</text>
    </predicate>
    <arg2 id="V2453496" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000489"/>
    <text>AKT activation,</text>
  </EVENT>
  <TERM end="276" id="V2453496" paragraph="paragraph19" rule="-SIMPLE-REF" start="272" uttnum="167">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="305" id="V2453589" paragraph="paragraph19" rule="-SIMPLE-REF" start="299" uttnum="167">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Threonine</name>
        <code>T</code>
        <pos>308</pos>
      </site>
    </features>
    <name>THR-308</name>
    <text>Thr308</text>
  </TERM>
  <TERM end="357" id="V2453656" paragraph="paragraph19" rule="-SIMPLE-REF" start="340" uttnum="167">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>9</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S9B</text>
  </TERM>
  <TERM dbid="CVCL:4240|CVCL:G312" end="364" id="V2466951" paragraph="paragraph19" rule="-SIMPLE-REF" start="360" uttnum="168">
    <type>ONT::CELL-LINE</type>
    <name>MEF-1</name>
    <text>MEF1</text>
  </TERM>
  <EVENT end="500" id="V2466998" paragraph="paragraph19" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="373" uttnum="168">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="500" id="V2466998" start="373">
      <type>ONT::TRANSFORM</type>
      <text>cells expressing myr-Y176F exhibited significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg1 id="V2466977" role=":AGENT"/>
    <arg2 id="V2467139" role=":FORMAL"/>
    <text>cells expressing myr-Y176F exhibited significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation</text>
  </EVENT>
  <EVENT end="500" id="V2467139" paragraph="paragraph19" rule="-RULE60_AGENT_AFFECTED-LOC11" start="410" uttnum="168">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="500" id="V2467139" start="410">
      <type>ONT::PHOSPHORYLATION</type>
      <text>significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg1 id="V2467006" role=":AGENT"/>
    <arg2 id="V2467123" role=":AFFECTED"/>
    <arg id="R000299" role=":RESULT"/>
    <site end="500" id="V2467133" start="410">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation</text>
    </site>
    <text>significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="400" id="V2466977" paragraph="paragraph19" rule="-SIMPLE-REF" start="373" uttnum="168">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells expressing myr-Y176F</text>
  </TERM>
  <TERM end="500" id="V2467133" paragraph="paragraph19" rule="-SIMPLE-REF" start="410" uttnum="168">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation</text>
  </TERM>
  <EVENT end="457" id="V2467006" paragraph="paragraph19" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="410" uttnum="168">
    <type>ONT::DECREASE</type>
    <predicate end="457" id="V2467006" start="410">
      <type>ONT::DECREASE</type>
      <text>significant decrease in Thr308-phosphorylation</text>
    </predicate>
    <arg2 id="V2467085" role=":AFFECTED"/>
    <text>significant decrease in Thr308-phosphorylation</text>
  </EVENT>
  <TERM end="477" id="V2467123" paragraph="paragraph19" rule="-SIMPLE-REF" start="468" uttnum="168">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">that AKT</text>
    <not-features>
      <ptm event="V2467139" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <EVENT end="457" id="V2467085" paragraph="paragraph19" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="431" uttnum="168">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="457" id="V2467085" start="431">
      <type>ONT::PHOSPHORYLATION</type>
      <text>in Thr308-phosphorylation</text>
    </predicate>
    <site end="440" id="V2467079" start="434">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Thr308</text>
    </site>
    <text>in Thr308-phosphorylation</text>
  </EVENT>
  <TERM end="440" id="V2467079" paragraph="paragraph19" rule="-SIMPLE-REF" start="434" uttnum="168">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Threonine</name>
        <code>T</code>
        <pos>308</pos>
      </site>
    </features>
    <name>THR-308</name>
    <text>Thr308</text>
  </TERM>
  <TERM dbid="CHEBI:25456" end="393" id="V2466756" paragraph="paragraph19" rule="-SIMPLE-REF" start="390" uttnum="168">
    <type>ONT::MOLECULE</type>
    <name>MYR</name>
    <text>myr</text>
  </TERM>
  <TERM end="400" id="V2466788" paragraph="paragraph19" rule="-SIMPLE-REF" start="394" uttnum="168">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="541" id="V2467206" paragraph="paragraph19" rule="-SIMPLE-REF" start="526" uttnum="168">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">subsequent AKT</text>
  </TERM>
  <TERM dbid="XFAM:PF08824|XFAM:PF12026|XFAM:PF14604|UP:O35177" end="566" id="V2481435" paragraph="paragraph19" rule="-SIMPLE-REF" start="553" uttnum="169">
    <type>ONT::PROTEIN</type>
    <name>MEF-1</name>
    <text>Further, MEF1</text>
  </TERM>
  <TERM end="600" id="V2481458" paragraph="paragraph19" rule="-INEVENT2B,-SIMPLE-REF" start="571" uttnum="169">
    <type>ONT::CELL</type>
    <features>
      <inevent>
        <event id="V2481470"/>
      </inevent>
    </features>
    <name>CELL</name>
    <text>2KO cells expressing myr-AKT</text>
  </TERM>
  <TERM dbid="UP:P05787|HGNC:6446" end="575" id="V2481449" paragraph="paragraph19" rule="-SIMPLE-REF" start="572" uttnum="169">
    <type>ONT::GENE</type>
    <name>KO</name>
    <text>KO</text>
  </TERM>
  <EVENT end="600" id="V2481470" paragraph="paragraph19" rule="-RULE50_AGENT_AFFECTED-RESULT" start="571" uttnum="169">
    <type>ONT::EXPRESS</type>
    <force>ONT::TRUE</force>
    <predicate end="600" id="V2481470" start="571">
      <type>ONT::EXPRESS</type>
      <text>2KO cells expressing myr-AKT</text>
    </predicate>
    <arg2 id="V2481488" role=":AFFECTED-RESULT"/>
    <text>2KO cells expressing myr-AKT</text>
    <location mod="IN-LOC" id="V2481458"/>
  </EVENT>
  <TERM end="600" id="V2481488" paragraph="paragraph19" rule="-SIMPLE-REF" start="592" uttnum="169">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">myr-AKT</text>
  </TERM>
  <TERM dbid="CHEBI:25456" end="600" id="V2481480" paragraph="paragraph19" rule="-SIMPLE-REF" start="592" uttnum="169">
    <type>ONT::MOLECULE</type>
    <name>MYR</name>
    <text>myr-AKT</text>
  </TERM>
  <TERM end="709" id="V2481737" paragraph="paragraph19" rule="-LOGICALOP-REF" start="660" uttnum="169">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="AND">
      <member id="V2481725"/>
      <member id="V2481773"/>
    </aggregate>
    <text normalization="">of the double-positive HA and phospho-H3 (Ser10)</text>
  </TERM>
  <TERM dbid="XFAM:PF03457.11" end="686" id="V2481725" paragraph="paragraph19" rule="-SIMPLE-REF" start="663" uttnum="169">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>HA</name>
    <text>the double-positive HA</text>
  </TERM>
  <TERM end="709" id="V2481773" paragraph="paragraph19" rule="-INEVENT2B,-SIMPLE-REF" start="690" uttnum="169">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Histidine</name>
        <code>H</code>
        <pos>3</pos>
      </site>
      <ptm type="ONT::PHOSPHORYLATION" event="V2481746"/>
    </features>
    <name>H-3</name>
    <text>phospho-H3 (Ser10)</text>
  </TERM>
  <TERM end="686" id="V2481705" paragraph="paragraph19" rule="-SIMPLE-REF" start="663" uttnum="169">
    <type>ONT::EQUIPMENT</type>
    <name>POSITIVE</name>
    <text>the double-positive HA</text>
  </TERM>
  <EVENT end="709" id="V2481746" paragraph="paragraph19" rule="-PHOSPHO" start="690" uttnum="169">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="709" id="V2481746" start="690">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phospho-H3 (Ser10)</text>
    </predicate>
    <arg2 id="V2481773" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000023"/>
    <text>phospho-H3 (Ser10)</text>
  </EVENT>
  <TERM end="707" id="V2481792" paragraph="paragraph19" rule="-SIMPLE-REF" start="702" uttnum="169">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>10</pos>
      </site>
    </features>
    <name>SER-10</name>
    <text>Ser10</text>
  </TERM>
  <TERM end="724" id="V2481807" paragraph="paragraph19" rule="-SIMPLE-REF" start="717" uttnum="169">
    <type>ONT::DEVICE</type>
    <name>CELL</name>
    <text>cells,</text>
  </TERM>
  <TERM end="798" id="V2481828" paragraph="paragraph19" rule="-INEVENT2B,-SIMPLE-REF" start="738" uttnum="169">
    <type>ONT::CELL</type>
    <features>
      <inevent>
        <event id="V2481839"/>
      </inevent>
    </features>
    <name>CELL</name>
    <text>cells undergoing mitosis (Fig. 4D)</text>
  </TERM>
  <EVENT end="798" id="V2481839" paragraph="paragraph19" rule="-RULE5_AGENT_AFFECTED" start="738" uttnum="169">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="798" id="V2481839" start="738">
      <type>ONT::TRANSFORM</type>
      <text>cells undergoing mitosis (Fig. 4D)</text>
    </predicate>
    <arg1 id="V2481828" role=":AGENT"/>
    <arg2 id="V2481845" role=":AFFECTED"/>
    <text>cells undergoing mitosis (Fig. 4D)</text>
  </EVENT>
  <TERM dbid="GO:0007067" end="798" id="V2481845" paragraph="paragraph19" rule="-SIMPLE-REF" start="755" uttnum="169">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>MITOSIS</name>
    <text>mitosis (Fig. 4D)</text>
  </TERM>
  <TERM end="797" id="V2481900" paragraph="paragraph19" rule="-SIMPLE-REF" start="781" uttnum="169">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">4D</text>
  </TERM>
  <TERM end="870" id="V2493425" paragraph="paragraph19" rule="-SIMPLE-REF" start="824" uttnum="170">
    <type>ONT::DEVICE</type>
    <name>CELL</name>
    <text>of double-positive myr-Y176F expressing cells</text>
  </TERM>
  <TERM dbid="CHEBI:25456" end="846" id="V2493088" paragraph="paragraph19" rule="-SIMPLE-REF" start="843" uttnum="170">
    <type>ONT::MOLECULE</type>
    <name>MYR</name>
    <text>myr</text>
  </TERM>
  <TERM end="853" id="V2493120" paragraph="paragraph19" rule="-SIMPLE-REF" start="847" uttnum="170">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>176</pos>
      <aa-from>
        <aa>
          <name>Tyrosine</name>
          <code>Y</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Y176F</text>
  </TERM>
  <TERM end="938" id="V2493513" paragraph="paragraph19" rule="-SIMPLE-REF" start="922" uttnum="170">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>4</pos>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">4D</text>
  </TERM>
  <TERM end="974" id="V2507950" paragraph="paragraph19" rule="-SIMPLE-REF" start="947" uttnum="171">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT Tyr176-phosphorylation</text>
  </TERM>
  <EVENT end="1025" id="V2508045" paragraph="paragraph19" rule="-RULE50_AGENT_AFFECTED-AFFECTED" start="992" uttnum="171">
    <type>ONT::TRANSCRIBE</type>
    <predicate end="1025" id="V2508045" start="992">
      <type>ONT::TRANSCRIBE</type>
      <text>pro-apoptotic gene transcription</text>
    </predicate>
    <arg2 id="V2508037" role=":AFFECTED"/>
    <text>pro-apoptotic gene transcription</text>
  </EVENT>
  <TERM end="1011" id="V2508037" paragraph="paragraph19" rule="-SIMPLE-REF" start="992" uttnum="171">
    <type>ONT::GENE</type>
    <name>GENE</name>
    <text>pro-apoptotic gene</text>
  </TERM>
  <TERM end="6" id="V2521859" paragraph="paragraph20" rule="-ROBUSTPRO" start="3" uttnum="172">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="35" id="V2521926" paragraph="paragraph20" rule="-SIMPLE-REF" start="16" uttnum="172">
    <type>ONT::COMPUTER-INPUT-DEVICE</type>
    <name>MOUSE</name>
    <text>a transgenic mouse</text>
  </TERM>
  <TERM dbid="EFO:0004020" end="29" id="V2521922" paragraph="paragraph20" rule="-SIMPLE-REF" start="18" uttnum="172">
    <type>ONT::PROCESS</type>
    <name>TRANSGENIC</name>
    <text>transgenic</text>
  </TERM>
  <TERM end="41" id="V2521940" paragraph="paragraph20" rule="-SIMPLE-REF" start="35" uttnum="172">
    <type>ONT::PRODUCT-MODEL</type>
    <name>MODEL</name>
    <text>model</text>
  </TERM>
  <EVENT end="142" id="V2522086" paragraph="paragraph20" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="96" uttnum="172">
    <type>ONT::MODULATE</type>
    <predicate end="142" id="V2522086" start="96">
      <type>ONT::MODULATE</type>
      <text>the control of modified Probasin (PB) promoter</text>
    </predicate>
    <arg2 id="V2522154" role=":AFFECTED"/>
    <text>the control of modified Probasin (PB) promoter</text>
  </EVENT>
  <TERM dbid="XFAM:PF00061|UP:O08976" end="142" id="V2522154" paragraph="paragraph20" rule="-INEVENT2B,-EXPLICIT-REF1" start="108" uttnum="172">
    <type>ONT::PROMOTER</type>
    <features>
      <inevent>
        <event id="V2522104"/>
      </inevent>
    </features>
    <name>PROBASIN</name>
    <assoc-with id="V2522128"/>
    <text>of modified Probasin (PB) promoter</text>
  </TERM>
  <EVENT end="142" id="V2522104" paragraph="paragraph20" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="108" uttnum="172">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="142" id="V2522104" start="108">
      <type>ONT::MODULATE</type>
      <text>of modified Probasin (PB) promoter</text>
    </predicate>
    <arg2 id="V2522154" role=":AFFECTED"/>
    <text>of modified Probasin (PB) promoter</text>
  </EVENT>
  <TERM dbid="XFAM:PF00061|UP:O08976" end="134" id="V2522128" paragraph="paragraph20" rule="-SIMPLE-REF" start="120" uttnum="172">
    <type>ONT::PROTEIN</type>
    <name>PROBASIN</name>
    <text>Probasin (PB)</text>
  </TERM>
  <TERM dbid="HGNC:5284|UP:P15516|XFAM:PF00061|UP:O08976" end="132" id="V2522136" paragraph="paragraph20" rule="-SIMPLE-REF" start="130" uttnum="172">
    <type>ONT::PROTEIN</type>
    <name>PB</name>
    <text>PB</text>
  </TERM>
  <TERM dbid="HGNC:5284|UP:P15516|XFAM:PF00061|UP:O08976" end="151" id="V2522172" paragraph="paragraph20" rule="-SIMPLE-REF" start="144" uttnum="172">
    <type>ONT::PROTEIN</type>
    <name>PB</name>
    <text>ARR2PB</text>
  </TERM>
  <TERM dbid="HGNC:712|UP:P32121" end="151" id="V2522167" paragraph="paragraph20" rule="-SIMPLE-REF" start="144" uttnum="172">
    <type>ONT::GENE</type>
    <name>ARR-2</name>
    <text>ARR2PB</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="167" id="V2522200" paragraph="paragraph20" rule="-SIMPLE-REF" start="164" uttnum="172">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="179" id="V2522262" paragraph="paragraph20" rule="-SIMPLE-REF" start="169" uttnum="172">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">5A</text>
  </TERM>
  <TERM end="204" id="V2522288" paragraph="paragraph20" rule="-SIMPLE-REF" start="189" uttnum="172">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="215" id="V2538688" paragraph="paragraph20" rule="-SIMPLE-REF" start="207" uttnum="173">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>PB-Ack1</text>
  </TERM>
  <TERM end="215" id="V2538674" paragraph="paragraph20" rule="-SIMPLE-REF" start="207" uttnum="173">
    <type>ONT::SUBSTANCE</type>
    <name>PB</name>
    <text>PB-Ack1</text>
  </TERM>
  <TERM dbid="EFO:0004020" end="226" id="V2538710" paragraph="paragraph20" rule="-SIMPLE-REF" start="215" uttnum="173">
    <type>ONT::PROCESS</type>
    <name>TRANSGENIC</name>
    <text>transgenic</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="236" id="V2538715" paragraph="paragraph20" rule="-SIMPLE-REF" start="226" uttnum="173">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>mice (TG)</text>
  </TERM>
  <TERM dbid="HGNC:11764|UP:P01266" end="234" id="V2538728" paragraph="paragraph20" rule="-SIMPLE-REF" start="232" uttnum="173">
    <type>ONT::GENE</type>
    <name>TG</name>
    <text>TG</text>
  </TERM>
  <EVENT end="336" id="V2538841" paragraph="paragraph20" rule="-INEVENT2B,-RULE60_AGENT_AFFECTED-LOC13" start="244" uttnum="173">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="336" id="V2538841" start="244">
      <type>ONT::PHOSPHORYLATION</type>
      <text>significant increase in AKT Tyr176-phosphorylation leading to Ser473/Thr308-phosphorylation</text>
    </predicate>
    <arg1 id="V2538760" role=":AGENT"/>
    <site end="278" id="V2538835" start="272">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176</text>
    </site>
    <text>significant increase in AKT Tyr176-phosphorylation leading to Ser473/Thr308-phosphorylation</text>
  </EVENT>
  <EVENT end="272" id="V2538760" paragraph="paragraph20" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="244" uttnum="173">
    <type>ONT::INCREASE</type>
    <predicate end="272" id="V2538760" start="244">
      <type>ONT::INCREASE</type>
      <text>significant increase in AKT</text>
    </predicate>
    <arg2 id="V2538825" role=":AFFECTED"/>
    <text>significant increase in AKT</text>
  </EVENT>
  <TERM end="278" id="V2538835" paragraph="paragraph20" rule="-SIMPLE-REF" start="272" uttnum="173">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <TERM end="272" id="V2538825" paragraph="paragraph20" rule="-SIMPLE-REF" start="265" uttnum="173">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">in AKT</text>
  </TERM>
  <TERM end="312" id="V2538161" paragraph="paragraph20" rule="-SIMPLE-REF" start="306" uttnum="173">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473</text>
  </TERM>
  <EVENT end="336" id="V2538183" paragraph="paragraph20" rule="-RULE60_AGENT_AFFECTED-LOC11-NONE" start="313" uttnum="173">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="336" id="V2538183" start="313">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Thr308-phosphorylation</text>
    </predicate>
    <site end="336" id="V2538177" start="313">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Thr308-phosphorylation</text>
    </site>
    <text>Thr308-phosphorylation</text>
  </EVENT>
  <TERM end="336" id="V2538177" paragraph="paragraph20" rule="-SIMPLE-REF" start="313" uttnum="173">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Threonine</name>
        <code>T</code>
        <pos>308</pos>
      </site>
    </features>
    <name>THR-308</name>
    <text>Thr308-phosphorylation</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="352" id="V2538891" paragraph="paragraph20" rule="-SIMPLE-REF" start="349" uttnum="173">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="372" id="V2538944" paragraph="paragraph20" rule="-SIMPLE-REF" start="354" uttnum="173">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-to>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">5C,</text>
  </TERM>
  <TERM end="384" id="V2538961" paragraph="paragraph20" rule="-SIMPLE-REF" start="376" uttnum="173">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>3 panels</text>
  </TERM>
  <TERM end="394" id="V2538979" paragraph="paragraph20" rule="-SIMPLE-REF" start="390" uttnum="173">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="404" id="V2538986" paragraph="paragraph20" rule="-SIMPLE-REF" start="394" uttnum="173">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATE</name>
    <text>substrate</text>
  </TERM>
  <TERM dbid="UP:O43524|HGNC:3821" end="438" id="V2539043" paragraph="paragraph20" rule="-SIMPLE-REF" start="404" uttnum="173">
    <type>ONT::GENE</type>
    <name>FOXO-3-A</name>
    <text>FOXO3a Ser318/321-phosphorylation</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="454" id="V2539081" paragraph="paragraph20" rule="-SIMPLE-REF" start="451" uttnum="173">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="474" id="V2539120" paragraph="paragraph20" rule="-SIMPLE-REF" start="456" uttnum="173">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">5B,</text>
  </TERM>
  <TERM end="480" id="V2539130" paragraph="paragraph20" rule="-SIMPLE-REF" start="474" uttnum="173">
    <type>ONT::SHAPE-OBJECT</type>
    <name>PANEL</name>
    <text>panel</text>
  </TERM>
  <TERM end="499" id="V2539198" paragraph="paragraph20" rule="-SIMPLE-REF" start="486" uttnum="173">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>the prostates</text>
  </TERM>
  <TERM end="512" id="V2551576" paragraph="paragraph20" rule="-SIMPLE-REF" start="501" uttnum="174">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>These mice</text>
  </TERM>
  <TERM dbid="XFAM:PF01221|UP:P63168" end="620" id="V2551772" paragraph="paragraph20" rule="-SIMPLE-REF" start="602" uttnum="174">
    <type>ONT::PROTEIN</type>
    <name>MPINS</name>
    <text>mPINs by 44 weeks</text>
  </TERM>
  <TERM end="596" id="V2551686" paragraph="paragraph20" rule="-SIMPLE-REF" start="580" uttnum="174">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-to>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">5E</text>
  </TERM>
  <TERM end="640" id="V2551849" paragraph="paragraph20" rule="-SIMPLE-REF" start="638" uttnum="174">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">5F</text>
  </TERM>
  <TERM dbid="CVCL:F563" end="659" id="V2551889" paragraph="paragraph20" rule="-SIMPLE-REF" start="642" uttnum="174">
    <type>ONT::CELL-LINE</type>
    <name>J-L</name>
    <text>J–L</text>
  </TERM>
  <TERM end="697" id="V2560767" paragraph="paragraph20" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="662" uttnum="175">
    <type>ONT::BODY-PART</type>
    <features>
      <location id="V2560763"/>
    </features>
    <name>EPITHELIUM</name>
    <text>The prostate epithelium of TG mice</text>
  </TERM>
  <TERM end="720" id="V2560847" paragraph="paragraph20" rule="-SIMPLE-REF" start="709" uttnum="175">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>ROUND</name>
    <text>with round</text>
  </TERM>
  <TERM end="697" id="V2560763" paragraph="paragraph20" rule="-SIMPLE-REF" start="662" uttnum="175">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>The prostate epithelium of TG mice</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="697" id="V2560796" paragraph="paragraph20" rule="-SIMPLE-REF" start="686" uttnum="175">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>of TG mice</text>
  </TERM>
  <TERM dbid="HGNC:11764|UP:P01266" end="692" id="V2560779" paragraph="paragraph20" rule="-SIMPLE-REF" start="689" uttnum="175">
    <type>ONT::GENE</type>
    <name>TG</name>
    <text>TG</text>
  </TERM>
  <TERM dbid="UP:SL-0191" end="751" id="V2560889" paragraph="paragraph20" rule="-SIMPLE-REF" start="723" uttnum="175">
    <type>ONT::CELL-PART</type>
    <name>NUCLEI</name>
    <text>polygonal stratified nuclei,</text>
  </TERM>
  <TERM end="831" id="V2565108" paragraph="paragraph20" rule="-SIMPLE-REF" start="815" uttnum="175">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-to>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">5E</text>
  </TERM>
  <TERM dbid="HGNC:17066|XFAM:PF02037|XFAM:PF16294|UP:Q9JIX8|UP:Q9UKV3" end="844" id="V2566448" paragraph="paragraph20" rule="-SIMPLE-REF" start="834" uttnum="176">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACINI</name>
    <text>The acini</text>
  </TERM>
  <TERM end="914" id="V2566555" paragraph="paragraph20" rule="-SIMPLE-REF" start="855" uttnum="176">
    <type>ONT::EDGE</type>
    <name>RIM</name>
    <text>by a rim of basal cells (Fig. 5F)</text>
  </TERM>
  <TERM dbid="BTO:0000939|CO:0000646" end="914" id="V2566588" paragraph="paragraph20" rule="-SIMPLE-REF" start="864" uttnum="176">
    <type>ONT::CELL</type>
    <name>BASAL-CELLS</name>
    <text>of basal cells (Fig. 5F)</text>
  </TERM>
  <TERM end="913" id="V2566633" paragraph="paragraph20" rule="-SIMPLE-REF" start="897" uttnum="176">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-to>
        <aa>
          <name>Phenylalanine</name>
          <code>F</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">5F</text>
  </TERM>
  <TERM dbid="XFAM:PF01221|UP:P63168" end="935" id="V2581644" paragraph="paragraph20" rule="-SIMPLE-REF" start="926" uttnum="177">
    <type>ONT::PROTEIN</type>
    <name>MPINS</name>
    <text>of mPINs</text>
  </TERM>
  <TERM dbid="HGNC:17066|XFAM:PF02037|XFAM:PF16294|UP:Q9JIX8|UP:Q9UKV3" end="1002" id="V2581737" paragraph="paragraph20" rule="-SIMPLE-REF" start="983" uttnum="177">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACINI</name>
    <text>by prostatic acini</text>
  </TERM>
  <TERM end="1071" id="V2581812" paragraph="paragraph20" rule="-SIMPLE-REF" start="1056" uttnum="177">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>atypical cells</text>
  </TERM>
  <TERM dbid="UP:SL-0191" end="1093" id="V2581836" paragraph="paragraph20" rule="-INEVENT2B,-SIMPLE-REF" start="1076" uttnum="177">
    <type>ONT::CELL-PART</type>
    <features>
      <inevent>
        <event id="V2581831"/>
      </inevent>
    </features>
    <name>NUCLEI</name>
    <text>elongated nuclei</text>
  </TERM>
  <EVENT end="1093" id="V2581831" paragraph="paragraph20" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1076" uttnum="177">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1093" id="V2581831" start="1076">
      <type>ONT::MODULATE</type>
      <text>elongated nuclei</text>
    </predicate>
    <arg2 id="V2581836" role=":AFFECTED"/>
    <text>elongated nuclei</text>
  </EVENT>
  <TERM dbid="UP:SL-0188" end="1122" id="V2581851" paragraph="paragraph20" rule="-SIMPLE-REF" start="1114" uttnum="177">
    <type>ONT::CELL-PART</type>
    <name>NUCLEOLI</name>
    <text>nucleoli</text>
  </TERM>
  <EVENT end="1227" id="V2596214" paragraph="paragraph20" rule="-RULE20C_AGENT_AFFECTED-LOC5-GD-AGENT" start="1124" uttnum="178">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1227" id="V2596214" start="1124">
      <type>ONT::BIND</type>
      <text>Focally, the papillae merged into each other within the acini generating a cribiform pattern of growth</text>
    </predicate>
    <arg1 id="V2596208" role=":AGENT"/>
    <site end="1227" id="V2596259" start="1176">
      <type>ONT::GENE-PROTEIN</type>
      <text normalization="">the acini generating a cribiform pattern of growth</text>
    </site>
    <text>Focally, the papillae merged into each other within the acini generating a cribiform pattern of growth</text>
  </EVENT>
  <TERM end="1146" id="V2596208" paragraph="paragraph20" rule="-SIMPLE-REF" start="1133" uttnum="178">
    <type>ONT::BODY-PART</type>
    <name>PAPILLAE</name>
    <text>the papillae</text>
  </TERM>
  <TERM end="1169" id="V2596230" paragraph="paragraph20" rule="-ROBUSTPRO" start="1158" uttnum="178">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>each other</text>
  </TERM>
  <TERM dbid="HGNC:17066|XFAM:PF02037|XFAM:PF16294|UP:Q9JIX8|UP:Q9UKV3" end="1227" id="V2596259" paragraph="paragraph20" rule="-SIMPLE-REF" start="1176" uttnum="178">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACINI</name>
    <text>the acini generating a cribiform pattern of growth</text>
  </TERM>
  <TERM dbid="GO:0040007" end="1227" id="V2596324" paragraph="paragraph20" rule="-SIMPLE-REF" start="1220" uttnum="178">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>GROWTH</name>
    <text>growth</text>
  </TERM>
  <TERM end="1247" id="V2595624" paragraph="paragraph20" rule="-SIMPLE-REF" start="1245" uttnum="178">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-to>
        <aa>
          <name>Leucine or Isoleucine</name>
          <code>J</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">5J</text>
  </TERM>
  <EVENT end="1411" id="V2610772" paragraph="paragraph20" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="1266" uttnum="179">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="1411" id="V2610772" start="1266">
      <type>ONT::TRANSFORM</type>
      <text>Dorsal lobe exhibited an increased number of small acini lined by cells containing nuclei exhibiting prominent nucleoli and the neoplastic acini</text>
    </predicate>
    <arg1 id="V2610767" role=":AGENT"/>
    <text>Dorsal lobe exhibited an increased number of small acini lined by cells containing nuclei exhibiting prominent nucleoli and the neoplastic acini</text>
  </EVENT>
  <TERM dbid="UP:Q96B36|HGNC:28426" end="1278" id="V2610767" paragraph="paragraph20" rule="-SIMPLE-REF" start="1266" uttnum="179">
    <type>ONT::GENE</type>
    <name>LOBE</name>
    <text>Dorsal lobe</text>
  </TERM>
  <TERM dbid="HGNC:17066|XFAM:PF02037|XFAM:PF16294|UP:Q9JIX8|UP:Q9UKV3" end="1411" id="V2610805" paragraph="paragraph20" rule="-SIMPLE-REF" start="1308" uttnum="179">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACINI</name>
    <text>of small acini lined by cells containing nuclei exhibiting prominent nucleoli and the neoplastic acini</text>
  </TERM>
  <TERM end="1411" id="V2610848" paragraph="paragraph20" rule="-SIMPLE-REF" start="1329" uttnum="179">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>by cells containing nuclei exhibiting prominent nucleoli and the neoplastic acini</text>
  </TERM>
  <TERM dbid="UP:SL-0191" end="1411" id="V2610859" paragraph="paragraph20" rule="-INEVENT2B,-SIMPLE-REF" start="1349" uttnum="179">
    <type>ONT::CELL-PART</type>
    <features>
      <inevent>
        <event id="V2610865"/>
      </inevent>
    </features>
    <name>NUCLEI</name>
    <text>nuclei exhibiting prominent nucleoli and the neoplastic acini</text>
  </TERM>
  <EVENT end="1411" id="V2610865" paragraph="paragraph20" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="1356" uttnum="179">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="1411" id="V2610865" start="1356">
      <type>ONT::TRANSFORM</type>
      <text>exhibiting prominent nucleoli and the neoplastic acini</text>
    </predicate>
    <arg1 id="V2610859" role=":AGENT"/>
    <text>exhibiting prominent nucleoli and the neoplastic acini</text>
  </EVENT>
  <TERM dbid="UP:SL-0188" end="1386" id="V2610874" paragraph="paragraph20" rule="-SIMPLE-REF" start="1367" uttnum="179">
    <type>ONT::CELL-PART</type>
    <name>NUCLEOLI</name>
    <text>prominent nucleoli</text>
  </TERM>
  <TERM dbid="HGNC:17066|XFAM:PF02037|XFAM:PF16294|UP:Q9JIX8|UP:Q9UKV3" end="1411" id="V2610908" paragraph="paragraph20" rule="-SIMPLE-REF" start="1390" uttnum="179">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACINI</name>
    <text>the neoplastic acini</text>
  </TERM>
  <TERM dbid="CO:0000185|BTO:0002309" end="1446" id="V2610959" paragraph="paragraph20" rule="-SIMPLE-REF" start="1426" uttnum="179">
    <type>ONT::CELL</type>
    <name>MYOEPITHELIAL-CELLS</name>
    <text>myoepithelial cells</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="1462" id="V2610970" paragraph="paragraph20" rule="-SIMPLE-REF" start="1459" uttnum="179">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="1480" id="V2611010" paragraph="paragraph20" rule="-SIMPLE-REF" start="1464" uttnum="179">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>5</pos>
      <aa-to>
        <aa>
          <name>Leucine</name>
          <code>L</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">5L</text>
  </TERM>
  <EPI end="1598" id="V2622749" paragraph="paragraph20" rule="-RULE50_0_AGENT_FORMAL" start="1483" uttnum="180">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg1 id="V2622739" role=":AGENT"/>
    <arg2 id="V2622787" role=":FORMAL"/>
    <text>We previously demonstrated that Ack1 regulates phosphorylation of androgen receptor [26]</text>
  </EPI>
  <TERM end="1486" id="V2622739" paragraph="paragraph20" rule="-ROBUSTPRO" start="1483" uttnum="180">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <EVENT end="1598" id="V2622787" paragraph="paragraph20" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE10_AGENT_AFFECTED" start="1483" uttnum="180">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V2622749"/>
    <predicate end="1598" id="V2622787" start="1483">
      <type>ONT::MODULATE</type>
      <text>We previously demonstrated that Ack1 regulates phosphorylation of androgen receptor [26]</text>
    </predicate>
    <arg1 id="V2622783" role=":AGENT"/>
    <arg2 id="V2622790" role=":AFFECTED"/>
    <text>We previously demonstrated that Ack1 regulates phosphorylation of androgen receptor [26]</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1520" id="V2622783" paragraph="paragraph20" rule="-SIMPLE-REF" start="1515" uttnum="180">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <EVENT end="1598" id="V2622790" paragraph="paragraph20" rule="-RULE60_AGENT_AFFECTED-LOC5-GD-NONE" start="1530" uttnum="180">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1598" id="V2622790" start="1530">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation of androgen receptor [26]</text>
    </predicate>
    <site end="1598" id="V2622790" start="1530">
      <type>ONT::PHOSPHORYLATION</type>
      <text normalization="">phosphorylation of androgen receptor [26]</text>
    </site>
    <text>phosphorylation of androgen receptor [26]</text>
  </EVENT>
  <TERM dbid="GO:0004872" end="1598" id="V2622807" paragraph="paragraph20" rule="-SIMPLE-REF" start="1549" uttnum="180">
    <type>ONT::PROTEIN</type>
    <name>RECEPTOR</name>
    <text>androgen receptor [26]</text>
  </TERM>
  <TERM dbid="CHEBI:50113" end="1558" id="V2622802" paragraph="paragraph20" rule="-SIMPLE-REF" start="1549" uttnum="180">
    <type>ONT::CHEMICAL</type>
    <name>ANDROGEN</name>
    <text>androgen</text>
  </TERM>
  <TERM end="1619" id="V2622843" paragraph="paragraph20" rule="-SIMPLE-REF" start="1608" uttnum="180">
    <type>ONT::PERSON</type>
    <name>SUPPRESSOR</name>
    <text>suppressor</text>
  </TERM>
  <TERM dbid="HGNC:12799|UP:Q9NZC7" end="1630" id="V2622854" paragraph="paragraph20" rule="-SIMPLE-REF" start="1619" uttnum="180">
    <type>ONT::GENE</type>
    <name>WWOX</name>
    <text>Wwox</text>
  </TERM>
  <TERM end="1660" id="V2622925" paragraph="paragraph20" rule="-SIMPLE-REF" start="1651" uttnum="180">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>prostate</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="1703" id="V2638569" paragraph="paragraph20" rule="-SIMPLE-REF" start="1698" uttnum="181">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>mice</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1698" id="V2638559" paragraph="paragraph20" rule="-SIMPLE-REF" start="1690" uttnum="181">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>PB-Ack1</text>
  </TERM>
  <TERM end="1698" id="V2638545" paragraph="paragraph20" rule="-SIMPLE-REF" start="1690" uttnum="181">
    <type>ONT::SUBSTANCE</type>
    <name>PB</name>
    <text>PB-Ack1</text>
  </TERM>
  <EVENT end="1747" id="V2638659" paragraph="paragraph20" rule="-INEVENT2B,-RULE10_AGENT_AFFECTED-AGENT" start="1719" uttnum="181">
    <type>ONT::MODULATE</type>
    <predicate end="1747" id="V2638659" start="1719">
      <type>ONT::MODULATE</type>
      <text>the combined effect of Ack1</text>
    </predicate>
    <arg1 id="V2638682" role=":AGENT"/>
    <text>the combined effect of Ack1</text>
  </EVENT>
  <EVENT end="1747" id="V2638652" paragraph="paragraph20" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="1719" uttnum="181">
    <type>ONT::TRANSFORM</type>
    <force>ONT::TRUE</force>
    <predicate end="1747" id="V2638652" start="1719">
      <type>ONT::TRANSFORM</type>
      <text>the combined effect of Ack1</text>
    </predicate>
    <arg2 id="V2638659" role=":AFFECTED"/>
    <text>the combined effect of Ack1</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1747" id="V2638682" paragraph="paragraph20" rule="-SIMPLE-REF" start="1739" uttnum="181">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>of Ack1</text>
  </TERM>
  <TERM end="1759" id="V2638692" paragraph="paragraph20" rule="-SIMPLE-REF" start="1756" uttnum="181">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="UP:P10275" end="1764" id="V2638700" paragraph="paragraph20" rule="-SIMPLE-REF" start="1761" uttnum="181">
    <type>ONT::PROTEIN</type>
    <name>AR</name>
    <text>AR</text>
  </TERM>
  <TERM dbid="GO:0016310" end="1793" id="V2638728" paragraph="paragraph20" rule="-SIMPLE-REF" start="1768" uttnum="181">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>PHOSPHORYLATIONS</name>
    <text>Wwox Tyr-phosphorylations</text>
  </TERM>
  <TERM end="1793" id="V2638720" paragraph="paragraph20" rule="-SIMPLE-REF" start="1768" uttnum="181">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Wwox Tyr-phosphorylations</text>
  </TERM>
  <TERM dbid="HGNC:12799|UP:Q9NZC7" end="1773" id="V2638715" paragraph="paragraph20" rule="-SIMPLE-REF" start="1768" uttnum="181">
    <type>ONT::GENE</type>
    <name>WWOX</name>
    <text>Wwox</text>
  </TERM>
  <TERM dbid="UP:P10275" end="1798" id="V2652622" paragraph="paragraph20" rule="-SIMPLE-REF" start="1795" uttnum="182">
    <type>ONT::PROTEIN</type>
    <name>AR</name>
    <text>AR</text>
  </TERM>
  <TERM dbid="GO:0016310" end="1828" id="V2652650" paragraph="paragraph20" rule="-SIMPLE-REF" start="1802" uttnum="182">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>PHOSPHORYLATIONS</name>
    <text>Wwox Tyr-phosphorylations</text>
  </TERM>
  <TERM end="1828" id="V2652642" paragraph="paragraph20" rule="-SIMPLE-REF" start="1802" uttnum="182">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Wwox Tyr-phosphorylations</text>
  </TERM>
  <TERM dbid="HGNC:12799|UP:Q9NZC7" end="1807" id="V2652637" paragraph="paragraph20" rule="-SIMPLE-REF" start="1802" uttnum="182">
    <type>ONT::GENE</type>
    <name>WWOX</name>
    <text>Wwox</text>
  </TERM>
  <TERM end="1937" id="V2652849" paragraph="paragraph20" rule="-SIMPLE-REF" start="1898" uttnum="182">
    <type>ONT::NONESSENTIAL-CONTRACT</type>
    <name>INDEPENDENCE</name>
    <text>androgen-independence [26]</text>
  </TERM>
  <TERM dbid="CHEBI:50113" end="1937" id="V2652838" paragraph="paragraph20" rule="-SIMPLE-REF" start="1898" uttnum="182">
    <type>ONT::CHEMICAL</type>
    <name>ANDROGEN</name>
    <text>androgen-independence [26]</text>
  </TERM>
  <EVENT end="1980" id="V2667116" paragraph="paragraph20" rule="-RULE10_AGENT_AFFECTED" start="1939" uttnum="183">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1980" id="V2667116" start="1939">
      <type>ONT::MODULATE</type>
      <text>Ack1 mediated AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg1 id="V2667111" role=":AGENT"/>
    <arg2 id="V2667137" role=":AFFECTED"/>
    <text>Ack1 mediated AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1944" id="V2667111" paragraph="paragraph20" rule="-SIMPLE-REF" start="1939" uttnum="183">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <EVENT end="1980" id="V2667137" paragraph="paragraph20" rule="-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="1953" uttnum="183">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1980" id="V2667137" start="1953">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg2 id="V2667121" role=":AFFECTED"/>
    <arg id="R000304" role=":RESULT"/>
    <site end="1980" id="V2667131" start="1953">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">AKT Tyr176-phosphorylation</text>
    </site>
    <text>AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="1980" id="V2667131" paragraph="paragraph20" rule="-SIMPLE-REF" start="1953" uttnum="183">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>AKT Tyr176-phosphorylation</text>
  </TERM>
  <TERM end="1957" id="V2667121" paragraph="paragraph20" rule="-SIMPLE-REF" start="1953" uttnum="183">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2667137"/>
    </not-features>
  </TERM>
  <EVENT end="2043" id="V2667199" paragraph="paragraph20" rule="-RULE10_AGENT_AFFECTED-NONE" start="2016" uttnum="183">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="2043" id="V2667199" start="2016">
      <type>ONT::MODULATE</type>
      <text>stage initiating processes</text>
    </predicate>
    <arg2 id="V2667205" role=":FORMAL"/>
    <text>stage initiating processes</text>
  </EVENT>
  <CC end="2043" id="V2667205" paragraph="paragraph20" rule="-RULE5B_AGENT_RESULT-NONE" start="2022" uttnum="183">
    <type>ONT::CAUSE</type>
    <arg id="V2667210" role=":AFFECTED"/>
    <text>initiating processes</text>
  </CC>
  <TERM end="2043" id="V2667210" paragraph="paragraph20" rule="-SIMPLE-REF" start="2033" uttnum="183">
    <type>ONT::PROCESS</type>
    <name>PROCESS</name>
    <text>processes</text>
  </TERM>
  <TERM dbid="MESH:C082026" end="2080" id="V2667293" paragraph="paragraph20" rule="-SIMPLE-REF" start="2069" uttnum="183">
    <type>ONT::PHARMACOLOGIC-SUBSTANCE</type>
    <name>MIMIC</name>
    <text>that mimic</text>
  </TERM>
  <TERM end="2107" id="V2667344" paragraph="paragraph20" rule="-SIMPLE-REF" start="2092" uttnum="183">
    <type>ONT::OPTION</type>
    <name>ALTERNATIVE</name>
    <text>an alternative</text>
  </TERM>
  <TERM end="2225" id="V2667372" paragraph="paragraph20" rule="-ROBUSTPRO" start="2110" uttnum="183">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>those of PTEN loss which has been prominently emphasized in other mouse models of prostate cancer [33]</text>
  </TERM>
  <TERM dbid="UP:P60484" end="2124" id="V2667385" paragraph="paragraph20" rule="-SIMPLE-REF" start="2119" uttnum="183">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>PTEN</text>
  </TERM>
  <TERM end="2225" id="V2667513" paragraph="paragraph20" rule="-SIMPLE-REF" start="2170" uttnum="183">
    <type>ONT::COMPUTER-INPUT-DEVICE</type>
    <name>MOUSE</name>
    <text>other mouse models of prostate cancer [33]</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="39" id="V2677618" paragraph="paragraph21" rule="-SIMPLE-REF" start="34" uttnum="184">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="55" id="V2677400" paragraph="paragraph21" rule="-SIMPLE-REF" start="51" uttnum="184">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="87" id="V2691942" paragraph="paragraph21" rule="-ROBUSTPRO" start="84" uttnum="184">
    <type>ONT::PERSON</type>
    <text>we</text>
  </TERM>
  <TERM end="122" id="V2691956" paragraph="paragraph21" rule="-SIMPLE-REF" start="97" uttnum="184">
    <type>ONT::INTERNAL-BODY-PART</type>
    <name>TISSUE</name>
    <text>an extensive tissue micro</text>
  </TERM>
  <EPI end="143" id="V2691993" paragraph="paragraph21" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="128" uttnum="184">
    <type>ONT::TEST</type>
    <text>analysis (TMA)</text>
  </EPI>
  <TERM end="174" id="V2692027" paragraph="paragraph21" rule="-INEVENT2B,-SIMPLE-REF" start="143" uttnum="184">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <features>
      <inevent>
        <event id="V2692024"/>
      </inevent>
    </features>
    <name>BREAST</name>
    <text>of clinically annotated breast</text>
  </TERM>
  <EVENT end="174" id="V2692024" paragraph="paragraph21" rule="-RULE40_AGENT_AFFECTED-RESULT-LOC5-GD-NONE" start="143" uttnum="184">
    <type>ONT::PRODUCE</type>
    <force>ONT::TRUE</force>
    <predicate end="174" id="V2692024" start="143">
      <type>ONT::PRODUCE</type>
      <text>of clinically annotated breast</text>
    </predicate>
    <arg2 id="V2692027" role=":AFFECTED"/>
    <site end="143" id="V2691993" start="128">
      <type>ONT::TEST</type>
      <text normalization="">analysis (TMA)</text>
    </site>
    <text>of clinically annotated breast</text>
  </EVENT>
  <TERM end="179" id="V2692044" paragraph="paragraph21" rule="-SIMPLE-REF" start="175" uttnum="184">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>N</name>
    <text>n = </text>
  </TERM>
  <TERM end="206" id="V2706226" paragraph="paragraph21" rule="-SIMPLE-REF" start="199" uttnum="185">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>284</pos>
      </site>
    </features>
    <name>TYR-284</name>
    <text>Tyr284</text>
  </TERM>
  <TERM end="255" id="V2706275" paragraph="paragraph21" rule="-SIMPLE-REF" start="209" uttnum="185">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>the primary autophosphorylation site in Ack1,</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="253" id="V2706339" paragraph="paragraph21" rule="-SIMPLE-REF" start="249" uttnum="185">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="GO:0042571" end="294" id="V2710175" paragraph="paragraph21" rule="-INEVENT2B,-SIMPLE-REF" start="262" uttnum="185">
    <type>ONT::CELL-PART</type>
    <features>
      <inevent>
        <event id="V2710136"/>
      </inevent>
    </features>
    <name>ANTIBODIES</name>
    <text>phospho-Ack1(Tyr284) antibodies</text>
  </TERM>
  <EVENT end="294" id="V2710136" paragraph="paragraph21" rule="-PHOSPHO" start="262" uttnum="185">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="294" id="V2710136" start="262">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phospho-Ack1(Tyr284) antibodies</text>
    </predicate>
    <arg2 id="V2710175" role=":AFFECTED"/>
    <text>phospho-Ack1(Tyr284) antibodies</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="283" id="V2710149" paragraph="paragraph21" rule="-SIMPLE-REF" start="270" uttnum="185">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1(Tyr284)</text>
  </TERM>
  <TERM end="281" id="V2710168" paragraph="paragraph21" rule="-SIMPLE-REF" start="275" uttnum="185">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>284</pos>
      </site>
    </features>
    <name>TYR-284</name>
    <text>Tyr284</text>
  </TERM>
  <EPI end="366" id="V2710258" paragraph="paragraph21" rule="-RULE50_0_AGENT_NEUTRAL-NEUTRAL" start="307" uttnum="185">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V2710273" role=":NEUTRAL"/>
    <text>assess Ack1 activation [27], [29]</text>
  </EPI>
  <EVENT end="366" id="V2710273" paragraph="paragraph21" rule="-RULE50_0_AGENT_NEUTRAL-EVENT,-RULE40A_AGENT_AFFECTED-NONE" start="307" uttnum="185">
    <type>ONT::ACTIVATE</type>
    <epistemic-modality id="V2710258"/>
    <predicate end="366" id="V2710273" start="307">
      <type>ONT::ACTIVATE</type>
      <text>assess Ack1 activation [27], [29]</text>
    </predicate>
    <text>assess Ack1 activation [27], [29]</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="366" id="V2710269" paragraph="paragraph21" rule="-SIMPLE-REF" start="314" uttnum="185">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1 activation [27], [29]</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="411" id="V2727504" paragraph="paragraph21" rule="-SIMPLE-REF" start="406" uttnum="186">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>that</text>
  </TERM>
  <TERM end="484" id="V2727608" paragraph="paragraph21" rule="-LOGICALOP-REF" start="458" uttnum="186">
    <type>ONT::CELL-PART</type>
    <aggregate operator="BOTH">
      <member id="V2727616"/>
      <member id="V2727631"/>
    </aggregate>
    <text normalization="">both membrane and nucleus</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="472" id="V2727616" paragraph="paragraph21" rule="-SIMPLE-REF" start="463" uttnum="186">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>membrane</text>
  </TERM>
  <TERM dbid="UP:SL-0191|GO:0005634" end="484" id="V2727631" paragraph="paragraph21" rule="-SIMPLE-REF" start="476" uttnum="186">
    <type>ONT::CELL-PART</type>
    <name>NUCLEUS</name>
    <text>nucleus</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="424" id="V2727288" paragraph="paragraph21" rule="-SIMPLE-REF" start="419" uttnum="186">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="440" id="V2727070" paragraph="paragraph21" rule="-SIMPLE-REF" start="436" uttnum="186">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="523" id="V2727722" paragraph="paragraph21" rule="-SIMPLE-REF" start="502" uttnum="186">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>10</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S10A,B)</text>
  </TERM>
  <TERM end="522" id="V2727741" paragraph="paragraph21" rule="-SIMPLE-REF" start="514" uttnum="186">
    <type>ONT::BACTERIUM</type>
    <name>B</name>
    <text>B</text>
  </TERM>
  <EPI end="660" id="V2740594" paragraph="paragraph21" rule="-RULE50_0_AGENT_NEUTRAL-NEUTRAL" start="525" uttnum="187">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg2 id="V2740485" role=":NEUTRAL"/>
    <text>A significant increase in expression of pTyr284-Ack1 and pTyr176-AKT was seen when breast cancers from progressive stages were examined</text>
  </EPI>
  <EVENT end="660" id="V2740485" paragraph="paragraph21" rule="-RULE50_0_AGENT_NEUTRAL-EVENT,-RULE20_AGENT_AFFECTED-AFFECTED" start="525" uttnum="187">
    <type>ONT::INCREASE</type>
    <epistemic-modality id="V2740594"/>
    <predicate end="660" id="V2740485" start="525">
      <type>ONT::INCREASE</type>
      <text>A significant increase in expression of pTyr284-Ack1 and pTyr176-AKT was seen when breast cancers from progressive stages were examined</text>
    </predicate>
    <arg2 id="V2740552" role=":AFFECTED"/>
    <text>A significant increase in expression of pTyr284-Ack1 and pTyr176-AKT was seen when breast cancers from progressive stages were examined</text>
  </EVENT>
  <TERM end="647" id="V2740624" paragraph="paragraph21" rule="-SIMPLE-REF" start="608" uttnum="187">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>BREAST</name>
    <text>breast cancers from progressive stages</text>
  </TERM>
  <EVENT end="594" id="V2740552" paragraph="paragraph21" rule="-RULE50_AGENT_AFFECTED-RESULT-NONE" start="548" uttnum="187">
    <type>ONT::EXPRESS</type>
    <predicate end="594" id="V2740552" start="548">
      <type>ONT::EXPRESS</type>
      <text>in expression of pTyr284-Ack1 and pTyr176-AKT</text>
    </predicate>
    <text>in expression of pTyr284-Ack1 and pTyr176-AKT</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="578" id="V2740250" paragraph="paragraph21" rule="-SIMPLE-REF" start="573" uttnum="187">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="594" id="V2740032" paragraph="paragraph21" rule="-SIMPLE-REF" start="590" uttnum="187">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="811" id="V2754150" paragraph="paragraph21" rule="-SIMPLE-REF" start="782" uttnum="187">
    <type>ONT::BODY-PART</type>
    <name>LYMPH-NODE</name>
    <text>lymph node metastatic (LNMM)</text>
  </TERM>
  <TERM dbid="CHEBI:9937|CHEBI:34543" end="693" id="V2753930" paragraph="paragraph21" rule="-SIMPLE-REF" start="690" uttnum="187">
    <type>ONT::MOLECULE</type>
    <name>ADH</name>
    <text>ADH</text>
  </TERM>
  <TERM end="892" id="V2754219" paragraph="paragraph21" rule="-SIMPLE-REF" start="871" uttnum="187">
    <type>ONT::CHART</type>
    <name>TABLE</name>
    <text>Table 1</text>
  </TERM>
  <TERM end="838" id="V2753607" paragraph="paragraph21" rule="-SIMPLE-REF" start="836" uttnum="187">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>6</pos>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">6A</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="922" id="V2764460" paragraph="paragraph21" rule="-SIMPLE-REF" start="918" uttnum="188">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="939" id="V2764814" paragraph="paragraph21" rule="-SIMPLE-REF" start="934" uttnum="188">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="998" id="V2764863" paragraph="paragraph21" rule="-SIMPLE-REF" start="984" uttnum="188">
    <type>ONT::GEO-SAMPLE</type>
    <name>SAMPLE</name>
    <text>tumor samples</text>
  </TERM>
  <TERM end="1043" id="V2764952" paragraph="paragraph21" rule="-SIMPLE-REF" start="1024" uttnum="188">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>10</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S10D</text>
  </TERM>
  <TERM end="1100" id="V2764971" paragraph="paragraph21" rule="-SIMPLE-REF" start="1053" uttnum="188">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>E with F and G</text>
  </TERM>
  <TERM end="1082" id="V2764992" paragraph="paragraph21" rule="-SIMPLE-REF" start="1073" uttnum="188">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>F</name>
    <text>F</text>
  </TERM>
  <TERM end="1117" id="V2782389" paragraph="paragraph21" rule="-SIMPLE-REF" start="1103" uttnum="189">
    <type>ONT::RESULT</type>
    <name>RESULT</name>
    <text>ANOVA results</text>
  </TERM>
  <TERM dbid="UP:Q9UNW9|HGNC:7887" end="1109" id="V2782382" paragraph="paragraph21" rule="-SIMPLE-REF" start="1103" uttnum="189">
    <type>ONT::GENE</type>
    <name>ANOVA</name>
    <text>ANOVA</text>
  </TERM>
  <TERM end="1166" id="V2780590" paragraph="paragraph21" rule="-SIMPLE-REF" start="1162" uttnum="189">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1150" id="V2781462" paragraph="paragraph21" rule="-SIMPLE-REF" start="1145" uttnum="189">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="1288" id="V2796982" paragraph="paragraph21" rule="-SIMPLE-REF" start="1268" uttnum="190">
    <type>ONT::METHOD</type>
    <name>METHOD</name>
    <text>Tukey-Kramer method</text>
  </TERM>
  <EPI end="1349" id="V2797011" paragraph="paragraph21" rule="-RULE50_0_AGENT_FORMAL-NONE" start="1291" uttnum="190">
    <type>ONT::TEST</type>
    <force>ONT::TRUE</force>
    <arg2 id="V2797035" role=":NEUTRAL"/>
    <text>examine all pairwise differences between different stages,</text>
  </EPI>
  <TERM end="1349" id="V2797035" paragraph="paragraph21" rule="-SIMPLE-REF" start="1299" uttnum="190">
    <type>ONT::COMPARISON</type>
    <name>DIFFERENCE</name>
    <text>all pairwise differences between different stages,</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1388" id="V2811814" paragraph="paragraph21" rule="-SIMPLE-REF" start="1383" uttnum="190">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="1404" id="V2810942" paragraph="paragraph21" rule="-SIMPLE-REF" start="1400" uttnum="190">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1551" id="V2824584" paragraph="paragraph21" rule="-SIMPLE-REF" start="1532" uttnum="190">
    <type>ONT::GEO-SAMPLE</type>
    <name>SAMPLE</name>
    <text>the normal samples</text>
  </TERM>
  <TERM end="1689" id="V2824641" paragraph="paragraph21" rule="-SIMPLE-REF" start="1565" uttnum="190">
    <type>ONT::GEO-SAMPLE</type>
    <name>SAMPLE</name>
    <text>to those of all the later stages except for hyperplasia (Tables 2 and 3)</text>
  </TERM>
  <TERM end="1688" id="V2824734" paragraph="paragraph21" rule="-SIMPLE-REF" start="1634" uttnum="190">
    <type>ONT::CHART</type>
    <name>TABLE</name>
    <text>Tables 2 and 3</text>
  </TERM>
  <TERM end="1772" id="V2841047" paragraph="paragraph21" rule="-SIMPLE-REF" start="1726" uttnum="191">
    <type>ONT::PATIENT</type>
    <name>PATIENT</name>
    <text>patients with high expression of pTyr284-Ack1</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1772" id="V2839969" paragraph="paragraph21" rule="-SIMPLE-REF" start="1767" uttnum="191">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="1788" id="V2839097" paragraph="paragraph21" rule="-SIMPLE-REF" start="1784" uttnum="191">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="GO:0016265" end="1911" id="V2841233" paragraph="paragraph21" rule="-SIMPLE-REF" start="1813" uttnum="191">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>DEATHS</name>
    <text>cancer-related deaths (Fig. 6D, E and Table 4)</text>
  </TERM>
  <TERM end="1873" id="V2841310" paragraph="paragraph21" rule="-SIMPLE-REF" start="1857" uttnum="191">
    <type>ONT::NUTRITIONAL-SUPPLEMENT</type>
    <name>E</name>
    <text>E</text>
  </TERM>
  <TERM end="1910" id="V2841325" paragraph="paragraph21" rule="-SIMPLE-REF" start="1889" uttnum="191">
    <type>ONT::TABLE</type>
    <name>TABLE</name>
    <text>Table 4</text>
  </TERM>
  <TERM end="1855" id="V2841298" paragraph="paragraph21" rule="-SIMPLE-REF" start="1853" uttnum="191">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>6</pos>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">6D</text>
  </TERM>
  <TERM end="2024" id="V2855798" paragraph="paragraph21" rule="-RULE50_0_NEUTRAL1_NEUTRAL2-ROBUST-NEUTRAL2-TERM" start="1926" uttnum="192">
    <type>ONT::REFERENTIAL-SEM</type>
    <name>PTYR-176-AKT</name>
    <text>expression of pTyr284-Ack1 was significantly correlated with pTyr176-AKT in situ</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1953" id="V2854478" paragraph="paragraph21" rule="-SIMPLE-REF" start="1948" uttnum="192">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="2084" id="V2855629" paragraph="paragraph21" rule="-SIMPLE-REF" start="2025" uttnum="192">
    <type>ONT::MENTAL-OBJECT</type>
    <name>CORRELATION-COEFFICIENT</name>
    <text>Spearman rank correlation coefficient ρ = </text>
  </TERM>
  <TERM end="2155" id="V2855786" paragraph="paragraph21" rule="-SIMPLE-REF" start="2137" uttnum="192">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>10</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S10C</text>
  </TERM>
  <TERM end="12" id="V2869554" paragraph="paragraph22" rule="-SIMPLE-REF" start="3" uttnum="193">
    <type>ONT::INFORMATION</type>
    <name>DATA</name>
    <text>Our data</text>
  </TERM>
  <TERM end="12" id="V2869550" paragraph="paragraph22" rule="-ROBUSTPRO" start="3" uttnum="193">
    <type>ONT::PERSON</type>
    <text>Our data</text>
  </TERM>
  <TERM end="46" id="V2869578" paragraph="paragraph22" rule="-SIMPLE-REF" start="38" uttnum="193">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>PATHWAY</name>
    <text>pathway</text>
  </TERM>
  <EVENT end="64" id="V2869594" paragraph="paragraph22" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="49" uttnum="193">
    <type>ONT::ACTIVATE</type>
    <predicate end="64" id="V2869594" start="49">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V2869590" role=":AFFECTED"/>
    <arg id="R000494" role=":RESULT"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="53" id="V2869590" paragraph="paragraph22" rule="-SIMPLE-REF" start="49" uttnum="193">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="109" id="V2869660" paragraph="paragraph22" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="88" uttnum="193">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="109" id="V2869660" start="88">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Ack1 phosphorylation</text>
    </predicate>
    <arg2 id="V2869657" role=":AFFECTED"/>
    <arg id="R000309" role=":RESULT"/>
    <text>Ack1 phosphorylation</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="93" id="V2869657" paragraph="paragraph22" rule="-SIMPLE-REF" start="88" uttnum="193">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2869660"/>
    </not-features>
  </TERM>
  <TERM end="151" id="V2869688" paragraph="paragraph22" rule="-INEVENT2B,-SIMPLE-REF" start="112" uttnum="193">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>284</pos>
      </site>
      <inevent>
        <event id="V2869693"/>
      </inevent>
    </features>
    <name>TYR-284</name>
    <text>Tyr284 leading to its kinase activation</text>
  </TERM>
  <CC end="151" id="V2869693" paragraph="paragraph22" rule="-RULE5B_AGENT_RESULT" start="112" uttnum="193">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2869688" role=":FACTOR"/>
    <text>Tyr284 leading to its kinase activation</text>
  </CC>
  <TERM dbid="GO:0016301" end="141" id="V2869730" paragraph="paragraph22" rule="-SIMPLE-REF" start="134" uttnum="193">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
  </TERM>
  <EVENT end="234" id="V2885208" paragraph="paragraph22" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="153" uttnum="194">
    <type>ONT::ACTIVATE</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::COULD</modality>
    <predicate end="234" id="V2885208" start="153">
      <type>ONT::ACTIVATE</type>
      <text>Ack1 could also be activated in some tumors by autoactivating somatic mutations,</text>
    </predicate>
    <arg2 id="V2885176" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000499"/>
    <text>Ack1 could also be activated in some tumors by autoactivating somatic mutations,</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="158" id="V2885176" paragraph="paragraph22" rule="-SIMPLE-REF" start="153" uttnum="194">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="234" id="V2885311" paragraph="paragraph22" rule="-BMO2-EVENT,-RULE40A_AGENT_AFFECTED-MODA1_2-AFFECTED" start="153" uttnum="194">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <mods>
      <mod>
        <type>ONT::MANNER-REFL</type>
        <value>AUTO-</value>
      </mod>
    </mods>
    <predicate end="234" id="V2885311" start="153">
      <type>ONT::ACTIVATE</type>
      <text>Ack1 could also be activated in some tumors by autoactivating somatic mutations,</text>
    </predicate>
    <arg1 id="V2885176" role=":AGENT"/>
    <arg2 id="V2885331" role=":AFFECTED"/>
    <text>Ack1 could also be activated in some tumors by autoactivating somatic mutations,</text>
  </EVENT>
  <TERM end="234" id="V2885331" paragraph="paragraph22" rule="-SIMPLE-REF-MUTATION8" start="215" uttnum="194">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTATIONS</name>
    <text>somatic mutations,</text>
  </TERM>
  <MODALITY end="234" id="X2901460" paragraph="paragraph22" rule="-MODALITY" start="153" uttnum="194">
    <type>ONT::CONDITIONAL</type>
    <arg2 id="V2885208" role=":EVENT"/>
    <text>Ack1 could also be activated in some tumors by autoactivating somatic mutations,</text>
  </MODALITY>
  <CC end="234" id="X2901461" paragraph="paragraph22" rule="-BMO2" start="153" uttnum="194">
    <type>ONT::BY-MEANS-OF</type>
    <arg id="V2885311" role=":FACTOR"/>
    <arg id="V2885208" role=":OUTCOME"/>
    <text>Ack1 could also be activated in some tumors by autoactivating somatic mutations,</text>
  </CC>
  <TERM end="244" id="V2885395" paragraph="paragraph22" rule="-SIMPLE-REF" start="239" uttnum="194">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>346</pos>
      <aa-from>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Lysine</name>
          <code>K</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">E346K</text>
  </TERM>
  <EVENT end="361" id="V2900927" paragraph="paragraph22" rule="-RULE60_AGENT_AFFECTED" start="246" uttnum="195">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="361" id="V2900927" start="246">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Activated Ack1 phosphorylates AKT at Tyr176 resulting in its binding to the anionic plasma membrane phospholipid PA</text>
    </predicate>
    <arg1 id="V2900923" role=":AGENT"/>
    <arg2 id="V2900932" role=":AFFECTED"/>
    <arg id="R000314" role=":RESULT"/>
    <text>Activated Ack1 phosphorylates AKT at Tyr176 resulting in its binding to the anionic plasma membrane phospholipid PA</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="261" id="V2900923" paragraph="paragraph22" rule="-INEVENT2B,-SIMPLE-REF" start="246" uttnum="195">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Activated Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <TERM end="280" id="V2900932" paragraph="paragraph22" rule="-SIMPLE-REF" start="276" uttnum="195">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2900927"/>
    </not-features>
  </TERM>
  <EVENT end="261" id="V2900911" paragraph="paragraph22" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="246" uttnum="195">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="261" id="V2900911" start="246">
      <type>ONT::ACTIVATE</type>
      <text>Activated Ack1</text>
    </predicate>
    <arg2 id="V2900923" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000092"/>
    <text>Activated Ack1</text>
  </EVENT>
  <TERM end="290" id="V2900960" paragraph="paragraph22" rule="-SIMPLE-REF" start="283" uttnum="195">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <TERM dbid="HGNC:8549|XFAM:PF02225.19|UP:P04746|UP:P16452|XFAM:PF00128|HGNC:3381|HGNC:477|UP:P00688|XFAM:PF02806|UP:Q9UL45" end="361" id="V2901108" paragraph="paragraph22" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="315" uttnum="195">
    <type>ONT::GENE-PROTEIN</type>
    <features>
      <location id="V2901094"/>
    </features>
    <name>PA</name>
    <text>to the anionic plasma membrane phospholipid PA</text>
  </TERM>
  <TERM dbid="CHEBI:16247" end="361" id="V2901100" paragraph="paragraph22" rule="-SIMPLE-REF" start="315" uttnum="195">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHOLIPID</name>
    <text>to the anionic plasma membrane phospholipid PA</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="346" id="V2901094" paragraph="paragraph22" rule="-SIMPLE-REF" start="330" uttnum="195">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>plasma membrane</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="447" id="V2901180" paragraph="paragraph22" rule="-SIMPLE-REF" start="385" uttnum="195">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>to the plasma membrane, where it is targeted by PDK1 and PDK2</text>
  </TERM>
  <TERM end="447" id="V2901262" paragraph="paragraph22" rule="-LOGICALOP-REF" start="430" uttnum="195">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V2901258"/>
      <member id="V2901278"/>
    </aggregate>
    <text normalization="">by PDK1 and PDK2</text>
  </TERM>
  <TERM dbid="UP:O15530" end="438" id="V2901258" paragraph="paragraph22" rule="-SIMPLE-REF" start="433" uttnum="195">
    <type>ONT::PROTEIN</type>
    <name>PDK-1</name>
    <text>PDK1</text>
  </TERM>
  <TERM dbid="UP:Q15119|HGNC:8810" end="447" id="V2901278" paragraph="paragraph22" rule="-SIMPLE-REF" start="442" uttnum="195">
    <type>ONT::GENE</type>
    <name>PDK-2</name>
    <text>PDK2</text>
  </TERM>
  <TERM dbid="GO:0031932" end="455" id="V2901332" paragraph="paragraph22" rule="-SIMPLE-REF" start="448" uttnum="195">
    <type>ONT::CELL-PART</type>
    <name>MTORC-2</name>
    <text>mTORC2</text>
  </TERM>
  <TERM end="462" id="V2901348" paragraph="paragraph22" rule="-SIMPLE-REF" start="455" uttnum="195">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <text>complex</text>
  </TERM>
  <TERM dbid="GO:0016310" end="500" id="V2901387" paragraph="paragraph22" rule="-SIMPLE-REF" start="468" uttnum="195">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>PHOSPHORYLATIONS</name>
    <text>Thr308/Ser473 phosphorylations,</text>
  </TERM>
  <TERM end="500" id="V2901457" paragraph="paragraph22" rule="-SIMPLE-REF" start="468" uttnum="195">
    <type>ONT::MOLECULAR-SITE</type>
    <name>THR-308/SER-473</name>
    <text>Thr308/Ser473 phosphorylations,</text>
  </TERM>
  <EVENT end="554" id="V2901447" paragraph="paragraph22" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="522" uttnum="195">
    <type>ONT::ACTIVATE</type>
    <predicate end="554" id="V2901447" start="522">
      <type>ONT::ACTIVATE</type>
      <text>to optimal AKT kinase activation</text>
    </predicate>
    <arg2 id="V2901443" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000504"/>
    <text>to optimal AKT kinase activation</text>
  </EVENT>
  <TERM end="544" id="V2901443" paragraph="paragraph22" rule="-EXPLICIT-REF1" start="533" uttnum="195">
    <type>ONT::PROTEIN</type>
    <name>AKT</name>
    <assoc-with id="V2901438"/>
    <text>AKT kinase</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="537" id="V2901438" paragraph="paragraph22" rule="-SIMPLE-REF" start="533" uttnum="195">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <EVENT end="598" id="V2916002" paragraph="paragraph22" rule="-RULE10C_AGENT_AFFECTED-CELL_LOC3-GD-TO-AGENT" start="556" uttnum="196">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="598" id="V2916002" start="556">
      <type>ONT::TRANSLOCATE</type>
      <text>Activated AKT translocates to the nucleus,</text>
    </predicate>
    <arg1 id="V2915998" role=":AGENT"/>
    <to-location end="598" id="V2916038" start="586">
      <type>ONT::CELL-PART</type>
      <text normalization="">the nucleus,</text>
    </to-location>
    <text>Activated AKT translocates to the nucleus,</text>
  </EVENT>
  <TERM end="570" id="V2915998" paragraph="paragraph22" rule="-INEVENT2B,-SIMPLE-REF" start="556" uttnum="196">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Activated AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="570" id="V2915991" paragraph="paragraph22" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="556" uttnum="196">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="570" id="V2915991" start="556">
      <type>ONT::ACTIVATE</type>
      <text>Activated AKT</text>
    </predicate>
    <arg2 id="V2915998" role=":RESULT"/>
    <arg id="R000097" role=":AFFECTED"/>
    <text>Activated AKT</text>
  </EVENT>
  <TERM dbid="UP:SL-0191|GO:0005634" end="598" id="V2916038" paragraph="paragraph22" rule="-SIMPLE-REF" start="586" uttnum="196">
    <type>ONT::CELL-PART</type>
    <name>NUCLEUS</name>
    <text>the nucleus,</text>
  </TERM>
  <EVENT end="688" id="V2916864" paragraph="paragraph22" rule="-RULE60_AGENT_AFFECTED-AFFECTED" start="599" uttnum="196">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="688" id="V2916864" start="599">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylates FoxO transcription factors to downregulate expression of FoxO target genes</text>
    </predicate>
    <arg2 id="V2916927" role=":AFFECTED"/>
    <arg id="R000319" role=":RESULT"/>
    <text>phosphorylates FoxO transcription factors to downregulate expression of FoxO target genes</text>
  </EVENT>
  <TERM dbid="GO:0001071|GO:0001070" end="641" id="V2916927" paragraph="paragraph22" rule="-SIMPLE-REF" start="614" uttnum="196">
    <type>ONT::PROTEIN</type>
    <name>TRANSCRIPTION-FACTORS</name>
    <text>FoxO transcription factors</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2916864"/>
    </not-features>
  </TERM>
  <TERM end="641" id="V2916891" paragraph="paragraph22" rule="-SIMPLE-REF" start="614" uttnum="196">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>O</name>
    <text>FoxO transcription factors</text>
  </TERM>
  <TERM end="641" id="V2916867" paragraph="paragraph22" rule="-SIMPLE-REF" start="614" uttnum="196">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>FOX</name>
    <text>FoxO transcription factors</text>
  </TERM>
  <EVENT end="688" id="V2916960" paragraph="paragraph22" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="644" uttnum="196">
    <type>ONT::INHIBIT</type>
    <force>ONT::TRUE</force>
    <predicate end="688" id="V2916960" start="644">
      <type>ONT::INHIBIT</type>
      <text>downregulate expression of FoxO target genes</text>
    </predicate>
    <arg2 id="V2916967" role=":AFFECTED"/>
    <text>downregulate expression of FoxO target genes</text>
  </EVENT>
  <EVENT end="688" id="V2916967" paragraph="paragraph22" rule="-RULE50_AGENT_AFFECTED-AFFECTED" start="657" uttnum="196">
    <type>ONT::EXPRESS</type>
    <predicate end="688" id="V2916967" start="657">
      <type>ONT::EXPRESS</type>
      <text>expression of FoxO target genes</text>
    </predicate>
    <arg2 id="V2917028" role=":AFFECTED"/>
    <text>expression of FoxO target genes</text>
  </EVENT>
  <TERM end="688" id="V2917028" paragraph="paragraph22" rule="-SIMPLE-REF" start="668" uttnum="196">
    <type>ONT::GENE</type>
    <name>GENE</name>
    <text>of FoxO target genes</text>
  </TERM>
  <TERM end="688" id="V2917023" paragraph="paragraph22" rule="-SIMPLE-REF" start="668" uttnum="196">
    <type>ONT::GOAL</type>
    <name>TARGET</name>
    <text>of FoxO target genes</text>
  </TERM>
  <TERM end="688" id="V2917005" paragraph="paragraph22" rule="-SIMPLE-REF" start="668" uttnum="196">
    <type>ONT::GAS-SUBSTANCE</type>
    <name>O</name>
    <text>of FoxO target genes</text>
  </TERM>
  <TERM end="688" id="V2916981" paragraph="paragraph22" rule="-SIMPLE-REF" start="668" uttnum="196">
    <type>ONT::NONHUMAN-ANIMAL</type>
    <name>FOX</name>
    <text>of FoxO target genes</text>
  </TERM>
  <CC end="688" id="X2930558" paragraph="paragraph22" rule="-PURPOSE" start="599" uttnum="196">
    <type>ONT::BY-MEANS-OF</type>
    <arg id="V2916864" role=":FACTOR"/>
    <arg id="V2916960" role=":OUTCOME"/>
    <text>phosphorylates FoxO transcription factors to downregulate expression of FoxO target genes</text>
  </CC>
  <EPI end="13" id="V2930673" paragraph="paragraph23" rule="-RULE50_0_AGENT_NEUTRAL-AGENT" start="3" uttnum="197">
    <type>ONT::TEST</type>
    <arg1 id="V2930670" role=":AGENT"/>
    <text>Our study</text>
  </EPI>
  <TERM end="28" id="V2930691" paragraph="paragraph23" rule="-ROBUSTPRO" start="23" uttnum="197">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>that</text>
  </TERM>
  <TERM end="13" id="V2930670" paragraph="paragraph23" rule="-ROBUSTPRO" start="3" uttnum="197">
    <type>ONT::PERSON</type>
    <text>Our study</text>
  </TERM>
  <TERM end="34" id="V2930701" paragraph="paragraph23" rule="-SIMPLE-REF" start="28" uttnum="197">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cells</text>
  </TERM>
  <TERM end="105" id="V2930743" paragraph="paragraph23" rule="-INEVENT2B,-SIMPLE-REF" start="63" uttnum="197">
    <type>ONT::DEVICE</type>
    <features>
      <inevent>
        <event id="V2930772"/>
      </inevent>
    </features>
    <name>MECHANISM</name>
    <text>mutually exclusive mechanisms to activate</text>
  </TERM>
  <CC end="105" id="V2930772" paragraph="paragraph23" rule="-RULE5B_AGENT_RESULT-NONE" start="93" uttnum="197">
    <type>ONT::CAUSE</type>
    <force>ONT::TRUE</force>
    <arg id="V2930743" role=":AFFECTED"/>
    <text>to activate</text>
  </CC>
  <TERM end="143" id="V2930779" paragraph="paragraph23" rule="-SIMPLE-REF" start="105" uttnum="197">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT (Fig. 7)</text>
  </TERM>
  <TERM end="216" id="V2932911" paragraph="paragraph23" rule="-SIMPLE-REF" start="145" uttnum="198">
    <type>ONT::MOTIVE</type>
    <name>REASON</name>
    <text>The reasons why RTKs would employ two distinct modes of AKT activation</text>
  </TERM>
  <EVENT end="216" id="V2932968" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="201" uttnum="198">
    <type>ONT::ACTIVATE</type>
    <predicate end="216" id="V2932968" start="201">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V2932965" role=":AFFECTED"/>
    <arg id="R000509" role=":RESULT"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="205" id="V2932965" paragraph="paragraph23" rule="-SIMPLE-REF" start="201" uttnum="198">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="267" id="V2936831" paragraph="paragraph23" rule="-SIMPLE-REF" start="263" uttnum="199">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="322" id="V2936880" paragraph="paragraph23" rule="-SIMPLE-REF" start="286" uttnum="199">
    <type>ONT::OPTION</type>
    <name>ALTERNATIVE</name>
    <text>this alternative mode of activation</text>
  </TERM>
  <EVENT end="322" id="V2936896" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-LOC5-GD-NONE" start="260" uttnum="199">
    <type>ONT::ACTIVATE</type>
    <predicate end="322" id="V2936896" start="260">
      <type>ONT::ACTIVATE</type>
      <text>of AKT appears to utilize this alternative mode of activation</text>
    </predicate>
    <site end="267" id="V2936819" start="249">
      <type>ONT::MATHEMATICAL-TERM</type>
      <text normalization="FRACTION">a fraction of AKT</text>
    </site>
    <text>of AKT appears to utilize this alternative mode of activation</text>
  </EVENT>
  <TERM end="366" id="V2937028" paragraph="paragraph23" rule="-SIMPLE-REF" start="351" uttnum="199">
    <type>ONT::CELL</type>
    <name>CELL</name>
    <text>cancerous cells</text>
  </TERM>
  <EPI end="454" id="V2952918" paragraph="paragraph23" rule="-RULE50_0_NEUTRAL_FORMAL" start="368" uttnum="200">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V2953092" role=":FORMAL"/>
    <text>Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB</text>
  </EPI>
  <EVENT end="454" id="V2953092" paragraph="paragraph23" rule="-RULE50_0_NEUTRAL_FORMAL-EVENT,-RULE20C_AGENT_AFFECTED" start="368" uttnum="200">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V2952918"/>
    <predicate end="454" id="V2953092" start="368">
      <type>ONT::BIND</type>
      <text>Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB</text>
    </predicate>
    <arg1 id="V2953079" role=":AGENT"/>
    <arg2 id="V2953359" role=":AFFECTED"/>
    <arg id="R000155" role=":RESULT"/>
    <text>Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB</text>
  </EVENT>
  <TERM end="380" id="V2952879" paragraph="paragraph23" rule="-ROBUSTPRO" start="368" uttnum="200">
    <type>ONT::PERSON</type>
    <text>Our studies</text>
  </TERM>
  <TERM dbid="CHEBI:52214" end="439" id="V2953079" paragraph="paragraph23" rule="-SIMPLE-REF" start="432" uttnum="200">
    <type>ONT::CHEMICAL</type>
    <name>LIGAND</name>
    <text>ligand</text>
    <not-features>
      <bound-to id="V2953359" event="V2953092"/>
    </not-features>
  </TERM>
  <TERM end="454" id="V2953359" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0B" start="445" uttnum="200">
    <type>ONT::PROTEIN</type>
    <components>
      <component id="V2952758"/>
      <component id="V2952789"/>
    </components>
    <text normalization="">HER2/ErbB</text>
    <not-features>
      <bound-to event="V2953092" id="V2953079"/>
    </not-features>
  </TERM>
  <TERM dbid="CHEBI:35222" end="430" id="V2953065" paragraph="paragraph23" rule="-SIMPLE-REF" start="416" uttnum="200">
    <type>ONT::CHEMICAL</type>
    <name>INHIBITOR</name>
    <text>PI3K inhibitor</text>
  </TERM>
  <TERM end="421" id="V2953060" paragraph="paragraph23" rule="-SIMPLE-REF" start="416" uttnum="200">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K</text>
  </TERM>
  <TERM dbid="UP:P04626" end="454" id="V2952758" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0B-TERM" start="445" uttnum="200">
    <type>ONT::PROTEIN</type>
    <name>HER-2</name>
    <text>HER2/ErbB</text>
  </TERM>
  <TERM dbid="UP:P00533" end="454" id="V2952789" paragraph="paragraph23" rule="-SIMPLE-REF" start="450" uttnum="200">
    <type>ONT::PROTEIN</type>
    <name>ERBB</name>
    <text>ErbB</text>
  </TERM>
  <EVENT end="480" id="V2953155" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED" start="460" uttnum="200">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="480" id="V2953155" start="460">
      <type>ONT::ACTIVATE</type>
      <text>EGFR activated Ack1</text>
    </predicate>
    <arg1 id="V2953150" role=":AGENT"/>
    <arg2 id="V2953167" role=":AFFECTED"/>
    <arg id="R000514" role=":RESULT"/>
    <text>EGFR activated Ack1</text>
  </EVENT>
  <TERM dbid="UP:P00533" end="465" id="V2953150" paragraph="paragraph23" rule="-SIMPLE-REF" start="460" uttnum="200">
    <type>ONT::PROTEIN</type>
    <name>EGFR</name>
    <text>EGFR</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="480" id="V2953167" paragraph="paragraph23" rule="-SIMPLE-REF" start="475" uttnum="200">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="530" id="V2953347" paragraph="paragraph23" rule="-INEVENT2B,-SIMPLE-REF" start="517" uttnum="200">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">activated AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="530" id="V2953340" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="517" uttnum="200">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="530" id="V2953340" start="517">
      <type>ONT::ACTIVATE</type>
      <text>activated AKT</text>
    </predicate>
    <arg2 id="V2953347" role=":RESULT"/>
    <arg id="R000102" role=":AFFECTED"/>
    <text>activated AKT</text>
  </EVENT>
  <EVENT end="634" id="V2966883" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="532" uttnum="201">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <mods>
      <frequency>
        <type>ONT::FREQUENCY</type>
        <value>FREQUENTLY</value>
      </frequency>
    </mods>
    <predicate end="634" id="V2966883" start="532">
      <type>ONT::ACTIVATE</type>
      <text>AKT is frequently activated in pancreatic cancer which has been shown to be highly correlated to HER-2</text>
    </predicate>
    <arg2 id="V2966852" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000519"/>
    <text>AKT is frequently activated in pancreatic cancer which has been shown to be highly correlated to HER-2</text>
  </EVENT>
  <TERM end="536" id="V2966852" paragraph="paragraph23" rule="-SIMPLE-REF" start="532" uttnum="201">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EPI end="634" id="V2967003" paragraph="paragraph23" rule="-RULE50_0_AGENT_NEUTRAL-NONE" start="596" uttnum="201">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V2967055" role=":FORMAL"/>
    <text>shown to be highly correlated to HER-2</text>
  </EPI>
  <EPI end="634" id="V2967055" paragraph="paragraph23" rule="-RULE50_0_NEUTRAL_NEUTRAL1-NONE" start="602" uttnum="201">
    <type>ONT::ASSOCIATE</type>
    <force>ONT::TRUE</force>
    <text>to be highly correlated to HER-2</text>
  </EPI>
  <TERM dbid="UP:P04626" end="634" id="V2967098" paragraph="paragraph23" rule="-SIMPLE-REF" start="626" uttnum="201">
    <type>ONT::PROTEIN</type>
    <name>HER-2</name>
    <text>to HER-2</text>
  </TERM>
  <EVENT end="688" id="V2967119" paragraph="paragraph23" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="643" uttnum="201">
    <type>ONT::EXPRESS</type>
    <mods>
      <degree>
        <type>ONT::DEGREE-MODIFIER-HIGH</type>
        <value>OVER-</value>
      </degree>
    </mods>
    <predicate end="688" id="V2967119" start="643">
      <type>ONT::EXPRESS</type>
      <text>neu overexpression [34]</text>
    </predicate>
    <arg2 id="V2967106" role=":AFFECTED-RESULT"/>
    <text>neu overexpression [34]</text>
  </EVENT>
  <TERM dbid="UP:P04626" end="656" id="V2967106" paragraph="paragraph23" rule="-SIMPLE-REF" start="643" uttnum="201">
    <type>ONT::PROTEIN</type>
    <name>NEU</name>
    <text>neu</text>
  </TERM>
  <TERM dbid="BTO:0000183" end="734" id="V2981963" paragraph="paragraph23" rule="-SIMPLE-REF" start="700" uttnum="202">
    <type>ONT::CELL-LINE</type>
    <name>PANCREATIC-CELL-LINES</name>
    <text>many of the pancreatic cell lines</text>
  </TERM>
  <TERM dbid="BTO:0000183" end="734" id="V2981463" paragraph="paragraph23" rule="-SIMPLE-REF" start="705" uttnum="202">
    <type>ONT::CELL-LINE</type>
    <name>PANCREATIC-CELL-LINES</name>
    <text>of the pancreatic cell lines</text>
  </TERM>
  <EVENT end="834" id="V2981529" paragraph="paragraph23" rule="-RULE10_AGENT_AFFECTED" start="745" uttnum="202">
    <type>ONT::NO-CHANGE</type>
    <force>ONT::TRUE</force>
    <predicate end="834" id="V2981529" start="745">
      <type>ONT::NO-CHANGE</type>
      <text>expressing activated AKT had retained wild-type PTEN [35], [36]</text>
    </predicate>
    <arg1 id="V2981489" role=":AGENT"/>
    <arg2 id="V2981589" role=":AFFECTED"/>
    <text>expressing activated AKT had retained wild-type PTEN [35], [36]</text>
  </EVENT>
  <EVENT end="770" id="V2981489" paragraph="paragraph23" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="745" uttnum="202">
    <type>ONT::EXPRESS</type>
    <predicate end="770" id="V2981489" start="745">
      <type>ONT::EXPRESS</type>
      <text>expressing activated AKT</text>
    </predicate>
    <arg2 id="V2981505" role=":AFFECTED-RESULT"/>
    <text>expressing activated AKT</text>
  </EVENT>
  <TERM dbid="UP:P60484" end="834" id="V2981589" paragraph="paragraph23" rule="-SIMPLE-REF-MUTATION3,-SIMPLE-REF" start="783" uttnum="202">
    <type>ONT::PROTEIN</type>
    <features>
      <mutation>FALSE</mutation>
    </features>
    <name>PTEN</name>
    <text>wild-type PTEN [35], [36]</text>
  </TERM>
  <TERM end="770" id="V2981505" paragraph="paragraph23" rule="-INEVENT2B,-SIMPLE-REF" start="756" uttnum="202">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">activated AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT end="770" id="V2981498" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="756" uttnum="202">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="770" id="V2981498" start="756">
      <type>ONT::ACTIVATE</type>
      <text>activated AKT</text>
    </predicate>
    <arg2 id="V2981505" role=":RESULT"/>
    <arg id="R000107" role=":AFFECTED"/>
    <text>activated AKT</text>
  </EVENT>
  <TERM end="839" id="V2993690" paragraph="paragraph23" rule="-ROBUSTPRO" start="836" uttnum="203">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="937" id="V2993873" paragraph="paragraph23" rule="-SIMPLE-REF" start="906" uttnum="203">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>MMTV-neu mice</text>
  </TERM>
  <TERM dbid="UP:P04626" end="937" id="V2993868" paragraph="paragraph23" rule="-SIMPLE-REF" start="906" uttnum="203">
    <type>ONT::PROTEIN</type>
    <name>NEU</name>
    <text>MMTV-neu mice</text>
  </TERM>
  <TERM end="1022" id="V2993917" paragraph="paragraph23" rule="-SIMPLE-REF" start="1006" uttnum="203">
    <type>ONT::INFORMATION</type>
    <name>DATA</name>
    <text>unpublished data</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="989" id="V2993479" paragraph="paragraph23" rule="-SIMPLE-REF" start="984" uttnum="203">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM end="1005" id="V2993261" paragraph="paragraph23" rule="-SIMPLE-REF" start="1001" uttnum="203">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1054" id="V3005760" paragraph="paragraph23" rule="-SIMPLE-REF" start="1045" uttnum="204">
    <type>ONT::INFORMATION</type>
    <name>DATA</name>
    <text>our data</text>
  </TERM>
  <TERM end="1054" id="V3005756" paragraph="paragraph23" rule="-ROBUSTPRO" start="1045" uttnum="204">
    <type>ONT::PERSON</type>
    <text>our data</text>
  </TERM>
  <EVENT end="1081" id="V3005788" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1066" uttnum="204">
    <type>ONT::ACTIVATE</type>
    <predicate end="1081" id="V3005788" start="1066">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V3005784" role=":AFFECTED"/>
    <arg id="R000524" role=":RESULT"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="1070" id="V3005784" paragraph="paragraph23" rule="-SIMPLE-REF" start="1066" uttnum="204">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="1169" id="V3005946" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0B" start="1159" uttnum="204">
    <type>ONT::PROTEIN</type>
    <components>
      <component id="V3005300"/>
      <component id="V3005308"/>
    </components>
    <text normalization="">PI3K/PTEN</text>
  </TERM>
  <TERM end="1169" id="V3005300" paragraph="paragraph23" rule="-EXPLICIT-REF-SEQ0B-TERM" start="1159" uttnum="204">
    <type>ONT::PROTEIN</type>
    <members>
      <member dbid="UP:Q8NEB9" type="ONT::PROTEIN"/>
      <member dbid="UP:Q8WYR1" type="ONT::PROTEIN"/>
      <member dbid="UP:O00443" type="ONT::PROTEIN"/>
      <member dbid="UP:P42336" type="ONT::PROTEIN"/>
      <member dbid="UP:O00750" type="ONT::PROTEIN"/>
      <member dbid="UP:P48736" type="ONT::PROTEIN"/>
      <member dbid="UP:P42338" type="ONT::PROTEIN"/>
      <member dbid="UP:O00329" type="ONT::PROTEIN"/>
    </members>
    <name>PI-3-K</name>
    <text normalization="">PI3K/PTEN</text>
  </TERM>
  <TERM dbid="UP:P60484" end="1169" id="V3005308" paragraph="paragraph23" rule="-SIMPLE-REF" start="1164" uttnum="204">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>PTEN</text>
  </TERM>
  <TERM end="1180" id="V3017290" paragraph="paragraph23" rule="-ROBUSTPRO" start="1177" uttnum="205">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="1193" id="V3017305" paragraph="paragraph23" rule="-SIMPLE-REF" start="1188" uttnum="205">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">that</text>
  </TERM>
  <TERM end="1211" id="V3017330" paragraph="paragraph23" rule="-SIMPLE-REF" start="1206" uttnum="205">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">that</text>
  </TERM>
  <TERM end="1331" id="V3017508" paragraph="paragraph23" rule="-SIMPLE-REF" start="1312" uttnum="205">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>similar mechanisms</text>
  </TERM>
  <TERM end="1252" id="V3017371" paragraph="paragraph23" rule="-INEVENT2B,-SIMPLE-REF-MUTATION8" start="1227" uttnum="205">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <mutation>TRUE</mutation>
      <inevent>
        <event id="V3017355"/>
      </inevent>
    </features>
    <name>MUTATIONS</name>
    <text>autoactivating mutations</text>
  </TERM>
  <EVENT end="1252" id="V3017355" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-MODA1_2-AGENT" start="1227" uttnum="205">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <mods>
      <mod>
        <type>ONT::MANNER-REFL</type>
        <value>AUTO-</value>
      </mod>
    </mods>
    <predicate end="1252" id="V3017355" start="1227">
      <type>ONT::ACTIVATE</type>
      <text>autoactivating mutations</text>
    </predicate>
    <arg1 id="V3017371" role=":AGENT"/>
    <text>autoactivating mutations</text>
  </EVENT>
  <TERM end="1302" id="V3017476" paragraph="paragraph23" rule="-EXPLICIT-REF1" start="1272" uttnum="205">
    <type>ONT::PROTEIN</type>
    <name>TYROSINE</name>
    <assoc-with id="V3017469"/>
    <text>non-receptor tyrosine kinases</text>
  </TERM>
  <TERM end="1294" id="V3017469" paragraph="paragraph23" rule="-SIMPLE-REF" start="1285" uttnum="205">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>tyrosine</text>
  </TERM>
  <EVENT end="1367" id="V3017542" paragraph="paragraph23" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1335" uttnum="205">
    <type>ONT::ACTIVATE</type>
    <predicate end="1367" id="V3017542" start="1335">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation [37]</text>
    </predicate>
    <arg2 id="V3017539" role=":AFFECTED"/>
    <arg id="R000529" role=":RESULT"/>
    <text>AKT activation [37]</text>
  </EVENT>
  <TERM end="1339" id="V3017539" paragraph="paragraph23" rule="-SIMPLE-REF" start="1335" uttnum="205">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="13" id="V3032477" paragraph="paragraph24" rule="-ROBUSTPRO" start="7" uttnum="206">
    <type>ONT::LOCATION</type>
    <text>there</text>
  </TERM>
  <EVENT end="49" id="V3032514" paragraph="paragraph24" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="29" uttnum="206">
    <type>ONT::MODULATE</type>
    <predicate end="49" id="V3032514" start="29">
      <type>ONT::MODULATE</type>
      <text>Tyr176 modification</text>
    </predicate>
    <arg2 id="V3032511" role=":AFFECTED"/>
    <text>Tyr176 modification</text>
  </EVENT>
  <TERM end="36" id="V3032511" paragraph="paragraph24" rule="-SIMPLE-REF" start="29" uttnum="206">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <EVENT end="81" id="V3032593" paragraph="paragraph24" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="67" uttnum="206">
    <type>ONT::ACTIVATE</type>
    <predicate end="81" id="V3032593" start="67">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V3032590" role=":AFFECTED"/>
    <arg id="R000534" role=":RESULT"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="71" id="V3032590" paragraph="paragraph24" rule="-SIMPLE-REF" start="67" uttnum="206">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <CC end="176" id="V3036163" paragraph="paragraph24" rule="-NECESSARY3-GD" start="106" uttnum="207">
    <type>ONT::DEPENDENT</type>
    <negation>+</negation>
    <force>ONT::FALSE</force>
    <arg id="V3036112" role=":FACTOR"/>
    <arg id="V3036198" role=":OUTCOME"/>
    <text>when Tyr176 phosphorylation of AKT is not required for AKT activation</text>
  </CC>
  <EVENT end="141" id="V3036112" paragraph="paragraph24" rule="-RULE60_AGENT_AFFECTED-A" start="111" uttnum="207">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="141" id="V3036112" start="111">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr176 phosphorylation of AKT</text>
    </predicate>
    <arg2 id="V3036124" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000324"/>
    <site end="118" id="V3036109" start="111">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176</text>
    </site>
    <text>Tyr176 phosphorylation of AKT</text>
  </EVENT>
  <TERM end="118" id="V3036109" paragraph="paragraph24" rule="-SIMPLE-REF" start="111" uttnum="207">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <TERM end="141" id="V3036124" paragraph="paragraph24" rule="-SIMPLE-REF" start="134" uttnum="207">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of AKT</text>
    <not-features>
      <ptm event="V3036112" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <EVENT end="176" id="V3036198" paragraph="paragraph24" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="161" uttnum="207">
    <type>ONT::ACTIVATE</type>
    <predicate end="176" id="V3036198" start="161">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation</text>
    </predicate>
    <arg2 id="V3036194" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000539"/>
    <text>AKT activation</text>
  </EVENT>
  <TERM end="165" id="V3036194" paragraph="paragraph24" rule="-SIMPLE-REF" start="161" uttnum="207">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EPI end="335" id="V3047961" paragraph="paragraph24" rule="-RULE50_0_AGENT_NEUTRAL-AGENT" start="201" uttnum="207">
    <type>ONT::OBSERVE</type>
    <force>ONT::TRUE</force>
    <arg1 id="V3047950" role=":AGENT"/>
    <text>constitutively active PIK3CA mutations, observed in colorectal, glioblastomas, gastric breast and lung cancers</text>
  </EPI>
  <TERM end="258" id="V3047950" paragraph="paragraph24" rule="-SIMPLE-REF-MODACTIVE1,-SIMPLE-REF-MUTATION8" start="216" uttnum="207">
    <type>ONT::MUTANT-OBJ</type>
    <features>
      <active>TRUE</active>
      <mutation>TRUE</mutation>
    </features>
    <name>MUTATIONS</name>
    <text>active PIK3CA mutations,</text>
  </TERM>
  <TERM dbid="UP:P42336" end="247" id="V3047944" paragraph="paragraph24" rule="-SIMPLE-REF" start="231" uttnum="207">
    <type>ONT::PROTEIN</type>
    <name>PIK-3-CA</name>
    <text>PIK3CA</text>
  </TERM>
  <TERM end="312" id="V3048045" paragraph="paragraph24" rule="-SIMPLE-REF-MODBP,-SIMPLE-REF" start="297" uttnum="207">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>BREAST</name>
    <text>gastric breast</text>
  </TERM>
  <TERM dbid="UP:P60484" end="427" id="V3060132" paragraph="paragraph24" rule="-SIMPLE-REF" start="356" uttnum="208">
    <type>ONT::PROTEIN</type>
    <name>PTEN</name>
    <text>of tumor suppressor PTEN resulting in increased levels of cellular PIP3</text>
  </TERM>
  <TERM end="427" id="V3060121" paragraph="paragraph24" rule="-SIMPLE-REF" start="356" uttnum="208">
    <type>ONT::PERSON</type>
    <name>SUPPRESSOR</name>
    <text>of tumor suppressor PTEN resulting in increased levels of cellular PIP3</text>
  </TERM>
  <TERM dbid="CHEBI:16618" end="427" id="V3060230" paragraph="paragraph24" rule="-SIMPLE-REF" start="414" uttnum="208">
    <type>ONT::MOLECULE</type>
    <name>PIP-3</name>
    <text>cellular PIP3</text>
  </TERM>
  <EVENT end="572" id="V3070571" paragraph="paragraph24" rule="-RULE5_AFFECTED_AFFECTED1-NONE" start="562" uttnum="209">
    <type>ONT::TRANSFORM</type>
    <predicate end="572" id="V3070571" start="562">
      <type>ONT::TRANSFORM</type>
      <text>mutation,</text>
    </predicate>
    <text>mutation,</text>
  </EVENT>
  <TERM end="577" id="V3070606" paragraph="paragraph24" rule="-SIMPLE-REF" start="572" uttnum="209">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>17</pos>
      <aa-from>
        <aa>
          <name>Glutamic acid</name>
          <code>E</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Lysine</name>
          <code>K</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">E17K</text>
  </TERM>
  <TERM end="677" id="V3070707" paragraph="paragraph24" rule="-INEVENT2B,-SIMPLE-REF" start="580" uttnum="209">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <features>
      <inevent>
        <event id="V3070739"/>
      </inevent>
    </features>
    <name>DOMAIN</name>
    <text>the pH domain which facilitates AKT recruitment to the membrane in PIP3-independent manner</text>
  </TERM>
  <EVENT end="677" id="V3070739" paragraph="paragraph24" rule="-RULE30_AGENT_AFFECTED" start="580" uttnum="209">
    <type>ONT::STIMULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="677" id="V3070739" start="580">
      <type>ONT::STIMULATE</type>
      <text>the pH domain which facilitates AKT recruitment to the membrane in PIP3-independent manner</text>
    </predicate>
    <arg1 id="V3070707" role=":AGENT"/>
    <arg2 id="V3070758" role=":AFFECTED"/>
    <text>the pH domain which facilitates AKT recruitment to the membrane in PIP3-independent manner</text>
  </EVENT>
  <EVENT end="628" id="V3070758" paragraph="paragraph24" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="612" uttnum="209">
    <type>ONT::BIND</type>
    <predicate end="628" id="V3070758" start="612">
      <type>ONT::BIND</type>
      <text>AKT recruitment</text>
    </predicate>
    <arg2 id="V3070755" role=":AFFECTED"/>
    <text>AKT recruitment</text>
  </EVENT>
  <TERM end="616" id="V3070755" paragraph="paragraph24" rule="-SIMPLE-REF" start="612" uttnum="209">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="677" id="V3070794" paragraph="paragraph24" rule="-SIMPLE-REF" start="631" uttnum="209">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>the membrane in PIP3-independent manner</text>
  </TERM>
  <TERM end="677" id="V3070878" paragraph="paragraph24" rule="-SIMPLE-REF" start="647" uttnum="209">
    <type>ONT::METHOD</type>
    <name>MANNER</name>
    <text>PIP3-independent manner</text>
  </TERM>
  <TERM dbid="CHEBI:16618" end="664" id="V3070860" paragraph="paragraph24" rule="-SIMPLE-REF" start="647" uttnum="209">
    <type>ONT::MOLECULE</type>
    <name>PIP-3</name>
    <text>PIP3-independent</text>
  </TERM>
  <TERM end="6" id="V3080317" paragraph="paragraph25" rule="-ROBUSTPRO" start="3" uttnum="210">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="29" id="V3080364" paragraph="paragraph25" rule="-SIMPLE-REF" start="25" uttnum="210">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="138" id="V3080437" paragraph="paragraph25" rule="-SIMPLE-REF" start="82" uttnum="210">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT in the plasma membrane in response to growth factors</text>
  </TERM>
  <TERM end="138" id="V3080512" paragraph="paragraph25" rule="-SIMPLE-REF" start="89" uttnum="210">
    <type>ONT::PLASMA-MEMBRANE</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane in response to growth factors</text>
  </TERM>
  <TERM dbid="GO:0070848" end="138" id="V3080623" paragraph="paragraph25" rule="-SIMPLE-REF" start="112" uttnum="210">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>RESPONSE-TO-GROWTH-FACTORS</name>
    <text>response to growth factors</text>
  </TERM>
  <TERM end="149" id="V3091286" paragraph="paragraph25" rule="-SIMPLE-REF" start="144" uttnum="211">
    <type>ONT::INFORMATION</type>
    <name>DATA</name>
    <text>data</text>
  </TERM>
  <TERM end="190" id="V3091341" paragraph="paragraph25" rule="-LOGICALOP-REF" start="167" uttnum="211">
    <type>ONT::MUTATION</type>
    <aggregate operator="AND">
      <member id="V3091337"/>
      <member id="V3091384"/>
    </aggregate>
    <text normalization="">2B and 2C</text>
  </TERM>
  <TERM end="170" id="V3091337" paragraph="paragraph25" rule="-SIMPLE-REF" start="167" uttnum="211">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2B</text>
  </TERM>
  <TERM end="190" id="V3091384" paragraph="paragraph25" rule="-SIMPLE-REF" start="174" uttnum="211">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Cysteine</name>
          <code>C</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2C</text>
  </TERM>
  <EPI end="298" id="V3091396" paragraph="paragraph25" rule="-RULE50_0_NEUTRAL_FORMAL" start="192" uttnum="211">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V3091524" role=":FORMAL"/>
    <text>demonstrate that AKT in the plasma membrane is phosphorylated at Tyr 176 and mutation of this site in AKT</text>
  </EPI>
  <EVENT end="298" id="V3091524" paragraph="paragraph25" rule="-RULE50_0_NEUTRAL_FORMAL-EVENT,-RULE60_AGENT_AFFECTED-AFFECTED" start="192" uttnum="211">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <epistemic-modality id="V3091396"/>
    <predicate end="298" id="V3091524" start="192">
      <type>ONT::PHOSPHORYLATION</type>
      <text>demonstrate that AKT in the plasma membrane is phosphorylated at Tyr 176 and mutation of this site in AKT</text>
    </predicate>
    <arg2 id="V3091421" role=":AFFECTED"/>
    <arg id="R000329" role=":RESULT"/>
    <text>demonstrate that AKT in the plasma membrane is phosphorylated at Tyr 176 and mutation of this site in AKT</text>
  </EVENT>
  <TERM end="236" id="V3091421" paragraph="paragraph25" rule="-SIMPLE-REF" start="209" uttnum="211">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT in the plasma membrane</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3091524"/>
    </not-features>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="236" id="V3091499" paragraph="paragraph25" rule="-SIMPLE-REF" start="216" uttnum="211">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <TERM end="265" id="V3091555" paragraph="paragraph25" rule="-SIMPLE-REF" start="257" uttnum="211">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr 176</text>
  </TERM>
  <EVENT end="298" id="V3091568" paragraph="paragraph25" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="269" uttnum="211">
    <type>ONT::TRANSFORM</type>
    <predicate end="298" id="V3091568" start="269">
      <type>ONT::TRANSFORM</type>
      <text>mutation of this site in AKT</text>
    </predicate>
    <arg2 id="V3091583" role=":AFFECTED"/>
    <text>mutation of this site in AKT</text>
  </EVENT>
  <TERM end="291" id="V3091583" paragraph="paragraph25" rule="-SIMPLE-REF" start="278" uttnum="211">
    <type>ONT::MOLECULAR-SITE</type>
    <name>SITE</name>
    <text>of this site</text>
  </TERM>
  <TERM end="298" id="V3091642" paragraph="paragraph25" rule="-SIMPLE-REF" start="294" uttnum="211">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="326" id="V3091669" paragraph="paragraph25" rule="-SIMPLE-REF" start="319" uttnum="211">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of AKT</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="349" id="V3091747" paragraph="paragraph25" rule="-SIMPLE-REF" start="329" uttnum="211">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <TERM end="383" id="V3091803" paragraph="paragraph25" rule="-SIMPLE-REF" start="367" uttnum="211">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>2</pos>
      <aa-to>
        <aa>
          <name>Aspartic acid</name>
          <code>D</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">2D</text>
  </TERM>
  <TERM end="409" id="V3107727" paragraph="paragraph25" rule="-SIMPLE-REF" start="392" uttnum="212">
    <type>ONT::INFORMATION</type>
    <name>EVIDENCE</name>
    <text>on the evidence,</text>
  </TERM>
  <TERM end="419" id="V3107741" paragraph="paragraph25" rule="-SIMPLE-REF" start="409" uttnum="212">
    <type>ONT::PRODUCT-MODEL</type>
    <name>MODEL</name>
    <text>our model</text>
  </TERM>
  <TERM end="419" id="V3107733" paragraph="paragraph25" rule="-ROBUSTPRO" start="409" uttnum="212">
    <type>ONT::PERSON</type>
    <text>our model</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="435" id="V3107754" paragraph="paragraph25" rule="-SIMPLE-REF" start="432" uttnum="212">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="468" id="V3107794" paragraph="paragraph25" rule="-SIMPLE-REF" start="463" uttnum="212">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>that</text>
  </TERM>
  <EVENT end="537" id="V3107875" paragraph="paragraph25" rule="-RULE40A_AGENT_AFFECTED-CELL_LOC2-GD-OTHERS-AFFECTED" start="471" uttnum="212">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="537" id="V3107875" start="471">
      <type>ONT::ACTIVATE</type>
      <text>Ack1 signaling pathway is initiated at the plasma membrane by RTKs</text>
    </predicate>
    <arg2 id="V3107846" role=":AFFECTED"/>
    <location end="537" id="V3107919" mod="null" start="510">
      <type>ONT::CELL-PART</type>
      <text normalization="">the plasma membrane by RTKs</text>
    </location>
    <text>Ack1 signaling pathway is initiated at the plasma membrane by RTKs</text>
  </EVENT>
  <TERM end="494" id="V3107846" paragraph="paragraph25" rule="-SIMPLE-REF" start="471" uttnum="212">
    <type>ONT::SIGNALING-PATHWAY</type>
    <name>SIGNALING-PATHWAY</name>
    <text>Ack1 signaling pathway</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="476" id="V3107840" paragraph="paragraph25" rule="-SIMPLE-REF" start="471" uttnum="212">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="537" id="V3107919" paragraph="paragraph25" rule="-SIMPLE-REF" start="510" uttnum="212">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane by RTKs</text>
  </TERM>
  <TERM end="567" id="V3122396" paragraph="paragraph25" rule="-SIMPLE-REF" start="539" uttnum="213">
    <type>ONT::FRIEND</type>
    <name>ASSOCIATES</name>
    <text>Ack1 associates with growth</text>
  </TERM>
  <TERM end="657" id="V3122461" paragraph="paragraph25" rule="-SIMPLE-REF" start="574" uttnum="213">
    <type>ONT::EDGE</type>
    <name>BOUND</name>
    <text>bound RTKs (via Mig6 homology domain in Ack1 carboxy terminal proline rich region)</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="544" id="V3122388" paragraph="paragraph25" rule="-SIMPLE-REF" start="539" uttnum="213">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="GO:0040007" end="567" id="V3122419" paragraph="paragraph25" rule="-SIMPLE-REF" start="560" uttnum="213">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>GROWTH</name>
    <text>growth</text>
  </TERM>
  <TERM dbid="UP:Q9UJM3|UP:Q99JZ7|HGNC:18185|XFAM:PF11555|FA:02304|XFAM:PF09027" end="655" id="V3122521" paragraph="paragraph25" rule="-SIMPLE-REF" start="590" uttnum="213">
    <type>ONT::GENE-PROTEIN</type>
    <name>MIG-6</name>
    <text>Mig6 homology domain in Ack1 carboxy terminal proline rich region</text>
  </TERM>
  <TERM end="655" id="V3122630" paragraph="paragraph25" rule="-SIMPLE-REF" start="614" uttnum="213">
    <type>ONT::AREA-DEF-BY-USE</type>
    <name>REGION</name>
    <text>Ack1 carboxy terminal proline rich region</text>
  </TERM>
  <TERM end="655" id="V3122605" paragraph="paragraph25" rule="-SIMPLE-REF" start="614" uttnum="213">
    <type>ONT::TERMINUS</type>
    <name>TERMINAL</name>
    <text>Ack1 carboxy terminal proline rich region</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="655" id="V3122597" paragraph="paragraph25" rule="-SIMPLE-REF" start="614" uttnum="213">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1 carboxy terminal proline rich region</text>
  </TERM>
  <TERM dbid="CHEBI:46883" end="627" id="V3122602" paragraph="paragraph25" rule="-SIMPLE-REF" start="619" uttnum="213">
    <type>ONT::MOLECULE</type>
    <name>CARBOXY</name>
    <text>carboxy</text>
  </TERM>
  <TERM end="644" id="V3122624" paragraph="paragraph25" rule="-SIMPLE-REF" start="636" uttnum="213">
    <type>ONT::AMINO-ACID</type>
    <name>PROLINE</name>
    <text>proline</text>
  </TERM>
  <EVENT end="821" id="V3134280" paragraph="paragraph25" rule="-RULE20C_AFFECTED_AFFECTED1" start="731" uttnum="214">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="821" id="V3134280" start="731">
      <type>ONT::BIND</type>
      <text>Ack1 is constitutively bound to AKT (Fig. 1B and G)</text>
    </predicate>
    <arg1 id="V3134245" role=":AFFECTED"/>
    <arg2 id="V3134323" role=":AFFECTED1"/>
    <arg id="R000164" role=":RESULT"/>
    <text>Ack1 is constitutively bound to AKT (Fig. 1B and G)</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="736" id="V3134245" paragraph="paragraph25" rule="-SIMPLE-REF" start="731" uttnum="214">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <not-features>
      <bound-to id="V3134323" event="V3134280"/>
    </not-features>
  </TERM>
  <TERM end="821" id="V3134323" paragraph="paragraph25" rule="-SIMPLE-REF" start="760" uttnum="214">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">to AKT (Fig. 1B and G)</text>
    <not-features>
      <bound-to event="V3134280" id="V3134245"/>
    </not-features>
  </TERM>
  <TERM end="795" id="V3134373" paragraph="paragraph25" rule="-SIMPLE-REF" start="785" uttnum="214">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">1B</text>
  </TERM>
  <EVENT end="876" id="V3150178" paragraph="paragraph25" rule="-RULE60_AGENT_AFFECTED-LOC4-GD" start="823" uttnum="214">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="876" id="V3150178" start="823">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Activated Ack1 directly phosphorylates AKT at Tyr176,</text>
    </predicate>
    <arg1 id="V3150169" role=":AGENT"/>
    <arg2 id="V3150183" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000334"/>
    <site end="876" id="V3150211" start="869">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176,</text>
    </site>
    <text>Activated Ack1 directly phosphorylates AKT at Tyr176,</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="838" id="V3150169" paragraph="paragraph25" rule="-INEVENT2B,-SIMPLE-REF" start="823" uttnum="214">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Activated Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <TERM end="866" id="V3150183" paragraph="paragraph25" rule="-SIMPLE-REF" start="862" uttnum="214">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm event="V3150178" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <EVENT end="838" id="V3150155" paragraph="paragraph25" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="823" uttnum="214">
    <type>ONT::ACTIVATE</type>
    <force>ONT::TRUE</force>
    <predicate end="838" id="V3150155" start="823">
      <type>ONT::ACTIVATE</type>
      <text>Activated Ack1</text>
    </predicate>
    <arg2 id="V3150169" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000112"/>
    <text>Activated Ack1</text>
  </EVENT>
  <TERM end="876" id="V3150211" paragraph="paragraph25" rule="-SIMPLE-REF" start="869" uttnum="214">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176,</text>
  </TERM>
  <EVENT end="959" id="V3151981" paragraph="paragraph25" rule="-RULE30_AGENT_AFFECTED-AFFECTED" start="877" uttnum="214">
    <type>ONT::STIMULATE</type>
    <predicate end="959" id="V3151981" start="877">
      <type>ONT::STIMULATE</type>
      <text>thus facilitating accumulation of Tyr176-phosphorylated AKT at the plasma membrane</text>
    </predicate>
    <arg2 id="V3151996" role=":AFFECTED"/>
    <text>thus facilitating accumulation of Tyr176-phosphorylated AKT at the plasma membrane</text>
  </EVENT>
  <EVENT end="937" id="V3151996" paragraph="paragraph25" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="895" uttnum="214">
    <type>ONT::BIND</type>
    <predicate end="937" id="V3151996" start="895">
      <type>ONT::BIND</type>
      <text>accumulation of Tyr176-phosphorylated AKT</text>
    </predicate>
    <arg2 id="V3152032" role=":AFFECTED"/>
    <text>accumulation of Tyr176-phosphorylated AKT</text>
  </EVENT>
  <TERM end="937" id="V3152032" paragraph="paragraph25" rule="-INEVENT2B,-SIMPLE-REF" start="908" uttnum="214">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Tyr176-phosphorylated AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3152022"/>
    </features>
  </TERM>
  <EVENT end="937" id="V3152022" paragraph="paragraph25" rule="-RULE60_AGENT_AFFECTED-A" start="908" uttnum="214">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="937" id="V3152022" start="908">
      <type>ONT::PHOSPHORYLATION</type>
      <text>of Tyr176-phosphorylated AKT</text>
    </predicate>
    <arg2 id="V3152032" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000024"/>
    <site end="933" id="V3152014" start="911">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176-phosphorylated</text>
    </site>
    <text>of Tyr176-phosphorylated AKT</text>
  </EVENT>
  <TERM end="933" id="V3152014" paragraph="paragraph25" rule="-SIMPLE-REF" start="911" uttnum="214">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176-phosphorylated</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="959" id="V3152076" paragraph="paragraph25" rule="-SIMPLE-REF" start="940" uttnum="214">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <EVENT end="1078" id="V3153467" paragraph="paragraph25" rule="-RULE20C_AGENT_AFFECTED" start="961" uttnum="215">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="1078" id="V3153467" start="961">
      <type>ONT::BIND</type>
      <text>Tyr176-phosphorylated AKT preferentially binds PA, a plasma membrane phospholipid as opposed to unphosphorylated AKT</text>
    </predicate>
    <arg1 id="V3153455" role=":AGENT"/>
    <arg2 id="V3153553" role=":AFFECTED"/>
    <arg id="R000173" role=":RESULT"/>
    <text>Tyr176-phosphorylated AKT preferentially binds PA, a plasma membrane phospholipid as opposed to unphosphorylated AKT</text>
  </EVENT>
  <TERM end="987" id="V3153455" paragraph="paragraph25" rule="-INEVENT2B,-SIMPLE-REF" start="961" uttnum="215">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr176-phosphorylated AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3153445"/>
    </features>
    <not-features>
      <bound-to event="V3153467" id="V3153553"/>
    </not-features>
  </TERM>
  <TERM dbid="CHEBI:16247" end="1043" id="V3153553" paragraph="paragraph25" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="1008" uttnum="215">
    <type>ONT::MOLECULE</type>
    <features>
      <location id="V3153547"/>
    </features>
    <name>PHOSPHOLIPID</name>
    <text>PA, a plasma membrane phospholipid</text>
    <not-features>
      <bound-to event="V3153467" id="V3153455"/>
    </not-features>
  </TERM>
  <EVENT end="987" id="V3153445" paragraph="paragraph25" rule="-RULE60_AGENT_AFFECTED-A" start="961" uttnum="215">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="987" id="V3153445" start="961">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr176-phosphorylated AKT</text>
    </predicate>
    <arg2 id="V3153455" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000025"/>
    <site end="983" id="V3153437" start="961">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176-phosphorylated</text>
    </site>
    <text>Tyr176-phosphorylated AKT</text>
  </EVENT>
  <TERM end="983" id="V3153437" paragraph="paragraph25" rule="-SIMPLE-REF" start="961" uttnum="215">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176-phosphorylated</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="1043" id="V3153547" paragraph="paragraph25" rule="-SIMPLE-REF" start="1008" uttnum="215">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>PA, a plasma membrane phospholipid</text>
  </TERM>
  <TERM dbid="HGNC:8549|XFAM:PF02225.19|UP:P04746|UP:P16452|XFAM:PF00128|HGNC:3381|HGNC:477|UP:P00688|XFAM:PF02806|UP:Q9UL45" end="1012" id="V3153479" paragraph="paragraph25" rule="-SIMPLE-REF" start="1008" uttnum="215">
    <type>ONT::GENE-PROTEIN</type>
    <name>PA</name>
    <text>PA,</text>
  </TERM>
  <TERM end="1078" id="V3153634" paragraph="paragraph25" rule="-INEVENT2B,-SIMPLE-REF" start="1057" uttnum="215">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">unphosphorylated AKT</text>
    <not-features>
      <ptm event="V3153624" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <EVENT end="1078" id="V3153624" paragraph="paragraph25" rule="-RULE60_AGENT_AFFECTED-MODN1_2-AFFECTED" start="1057" uttnum="215">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <mods>
      <mod>
        <type>ONT::MANNER-UNDO</type>
        <value>UN-</value>
      </mod>
    </mods>
    <predicate end="1078" id="V3153624" start="1057">
      <type>ONT::PHOSPHORYLATION</type>
      <text>unphosphorylated AKT</text>
    </predicate>
    <arg2 id="V3153634" role=":AFFECTED"/>
    <text>unphosphorylated AKT</text>
  </EVENT>
  <TERM end="1133" id="V3153703" paragraph="paragraph25" rule="-SIMPLE-REF" start="1105" uttnum="215">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>8</pos>
      </site>
    </features>
    <name>S-8</name>
    <text>S8 for details</text>
  </TERM>
  <TERM end="1133" id="V3153740" paragraph="paragraph25" rule="-SIMPLE-REF" start="1126" uttnum="215">
    <type>ONT::INFORMATION-FUNCTION-OBJECT</type>
    <name>DETAIL</name>
    <text>details</text>
  </TERM>
  <TERM dbid="XFAM:PF16453.2|XFAM:PF00169.26" end="1146" id="V3168755" paragraph="paragraph25" rule="-SIMPLE-REF" start="1136" uttnum="216">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PH-DOMAIN</name>
    <text>PH domain</text>
  </TERM>
  <EVENT end="1258" id="V3169014" paragraph="paragraph25" rule="-RULE20C_AGENT_AFFECTED" start="1206" uttnum="216">
    <type>ONT::BIND</type>
    <predicate end="1258" id="V3169014" start="1206">
      <type>ONT::BIND</type>
      <text>in the membrane binding of Tyr176-phosphorylated AKT</text>
    </predicate>
    <arg1 id="V3169010" role=":AGENT"/>
    <arg2 id="V3169061" role=":AFFECTED"/>
    <arg id="R000182" role=":RESULT"/>
    <text>in the membrane binding of Tyr176-phosphorylated AKT</text>
  </EVENT>
  <TERM dbid="GO:0016020|UP:SL-0162" end="1222" id="V3169010" paragraph="paragraph25" rule="-SIMPLE-REF" start="1209" uttnum="216">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>the membrane</text>
    <not-features>
      <bound-to id="V3169061" event="V3169014"/>
    </not-features>
  </TERM>
  <TERM end="1258" id="V3169061" paragraph="paragraph25" rule="-INEVENT2B,-SIMPLE-REF" start="1230" uttnum="216">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Tyr176-phosphorylated AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3169051"/>
    </features>
    <not-features>
      <bound-to event="V3169014" id="V3169010"/>
    </not-features>
  </TERM>
  <EVENT end="1258" id="V3169051" paragraph="paragraph25" rule="-RULE60_AGENT_AFFECTED-A" start="1230" uttnum="216">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="1258" id="V3169051" start="1230">
      <type>ONT::PHOSPHORYLATION</type>
      <text>of Tyr176-phosphorylated AKT</text>
    </predicate>
    <arg2 id="V3169061" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000026"/>
    <site end="1255" id="V3169043" start="1233">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176-phosphorylated</text>
    </site>
    <text>of Tyr176-phosphorylated AKT</text>
  </EVENT>
  <TERM end="1255" id="V3169043" paragraph="paragraph25" rule="-SIMPLE-REF" start="1233" uttnum="216">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176-phosphorylated</text>
  </TERM>
  <TERM end="1179" id="V3168900" paragraph="paragraph25" rule="-SIMPLE-REF" start="1156" uttnum="216">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>DOMAIN</name>
    <text>a lipid binding domain</text>
  </TERM>
  <TERM dbid="GO:0008289" end="1172" id="V3168897" paragraph="paragraph25" rule="-SIMPLE-REF" start="1158" uttnum="216">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>LIPID-BINDING</name>
    <text>lipid binding</text>
  </TERM>
  <TERM end="1153" id="V3168816" paragraph="paragraph25" rule="-SIMPLE-REF" start="1149" uttnum="216">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1283" id="V3184652" paragraph="paragraph25" rule="-SIMPLE-REF" start="1274" uttnum="217">
    <type>ONT::INFORMATION</type>
    <name>DATA</name>
    <text>our data</text>
  </TERM>
  <TERM end="1283" id="V3184648" paragraph="paragraph25" rule="-ROBUSTPRO" start="1274" uttnum="217">
    <type>ONT::PERSON</type>
    <text>our data</text>
  </TERM>
  <EVENT end="1338" id="V3184713" paragraph="paragraph25" rule="-INEVENT2B,-RULE60_AGENT_AFFECTED-LOC11" start="1297" uttnum="217">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1338" id="V3184713" start="1297">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Ack1 mediated AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg1 id="V3184687" role=":AGENT"/>
    <arg2 id="V3184697" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000339"/>
    <site end="1338" id="V3184707" start="1297">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Ack1 mediated AKT Tyr176-phosphorylation</text>
    </site>
    <text>Ack1 mediated AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="1375" id="V3184765" paragraph="paragraph25" rule="-SIMPLE-REF" start="1349" uttnum="217">
    <type>ONT::PROCESS</type>
    <name>PROCESS</name>
    <text>this translocation process</text>
  </TERM>
  <TERM end="1338" id="V3184707" paragraph="paragraph25" rule="-SIMPLE-REF" start="1297" uttnum="217">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Ack1 mediated AKT Tyr176-phosphorylation</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1302" id="V3184687" paragraph="paragraph25" rule="-SIMPLE-REF" start="1297" uttnum="217">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <EVENT end="1338" id="V3184692" paragraph="paragraph25" rule="-RULE10_AGENT_AFFECTED-AFFECTED" start="1297" uttnum="217">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="1338" id="V3184692" start="1297">
      <type>ONT::MODULATE</type>
      <text>Ack1 mediated AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg2 id="V3184713" role=":AFFECTED"/>
    <text>Ack1 mediated AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="1315" id="V3184697" paragraph="paragraph25" rule="-SIMPLE-REF" start="1311" uttnum="217">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3184713"/>
    </not-features>
  </TERM>
  <EVENT end="1419" id="V3200196" paragraph="paragraph25" rule="-RULE60_AGENT_AFFECTED-LOC11-AFFECTED" start="1392" uttnum="218">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="1419" id="V3200196" start="1392">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT Tyr176-phosphorylation</text>
    </predicate>
    <arg2 id="V3200180" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000344"/>
    <site end="1419" id="V3200190" start="1392">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">AKT Tyr176-phosphorylation</text>
    </site>
    <text>AKT Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="1419" id="V3200190" paragraph="paragraph25" rule="-SIMPLE-REF" start="1392" uttnum="218">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>AKT Tyr176-phosphorylation</text>
  </TERM>
  <TERM end="1396" id="V3200180" paragraph="paragraph25" rule="-SIMPLE-REF" start="1392" uttnum="218">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm event="V3200196" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="1460" id="V3200267" paragraph="paragraph25" rule="-SIMPLE-REF" start="1440" uttnum="218">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <TERM dbid="CHEBI:16618" end="1479" id="V3200301" paragraph="paragraph25" rule="-SIMPLE-REF" start="1463" uttnum="218">
    <type>ONT::MOLECULE</type>
    <name>PIP-3</name>
    <text>PIP3 independent</text>
  </TERM>
  <CC end="1568" id="V3213545" paragraph="paragraph25" rule="-NECESSARY2" start="1481" uttnum="218">
    <type>ONT::DEPENDENT</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::POSSIBILITY</modality>
    <arg id="V3213603" role=":FACTOR"/>
    <arg id="V3213428" role=":OUTCOME"/>
    <text>the recruitment of Tyr176 AKT in the plasma membrane may require a functional PH domain</text>
  </CC>
  <EVENT end="1534" id="V3213428" paragraph="paragraph25" rule="-RULE20C_AGENT_AFFECTED-LOC9-AFFECTED" start="1481" uttnum="218">
    <type>ONT::BIND</type>
    <predicate end="1534" id="V3213428" start="1481">
      <type>ONT::BIND</type>
      <text>the recruitment of Tyr176 AKT in the plasma membrane</text>
    </predicate>
    <arg2 id="V3213450" role=":AFFECTED"/>
    <site end="1507" id="V3213445" start="1500">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176</text>
    </site>
    <text>the recruitment of Tyr176 AKT in the plasma membrane</text>
  </EVENT>
  <TERM dbid="XFAM:PF00169.26" end="1568" id="V3213603" paragraph="paragraph25" rule="-EXPLICIT-REF1" start="1546" uttnum="218">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PH</name>
    <assoc-with id="V3213596"/>
    <text>a functional PH domain</text>
  </TERM>
  <TERM end="1534" id="V3213450" paragraph="paragraph25" rule="-SIMPLE-REF" start="1497" uttnum="218">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Tyr176 AKT in the plasma membrane</text>
  </TERM>
  <TERM end="1507" id="V3213445" paragraph="paragraph25" rule="-SIMPLE-REF" start="1500" uttnum="218">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="1534" id="V3213528" paragraph="paragraph25" rule="-SIMPLE-REF" start="1514" uttnum="218">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane</text>
  </TERM>
  <TERM dbid="XFAM:PF00169.26" end="1568" id="V3213596" paragraph="paragraph25" rule="-SIMPLE-REF" start="1546" uttnum="218">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PH</name>
    <text>a functional PH domain</text>
  </TERM>
  <TERM dbid="HGNC:8549|XFAM:PF02225.19|UP:P04746|UP:P16452|XFAM:PF00128|HGNC:3381|HGNC:477|UP:P00688|XFAM:PF02806|UP:Q9UL45" end="99" id="V3228895" paragraph="paragraph26" rule="-SIMPLE-REF-MODBP2,-SIMPLE-REF" start="54" uttnum="219">
    <type>ONT::GENE-PROTEIN</type>
    <features>
      <location id="V3228868"/>
    </features>
    <name>PA</name>
    <text>the plasma membrane anionic phospholipid, PA</text>
  </TERM>
  <TERM end="21" id="V3228826" paragraph="paragraph26" rule="-SIMPLE-REF" start="18" uttnum="219">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="99" id="V3228868" paragraph="paragraph26" rule="-SIMPLE-REF" start="54" uttnum="219">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>the plasma membrane anionic phospholipid, PA</text>
  </TERM>
  <TERM dbid="CHEBI:62643" end="96" id="V3228884" paragraph="paragraph26" rule="-SIMPLE-REF" start="74" uttnum="219">
    <type>ONT::MOLECULE</type>
    <name>ANIONIC-PHOSPHOLIPID</name>
    <text>anionic phospholipid,</text>
  </TERM>
  <TERM end="35" id="V3228518" paragraph="paragraph26" rule="-SIMPLE-REF" start="31" uttnum="219">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM dbid="XFAM:PF15343|UP:Q9NTK1|UP:Q9HD26|HGNC:17643|HGNC:23355" end="115" id="V3228910" paragraph="paragraph26" rule="-SIMPLE-REF" start="112" uttnum="219">
    <type>ONT::GENE-PROTEIN</type>
    <name>FIG</name>
    <text>Fig</text>
  </TERM>
  <TERM end="133" id="V3228938" paragraph="paragraph26" rule="-SIMPLE-REF" start="117" uttnum="219">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>8</pos>
      </site>
    </features>
    <name>S-8</name>
    <text>S8</text>
  </TERM>
  <EVENT end="172" id="V3244654" paragraph="paragraph26" rule="-RULE40_AGENT_AFFECTED-RESULT-AGENT" start="136" uttnum="220">
    <type>ONT::PRODUCE</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::COULD</modality>
    <predicate end="172" id="V3244654" start="136">
      <type>ONT::PRODUCE</type>
      <text>Tyr176-phosphorylation could induce</text>
    </predicate>
    <arg1 id="V3244636" role=":AGENT"/>
    <text>Tyr176-phosphorylation could induce</text>
  </EVENT>
  <EVENT end="159" id="V3244636" paragraph="paragraph26" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="136" uttnum="220">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="159" id="V3244636" start="136">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr176-phosphorylation</text>
    </predicate>
    <site end="142" id="V3244630" start="136">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176</text>
    </site>
    <text>Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="142" id="V3244630" paragraph="paragraph26" rule="-SIMPLE-REF" start="136" uttnum="220">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <TERM end="206" id="V3244736" paragraph="paragraph26" rule="-SIMPLE-REF" start="198" uttnum="220">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">the AKT</text>
  </TERM>
  <TERM dbid="XFAM:PF16453.2|XFAM:PF00169.26" end="216" id="V3244753" paragraph="paragraph26" rule="-SIMPLE-REF" start="206" uttnum="220">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PH-DOMAIN</name>
    <text>PH domain</text>
  </TERM>
  <EVENT end="234" id="V3244794" paragraph="paragraph26" rule="-RULE20C_AFFECTED_AFFECTED1-NONE" start="226" uttnum="220">
    <type>ONT::BIND</type>
    <predicate end="234" id="V3244794" start="226">
      <type>ONT::BIND</type>
      <text>binding</text>
    </predicate>
    <text>binding</text>
  </EVENT>
  <TERM dbid="CVCL:E800" end="239" id="V3244825" paragraph="paragraph26" rule="-SIMPLE-REF" start="237" uttnum="220">
    <type>ONT::CELL-LINE</type>
    <name>PA</name>
    <text>PA</text>
  </TERM>
  <TERM dbid="XFAM:PF16453.2|XFAM:PF00169.26" end="296" id="V3244861" paragraph="paragraph26" rule="-SIMPLE-REF" start="241" uttnum="220">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PH-DOMAIN</name>
    <text>The PH domain of Son of sevenless (SOS) and PX domains</text>
  </TERM>
  <TERM end="296" id="V3244912" paragraph="paragraph26" rule="-LOGICALOP-REF" start="258" uttnum="220">
    <type>ONT::MOLECULAR-PART</type>
    <aggregate operator="AND">
      <member id="V3244897"/>
      <member id="V3244931"/>
    </aggregate>
    <text normalization="">Son of sevenless (SOS) and PX domains</text>
  </TERM>
  <TERM end="281" id="V3244897" paragraph="paragraph26" rule="-SIMPLE-REF" start="258" uttnum="220">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q07889" type="ONT::PROTEIN"/>
      <member dbid="UP:Q07890" type="ONT::PROTEIN"/>
    </members>
    <name>SON-OF-SEVENLESS</name>
    <text normalization="">Son of sevenless (SOS)</text>
  </TERM>
  <TERM dbid="XFAM:PF00787.21" end="296" id="V3244931" paragraph="paragraph26" rule="-SIMPLE-REF" start="285" uttnum="220">
    <type>ONT::MOLECULAR-DOMAIN</type>
    <name>PX-DOMAINS</name>
    <text>PX domains</text>
  </TERM>
  <TERM end="279" id="V3244905" paragraph="paragraph26" rule="-SIMPLE-REF" start="276" uttnum="220">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:Q07889" type="ONT::PROTEIN"/>
      <member dbid="UP:Q07890" type="ONT::PROTEIN"/>
    </members>
    <name>SOS</name>
    <text normalization="">SOS</text>
  </TERM>
  <TERM dbid="UP:Q12802|UP:P08567" end="307" id="V3244971" paragraph="paragraph26" rule="-SIMPLE-REF" start="296" uttnum="220">
    <type>ONT::PROTEIN</type>
    <name>P-47</name>
    <text>of p47</text>
  </TERM>
  <TERM dbid="CHEBI:53076" end="318" id="V3244976" paragraph="paragraph26" rule="-SIMPLE-REF" start="307" uttnum="220">
    <type>ONT::MOLECULE</type>
    <name>PHOX</name>
    <text>phox</text>
  </TERM>
  <TERM end="383" id="V3245118" paragraph="paragraph26" rule="-SIMPLE-REF" start="356" uttnum="220">
    <type>ONT::MANUFACTURED-OBJECT</type>
    <name>BINDING</name>
    <text>a phosphoinositide-binding</text>
  </TERM>
  <TERM dbid="CHEBI:18179|CHEBI:16749|CHEBI:36315" end="383" id="V3245105" paragraph="paragraph26" rule="-SIMPLE-REF" start="356" uttnum="220">
    <type>ONT::MOLECULE</type>
    <name>PHOSPHOINOSITIDE</name>
    <text>a phosphoinositide-binding</text>
  </TERM>
  <TERM end="390" id="V3245135" paragraph="paragraph26" rule="-SIMPLE-REF" start="383" uttnum="220">
    <type>ONT::BAG</type>
    <name>POCKET</name>
    <text>pocket</text>
  </TERM>
  <TERM end="424" id="V3245226" paragraph="paragraph26" rule="-SIMPLE-REF-2" start="394" uttnum="220">
    <type>ONT::BAG</type>
    <name>POCKET</name>
    <text>a second anion binding pocket</text>
  </TERM>
  <TERM dbid="GO:0043168" end="417" id="V3245218" paragraph="paragraph26" rule="-SIMPLE-REF" start="403" uttnum="220">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>ANION-BINDING</name>
    <text>anion binding</text>
  </TERM>
  <TERM dbid="GO:0043168" end="529" id="V3245232" paragraph="paragraph26" rule="-SIMPLE-REF" start="424" uttnum="220">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>ANION-BINDING</name>
    <text>which enables them to interact with PA facilitating plasma membrane recruitment [40],</text>
  </TERM>
  <TERM end="443" id="V3245244" paragraph="paragraph26" rule="-ROBUSTPRO" start="438" uttnum="220">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>them</text>
  </TERM>
  <TERM dbid="HGNC:8549|XFAM:PF02225.19|UP:P04746|UP:P16452|XFAM:PF00128|HGNC:3381|HGNC:477|UP:P00688|XFAM:PF02806|UP:Q9UL45" end="463" id="V3245299" paragraph="paragraph26" rule="-SIMPLE-REF" start="455" uttnum="220">
    <type>ONT::GENE-PROTEIN</type>
    <name>PA</name>
    <text>with PA</text>
  </TERM>
  <EVENT end="529" id="V3245354" paragraph="paragraph26" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="476" uttnum="220">
    <type>ONT::BIND</type>
    <predicate end="529" id="V3245354" start="476">
      <type>ONT::BIND</type>
      <text>plasma membrane recruitment [40],</text>
    </predicate>
    <arg2 id="V3245350" role=":AFFECTED"/>
    <text>plasma membrane recruitment [40],</text>
  </EVENT>
  <TERM dbid="UP:SL-0039|UP:SL-0037|GO:0005886" end="492" id="V3245350" paragraph="paragraph26" rule="-SIMPLE-REF" start="476" uttnum="220">
    <type>ONT::CELL-PART</type>
    <name>PLASMA-MEMBRANE</name>
    <text>plasma membrane</text>
  </TERM>
  <TERM end="545" id="V3257026" paragraph="paragraph26" rule="-ROBUSTPRO" start="542" uttnum="221">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="568" id="V3257056" paragraph="paragraph26" rule="-SIMPLE-REF" start="560" uttnum="221">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT too</text>
  </TERM>
  <TERM end="611" id="V3257150" paragraph="paragraph26" rule="-SIMPLE-REF" start="582" uttnum="221">
    <type>ONT::BAG</type>
    <name>POCKET</name>
    <text>a masked anion binding pocket</text>
  </TERM>
  <TERM dbid="HGNC:24714|FA:02180|HGNC:18174|UP:Q9P289|UP:Q8IWZ3" end="611" id="V3257121" paragraph="paragraph26" rule="-SIMPLE-REF" start="582" uttnum="221">
    <type>ONT::GENE-PROTEIN</type>
    <name>MASKED</name>
    <text>a masked anion binding pocket</text>
  </TERM>
  <TERM dbid="GO:0043168" end="605" id="V3257142" paragraph="paragraph26" rule="-SIMPLE-REF" start="591" uttnum="221">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>ANION-BINDING</name>
    <text>anion binding</text>
  </TERM>
  <TERM end="715" id="V3258607" paragraph="paragraph26" rule="-SIMPLE-REF" start="681" uttnum="221">
    <type>ONT::BAG</type>
    <name>POCKET</name>
    <text>this pocket allowing it to bind PA</text>
  </TERM>
  <TERM end="620" id="V3258541" paragraph="paragraph26" rule="-SIMPLE-REF" start="617" uttnum="221">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr</text>
  </TERM>
  <EVENT end="645" id="V3258547" paragraph="paragraph26" rule="-RULE60_AGENT_AFFECTED-NONE" start="621" uttnum="221">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="645" id="V3258547" start="621">
      <type>ONT::PHOSPHORYLATION</type>
      <text>phosphorylation induced</text>
    </predicate>
    <text>phosphorylation induced</text>
  </EVENT>
  <TERM dbid="CVCL:E800" end="715" id="V3258660" paragraph="paragraph26" rule="-SIMPLE-REF" start="713" uttnum="221">
    <type>ONT::CELL-LINE</type>
    <name>PA</name>
    <text>PA</text>
  </TERM>
  <EVENT end="68" id="V3275567" paragraph="paragraph27" rule="-RULE20C_AFFECTED_AFFECTED1-AFFECTED1" start="3" uttnum="222">
    <type>ONT::BIND</type>
    <force>ONT::TRUE</force>
    <predicate end="68" id="V3275567" start="3">
      <type>ONT::BIND</type>
      <text>In endogenous systems Ack1 associates with AKT2 albeit weakly as</text>
    </predicate>
    <arg2 id="V3275592" role=":AFFECTED1"/>
    <text>In endogenous systems Ack1 associates with AKT2 albeit weakly as</text>
  </EVENT>
  <TERM dbid="UP:P31751" end="51" id="V3275592" paragraph="paragraph27" rule="-SIMPLE-REF" start="41" uttnum="222">
    <type>ONT::PROTEIN</type>
    <name>AKT-2</name>
    <text>with AKT2</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="30" id="V3275563" paragraph="paragraph27" rule="-SIMPLE-REF" start="6" uttnum="222">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>endogenous systems Ack1</text>
  </TERM>
  <TERM end="30" id="V3275549" paragraph="paragraph27" rule="-SIMPLE-REF" start="6" uttnum="222">
    <type>ONT::INSTRUMENTATION</type>
    <name>SYSTEM</name>
    <text>endogenous systems Ack1</text>
  </TERM>
  <TERM dbid="UP:P31749" end="120" id="V3275680" paragraph="paragraph27" rule="-SIMPLE-REF-MUTATION2,-SIMPLE-REF" start="77" uttnum="222">
    <type>ONT::PROTEIN</type>
    <features>
      <mutation id="V3275730"/>
    </features>
    <name>AKT-1</name>
    <text>to AKT1 (Fig. 1B)</text>
  </TERM>
  <TERM end="119" id="V3275730" paragraph="paragraph27" rule="-SIMPLE-REF" start="98" uttnum="222">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-to>
        <aa>
          <name>Asparagine or aspartic acid</name>
          <code>B</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">Fig. 1B</text>
  </TERM>
  <TERM end="126" id="V3291489" paragraph="paragraph27" rule="-SIMPLE-REF" start="122" uttnum="223">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="222" id="V3291553" paragraph="paragraph27" rule="-SIMPLE-REF-MODA2,-SIMPLE-REF" start="172" uttnum="223">
    <type>ONT::CELL-COMPARTMENT</type>
    <mods>
      <mod>
        <type>ONT::DIFFERENT</type>
        <value>DIFFERENT</value>
      </mod>
    </mods>
    <name>COMPARTMENT</name>
    <text>different cellular compartments [42]</text>
  </TERM>
  <TERM dbid="UP:P31749" end="244" id="V3291606" paragraph="paragraph27" rule="-SIMPLE-REF" start="236" uttnum="223">
    <type>ONT::PROTEIN</type>
    <name>AKT-1</name>
    <text>of AKT1</text>
  </TERM>
  <TERM dbid="UP:SL-0091|GO:0005829" end="260" id="V3291670" paragraph="paragraph27" rule="-SIMPLE-REF" start="247" uttnum="223">
    <type>ONT::CELL-PART</type>
    <name>CYTOSOL</name>
    <text>the cytosol,</text>
  </TERM>
  <TERM dbid="UP:P31751" end="288" id="V3291693" paragraph="paragraph27" rule="-SIMPLE-REF" start="264" uttnum="223">
    <type>ONT::PROTEIN</type>
    <name>AKT-2</name>
    <text>AKT2 in the mitochondria</text>
  </TERM>
  <TERM dbid="GO:0005739" end="288" id="V3291757" paragraph="paragraph27" rule="-SIMPLE-REF" start="272" uttnum="223">
    <type>ONT::CELL-PART</type>
    <name>MITOCHONDRIA</name>
    <text>the mitochondria</text>
  </TERM>
  <TERM dbid="UP:P31751" end="316" id="V3305347" paragraph="paragraph27" rule="-EXPLICIT-REF1" start="303" uttnum="224">
    <type>ONT::PROTEIN</type>
    <name>AKT-2</name>
    <assoc-with id="V3305342"/>
    <text>AKT2 protein</text>
  </TERM>
  <TERM dbid="UP:P31751" end="308" id="V3305342" paragraph="paragraph27" rule="-SIMPLE-REF" start="303" uttnum="224">
    <type>ONT::PROTEIN</type>
    <name>AKT-2</name>
    <text>AKT2</text>
  </TERM>
  <TERM dbid="UP:P31749" end="354" id="V3305487" paragraph="paragraph27" rule="-SIMPLE-REF" start="349" uttnum="224">
    <type>ONT::PROTEIN</type>
    <name>AKT-1</name>
    <text>AKT1</text>
  </TERM>
  <TERM dbid="EFO:0001203|CVCL:0031" end="363" id="V3305552" paragraph="paragraph27" rule="-SIMPLE-REF" start="357" uttnum="224">
    <type>ONT::CELL-LINE</type>
    <name>MCF-7</name>
    <text>MCF-7</text>
  </TERM>
  <TERM dbid="HGNC:6998|UP:O15553|HGNC:3319|UP:Q99607" end="372" id="V3305583" paragraph="paragraph27" rule="-SIMPLE-REF" start="367" uttnum="224">
    <type>ONT::GENE</type>
    <name>MEFS</name>
    <text>MEFs</text>
  </TERM>
  <TERM end="407" id="V3305670" paragraph="paragraph27" rule="-SIMPLE-REF" start="390" uttnum="224">
    <type>ONT::MUTATION</type>
    <mutation>
      <type>SUBSTITUTION</type>
      <pos>1</pos>
      <aa-from>
        <aa>
          <name>Serine</name>
          <code>S</code>
        </aa>
      </aa-from>
      <aa-to>
        <aa>
          <name>Alanine</name>
          <code>A</code>
        </aa>
      </aa-to>
    </mutation>
    <text normalization="">S1A</text>
  </TERM>
  <EVENT end="443" id="V3321037" paragraph="paragraph27" rule="-RULE20C_AGENT_AFFECTED-AFFECTED" start="416" uttnum="225">
    <type>ONT::BIND</type>
    <predicate end="443" id="V3321037" start="416">
      <type>ONT::BIND</type>
      <text>weak interaction with AKT2</text>
    </predicate>
    <arg2 id="V3321067" role=":AFFECTED"/>
    <text>weak interaction with AKT2</text>
  </EVENT>
  <TERM end="533" id="V3321143" paragraph="paragraph27" rule="-SIMPLE-REF" start="452" uttnum="225">
    <type>ONT::OUTCOME</type>
    <name>OUTCOME</name>
    <text>a combined outcome of differential cellular distribution and lower protein levels</text>
  </TERM>
  <TERM dbid="UP:P31751" end="443" id="V3321067" paragraph="paragraph27" rule="-SIMPLE-REF" start="433" uttnum="225">
    <type>ONT::PROTEIN</type>
    <name>AKT-2</name>
    <text>with AKT2</text>
  </TERM>
  <TERM end="533" id="V3321192" paragraph="paragraph27" rule="-SIMPLE-REF" start="513" uttnum="225">
    <type>ONT::PROTEIN</type>
    <name>PROTEIN</name>
    <text>lower protein levels</text>
  </TERM>
  <EPI end="674" id="V3337189" paragraph="paragraph27" rule="-RULE50_0_AGENT_FORMAL-FORMAL" start="564" uttnum="226">
    <type>ONT::SUPPORT</type>
    <force>ONT::TRUE</force>
    <arg2 id="V3337209" role=":FORMAL"/>
    <text>demonstrates significant tyrosine phosphorylation of AKT2 upon coexpression of Ack1 and AKT2 in HEK293T cells,</text>
  </EPI>
  <EVENT end="674" id="V3337209" paragraph="paragraph27" rule="-RULE50_0_AGENT_FORMAL-EVENT,-RULE60_AGENT_AFFECTED-A" start="564" uttnum="226">
    <type>ONT::PHOSPHORYLATION</type>
    <epistemic-modality id="V3337189"/>
    <predicate end="674" id="V3337209" start="564">
      <type>ONT::PHOSPHORYLATION</type>
      <text>demonstrates significant tyrosine phosphorylation of AKT2 upon coexpression of Ack1 and AKT2 in HEK293T cells,</text>
    </predicate>
    <arg2 id="V3337226" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000349"/>
    <site end="598" id="V3337206" start="589">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">tyrosine</text>
    </site>
    <text>demonstrates significant tyrosine phosphorylation of AKT2 upon coexpression of Ack1 and AKT2 in HEK293T cells,</text>
  </EVENT>
  <TERM end="598" id="V3337206" paragraph="paragraph27" rule="-SIMPLE-REF" start="589" uttnum="226">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>tyrosine</text>
  </TERM>
  <TERM dbid="UP:P31751" end="622" id="V3337226" paragraph="paragraph27" rule="-SIMPLE-REF" start="614" uttnum="226">
    <type>ONT::PROTEIN</type>
    <name>AKT-2</name>
    <text>of AKT2</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3337209"/>
    </not-features>
  </TERM>
  <EVENT end="674" id="V3337244" paragraph="paragraph27" rule="-RULE50_AGENT_AFFECTED-RESULT-AFFECTED-RESULT" start="627" uttnum="226">
    <type>ONT::EXPRESS</type>
    <predicate end="674" id="V3337244" start="627">
      <type>ONT::EXPRESS</type>
      <text>coexpression of Ack1 and AKT2 in HEK293T cells,</text>
    </predicate>
    <arg2 id="V3337275" role=":AFFECTED-RESULT"/>
    <text>coexpression of Ack1 and AKT2 in HEK293T cells,</text>
  </EVENT>
  <TERM end="657" id="V3337275" paragraph="paragraph27" rule="-LOGICALOP-REF" start="640" uttnum="226">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V3337271"/>
      <member id="V3337291"/>
    </aggregate>
    <text normalization="">of Ack1 and AKT2</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="648" id="V3337271" paragraph="paragraph27" rule="-SIMPLE-REF" start="643" uttnum="226">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="UP:P31751" end="657" id="V3337291" paragraph="paragraph27" rule="-SIMPLE-REF" start="652" uttnum="226">
    <type>ONT::PROTEIN</type>
    <name>AKT-2</name>
    <text>AKT2</text>
  </TERM>
  <TERM dbid="BTO:0002181" end="673" id="V3337396" paragraph="paragraph27" rule="-SIMPLE-REF" start="660" uttnum="226">
    <type>ONT::CELL-LINE</type>
    <name>HEK-293-T-CELLS</name>
    <text>HEK293T cells</text>
  </TERM>
  <TERM end="726" id="V3347766" paragraph="paragraph27" rule="-SIMPLE-REF" start="711" uttnum="226">
    <type>ONT::SUBSTANCE</type>
    <name>SUBSTRATES</name>
    <text>Ack1 substrates</text>
  </TERM>
  <TERM dbid="UP:P31749" end="701" id="V3347719" paragraph="paragraph27" rule="-SIMPLE-REF" start="696" uttnum="226">
    <type>ONT::PROTEIN</type>
    <name>AKT-1</name>
    <text>AKT1</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="716" id="V3347759" paragraph="paragraph27" rule="-SIMPLE-REF" start="711" uttnum="226">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <EVENT end="55" id="V3348804" paragraph="paragraph28" rule="-RULE60_AGENT_AFFECTED-LOC11-NONE" start="32" uttnum="227">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="55" id="V3348804" start="32">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr176-phosphorylation</text>
    </predicate>
    <site end="55" id="V3348798" start="32">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176-phosphorylation</text>
    </site>
    <text>Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="55" id="V3348798" paragraph="paragraph28" rule="-SIMPLE-REF" start="32" uttnum="227">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176-phosphorylation</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="86" id="V3348867" paragraph="paragraph28" rule="-SIMPLE-REF" start="73" uttnum="227">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>AKT membrane</text>
  </TERM>
  <TERM end="77" id="V3348862" paragraph="paragraph28" rule="-SIMPLE-REF" start="73" uttnum="227">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <EVENT end="140" id="V3348879" paragraph="paragraph28" rule="-RULE10C_AGENT_AFFECTED-AGENT" start="99" uttnum="227">
    <type>ONT::TRANSLOCATE</type>
    <force>ONT::TRUE</force>
    <predicate end="140" id="V3348879" start="99">
      <type>ONT::TRANSLOCATE</type>
      <text>followed by PDK1/PDK2 mediated activation</text>
    </predicate>
    <arg1 id="V3348916" role=":AGENT"/>
    <text>followed by PDK1/PDK2 mediated activation</text>
  </EVENT>
  <EVENT end="140" id="V3348916" paragraph="paragraph28" rule="-INEVENT2B,-RULE40A_AGENT_AFFECTED-NONE" start="108" uttnum="227">
    <type>ONT::ACTIVATE</type>
    <predicate end="140" id="V3348916" start="108">
      <type>ONT::ACTIVATE</type>
      <text>by PDK1/PDK2 mediated activation</text>
    </predicate>
    <text>by PDK1/PDK2 mediated activation</text>
  </EVENT>
  <EVENT end="140" id="V3348910" paragraph="paragraph28" rule="-RULE10_AGENT_AFFECTED" start="108" uttnum="227">
    <type>ONT::MODULATE</type>
    <force>ONT::TRUE</force>
    <predicate end="140" id="V3348910" start="108">
      <type>ONT::MODULATE</type>
      <text>by PDK1/PDK2 mediated activation</text>
    </predicate>
    <arg1 id="V3348926" role=":AGENT"/>
    <arg2 id="V3348916" role=":AFFECTED"/>
    <text>by PDK1/PDK2 mediated activation</text>
  </EVENT>
  <TERM end="130" id="V3348926" paragraph="paragraph28" rule="-SIMPLE-REF" start="111" uttnum="227">
    <type>ONT::GENE-PROTEIN</type>
    <name>PDK-1/PDK-2</name>
    <text>PDK1/PDK2 mediated</text>
  </TERM>
  <EVENT end="185" id="V3363319" paragraph="paragraph28" rule="-ACTIVITY1" start="151" uttnum="227">
    <type>ONT::ACTIVITY</type>
    <predicate end="185" id="V3363319" start="151">
      <type>ONT::ACTIVITY</type>
      <text>the upstream Ack1 kinase activity</text>
    </predicate>
    <arg1 id="V3363315" role=":AGENT"/>
    <text>the upstream Ack1 kinase activity</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="176" id="V3363315" paragraph="paragraph28" rule="-EXPLICIT-REF1" start="151" uttnum="227">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <assoc-with id="V3363310"/>
    <text>the upstream Ack1 kinase</text>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="169" id="V3363310" paragraph="paragraph28" rule="-SIMPLE-REF" start="164" uttnum="227">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="UP:Q15120|HGNC:8811" end="193" id="V3363369" paragraph="paragraph28" rule="-SIMPLE-REF" start="189" uttnum="227">
    <type>ONT::GENE</type>
    <name>PDK-3</name>
    <text>PDK3</text>
  </TERM>
  <TERM end="199" id="V3370993" paragraph="paragraph28" rule="-ROBUSTPRO" start="196" uttnum="228">
    <type>ONT::PERSON</type>
    <text>We</text>
  </TERM>
  <TERM end="259" id="V3371122" paragraph="paragraph28" rule="-EXPLICIT-REF1" start="236" uttnum="228">
    <type>ONT::PROTEIN</type>
    <name>TYROSINE</name>
    <assoc-with id="V3371115"/>
    <text>other tyrosine kinases</text>
  </TERM>
  <TERM end="251" id="V3371115" paragraph="paragraph28" rule="-SIMPLE-REF" start="242" uttnum="228">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>tyrosine</text>
  </TERM>
  <TERM end="285" id="V3371194" paragraph="paragraph28" rule="-SIMPLE-REF" start="281" uttnum="228">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <EVENT end="311" id="V3371236" paragraph="paragraph28" rule="-RULE60_AGENT_AFFECTED-LOC13-AFFECTED" start="289" uttnum="228">
    <type>ONT::PHOSPHORYLATION</type>
    <predicate end="311" id="V3371236" start="289">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr176-phosphorylation</text>
    </predicate>
    <site end="295" id="V3371230" start="289">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176</text>
    </site>
    <text>Tyr176-phosphorylation</text>
  </EVENT>
  <TERM end="295" id="V3371230" paragraph="paragraph28" rule="-SIMPLE-REF" start="289" uttnum="228">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <TERM dbid="UP:P31944|UP:O89094|XFAM:PF00656|HGNC:1502" end="332" id="V3386748" paragraph="paragraph28" rule="-SIMPLE-REF" start="313" uttnum="229">
    <type>ONT::GENE-PROTEIN</type>
    <name>MICE</name>
    <text>Ack1 knockout mice</text>
  </TERM>
  <EVENT end="332" id="V3386739" paragraph="paragraph28" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="313" uttnum="229">
    <type>ONT::TRANSFORM</type>
    <predicate end="332" id="V3386739" start="313">
      <type>ONT::TRANSFORM</type>
      <text>Ack1 knockout mice</text>
    </predicate>
    <arg2 id="V3386733" role=":AFFECTED"/>
    <text>Ack1 knockout mice</text>
  </EVENT>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="318" id="V3386733" paragraph="paragraph28" rule="-SIMPLE-REF" start="313" uttnum="229">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
  </TERM>
  <TERM dbid="GO:0016301" end="400" id="V3387510" paragraph="paragraph28" rule="-SIMPLE-REF" start="395" uttnum="230">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>they</text>
  </TERM>
  <TERM end="415" id="V3387529" paragraph="paragraph28" rule="-ROBUSTPRO" start="412" uttnum="230">
    <type>ONT::PERSON</type>
    <text>us</text>
  </TERM>
  <TERM dbid="GO:0016301" end="380" id="V3387478" paragraph="paragraph28" rule="-SIMPLE-REF" start="375" uttnum="230">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>they</text>
  </TERM>
  <EVENT end="393" id="V3387500" paragraph="paragraph28" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="375" uttnum="230">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="393" id="V3387500" start="375">
      <type>ONT::INCREASE</type>
      <text>they are developed</text>
    </predicate>
    <arg2 id="V3387478" role=":AFFECTED"/>
    <text>they are developed</text>
  </EVENT>
  <EVENT end="492" id="V3387600" paragraph="paragraph28" rule="-RULE60_AGENT_AFFECTED-LOC4-GD" start="438" uttnum="230">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::POSSIBLE</force>
    <modality>ONT::CAN</modality>
    <predicate end="492" id="V3387600" start="438">
      <type>ONT::PHOSPHORYLATION</type>
      <text>AKT can be phosphorylated at Tyr176 by other receptor</text>
    </predicate>
    <arg1 id="V3387660" role=":AGENT"/>
    <arg2 id="V3387567" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000354"/>
    <site end="474" id="V3387628" start="467">
      <type>ONT::MOLECULAR-SITE</type>
      <text normalization="">Tyr176</text>
    </site>
    <text>AKT can be phosphorylated at Tyr176 by other receptor</text>
  </EVENT>
  <TERM end="442" id="V3387567" paragraph="paragraph28" rule="-SIMPLE-REF" start="438" uttnum="230">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3387600"/>
    </not-features>
  </TERM>
  <TERM dbid="GO:0004872" end="492" id="V3387660" paragraph="paragraph28" rule="-SIMPLE-REF" start="474" uttnum="230">
    <type>ONT::PROTEIN</type>
    <name>RECEPTOR</name>
    <text>by other receptor</text>
  </TERM>
  <TERM end="474" id="V3387628" paragraph="paragraph28" rule="-SIMPLE-REF" start="467" uttnum="230">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <TERM end="554" id="V3387700" paragraph="paragraph28" rule="-EXPLICIT-REF1" start="508" uttnum="230">
    <type>ONT::PROTEIN</type>
    <name>TYROSINE</name>
    <assoc-with id="V3387693"/>
    <text>tyrosine kinases in response to growth factors</text>
  </TERM>
  <TERM end="517" id="V3387693" paragraph="paragraph28" rule="-SIMPLE-REF" start="508" uttnum="230">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>tyrosine</text>
  </TERM>
  <TERM dbid="GO:0070848" end="554" id="V3387817" paragraph="paragraph28" rule="-SIMPLE-REF" start="528" uttnum="230">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>RESPONSE-TO-GROWTH-FACTORS</name>
    <text>response to growth factors</text>
  </TERM>
  <TERM end="626" id="V3402871" paragraph="paragraph28" rule="-SIMPLE-REF" start="556" uttnum="231">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>Multiple non-receptor tyrosine kinases were earlier shown to increase</text>
  </TERM>
  <EVENT end="626" id="V3402957" paragraph="paragraph28" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="556" uttnum="231">
    <type>ONT::INCREASE</type>
    <force>ONT::TRUE</force>
    <predicate end="626" id="V3402957" start="556">
      <type>ONT::INCREASE</type>
      <text>Multiple non-receptor tyrosine kinases were earlier shown to increase</text>
    </predicate>
    <arg2 id="V3402871" role=":AFFECTED"/>
    <text>Multiple non-receptor tyrosine kinases were earlier shown to increase</text>
  </EVENT>
  <TERM dbid="GO:0016301" end="595" id="V3402878" paragraph="paragraph28" rule="-SIMPLE-REF" start="587" uttnum="231">
    <type>ONT::PROTEIN</type>
    <name>KINASES</name>
    <text>kinases</text>
  </TERM>
  <EVENT end="675" id="V3402970" paragraph="paragraph28" rule="-ACTIVITY1" start="626" uttnum="231">
    <type>ONT::ACTIVITY</type>
    <predicate end="675" id="V3402970" start="626">
      <type>ONT::ACTIVITY</type>
      <text>AKT activity [43], [44]</text>
    </predicate>
    <arg1 id="V3402966" role=":AGENT"/>
    <text>AKT activity [43], [44]</text>
  </EVENT>
  <TERM end="630" id="V3402966" paragraph="paragraph28" rule="-SIMPLE-REF" start="626" uttnum="231">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="704" id="V3416454" paragraph="paragraph28" rule="-SIMPLE-REF" start="686" uttnum="231">
    <type>ONT::DEVICE</type>
    <name>MECHANISM</name>
    <text>precise mechanism</text>
  </TERM>
  <EVENT end="754" id="V3416469" paragraph="paragraph28" rule="-RULE40A_AGENT_AFFECTED" start="707" uttnum="231">
    <type>ONT::ACTIVATE</type>
    <predicate end="754" id="V3416469" start="707">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation by any of the Tyr-modifications</text>
    </predicate>
    <arg1 id="V3416788" role=":AGENT"/>
    <arg2 id="V3416466" role=":AFFECTED"/>
    <arg id="R000544" role=":RESULT"/>
    <text>AKT activation by any of the Tyr-modifications</text>
  </EVENT>
  <TERM end="711" id="V3416466" paragraph="paragraph28" rule="-SIMPLE-REF" start="707" uttnum="231">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT end="754" id="V3416788" paragraph="paragraph28" rule="-RULE10_AGENT_AFFECTED-NONE" start="722" uttnum="231">
    <type>ONT::MODULATE</type>
    <predicate end="754" id="V3416788" start="722">
      <type>ONT::MODULATE</type>
      <text>by any of the Tyr-modifications</text>
    </predicate>
    <text>by any of the Tyr-modifications</text>
  </EVENT>
  <TERM end="754" id="V3416519" paragraph="paragraph28" rule="-SIMPLE-REF" start="729" uttnum="231">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>of the Tyr-modifications</text>
  </TERM>
  <TERM end="856" id="V3429879" paragraph="paragraph28" rule="-SIMPLE-REF" start="844" uttnum="232">
    <type>ONT::DOCUMENT</type>
    <name>REPORT</name>
    <text>this report</text>
  </TERM>
  <TERM end="842" id="V3429854" paragraph="paragraph28" rule="-SIMPLE-REF" start="829" uttnum="232">
    <type>ONT::MENTAL-OBJECT</type>
    <name>KNOWLEDGE</name>
    <text>our knowledge</text>
  </TERM>
  <TERM end="842" id="V3429842" paragraph="paragraph28" rule="-ROBUSTPRO" start="829" uttnum="232">
    <type>ONT::PERSON</type>
    <text>our knowledge</text>
  </TERM>
  <TERM end="954" id="V3430022" paragraph="paragraph28" rule="-INEVENT2B,-SIMPLE-REF" start="903" uttnum="232">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr-phosphorylated AKT in its compartmentalization,</text>
    <features>
      <ptm event="V3430012" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT end="954" id="V3430012" paragraph="paragraph28" rule="-RULE60_AGENT_AFFECTED-A" start="903" uttnum="232">
    <type>ONT::PHOSPHORYLATION</type>
    <force>ONT::TRUE</force>
    <predicate end="954" id="V3430012" start="903">
      <type>ONT::PHOSPHORYLATION</type>
      <text>Tyr-phosphorylated AKT in its compartmentalization,</text>
    </predicate>
    <arg2 id="V3430022" role=":RESULT"/>
    <arg role=":AFFECTED" id="R000027"/>
    <site end="922" id="V3430004" start="903">
      <type>ONT::AMINO-ACID</type>
      <text normalization="">Tyr-phosphorylated</text>
    </site>
    <text>Tyr-phosphorylated AKT in its compartmentalization,</text>
  </EVENT>
  <TERM end="922" id="V3430004" paragraph="paragraph28" rule="-SIMPLE-REF" start="903" uttnum="232">
    <type>ONT::AMINO-ACID</type>
    <name>TYR</name>
    <text>Tyr-phosphorylated</text>
  </TERM>
  <TERM end="972" id="V3439079" paragraph="paragraph28" rule="-ROBUSTPRO" start="969" uttnum="232">
    <type>ONT::PERSON</type>
    <text>us</text>
  </TERM>
  <EVENT end="1029" id="V3439201" paragraph="paragraph28" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1006" uttnum="232">
    <type>ONT::ACTIVATE</type>
    <predicate end="1029" id="V3439201" start="1006">
      <type>ONT::ACTIVATE</type>
      <text>AKT kinase activation,</text>
    </predicate>
    <arg2 id="V3439197" role=":AFFECTED"/>
    <arg id="R000549" role=":RESULT"/>
    <text>AKT kinase activation,</text>
  </EVENT>
  <TERM end="1017" id="V3439197" paragraph="paragraph28" rule="-EXPLICIT-REF1" start="1006" uttnum="232">
    <type>ONT::PROTEIN</type>
    <name>AKT</name>
    <assoc-with id="V3439192"/>
    <text>AKT kinase</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM end="1010" id="V3439192" paragraph="paragraph28" rule="-SIMPLE-REF" start="1006" uttnum="232">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1084" id="V3439305" paragraph="paragraph28" rule="-SIMPLE-REF" start="1068" uttnum="232">
    <type>ONT::EXTERNAL-BODY-PART</type>
    <name>PROSTATE</name>
    <text>mouse prostates</text>
  </TERM>
  <TERM end="1084" id="V3439301" paragraph="paragraph28" rule="-SIMPLE-REF" start="1068" uttnum="232">
    <type>ONT::COMPUTER-INPUT-DEVICE</type>
    <name>MOUSE</name>
    <text>mouse prostates</text>
  </TERM>
  <EVENT end="1296" id="V3453292" paragraph="paragraph28" rule="-RULE5_AGENT_AFFECTED-AFFECTED" start="1177" uttnum="233">
    <type>ONT::TRANSFORM</type>
    <predicate end="1296" id="V3453292" start="1177">
      <type>ONT::TRANSFORM</type>
      <text>upon AKT activation for survival and growth making it an attractive target for molecular therapeutics [45]</text>
    </predicate>
    <arg2 id="V3453304" role=":AFFECTED"/>
    <text>upon AKT activation for survival and growth making it an attractive target for molecular therapeutics [45]</text>
  </EVENT>
  <TERM end="1231" id="V3453304" paragraph="paragraph28" rule="-SIMPLE-REF" start="1228" uttnum="233">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">it</text>
  </TERM>
  <TERM end="1252" id="V3453335" paragraph="paragraph28" rule="-SIMPLE-REF" start="1231" uttnum="233">
    <type>ONT::GOAL</type>
    <name>TARGET</name>
    <text>an attractive target</text>
  </TERM>
  <EVENT end="1221" id="V3453233" paragraph="paragraph28" rule="-RULE40A_AGENT_AFFECTED-AFFECTED" start="1182" uttnum="233">
    <type>ONT::ACTIVATE</type>
    <predicate end="1221" id="V3453233" start="1182">
      <type>ONT::ACTIVATE</type>
      <text>AKT activation for survival and growth</text>
    </predicate>
    <arg2 id="V3453230" role=":AFFECTED"/>
    <arg role=":RESULT" id="R000554"/>
    <text>AKT activation for survival and growth</text>
  </EVENT>
  <TERM end="1186" id="V3453230" paragraph="paragraph28" rule="-SIMPLE-REF" start="1182" uttnum="233">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <TERM dbid="GO:0040007" end="1221" id="V3453285" paragraph="paragraph28" rule="-SIMPLE-REF" start="1214" uttnum="233">
    <type>ONT::BIOLOGICAL-PROCESS</type>
    <name>GROWTH</name>
    <text>growth</text>
  </TERM>
  <TERM end="1359" id="V3465471" paragraph="paragraph28" rule="-SIMPLE-REF" start="1298" uttnum="234">
    <type>ONT::MENTAL-OBJECT</type>
    <name>ASSAY</name>
    <text>The assay that was used during development of AKT inhibitors</text>
  </TERM>
  <TERM end="1313" id="V3465488" paragraph="paragraph28" rule="-SIMPLE-REF" start="1308" uttnum="234">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">that</text>
  </TERM>
  <EVENT end="1359" id="V3465528" paragraph="paragraph28" rule="-RULE20_AGENT_AFFECTED-AFFECTED" start="1329" uttnum="234">
    <type>ONT::INCREASE</type>
    <predicate end="1359" id="V3465528" start="1329">
      <type>ONT::INCREASE</type>
      <text>development of AKT inhibitors</text>
    </predicate>
    <arg2 id="V3465549" role=":AFFECTED"/>
    <text>development of AKT inhibitors</text>
  </EVENT>
  <TERM dbid="CHEBI:35222" end="1359" id="V3465549" paragraph="paragraph28" rule="-SIMPLE-REF" start="1341" uttnum="234">
    <type>ONT::CHEMICAL</type>
    <name>INHIBITORS</name>
    <text>of AKT inhibitors</text>
  </TERM>
  <TERM end="1348" id="V3465544" paragraph="paragraph28" rule="-SIMPLE-REF" start="1344" uttnum="234">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1408" id="V3465607" paragraph="paragraph28" rule="-SIMPLE-REF" start="1382" uttnum="234">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT Ser473-phosphorylation</text>
  </TERM>
  <TERM end="1392" id="V3465617" paragraph="paragraph28" rule="-SIMPLE-REF" start="1386" uttnum="234">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Serine</name>
        <code>S</code>
        <pos>473</pos>
      </site>
    </features>
    <name>SER-473</name>
    <text>Ser473</text>
  </TERM>
  <TERM end="1419" id="V3477680" paragraph="paragraph28" rule="-SIMPLE-REF" start="1410" uttnum="235">
    <type>ONT::INFORMATION</type>
    <name>DATA</name>
    <text>Our data</text>
  </TERM>
  <TERM end="1419" id="V3477676" paragraph="paragraph28" rule="-ROBUSTPRO" start="1410" uttnum="235">
    <type>ONT::PERSON</type>
    <text>Our data</text>
  </TERM>
  <TERM dbid="CHEBI:35222" end="1464" id="V3477769" paragraph="paragraph28" rule="-SIMPLE-REF" start="1446" uttnum="235">
    <type>ONT::CHEMICAL</type>
    <name>INHIBITORS</name>
    <text>of AKT inhibitors</text>
  </TERM>
  <TERM end="1453" id="V3477764" paragraph="paragraph28" rule="-SIMPLE-REF" start="1449" uttnum="235">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1517" id="V3477845" paragraph="paragraph28" rule="-SIMPLE-REF" start="1491" uttnum="235">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT Tyr176-phosphorylation</text>
  </TERM>
  <TERM end="1501" id="V3477855" paragraph="paragraph28" rule="-SIMPLE-REF" start="1495" uttnum="235">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>TYR-176</name>
    <text>Tyr176</text>
  </TERM>
  <TERM end="1525" id="V3492957" paragraph="paragraph28" rule="-ROBUSTPRO" start="1519" uttnum="236">
    <type>ONT::REFERENTIAL-SEM</type>
    <text>These</text>
  </TERM>
  <TERM dbid="CHEBI:35222" end="1542" id="V3492966" paragraph="paragraph28" rule="-SIMPLE-REF" start="1525" uttnum="236">
    <type>ONT::CHEMICAL</type>
    <name>INHIBITORS</name>
    <text>novel inhibitors</text>
  </TERM>
  <TERM dbid="GO:0016020|UP:SL-0162" end="1566" id="V3492999" paragraph="paragraph28" rule="-SIMPLE-REF" start="1553" uttnum="236">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>AKT membrane</text>
  </TERM>
  <TERM end="1557" id="V3492994" paragraph="paragraph28" rule="-SIMPLE-REF" start="1553" uttnum="236">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
  </TERM>
  <TERM end="1624" id="V3493055" paragraph="paragraph28" rule="-SIMPLE-REF" start="1605" uttnum="236">
    <type>ONT::MENTAL-OBJECT</type>
    <name>IMPLICATIONS</name>
    <text>major implications</text>
  </TERM>
  <EVENT paragraph="paragraph1" start="590" rule="EKR:LocateTerm" id="R000001" end="649" refid="V86138" uttnum="5">
    <type>ONT::LOCALIZATION</type>
    <text>Tyr176-phosphorylated AKT localizes to the plasma membrane </text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg role=":NEUTRAL" id="V86138"/>
    <location id="V86196"/>
  </EVENT>
  <EVENT uttnum="10" refid="V182741" id="R000002" end="536" rule="EKR:LocateTerm" start="501" paragraph="paragraph2">
    <text>the mTORC2 complex &lt;xref&gt;[9]&lt;/xref&gt;</text>
    <type>ONT::LOCALIZATION</type>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V182741" role=":NEUTRAL"/>
    <location id="V182725"/>
  </EVENT>
  <EVENT rule="EKR:LocateTerm" start="20" paragraph="paragraph5" uttnum="42" refid="V646107" end="59" id="R000003">
    <text>RWPE, normal prostate epithelial cells </text>
    <type>ONT::LOCALIZATION</type>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V646107" role=":NEUTRAL"/>
    <location id="V646091"/>
  </EVENT>
  <EVENT refid="V1049422" end="781" id="R000004" uttnum="78" paragraph="paragraph8" start="710" rule="EKR:LocateTerm">
    <text>of the prostate lateral lobe from a 22 wk old WT mouse (&lt;bold&gt;D&lt;/bold&gt;)</text>
    <type>ONT::LOCALIZATION</type>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V1049422" role=":NEUTRAL"/>
    <location id="V1049413"/>
  </EVENT>
  <EVENT start="468" rule="EKR:LocateTerm" paragraph="paragraph10" uttnum="93" refid="V1270962" end="493" id="R000005">
    <type>ONT::LOCALIZATION</type>
    <text>mouse embryo fibroblasts </text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V1270962" role=":NEUTRAL"/>
    <location id="V1270940"/>
  </EVENT>
  <EVENT start="514" rule="EKR:LocateTerm" paragraph="paragraph16" uttnum="136" id="R000006" end="540" refid="V1970510">
    <type>ONT::LOCALIZATION</type>
    <text>AKT at the plasma membrane</text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V1970510" role=":NEUTRAL"/>
    <location id="V1970554"/>
  </EVENT>
  <EVENT rule="EKR:LocateTerm" start="992" paragraph="paragraph16" uttnum="139" end="1024" id="R000007" refid="V2009416">
    <text>Normal prostate epithelial cells</text>
    <type>ONT::LOCALIZATION</type>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg role=":NEUTRAL" id="V2009416"/>
    <location id="V2009400"/>
  </EVENT>
  <EVENT rule="EKR:LocateTerm" start="1395" paragraph="paragraph17" uttnum="157" id="R000008" end="1426" refid="V2277115">
    <text>another membrane phospholipid, </text>
    <type>ONT::LOCALIZATION</type>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg role=":NEUTRAL" id="V2277115"/>
    <location id="V2277110"/>
  </EVENT>
  <EVENT end="697" id="R000009" refid="V2560767" uttnum="175" paragraph="paragraph20" rule="EKR:LocateTerm" start="662">
    <text>The prostate epithelium of TG mice </text>
    <type>ONT::LOCALIZATION</type>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V2560767" role=":NEUTRAL"/>
    <location id="V2560763"/>
  </EVENT>
  <EVENT paragraph="paragraph22" rule="EKR:LocateTerm" start="315" refid="V2901108" end="361" id="R000010" uttnum="195">
    <type>ONT::LOCALIZATION</type>
    <text>to the anionic plasma membrane phospholipid PA</text>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V2901108" role=":NEUTRAL"/>
    <location id="V2901094"/>
  </EVENT>
  <EVENT paragraph="paragraph25" start="1008" rule="EKR:LocateTerm" refid="V3153553" id="R000011" end="1043" uttnum="215">
    <text>PA, a plasma membrane phospholipid </text>
    <type>ONT::LOCALIZATION</type>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg id="V3153553" role=":NEUTRAL"/>
    <location id="V3153547"/>
  </EVENT>
  <EVENT refid="V3228895" end="99" id="R000012" uttnum="219" paragraph="paragraph26" rule="EKR:LocateTerm" start="54">
    <text>the plasma membrane anionic phospholipid, PA </text>
    <type>ONT::LOCALIZATION</type>
    <predicate>
      <type>ONT::LOCALIZATION</type>
    </predicate>
    <predicate>
      <type>ONT::BE-AT-LOC</type>
    </predicate>
    <arg role=":NEUTRAL" id="V3228895"/>
    <location id="V3228868"/>
  </EVENT>
  <TERM end="649" paragraph="paragraph1" start="590" uttnum="5" id="R000013" refid="V86138" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <features>
      <location id="V86196"/>
    </features>
    <name>AKT</name>
    <text normalization="">Tyr176-phosphorylated AKT localizes to the plasma membrane</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V86128"/>
    </not-features>
  </TERM>
  <TERM end="934" paragraph="paragraph1" start="908" uttnum="7" id="R000014" refid="V117380" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr176-phosphorylated-AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V117372"/>
    </not-features>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="965" paragraph="paragraph1" start="938" uttnum="7" id="R000015" refid="V117426" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <text>Tyr284-phosphorylated-Ack1</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V117413"/>
    </not-features>
  </TERM>
  <TERM end="630" paragraph="paragraph4" start="597" uttnum="31" id="R000016" refid="V478233" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">HA-tagged Tyr-phosphorylated AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V478220"/>
    </not-features>
  </TERM>
  <TERM end="721" paragraph="paragraph16" start="695" uttnum="137" id="R000017" refid="V1983911" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr176-phosphorylated AKT</text>
    <not-features>
      <ptm event="V1983901" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="1324" paragraph="paragraph16" start="1300" uttnum="141" id="R000018" refid="V2040766" rule="EKR:InEventPTM">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Tyrosine</name>
        <code>Y</code>
        <pos>176</pos>
      </site>
    </features>
    <name>Y-176</name>
    <text>phosphoAKT-Y176-peptide</text>
    <not-features>
      <ptm event="V2040737" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="1381" paragraph="paragraph16" start="1352" uttnum="141" id="R000019" refid="V2040910" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">to Tyr176-phosphorylated AKT</text>
    <not-features>
      <ptm event="V2040900" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM dbid="UP:Q9Y243" end="2392" paragraph="paragraph16" start="2369" uttnum="146" id="R000020" refid="V2126338" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN</type>
    <name>AKT-3</name>
    <text>Tyr-phosphorylated AKT3</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2126320"/>
    </not-features>
  </TERM>
  <TERM end="945" paragraph="paragraph17" start="922" uttnum="155" id="R000021" refid="V2249390" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr-phosphorylated AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2249377"/>
    </not-features>
  </TERM>
  <TERM end="1389" paragraph="paragraph17" start="1366" uttnum="157" id="R000022" refid="V2277079" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr-phosphorylated AKT</text>
    <not-features>
      <ptm event="V2277066" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="709" paragraph="paragraph19" start="690" uttnum="169" id="R000023" refid="V2481773" rule="EKR:InEventPTM">
    <type>ONT::MOLECULAR-SITE</type>
    <features>
      <site>
        <name>Histidine</name>
        <code>H</code>
        <pos>3</pos>
      </site>
    </features>
    <name>H-3</name>
    <text>phospho-H3 (Ser10)</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2481746"/>
    </not-features>
  </TERM>
  <TERM end="937" paragraph="paragraph25" start="908" uttnum="214" id="R000024" refid="V3152032" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Tyr176-phosphorylated AKT</text>
    <not-features>
      <ptm event="V3152022" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="987" paragraph="paragraph25" start="961" uttnum="215" id="R000025" refid="V3153455" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr176-phosphorylated AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3153445"/>
    </not-features>
  </TERM>
  <TERM end="1258" paragraph="paragraph25" start="1230" uttnum="216" id="R000026" refid="V3169061" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Tyr176-phosphorylated AKT</text>
    <not-features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3169051"/>
    </not-features>
  </TERM>
  <TERM end="954" paragraph="paragraph28" start="903" uttnum="232" id="R000027" refid="V3430022" rule="EKR:InEventPTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr-phosphorylated AKT in its compartmentalization,</text>
    <not-features>
      <ptm event="V3430012" type="ONT::PHOSPHORYLATION"/>
    </not-features>
  </TERM>
  <TERM end="1364" paragraph="paragraph17" start="1344" uttnum="157" id="R000028" refid="V2277007" rule="EKR:InEventBind">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT which bound PIP3</text>
    <not-features>
      <bound-to event="V2277027" id="V2277050"/>
    </not-features>
  </TERM>
  <TERM dbid="CHEBI:16618" end="1364" paragraph="paragraph17" start="1360" uttnum="157" id="R000029" refid="V2277050" rule="EKR:InEventBind">
    <type>ONT::MOLECULE</type>
    <name>PIP-3</name>
    <text>PIP3</text>
    <features>
      <bound-to id="V2277007" event="V2277027"/>
    </features>
  </TERM>
  <TERM rule="EKR:InEventBind" start="1344" paragraph="paragraph17" uttnum="157" end="1364" id="R000030" refid="V2277027,V2277007,R000029">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>AKT which bound PIP3</text>
    <name>AKT/PIP-3</name>
    <components>
      <component id="V2277007"/>
      <component id="R000029"/>
    </components>
  </TERM>
  <EVENT rule="EKR:InEventBind" start="1344" paragraph="paragraph17" uttnum="157" id="R000031" end="1364" refid="V2277027">
    <type>ONT::INCREASE</type>
    <text>AKT which bound PIP3</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000030" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="157" refid="V2277027" id="R000032" end="1364" start="1344" rule="EKR:InEventBind" paragraph="paragraph17">
    <text>AKT which bound PIP3</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2277027" role=":FACTOR"/>
    <arg id="R000031" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="157" refid="V2277027" id="R000033" end="1364" rule="EKR:InEventBind" start="1344" paragraph="paragraph17">
    <text>AKT which bound PIP3</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000028" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V2277027" end="1364" id="R000034" uttnum="157" paragraph="paragraph17" start="1344" rule="EKR:InEventBind">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT which bound PIP3</text>
    <arg role=":FACTOR" id="V2277027"/>
    <arg role=":OUTCOME" id="R000033"/>
  </CC>
  <EVENT uttnum="157" refid="V2277027" end="1364" id="R000035" start="1344" rule="EKR:InEventBind" paragraph="paragraph17">
    <type>ONT::DECREASE</type>
    <text>AKT which bound PIP3</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2277050" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph17" rule="EKR:InEventBind" start="1344" end="1364" id="R000036" refid="V2277027" uttnum="157">
    <text>AKT which bound PIP3</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2277027"/>
    <arg id="R000035" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="750" paragraph="paragraph1" start="735" uttnum="6" id="R000037" refid="V103138" rule="EKR:IneventActivate">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph1" start="735" rule="EKR:IneventActivate" id="R000038" end="750" refid="V103126" uttnum="6">
    <type>ONT::INCREASE</type>
    <text>activated Ack1 </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V103138"/>
  </EVENT>
  <CC uttnum="6" refid="V103126" end="750" id="R000039" rule="EKR:IneventActivate" start="735" paragraph="paragraph1">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activated Ack1 </text>
    <arg role=":FACTOR" id="V103126"/>
    <arg id="R000038" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph1" start="735" rule="EKR:IneventActivate" end="750" id="R000040" refid="V103126" uttnum="6">
    <text>activated Ack1 </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000037"/>
  </EVENT>
  <CC paragraph="paragraph1" rule="EKR:IneventActivate" start="735" refid="V103126" id="R000041" end="750" uttnum="6">
    <text>activated Ack1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V103126"/>
    <arg id="R000040" role=":OUTCOME"/>
  </CC>
  <TERM end="1651" paragraph="paragraph2" start="1620" uttnum="17" id="R000042" refid="V293013" rule="EKR:IneventActivate">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">activated AKT [15]</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph2" start="1620" rule="EKR:IneventActivate" id="R000043" end="1651" refid="V293007" uttnum="17">
    <type>ONT::INCREASE</type>
    <text>activated AKT &lt;xref&gt;[15]&lt;/xref&gt;</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V293013"/>
  </EVENT>
  <CC uttnum="17" end="1651" id="R000044" refid="V293007" start="1620" rule="EKR:IneventActivate" paragraph="paragraph2">
    <text>activated AKT &lt;xref&gt;[15]&lt;/xref&gt;</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V293007" role=":FACTOR"/>
    <arg id="R000043" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V293007" id="R000045" end="1651" uttnum="17" paragraph="paragraph2" start="1620" rule="EKR:IneventActivate">
    <type>ONT::DECREASE</type>
    <text>activated AKT &lt;xref&gt;[15]&lt;/xref&gt;</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000042" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:IneventActivate" start="1620" paragraph="paragraph2" uttnum="17" id="R000046" end="1651" refid="V293007">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activated AKT &lt;xref&gt;[15]&lt;/xref&gt;</text>
    <arg id="V293007" role=":FACTOR"/>
    <arg id="R000045" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="231" paragraph="paragraph13" start="216" uttnum="112" id="R000047" refid="V1591313" rule="EKR:IneventActivate">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT start="216" rule="EKR:IneventActivate" paragraph="paragraph13" uttnum="112" id="R000048" end="231" refid="V1591301">
    <type>ONT::INCREASE</type>
    <text>activated Ack1 </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V1591313" role=":AFFECTED"/>
  </EVENT>
  <CC end="231" id="R000049" refid="V1591301" uttnum="112" paragraph="paragraph13" start="216" rule="EKR:IneventActivate">
    <text>activated Ack1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1591301"/>
    <arg role=":OUTCOME" id="R000048"/>
  </CC>
  <EVENT paragraph="paragraph13" start="216" rule="EKR:IneventActivate" end="231" id="R000050" refid="V1591301" uttnum="112">
    <type>ONT::DECREASE</type>
    <text>activated Ack1 </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000047"/>
  </EVENT>
  <CC id="R000051" end="231" refid="V1591301" uttnum="112" paragraph="paragraph13" rule="EKR:IneventActivate" start="216">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activated Ack1 </text>
    <arg role=":FACTOR" id="V1591301"/>
    <arg role=":OUTCOME" id="R000050"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="710" paragraph="paragraph13" start="691" uttnum="114" id="R000052" refid="V1628112" rule="EKR:IneventActivate">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>with activated Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:IneventActivate" start="691" paragraph="paragraph13" uttnum="114" id="R000053" end="710" refid="V1628101">
    <type>ONT::INCREASE</type>
    <text>with activated Ack1</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V1628112" role=":AFFECTED"/>
  </EVENT>
  <CC end="710" id="R000054" refid="V1628101" uttnum="114" paragraph="paragraph13" rule="EKR:IneventActivate" start="691">
    <text>with activated Ack1</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1628101"/>
    <arg id="R000053" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph13" start="691" rule="EKR:IneventActivate" refid="V1628101" id="R000055" end="710" uttnum="114">
    <type>ONT::DECREASE</type>
    <text>with activated Ack1</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000052"/>
  </EVENT>
  <CC id="R000056" end="710" refid="V1628101" uttnum="114" paragraph="paragraph13" start="691" rule="EKR:IneventActivate">
    <text>with activated Ack1</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1628101"/>
    <arg id="R000055" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1124" paragraph="paragraph15" start="1107" uttnum="129" id="R000057" refid="V1860784" rule="EKR:IneventActivate">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>of activated Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph15" rule="EKR:IneventActivate" start="1107" id="R000058" end="1124" refid="V1860772" uttnum="129">
    <type>ONT::INCREASE</type>
    <text>of activated Ack1</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V1860784" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph15" start="1107" rule="EKR:IneventActivate" end="1124" id="R000059" refid="V1860772" uttnum="129">
    <type>ONT::CAUSE-EFFECT</type>
    <text>of activated Ack1</text>
    <arg role=":FACTOR" id="V1860772"/>
    <arg id="R000058" role=":OUTCOME"/>
  </CC>
  <EVENT start="1107" rule="EKR:IneventActivate" paragraph="paragraph15" uttnum="129" id="R000060" end="1124" refid="V1860772">
    <text>of activated Ack1</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000057" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph15" start="1107" rule="EKR:IneventActivate" refid="V1860772" id="R000061" end="1124" uttnum="129">
    <type>ONT::CAUSE-EFFECT</type>
    <text>of activated Ack1</text>
    <arg id="V1860772" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000060"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="271" paragraph="paragraph16" start="256" uttnum="134" id="R000062" refid="V1938965" rule="EKR:IneventActivate">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT start="256" rule="EKR:IneventActivate" paragraph="paragraph16" uttnum="134" refid="V1938953" end="271" id="R000063">
    <text>activated Ack1 </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1938965"/>
  </EVENT>
  <CC start="256" rule="EKR:IneventActivate" paragraph="paragraph16" uttnum="134" refid="V1938953" end="271" id="R000064">
    <text>activated Ack1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1938953"/>
    <arg id="R000063" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="134" refid="V1938953" id="R000065" end="271" start="256" rule="EKR:IneventActivate" paragraph="paragraph16">
    <type>ONT::DECREASE</type>
    <text>activated Ack1 </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000062"/>
  </EVENT>
  <CC start="256" rule="EKR:IneventActivate" paragraph="paragraph16" uttnum="134" refid="V1938953" id="R000066" end="271">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activated Ack1 </text>
    <arg role=":FACTOR" id="V1938953"/>
    <arg id="R000065" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="501" paragraph="paragraph16" start="486" uttnum="136" id="R000067" refid="V1970493" rule="EKR:IneventActivate">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT uttnum="136" end="501" id="R000068" refid="V1970481" rule="EKR:IneventActivate" start="486" paragraph="paragraph16">
    <text>activated Ack1 </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V1970493" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="136" refid="V1970481" end="501" id="R000069" start="486" rule="EKR:IneventActivate" paragraph="paragraph16">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activated Ack1 </text>
    <arg id="V1970481" role=":FACTOR"/>
    <arg id="R000068" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="136" end="501" id="R000070" refid="V1970481" rule="EKR:IneventActivate" start="486" paragraph="paragraph16">
    <type>ONT::DECREASE</type>
    <text>activated Ack1 </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000067"/>
  </EVENT>
  <CC paragraph="paragraph16" rule="EKR:IneventActivate" start="486" refid="V1970481" id="R000071" end="501" uttnum="136">
    <text>activated Ack1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1970481" role=":FACTOR"/>
    <arg id="R000070" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1196" paragraph="paragraph16" start="1181" uttnum="140" id="R000072" refid="V2023976" rule="EKR:IneventActivate">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT uttnum="140" end="1196" id="R000073" refid="V2023965" rule="EKR:IneventActivate" start="1181" paragraph="paragraph16">
    <type>ONT::INCREASE</type>
    <text>activated Ack1 </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2023976"/>
  </EVENT>
  <CC uttnum="140" refid="V2023965" end="1196" id="R000074" rule="EKR:IneventActivate" start="1181" paragraph="paragraph16">
    <text>activated Ack1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2023965" role=":FACTOR"/>
    <arg id="R000073" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000075" end="1196" refid="V2023965" uttnum="140" paragraph="paragraph16" rule="EKR:IneventActivate" start="1181">
    <type>ONT::DECREASE</type>
    <text>activated Ack1 </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000072"/>
  </EVENT>
  <CC paragraph="paragraph16" rule="EKR:IneventActivate" start="1181" refid="V2023965" id="R000076" end="1196" uttnum="140">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activated Ack1 </text>
    <arg id="V2023965" role=":FACTOR"/>
    <arg id="R000075" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="818" paragraph="paragraph17" start="803" uttnum="154" id="R000077" refid="V2235587" rule="EKR:IneventActivate">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph17" start="803" rule="EKR:IneventActivate" id="R000078" end="818" refid="V2235575" uttnum="154">
    <type>ONT::INCREASE</type>
    <text>activated Ack1 </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V2235587" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:IneventActivate" start="803" paragraph="paragraph17" uttnum="154" refid="V2235575" id="R000079" end="818">
    <text>activated Ack1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2235575"/>
    <arg role=":OUTCOME" id="R000078"/>
  </CC>
  <EVENT refid="V2235575" end="818" id="R000080" uttnum="154" paragraph="paragraph17" rule="EKR:IneventActivate" start="803">
    <text>activated Ack1 </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000077"/>
  </EVENT>
  <CC uttnum="154" id="R000081" end="818" refid="V2235575" rule="EKR:IneventActivate" start="803" paragraph="paragraph17">
    <text>activated Ack1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2235575"/>
    <arg role=":OUTCOME" id="R000080"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1257" paragraph="paragraph17" start="1216" uttnum="156" id="R000082" refid="V2263555" rule="EKR:IneventActivate">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>activated Ack1, in the absence of ligand</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT start="1216" rule="EKR:IneventActivate" paragraph="paragraph17" uttnum="156" refid="V2263543" id="R000083" end="1257">
    <type>ONT::INCREASE</type>
    <text>activated Ack1, in the absence of ligand </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V2263555" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:IneventActivate" start="1216" paragraph="paragraph17" uttnum="156" refid="V2263543" id="R000084" end="1257">
    <text>activated Ack1, in the absence of ligand </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2263543"/>
    <arg role=":OUTCOME" id="R000083"/>
  </CC>
  <EVENT uttnum="156" end="1257" id="R000085" refid="V2263543" rule="EKR:IneventActivate" start="1216" paragraph="paragraph17">
    <text>activated Ack1, in the absence of ligand </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000082" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="156" refid="V2263543" id="R000086" end="1257" rule="EKR:IneventActivate" start="1216" paragraph="paragraph17">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activated Ack1, in the absence of ligand </text>
    <arg id="V2263543" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000085"/>
  </CC>
  <TERM dbid="HGNC:19297|UP:Q07912" end="1033" paragraph="paragraph18" start="1015" uttnum="164" id="R000087" refid="V2387403" rule="EKR:IneventActivate">
    <type>ONT::GENE</type>
    <name>ACK</name>
    <text>the activated Ack</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT start="1015" rule="EKR:IneventActivate" paragraph="paragraph18" uttnum="164" refid="V2387396" end="1033" id="R000088">
    <type>ONT::INCREASE</type>
    <text>the activated Ack </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2387403"/>
  </EVENT>
  <CC refid="V2387396" id="R000089" end="1033" uttnum="164" paragraph="paragraph18" start="1015" rule="EKR:IneventActivate">
    <text>the activated Ack </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2387396"/>
    <arg id="R000088" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph18" rule="EKR:IneventActivate" start="1015" refid="V2387396" end="1033" id="R000090" uttnum="164">
    <text>the activated Ack </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000087"/>
  </EVENT>
  <CC paragraph="paragraph18" rule="EKR:IneventActivate" start="1015" id="R000091" end="1033" refid="V2387396" uttnum="164">
    <text>the activated Ack </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2387396"/>
    <arg id="R000090" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="261" paragraph="paragraph22" start="246" uttnum="195" id="R000092" refid="V2900923" rule="EKR:IneventActivate">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Activated Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:IneventActivate" start="246" paragraph="paragraph22" uttnum="195" end="261" id="R000093" refid="V2900911">
    <text>Activated Ack1 </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V2900923" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:IneventActivate" start="246" paragraph="paragraph22" uttnum="195" refid="V2900911" id="R000094" end="261">
    <text>Activated Ack1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2900911" role=":FACTOR"/>
    <arg id="R000093" role=":OUTCOME"/>
  </CC>
  <EVENT start="246" rule="EKR:IneventActivate" paragraph="paragraph22" uttnum="195" id="R000095" end="261" refid="V2900911">
    <type>ONT::DECREASE</type>
    <text>Activated Ack1 </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000092" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:IneventActivate" start="246" paragraph="paragraph22" uttnum="195" end="261" id="R000096" refid="V2900911">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Activated Ack1 </text>
    <arg id="V2900911" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000095"/>
  </CC>
  <TERM end="570" paragraph="paragraph22" start="556" uttnum="196" id="R000097" refid="V2915998" rule="EKR:IneventActivate">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Activated AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT start="556" rule="EKR:IneventActivate" paragraph="paragraph22" uttnum="196" id="R000098" end="570" refid="V2915991">
    <text>Activated AKT </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V2915998" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="196" refid="V2915991" id="R000099" end="570" start="556" rule="EKR:IneventActivate" paragraph="paragraph22">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Activated AKT </text>
    <arg id="V2915991" role=":FACTOR"/>
    <arg id="R000098" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph22" start="556" rule="EKR:IneventActivate" id="R000100" end="570" refid="V2915991" uttnum="196">
    <text>Activated AKT </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000097" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="196" refid="V2915991" id="R000101" end="570" start="556" rule="EKR:IneventActivate" paragraph="paragraph22">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Activated AKT </text>
    <arg id="V2915991" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000100"/>
  </CC>
  <TERM end="530" paragraph="paragraph23" start="517" uttnum="200" id="R000102" refid="V2953347" rule="EKR:IneventActivate">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">activated AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT refid="V2953340" id="R000103" end="530" uttnum="200" paragraph="paragraph23" rule="EKR:IneventActivate" start="517">
    <text>activated AKT</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V2953347" role=":AFFECTED"/>
  </EVENT>
  <CC end="530" id="R000104" refid="V2953340" uttnum="200" paragraph="paragraph23" rule="EKR:IneventActivate" start="517">
    <text>activated AKT</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2953340" role=":FACTOR"/>
    <arg id="R000103" role=":OUTCOME"/>
  </CC>
  <EVENT rule="EKR:IneventActivate" start="517" paragraph="paragraph23" uttnum="200" end="530" id="R000105" refid="V2953340">
    <type>ONT::DECREASE</type>
    <text>activated AKT</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000102" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="200" refid="V2953340" end="530" id="R000106" rule="EKR:IneventActivate" start="517" paragraph="paragraph23">
    <text>activated AKT</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2953340" role=":FACTOR"/>
    <arg id="R000105" role=":OUTCOME"/>
  </CC>
  <TERM end="770" paragraph="paragraph23" start="756" uttnum="202" id="R000107" refid="V2981505" rule="EKR:IneventActivate">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">activated AKT</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT start="756" rule="EKR:IneventActivate" paragraph="paragraph23" uttnum="202" refid="V2981498" id="R000108" end="770">
    <text>activated AKT </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2981505"/>
  </EVENT>
  <CC paragraph="paragraph23" start="756" rule="EKR:IneventActivate" refid="V2981498" end="770" id="R000109" uttnum="202">
    <text>activated AKT </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2981498"/>
    <arg role=":OUTCOME" id="R000108"/>
  </CC>
  <EVENT end="770" id="R000110" refid="V2981498" uttnum="202" paragraph="paragraph23" start="756" rule="EKR:IneventActivate">
    <text>activated AKT </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000107"/>
  </EVENT>
  <CC refid="V2981498" id="R000111" end="770" uttnum="202" paragraph="paragraph23" start="756" rule="EKR:IneventActivate">
    <type>ONT::CAUSE-EFFECT</type>
    <text>activated AKT </text>
    <arg role=":FACTOR" id="V2981498"/>
    <arg role=":OUTCOME" id="R000110"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="838" paragraph="paragraph25" start="823" uttnum="214" id="R000112" refid="V3150169" rule="EKR:IneventActivate">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Activated Ack1</text>
    <features>
      <active>FALSE</active>
    </features>
  </TERM>
  <EVENT uttnum="214" end="838" id="R000113" refid="V3150155" rule="EKR:IneventActivate" start="823" paragraph="paragraph25">
    <type>ONT::INCREASE</type>
    <text>Activated Ack1 </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="V3150169" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:IneventActivate" start="823" paragraph="paragraph25" uttnum="214" refid="V3150155" end="838" id="R000114">
    <text>Activated Ack1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3150155" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000113"/>
  </CC>
  <EVENT uttnum="214" refid="V3150155" id="R000115" end="838" start="823" rule="EKR:IneventActivate" paragraph="paragraph25">
    <text>Activated Ack1 </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="R000112" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph25" rule="EKR:IneventActivate" start="823" refid="V3150155" id="R000116" end="838" uttnum="214">
    <text>Activated Ack1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3150155" role=":FACTOR"/>
    <arg id="R000115" role=":OUTCOME"/>
  </CC>
  <TERM end="916" paragraph="paragraph2" start="903" uttnum="14" id="R000117" refid="V239337" rule="EKR:BindXY">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V239333"/>
      <member id="V239348"/>
    </aggregate>
    <text normalization="">PDK1 and AKT</text>
    <features>
      <bound-to id="R000118" event="V239353"/>
    </features>
  </TERM>
  <TERM dbid="CHEBI:16618" end="943" paragraph="paragraph2" start="921" uttnum="14" id="R000118" refid="V239383" rule="EKR:BindXY">
    <type>ONT::MOLECULE</type>
    <name>PIP-3</name>
    <text>the phospholipid PIP3</text>
    <features>
      <bound-to event="V239353" id="R000117"/>
    </features>
  </TERM>
  <TERM uttnum="14" id="R000119" end="964" refid="V239353,R000117,R000118" rule="EKR:BindXY" start="903" paragraph="paragraph2">
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains </text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>COMPLEX</name>
    <components>
      <component id="R000117"/>
      <component id="R000118"/>
    </components>
  </TERM>
  <EVENT uttnum="14" refid="V239353" end="964" id="R000120" start="903" rule="EKR:BindXY" paragraph="paragraph2">
    <type>ONT::INCREASE</type>
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000119" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph2" rule="EKR:BindXY" start="903" id="R000121" end="964" refid="V239353" uttnum="14">
    <type>ONT::CAUSE-EFFECT</type>
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains </text>
    <arg id="V239353" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000120"/>
  </CC>
  <EVENT start="903" rule="EKR:BindXY" paragraph="paragraph2" uttnum="14" refid="V239353" id="R000122" end="964">
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V239337"/>
  </EVENT>
  <CC start="903" rule="EKR:BindXY" paragraph="paragraph2" uttnum="14" id="R000123" end="964" refid="V239353">
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V239353" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000122"/>
  </CC>
  <EVENT paragraph="paragraph2" start="903" rule="EKR:BindXY" id="R000124" end="964" refid="V239353" uttnum="14">
    <type>ONT::DECREASE</type>
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V239383"/>
  </EVENT>
  <CC paragraph="paragraph2" start="903" rule="EKR:BindXY" refid="V239353" id="R000125" end="964" uttnum="14">
    <text>PDK1 and AKT bind the phospholipid PIP3 via their PH domains </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V239353" role=":FACTOR"/>
    <arg id="R000124" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="1192" paragraph="paragraph11" start="1183" uttnum="102" id="R000126" refid="V1429393" rule="EKR:BindXY">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>GST-Ack1</text>
    <features>
      <bound-to id="R000127" event="V1429412"/>
    </features>
  </TERM>
  <TERM end="1253" paragraph="paragraph11" start="1198" uttnum="102" id="R000127" refid="V1429462" rule="EKR:BindXY">
    <type>ONT::GENE-PROTEIN</type>
    <aggregate operator="AND">
      <member id="V1429458"/>
      <member id="V1429473"/>
    </aggregate>
    <text normalization="">to purified AKT and AR but not the Y176F mutant of AKT</text>
    <features>
      <bound-to event="V1429412" id="R000126"/>
    </features>
  </TERM>
  <TERM paragraph="paragraph11" rule="EKR:BindXY" start="1183" refid="V1429412,R000126,R000127" end="1253" id="R000128" uttnum="102">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>GST-Ack1 bound to purified AKT and AR but not the Y176F mutant of AKT </text>
    <name>COMPLEX</name>
    <components>
      <component id="R000126"/>
      <component id="R000127"/>
    </components>
  </TERM>
  <EVENT rule="EKR:BindXY" start="1183" paragraph="paragraph11" uttnum="102" refid="V1429412" id="R000129" end="1253">
    <type>ONT::INCREASE</type>
    <text>GST-Ack1 bound to purified AKT and AR but not the Y176F mutant of AKT </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000128" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph11" start="1183" rule="EKR:BindXY" refid="V1429412" id="R000130" end="1253" uttnum="102">
    <text>GST-Ack1 bound to purified AKT and AR but not the Y176F mutant of AKT </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1429412" role=":FACTOR"/>
    <arg id="R000129" role=":OUTCOME"/>
  </CC>
  <EVENT start="1183" rule="EKR:BindXY" paragraph="paragraph11" uttnum="102" end="1253" id="R000131" refid="V1429412">
    <type>ONT::DECREASE</type>
    <text>GST-Ack1 bound to purified AKT and AR but not the Y176F mutant of AKT </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1429393" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="102" end="1253" id="R000132" refid="V1429412" start="1183" rule="EKR:BindXY" paragraph="paragraph11">
    <text>GST-Ack1 bound to purified AKT and AR but not the Y176F mutant of AKT </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1429412"/>
    <arg id="R000131" role=":OUTCOME"/>
  </CC>
  <EVENT id="R000133" end="1253" refid="V1429412" uttnum="102" paragraph="paragraph11" rule="EKR:BindXY" start="1183">
    <type>ONT::DECREASE</type>
    <text>GST-Ack1 bound to purified AKT and AR but not the Y176F mutant of AKT </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1429462" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000134" end="1253" refid="V1429412" uttnum="102" paragraph="paragraph11" rule="EKR:BindXY" start="1183">
    <type>ONT::CAUSE-EFFECT</type>
    <text>GST-Ack1 bound to purified AKT and AR but not the Y176F mutant of AKT </text>
    <arg id="V1429412" role=":FACTOR"/>
    <arg id="R000133" role=":OUTCOME"/>
  </CC>
  <TERM end="863" paragraph="paragraph13" start="855" uttnum="116" id="R000135" refid="V1654117" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">ΔPH-AKT</text>
    <features>
      <bound-to id="R000136" event="V1654138"/>
    </features>
  </TERM>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="881" paragraph="paragraph13" start="876" uttnum="116" id="R000136" refid="V1654152" rule="EKR:BindXY">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <features>
      <bound-to id="R000135" event="V1654138"/>
    </features>
  </TERM>
  <TERM rule="EKR:BindXY" start="824" paragraph="paragraph13" uttnum="116" id="R000137" end="881" refid="V1654138,R000135,R000136">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>in contrast to AKT or ΔCT-AKT, ΔPH-AKT weakly binds Ack1 </text>
    <name>AKT/ACK-1</name>
    <components>
      <component id="R000135"/>
      <component id="R000136"/>
    </components>
  </TERM>
  <EVENT start="824" rule="EKR:BindXY" paragraph="paragraph13" uttnum="116" id="R000138" end="881" refid="V1654138">
    <text>in contrast to AKT or ΔCT-AKT, ΔPH-AKT weakly binds Ack1 </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000137" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V1654138" end="881" id="R000139" uttnum="116" paragraph="paragraph13" rule="EKR:BindXY" start="824">
    <text>in contrast to AKT or ΔCT-AKT, ΔPH-AKT weakly binds Ack1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1654138" role=":FACTOR"/>
    <arg id="R000138" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V1654138" end="881" id="R000140" uttnum="116" paragraph="paragraph13" rule="EKR:BindXY" start="824">
    <type>ONT::DECREASE</type>
    <text>in contrast to AKT or ΔCT-AKT, ΔPH-AKT weakly binds Ack1 </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1654117"/>
  </EVENT>
  <CC end="881" id="R000141" refid="V1654138" uttnum="116" paragraph="paragraph13" start="824" rule="EKR:BindXY">
    <type>ONT::CAUSE-EFFECT</type>
    <text>in contrast to AKT or ΔCT-AKT, ΔPH-AKT weakly binds Ack1 </text>
    <arg id="V1654138" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000140"/>
  </CC>
  <EVENT uttnum="116" end="881" id="R000142" refid="V1654138" rule="EKR:BindXY" start="824" paragraph="paragraph13">
    <type>ONT::DECREASE</type>
    <text>in contrast to AKT or ΔCT-AKT, ΔPH-AKT weakly binds Ack1 </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1654152"/>
  </EVENT>
  <CC uttnum="116" refid="V1654138" end="881" id="R000143" rule="EKR:BindXY" start="824" paragraph="paragraph13">
    <type>ONT::CAUSE-EFFECT</type>
    <text>in contrast to AKT or ΔCT-AKT, ΔPH-AKT weakly binds Ack1 </text>
    <arg role=":FACTOR" id="V1654138"/>
    <arg id="R000142" role=":OUTCOME"/>
  </CC>
  <TERM end="1389" paragraph="paragraph17" start="1366" uttnum="157" id="R000144" refid="V2277079" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr-phosphorylated AKT</text>
    <features>
      <ptm event="V2277066" type="ONT::PHOSPHORYLATION"/>
      <bound-to id="R000145" event="V2277092"/>
    </features>
  </TERM>
  <TERM dbid="CHEBI:16247" end="1426" paragraph="paragraph17" start="1395" uttnum="157" id="R000145" refid="V2277115" rule="EKR:BindXY">
    <type>ONT::MOLECULE</type>
    <features>
      <location id="V2277110"/>
      <bound-to id="R000144" event="V2277092"/>
    </features>
    <name>PHOSPHOLIPID</name>
    <text>another membrane phospholipid,</text>
  </TERM>
  <TERM paragraph="paragraph17" start="1314" rule="EKR:BindXY" end="1426" id="R000146" refid="V2277092,R000144,R000145" uttnum="157">
    <text>Interestingly, in contrast to AKT which bound PIP3, Tyr-phosphorylated AKT bound another membrane phospholipid, </text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>AKT/PHOSPHOLIPID</name>
    <components>
      <component id="R000144"/>
      <component id="R000145"/>
    </components>
  </TERM>
  <EVENT end="1426" id="R000147" refid="V2277092" uttnum="157" paragraph="paragraph17" start="1314" rule="EKR:BindXY">
    <type>ONT::INCREASE</type>
    <text>Interestingly, in contrast to AKT which bound PIP3, Tyr-phosphorylated AKT bound another membrane phospholipid, </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000146" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph17" rule="EKR:BindXY" start="1314" refid="V2277092" id="R000148" end="1426" uttnum="157">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Interestingly, in contrast to AKT which bound PIP3, Tyr-phosphorylated AKT bound another membrane phospholipid, </text>
    <arg role=":FACTOR" id="V2277092"/>
    <arg id="R000147" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph17" start="1314" rule="EKR:BindXY" refid="V2277092" id="R000149" end="1426" uttnum="157">
    <text>Interestingly, in contrast to AKT which bound PIP3, Tyr-phosphorylated AKT bound another membrane phospholipid, </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2277079"/>
  </EVENT>
  <CC paragraph="paragraph17" start="1314" rule="EKR:BindXY" refid="V2277092" id="R000150" end="1426" uttnum="157">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Interestingly, in contrast to AKT which bound PIP3, Tyr-phosphorylated AKT bound another membrane phospholipid, </text>
    <arg id="V2277092" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000149"/>
  </CC>
  <EVENT id="R000151" end="1426" refid="V2277092" uttnum="157" paragraph="paragraph17" start="1314" rule="EKR:BindXY">
    <text>Interestingly, in contrast to AKT which bound PIP3, Tyr-phosphorylated AKT bound another membrane phospholipid, </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2277115"/>
  </EVENT>
  <CC paragraph="paragraph17" start="1314" rule="EKR:BindXY" refid="V2277092" id="R000152" end="1426" uttnum="157">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Interestingly, in contrast to AKT which bound PIP3, Tyr-phosphorylated AKT bound another membrane phospholipid, </text>
    <arg id="V2277092" role=":FACTOR"/>
    <arg id="R000151" role=":OUTCOME"/>
  </CC>
  <TERM dbid="CHEBI:52214" end="439" paragraph="paragraph23" start="432" uttnum="200" id="R000153" refid="V2953079" rule="EKR:BindXY">
    <type>ONT::CHEMICAL</type>
    <name>LIGAND</name>
    <text>ligand</text>
    <features>
      <bound-to id="R000154" event="V2953092"/>
    </features>
  </TERM>
  <TERM end="454" paragraph="paragraph23" start="445" uttnum="200" id="R000154" refid="V2953359" rule="EKR:BindXY">
    <type>ONT::PROTEIN</type>
    <components>
      <component id="V2952758"/>
      <component id="V2952789"/>
    </components>
    <text normalization="">HER2/ErbB</text>
    <features>
      <bound-to event="V2953092" id="R000153"/>
    </features>
  </TERM>
  <TERM paragraph="paragraph23" start="368" rule="EKR:BindXY" end="454" id="R000155" refid="V2953092,R000153,R000154" uttnum="200">
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <text>Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB</text>
    <name>COMPLEX</name>
    <components>
      <component id="R000153"/>
      <component id="R000154"/>
    </components>
  </TERM>
  <EVENT paragraph="paragraph23" rule="EKR:BindXY" start="368" refid="V2953092" end="454" id="R000156" uttnum="200">
    <type>ONT::INCREASE</type>
    <text>Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000155"/>
  </EVENT>
  <CC paragraph="paragraph23" start="368" rule="EKR:BindXY" refid="V2953092" end="454" id="R000157" uttnum="200">
    <text>Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2953092"/>
    <arg id="R000156" role=":OUTCOME"/>
  </CC>
  <EVENT rule="EKR:BindXY" start="368" paragraph="paragraph23" uttnum="200" refid="V2953092" id="R000158" end="454">
    <text>Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2953079"/>
  </EVENT>
  <CC start="368" rule="EKR:BindXY" paragraph="paragraph23" uttnum="200" end="454" id="R000159" refid="V2953092">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB</text>
    <arg id="V2953092" role=":FACTOR"/>
    <arg id="R000158" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="200" refid="V2953092" id="R000160" end="454" start="368" rule="EKR:BindXY" paragraph="paragraph23">
    <text>Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2953359"/>
  </EVENT>
  <CC uttnum="200" refid="V2953092" end="454" id="R000161" start="368" rule="EKR:BindXY" paragraph="paragraph23">
    <text>Our studies showed that even in the presence of PI3K inhibitor, ligand bound HER2/ErbB</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2953092"/>
    <arg role=":OUTCOME" id="R000160"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="736" paragraph="paragraph25" start="731" uttnum="214" id="R000162" refid="V3134245" rule="EKR:BindXY">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <features>
      <bound-to event="V3134280" id="R000163"/>
    </features>
  </TERM>
  <TERM end="821" paragraph="paragraph25" start="760" uttnum="214" id="R000163" refid="V3134323" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">to AKT (Fig. 1B and G)</text>
    <features>
      <bound-to event="V3134280" id="R000162"/>
    </features>
  </TERM>
  <TERM start="731" rule="EKR:BindXY" paragraph="paragraph25" uttnum="214" end="821" id="R000164" refid="V3134280,R000162,R000163">
    <text>Ack1 is constitutively bound to AKT (&lt;xref&gt;&lt;bold&gt;Fig. 1B&lt;/bold&gt; and &lt;bold&gt;G&lt;/bold&gt;&lt;/xref&gt;)</text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>ACK-1/AKT</name>
    <components>
      <component id="R000162"/>
      <component id="R000163"/>
    </components>
  </TERM>
  <EVENT uttnum="214" refid="V3134280" end="821" id="R000165" start="731" rule="EKR:BindXY" paragraph="paragraph25">
    <text>Ack1 is constitutively bound to AKT (&lt;xref&gt;&lt;bold&gt;Fig. 1B&lt;/bold&gt; and &lt;bold&gt;G&lt;/bold&gt;&lt;/xref&gt;)</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000164"/>
  </EVENT>
  <CC paragraph="paragraph25" rule="EKR:BindXY" start="731" end="821" id="R000166" refid="V3134280" uttnum="214">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ack1 is constitutively bound to AKT (&lt;xref&gt;&lt;bold&gt;Fig. 1B&lt;/bold&gt; and &lt;bold&gt;G&lt;/bold&gt;&lt;/xref&gt;)</text>
    <arg id="V3134280" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000165"/>
  </CC>
  <EVENT refid="V3134280" end="821" id="R000167" uttnum="214" paragraph="paragraph25" rule="EKR:BindXY" start="731">
    <text>Ack1 is constitutively bound to AKT (&lt;xref&gt;&lt;bold&gt;Fig. 1B&lt;/bold&gt; and &lt;bold&gt;G&lt;/bold&gt;&lt;/xref&gt;)</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3134245"/>
  </EVENT>
  <CC paragraph="paragraph25" start="731" rule="EKR:BindXY" refid="V3134280" end="821" id="R000168" uttnum="214">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ack1 is constitutively bound to AKT (&lt;xref&gt;&lt;bold&gt;Fig. 1B&lt;/bold&gt; and &lt;bold&gt;G&lt;/bold&gt;&lt;/xref&gt;)</text>
    <arg role=":FACTOR" id="V3134280"/>
    <arg role=":OUTCOME" id="R000167"/>
  </CC>
  <EVENT rule="EKR:BindXY" start="731" paragraph="paragraph25" uttnum="214" refid="V3134280" id="R000169" end="821">
    <text>Ack1 is constitutively bound to AKT (&lt;xref&gt;&lt;bold&gt;Fig. 1B&lt;/bold&gt; and &lt;bold&gt;G&lt;/bold&gt;&lt;/xref&gt;)</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3134323"/>
  </EVENT>
  <CC uttnum="214" end="821" id="R000170" refid="V3134280" start="731" rule="EKR:BindXY" paragraph="paragraph25">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ack1 is constitutively bound to AKT (&lt;xref&gt;&lt;bold&gt;Fig. 1B&lt;/bold&gt; and &lt;bold&gt;G&lt;/bold&gt;&lt;/xref&gt;)</text>
    <arg id="V3134280" role=":FACTOR"/>
    <arg id="R000169" role=":OUTCOME"/>
  </CC>
  <TERM end="987" paragraph="paragraph25" start="961" uttnum="215" id="R000171" refid="V3153455" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">Tyr176-phosphorylated AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3153445"/>
      <bound-to id="R000172" event="V3153467"/>
    </features>
  </TERM>
  <TERM dbid="CHEBI:16247" end="1043" paragraph="paragraph25" start="1008" uttnum="215" id="R000172" refid="V3153553" rule="EKR:BindXY">
    <type>ONT::MOLECULE</type>
    <features>
      <location id="V3153547"/>
      <bound-to event="V3153467" id="R000171"/>
    </features>
    <name>PHOSPHOLIPID</name>
    <text>PA, a plasma membrane phospholipid</text>
  </TERM>
  <TERM refid="V3153467,R000171,R000172" id="R000173" end="1078" uttnum="215" paragraph="paragraph25" start="961" rule="EKR:BindXY">
    <text>Tyr176-phosphorylated AKT preferentially binds PA, a plasma membrane phospholipid as opposed to unphosphorylated AKT </text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>AKT/PHOSPHOLIPID</name>
    <components>
      <component id="R000171"/>
      <component id="R000172"/>
    </components>
  </TERM>
  <EVENT rule="EKR:BindXY" start="961" paragraph="paragraph25" uttnum="215" refid="V3153467" end="1078" id="R000174">
    <type>ONT::INCREASE</type>
    <text>Tyr176-phosphorylated AKT preferentially binds PA, a plasma membrane phospholipid as opposed to unphosphorylated AKT </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000173"/>
  </EVENT>
  <CC uttnum="215" id="R000175" end="1078" refid="V3153467" rule="EKR:BindXY" start="961" paragraph="paragraph25">
    <text>Tyr176-phosphorylated AKT preferentially binds PA, a plasma membrane phospholipid as opposed to unphosphorylated AKT </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3153467"/>
    <arg id="R000174" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph25" rule="EKR:BindXY" start="961" refid="V3153467" end="1078" id="R000176" uttnum="215">
    <type>ONT::DECREASE</type>
    <text>Tyr176-phosphorylated AKT preferentially binds PA, a plasma membrane phospholipid as opposed to unphosphorylated AKT </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3153455"/>
  </EVENT>
  <CC paragraph="paragraph25" start="961" rule="EKR:BindXY" refid="V3153467" end="1078" id="R000177" uttnum="215">
    <text>Tyr176-phosphorylated AKT preferentially binds PA, a plasma membrane phospholipid as opposed to unphosphorylated AKT </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3153467"/>
    <arg role=":OUTCOME" id="R000176"/>
  </CC>
  <EVENT end="1078" id="R000178" refid="V3153467" uttnum="215" paragraph="paragraph25" rule="EKR:BindXY" start="961">
    <text>Tyr176-phosphorylated AKT preferentially binds PA, a plasma membrane phospholipid as opposed to unphosphorylated AKT </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3153553" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph25" start="961" rule="EKR:BindXY" end="1078" id="R000179" refid="V3153467" uttnum="215">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Tyr176-phosphorylated AKT preferentially binds PA, a plasma membrane phospholipid as opposed to unphosphorylated AKT </text>
    <arg id="V3153467" role=":FACTOR"/>
    <arg id="R000178" role=":OUTCOME"/>
  </CC>
  <TERM dbid="GO:0016020|UP:SL-0162" end="1222" paragraph="paragraph25" start="1209" uttnum="216" id="R000180" refid="V3169010" rule="EKR:BindXY">
    <type>ONT::CELL-PART</type>
    <name>MEMBRANE</name>
    <text>the membrane</text>
    <features>
      <bound-to event="V3169014" id="R000181"/>
    </features>
  </TERM>
  <TERM end="1258" paragraph="paragraph25" start="1230" uttnum="216" id="R000181" refid="V3169061" rule="EKR:BindXY">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of Tyr176-phosphorylated AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3169051"/>
      <bound-to event="V3169014" id="R000180"/>
    </features>
  </TERM>
  <TERM start="1206" rule="EKR:BindXY" paragraph="paragraph25" uttnum="216" refid="V3169014,R000180,R000181" end="1258" id="R000182">
    <text>in the membrane binding of Tyr176-phosphorylated AKT</text>
    <type>ONT::MACROMOLECULAR-COMPLEX</type>
    <name>MEMBRANE/AKT</name>
    <components>
      <component id="R000180"/>
      <component id="R000181"/>
    </components>
  </TERM>
  <EVENT uttnum="216" refid="V3169014" id="R000183" end="1258" rule="EKR:BindXY" start="1206" paragraph="paragraph25">
    <type>ONT::INCREASE</type>
    <text>in the membrane binding of Tyr176-phosphorylated AKT</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000182"/>
  </EVENT>
  <CC id="R000184" end="1258" refid="V3169014" uttnum="216" paragraph="paragraph25" rule="EKR:BindXY" start="1206">
    <type>ONT::CAUSE-EFFECT</type>
    <text>in the membrane binding of Tyr176-phosphorylated AKT</text>
    <arg role=":FACTOR" id="V3169014"/>
    <arg role=":OUTCOME" id="R000183"/>
  </CC>
  <EVENT id="R000185" end="1258" refid="V3169014" uttnum="216" paragraph="paragraph25" rule="EKR:BindXY" start="1206">
    <text>in the membrane binding of Tyr176-phosphorylated AKT</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3169010" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:BindXY" start="1206" paragraph="paragraph25" uttnum="216" end="1258" id="R000186" refid="V3169014">
    <type>ONT::CAUSE-EFFECT</type>
    <text>in the membrane binding of Tyr176-phosphorylated AKT</text>
    <arg role=":FACTOR" id="V3169014"/>
    <arg role=":OUTCOME" id="R000185"/>
  </CC>
  <EVENT rule="EKR:BindXY" start="1206" paragraph="paragraph25" uttnum="216" refid="V3169014" id="R000187" end="1258">
    <text>in the membrane binding of Tyr176-phosphorylated AKT</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3169061" role=":AFFECTED"/>
  </EVENT>
  <CC start="1206" rule="EKR:BindXY" paragraph="paragraph25" uttnum="216" end="1258" id="R000188" refid="V3169014">
    <text>in the membrane binding of Tyr176-phosphorylated AKT</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3169014" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000187"/>
  </CC>
  <TERM end="50" paragraph="paragraph0" start="20" uttnum="1" id="R000189" refid="V32080" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <features>
      <inevent>
        <event id="V32037"/>
      </inevent>
      <ptm type="ONT::PHOSPHORYLATION" event="V32053"/>
    </features>
    <name>AKT/PKB</name>
    <text>Mediated AKT/PKB Tyrosine 176</text>
  </TERM>
  <EVENT uttnum="1" refid="V32053" end="66" id="R000190" start="15" rule="EKR:PTM" paragraph="paragraph0">
    <type>ONT::INCREASE</type>
    <text>Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000189"/>
  </EVENT>
  <CC refid="V32053" id="R000191" end="66" uttnum="1" paragraph="paragraph0" start="15" rule="EKR:PTM">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation </text>
    <arg id="V32053" role=":FACTOR"/>
    <arg id="R000190" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph0" rule="EKR:PTM" start="15" refid="V32053" end="66" id="R000192" uttnum="1">
    <text>Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V32080" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" start="15" paragraph="paragraph0" uttnum="1" end="66" id="R000193" refid="V32053">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation </text>
    <arg role=":FACTOR" id="V32053"/>
    <arg role=":OUTCOME" id="R000192"/>
  </CC>
  <TERM end="524" paragraph="paragraph1" start="520" uttnum="4" id="R000194" refid="V80046" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V80041"/>
    </features>
  </TERM>
  <EVENT paragraph="paragraph1" start="490" rule="EKR:PTM" refid="V80041" id="R000195" end="524" uttnum="4">
    <type>ONT::INCREASE</type>
    <text>which directly phosphorylates AKT </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000194"/>
  </EVENT>
  <CC id="R000196" end="524" refid="V80041" uttnum="4" paragraph="paragraph1" rule="EKR:PTM" start="490">
    <text>which directly phosphorylates AKT </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V80041" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000195"/>
  </CC>
  <EVENT paragraph="paragraph1" start="490" rule="EKR:PTM" refid="V80041" end="524" id="R000197" uttnum="4">
    <text>which directly phosphorylates AKT </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V80046" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph1" start="490" rule="EKR:PTM" refid="V80041" id="R000198" end="524" uttnum="4">
    <type>ONT::CAUSE-EFFECT</type>
    <text>which directly phosphorylates AKT </text>
    <arg role=":FACTOR" id="V80041"/>
    <arg role=":OUTCOME" id="R000197"/>
  </CC>
  <TERM end="791" paragraph="paragraph1" start="787" uttnum="6" id="R000199" refid="V103215" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm event="V103231" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT start="787" rule="EKR:PTM" paragraph="paragraph1" uttnum="6" refid="V103231" end="814" id="R000200">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000199" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="6" refid="V103231" end="814" id="R000201" start="787" rule="EKR:PTM" paragraph="paragraph1">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V103231"/>
    <arg role=":OUTCOME" id="R000200"/>
  </CC>
  <EVENT uttnum="6" refid="V103231" id="R000202" end="814" rule="EKR:PTM" start="787" paragraph="paragraph1">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V103215" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V103231" end="814" id="R000203" uttnum="6" paragraph="paragraph1" start="787" rule="EKR:PTM">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V103231" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000202"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="285" paragraph="paragraph3" start="280" uttnum="22" id="R000204" refid="V370502" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V370562"/>
    </features>
  </TERM>
  <EVENT paragraph="paragraph3" rule="EKR:PTM" start="280" refid="V370562" end="389" id="R000205" uttnum="22">
    <text>Ack1 is ubiquitously expressed and primarily phosphorylated at Tyr284 leading to its kinase activation &lt;xref&gt;</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000204" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph3" rule="EKR:PTM" start="280" end="389" id="R000206" refid="V370562" uttnum="22">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ack1 is ubiquitously expressed and primarily phosphorylated at Tyr284 leading to its kinase activation &lt;xref&gt;</text>
    <arg role=":FACTOR" id="V370562"/>
    <arg id="R000205" role=":OUTCOME"/>
  </CC>
  <EVENT start="280" rule="EKR:PTM" paragraph="paragraph3" uttnum="22" refid="V370562" end="389" id="R000207">
    <type>ONT::DECREASE</type>
    <text>Ack1 is ubiquitously expressed and primarily phosphorylated at Tyr284 leading to its kinase activation &lt;xref&gt;</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V370502" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V370562" id="R000208" end="389" uttnum="22" paragraph="paragraph3" start="280" rule="EKR:PTM">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ack1 is ubiquitously expressed and primarily phosphorylated at Tyr284 leading to its kinase activation &lt;xref&gt;</text>
    <arg role=":FACTOR" id="V370562"/>
    <arg id="R000207" role=":OUTCOME"/>
  </CC>
  <TERM end="1116" paragraph="paragraph4" start="1092" uttnum="33" id="R000209" refid="V511742" rule="EKR:PTM">
    <type>ONT::AMINO-ACID</type>
    <name>TYROSINE</name>
    <text>the C-terminal tyrosine</text>
    <features>
      <ptm event="V511764" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT paragraph="paragraph4" rule="EKR:PTM" start="1092" refid="V511764" end="1134" id="R000210" uttnum="33">
    <text>the C-terminal tyrosine was phosphorylated</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000209"/>
  </EVENT>
  <CC refid="V511764" id="R000211" end="1134" uttnum="33" paragraph="paragraph4" rule="EKR:PTM" start="1092">
    <text>the C-terminal tyrosine was phosphorylated</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V511764" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000210"/>
  </CC>
  <EVENT uttnum="33" refid="V511764" end="1134" id="R000212" start="1092" rule="EKR:PTM" paragraph="paragraph4">
    <type>ONT::DECREASE</type>
    <text>the C-terminal tyrosine was phosphorylated</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V511742"/>
  </EVENT>
  <CC id="R000213" end="1134" refid="V511764" uttnum="33" paragraph="paragraph4" rule="EKR:PTM" start="1092">
    <type>ONT::CAUSE-EFFECT</type>
    <text>the C-terminal tyrosine was phosphorylated</text>
    <arg role=":FACTOR" id="V511764"/>
    <arg id="R000212" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="118" paragraph="paragraph10" start="110" uttnum="91" id="R000214" refid="V1233432" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <text>of Ack1</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1233407"/>
    </features>
  </TERM>
  <EVENT start="81" rule="EKR:PTM" paragraph="paragraph10" uttnum="91" refid="V1233407" end="134" id="R000215">
    <text>in rapid Tyr-phosphorylation of Ack1 as well as Akt1 </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000214"/>
  </EVENT>
  <CC uttnum="91" refid="V1233407" id="R000216" end="134" rule="EKR:PTM" start="81" paragraph="paragraph10">
    <text>in rapid Tyr-phosphorylation of Ack1 as well as Akt1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1233407" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000215"/>
  </CC>
  <EVENT rule="EKR:PTM" start="81" paragraph="paragraph10" uttnum="91" refid="V1233407" end="134" id="R000217">
    <type>ONT::DECREASE</type>
    <text>in rapid Tyr-phosphorylation of Ack1 as well as Akt1 </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1233432" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" start="81" paragraph="paragraph10" uttnum="91" id="R000218" end="134" refid="V1233407">
    <text>in rapid Tyr-phosphorylation of Ack1 as well as Akt1 </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1233407"/>
    <arg id="R000217" role=":OUTCOME"/>
  </CC>
  <TERM end="919" paragraph="paragraph10" start="915" uttnum="94" id="R000219" refid="V1304982" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1304998"/>
    </features>
  </TERM>
  <EVENT end="943" id="R000220" refid="V1304998" uttnum="94" paragraph="paragraph10" rule="EKR:PTM" start="912">
    <text>in AKT Ser473-phosphorylation, </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000219" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000221" end="943" refid="V1304998" uttnum="94" paragraph="paragraph10" start="912" rule="EKR:PTM">
    <type>ONT::CAUSE-EFFECT</type>
    <text>in AKT Ser473-phosphorylation, </text>
    <arg id="V1304998" role=":FACTOR"/>
    <arg id="R000220" role=":OUTCOME"/>
  </CC>
  <EVENT rule="EKR:PTM" start="912" paragraph="paragraph10" uttnum="94" refid="V1304998" end="943" id="R000222">
    <text>in AKT Ser473-phosphorylation, </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1304982"/>
  </EVENT>
  <CC paragraph="paragraph10" rule="EKR:PTM" start="912" refid="V1304998" end="943" id="R000223" uttnum="94">
    <type>ONT::CAUSE-EFFECT</type>
    <text>in AKT Ser473-phosphorylation, </text>
    <arg role=":FACTOR" id="V1304998"/>
    <arg role=":OUTCOME" id="R000222"/>
  </CC>
  <TERM end="61" paragraph="paragraph11" start="48" uttnum="96" id="R000224" refid="V1331152" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT,</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1331147"/>
    </features>
  </TERM>
  <EVENT start="19" rule="EKR:PTM" paragraph="paragraph11" uttnum="96" refid="V1331147" end="87" id="R000225">
    <type>ONT::INCREASE</type>
    <text>Ack1 directly phosphorylates AKT, &lt;italic&gt;in vitro&lt;/italic&gt; binding </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000224"/>
  </EVENT>
  <CC id="R000226" end="87" refid="V1331147" uttnum="96" paragraph="paragraph11" start="19" rule="EKR:PTM">
    <text>Ack1 directly phosphorylates AKT, &lt;italic&gt;in vitro&lt;/italic&gt; binding </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1331147" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000225"/>
  </CC>
  <EVENT uttnum="96" refid="V1331147" id="R000227" end="87" start="19" rule="EKR:PTM" paragraph="paragraph11">
    <type>ONT::DECREASE</type>
    <text>Ack1 directly phosphorylates AKT, &lt;italic&gt;in vitro&lt;/italic&gt; binding </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1331152" role=":AFFECTED"/>
  </EVENT>
  <CC start="19" rule="EKR:PTM" paragraph="paragraph11" uttnum="96" refid="V1331147" end="87" id="R000228">
    <text>Ack1 directly phosphorylates AKT, &lt;italic&gt;in vitro&lt;/italic&gt; binding </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1331147" role=":FACTOR"/>
    <arg id="R000227" role=":OUTCOME"/>
  </CC>
  <TERM end="115" paragraph="paragraph11" start="111" uttnum="96" id="R000229" refid="V1331378" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm event="V1331389" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT refid="V1331389" end="147" id="R000230" uttnum="96" paragraph="paragraph11" start="111" rule="EKR:PTM">
    <type>ONT::INCREASE</type>
    <text>AKT Tyr-phosphorylation was assessed</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000229"/>
  </EVENT>
  <CC start="111" rule="EKR:PTM" paragraph="paragraph11" uttnum="96" end="147" id="R000231" refid="V1331389">
    <text>AKT Tyr-phosphorylation was assessed</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1331389" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000230"/>
  </CC>
  <EVENT paragraph="paragraph11" start="111" rule="EKR:PTM" refid="V1331389" end="147" id="R000232" uttnum="96">
    <text>AKT Tyr-phosphorylation was assessed</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1331378" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph11" start="111" rule="EKR:PTM" refid="V1331389" end="147" id="R000233" uttnum="96">
    <text>AKT Tyr-phosphorylation was assessed</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1331389"/>
    <arg role=":OUTCOME" id="R000232"/>
  </CC>
  <TERM end="472" paragraph="paragraph11" start="468" uttnum="98" id="R000234" refid="V1359388" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm event="V1359404" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT paragraph="paragraph11" start="465" rule="EKR:PTM" refid="V1359404" id="R000235" end="495" uttnum="98">
    <type>ONT::INCREASE</type>
    <text>in AKT Tyr176-phosphorylation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000234" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="98" id="R000236" end="495" refid="V1359404" start="465" rule="EKR:PTM" paragraph="paragraph11">
    <text>in AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1359404"/>
    <arg role=":OUTCOME" id="R000235"/>
  </CC>
  <EVENT uttnum="98" id="R000237" end="495" refid="V1359404" rule="EKR:PTM" start="465" paragraph="paragraph11">
    <type>ONT::DECREASE</type>
    <text>in AKT Tyr176-phosphorylation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1359388" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph11" start="465" rule="EKR:PTM" id="R000238" end="495" refid="V1359404" uttnum="98">
    <text>in AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1359404" role=":FACTOR"/>
    <arg id="R000237" role=":OUTCOME"/>
  </CC>
  <TERM end="149" paragraph="paragraph12" start="145" uttnum="103" id="R000239" refid="V1441497" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm event="V1441519" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT refid="V1441519" end="221" id="R000240" uttnum="103" paragraph="paragraph12" start="140" rule="EKR:PTM">
    <text>that AKT was phosphorylated at Tyrosine 176 (&lt;xref&gt;&lt;bold&gt;Fig. 1C–E&lt;/bold&gt;&lt;/xref&gt;)</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000239"/>
  </EVENT>
  <CC id="R000241" end="221" refid="V1441519" uttnum="103" paragraph="paragraph12" rule="EKR:PTM" start="140">
    <text>that AKT was phosphorylated at Tyrosine 176 (&lt;xref&gt;&lt;bold&gt;Fig. 1C–E&lt;/bold&gt;&lt;/xref&gt;)</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1441519" role=":FACTOR"/>
    <arg id="R000240" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V1441519" end="221" id="R000242" uttnum="103" paragraph="paragraph12" rule="EKR:PTM" start="140">
    <text>that AKT was phosphorylated at Tyrosine 176 (&lt;xref&gt;&lt;bold&gt;Fig. 1C–E&lt;/bold&gt;&lt;/xref&gt;)</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1441497" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" start="140" paragraph="paragraph12" uttnum="103" end="221" id="R000243" refid="V1441519">
    <type>ONT::CAUSE-EFFECT</type>
    <text>that AKT was phosphorylated at Tyrosine 176 (&lt;xref&gt;&lt;bold&gt;Fig. 1C–E&lt;/bold&gt;&lt;/xref&gt;)</text>
    <arg role=":FACTOR" id="V1441519"/>
    <arg role=":OUTCOME" id="R000242"/>
  </CC>
  <TERM end="861" paragraph="paragraph12" start="857" uttnum="107" id="R000244" refid="V1499609" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1499625"/>
    </features>
  </TERM>
  <EVENT refid="V1499625" id="R000245" end="884" uttnum="107" paragraph="paragraph12" rule="EKR:PTM" start="857">
    <type>ONT::INCREASE</type>
    <text>AKT Tyr176-phosphorylation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000244" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="107" id="R000246" end="884" refid="V1499625" rule="EKR:PTM" start="857" paragraph="paragraph12">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT Tyr176-phosphorylation </text>
    <arg id="V1499625" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000245"/>
  </CC>
  <EVENT uttnum="107" end="884" id="R000247" refid="V1499625" rule="EKR:PTM" start="857" paragraph="paragraph12">
    <type>ONT::DECREASE</type>
    <text>AKT Tyr176-phosphorylation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1499609" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph12" start="857" rule="EKR:PTM" end="884" id="R000248" refid="V1499625" uttnum="107">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1499625" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000247"/>
  </CC>
  <TERM end="1608" paragraph="paragraph12" start="1604" uttnum="110" id="R000249" refid="V1557205" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm event="V1557216" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT rule="EKR:PTM" start="1590" paragraph="paragraph12" uttnum="110" refid="V1557216" id="R000250" end="1628">
    <text>Ack1 mediated AKT Tyr-phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000249" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph12" start="1590" rule="EKR:PTM" end="1628" id="R000251" refid="V1557216" uttnum="110">
    <text>Ack1 mediated AKT Tyr-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1557216" role=":FACTOR"/>
    <arg id="R000250" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph12" rule="EKR:PTM" start="1590" refid="V1557216" id="R000252" end="1628" uttnum="110">
    <text>Ack1 mediated AKT Tyr-phosphorylation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1557205" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V1557216" id="R000253" end="1628" uttnum="110" paragraph="paragraph12" start="1590" rule="EKR:PTM">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ack1 mediated AKT Tyr-phosphorylation </text>
    <arg id="V1557216" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000252"/>
  </CC>
  <TERM end="212" paragraph="paragraph16" start="208" uttnum="134" id="R000254" refid="V1938887" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V1938898"/>
    </features>
  </TERM>
  <EVENT uttnum="134" refid="V1938898" id="R000255" end="232" rule="EKR:PTM" start="208" paragraph="paragraph16">
    <type>ONT::INCREASE</type>
    <text>AKT Tyr-phosphorylation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000254"/>
  </EVENT>
  <CC paragraph="paragraph16" start="208" rule="EKR:PTM" end="232" id="R000256" refid="V1938898" uttnum="134">
    <text>AKT Tyr-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1938898" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000255"/>
  </CC>
  <EVENT uttnum="134" end="232" id="R000257" refid="V1938898" rule="EKR:PTM" start="208" paragraph="paragraph16">
    <text>AKT Tyr-phosphorylation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1938887"/>
  </EVENT>
  <CC uttnum="134" refid="V1938898" end="232" id="R000258" rule="EKR:PTM" start="208" paragraph="paragraph16">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT Tyr-phosphorylation </text>
    <arg id="V1938898" role=":FACTOR"/>
    <arg id="R000257" role=":OUTCOME"/>
  </CC>
  <TERM end="573" paragraph="paragraph16" start="569" uttnum="137" id="R000259" refid="V1971316" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm event="V1971332" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT rule="EKR:PTM" start="566" paragraph="paragraph16" uttnum="137" refid="V1971332" id="R000260" end="596">
    <text>of AKT Tyr176-phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000259" role=":AFFECTED"/>
  </EVENT>
  <CC start="566" rule="EKR:PTM" paragraph="paragraph16" uttnum="137" id="R000261" end="596" refid="V1971332">
    <type>ONT::CAUSE-EFFECT</type>
    <text>of AKT Tyr176-phosphorylation </text>
    <arg id="V1971332" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000260"/>
  </CC>
  <EVENT rule="EKR:PTM" start="566" paragraph="paragraph16" uttnum="137" refid="V1971332" id="R000262" end="596">
    <text>of AKT Tyr176-phosphorylation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1971316" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph16" start="566" rule="EKR:PTM" id="R000263" end="596" refid="V1971332" uttnum="137">
    <text>of AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1971332"/>
    <arg id="R000262" role=":OUTCOME"/>
  </CC>
  <TERM end="1732" paragraph="paragraph16" start="1704" uttnum="143" id="R000264" refid="V2071409" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT Tyr-176 phosphorylation</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2071425"/>
    </features>
  </TERM>
  <EVENT refid="V2071425" id="R000265" end="1732" uttnum="143" paragraph="paragraph16" start="1704" rule="EKR:PTM">
    <type>ONT::INCREASE</type>
    <text>AKT Tyr-176 phosphorylation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000264" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph16" rule="EKR:PTM" start="1704" end="1732" id="R000266" refid="V2071425" uttnum="143">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT Tyr-176 phosphorylation </text>
    <arg id="V2071425" role=":FACTOR"/>
    <arg id="R000265" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="143" refid="V2071425" id="R000267" end="1732" start="1704" rule="EKR:PTM" paragraph="paragraph16">
    <text>AKT Tyr-176 phosphorylation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2071409" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph16" rule="EKR:PTM" start="1704" id="R000268" end="1732" refid="V2071425" uttnum="143">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT Tyr-176 phosphorylation </text>
    <arg id="V2071425" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000267"/>
  </CC>
  <TERM end="2454" paragraph="paragraph16" start="2450" uttnum="147" id="R000269" refid="V2140064" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2140080"/>
    </features>
  </TERM>
  <EVENT paragraph="paragraph16" rule="EKR:PTM" start="2450" end="2476" id="R000270" refid="V2140080" uttnum="147">
    <text>AKT Tyr176-phosphorylation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000269"/>
  </EVENT>
  <CC rule="EKR:PTM" start="2450" paragraph="paragraph16" uttnum="147" end="2476" id="R000271" refid="V2140080">
    <text>AKT Tyr176-phosphorylation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2140080" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000270"/>
  </CC>
  <EVENT rule="EKR:PTM" start="2450" paragraph="paragraph16" uttnum="147" end="2476" id="R000272" refid="V2140080">
    <type>ONT::DECREASE</type>
    <text>AKT Tyr176-phosphorylation</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2140064"/>
  </EVENT>
  <CC uttnum="147" refid="V2140080" id="R000273" end="2476" rule="EKR:PTM" start="2450" paragraph="paragraph16">
    <text>AKT Tyr176-phosphorylation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2140080" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000272"/>
  </CC>
  <TERM end="129" paragraph="paragraph17" start="125" uttnum="150" id="R000274" refid="V2196687" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2196703"/>
    </features>
  </TERM>
  <EVENT paragraph="paragraph17" start="125" rule="EKR:PTM" id="R000275" end="152" refid="V2196703" uttnum="150">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000274"/>
  </EVENT>
  <CC start="125" rule="EKR:PTM" paragraph="paragraph17" uttnum="150" end="152" id="R000276" refid="V2196703">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT Tyr176-phosphorylation </text>
    <arg role=":FACTOR" id="V2196703"/>
    <arg id="R000275" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph17" rule="EKR:PTM" start="125" end="152" id="R000277" refid="V2196703" uttnum="150">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2196687"/>
  </EVENT>
  <CC uttnum="150" refid="V2196703" id="R000278" end="152" start="125" rule="EKR:PTM" paragraph="paragraph17">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT Tyr176-phosphorylation </text>
    <arg id="V2196703" role=":FACTOR"/>
    <arg id="R000277" role=":OUTCOME"/>
  </CC>
  <TERM end="256" paragraph="paragraph17" start="241" uttnum="151" id="R000279" refid="V2210630" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">endogenous AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2210646"/>
    </features>
  </TERM>
  <EVENT uttnum="151" end="279" id="R000280" refid="V2210646" start="232" rule="EKR:PTM" paragraph="paragraph17">
    <text>affected endogenous AKT Tyr176-phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000279"/>
  </EVENT>
  <CC uttnum="151" id="R000281" end="279" refid="V2210646" start="232" rule="EKR:PTM" paragraph="paragraph17">
    <text>affected endogenous AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2210646"/>
    <arg role=":OUTCOME" id="R000280"/>
  </CC>
  <EVENT paragraph="paragraph17" start="232" rule="EKR:PTM" refid="V2210646" end="279" id="R000282" uttnum="151">
    <type>ONT::DECREASE</type>
    <text>affected endogenous AKT Tyr176-phosphorylation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2210630"/>
  </EVENT>
  <CC refid="V2210646" id="R000283" end="279" uttnum="151" paragraph="paragraph17" start="232" rule="EKR:PTM">
    <type>ONT::CAUSE-EFFECT</type>
    <text>affected endogenous AKT Tyr176-phosphorylation </text>
    <arg id="V2210646" role=":FACTOR"/>
    <arg id="R000282" role=":OUTCOME"/>
  </CC>
  <TERM end="571" paragraph="paragraph17" start="564" uttnum="153" id="R000284" refid="V2231376" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of AKT</text>
    <features>
      <ptm event="V2231364" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT start="541" rule="EKR:PTM" paragraph="paragraph17" uttnum="153" end="571" id="R000285" refid="V2231364">
    <text>Ser473 phosphorylation of AKT </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000284"/>
  </EVENT>
  <CC id="R000286" end="571" refid="V2231364" uttnum="153" paragraph="paragraph17" rule="EKR:PTM" start="541">
    <text>Ser473 phosphorylation of AKT </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2231364"/>
    <arg role=":OUTCOME" id="R000285"/>
  </CC>
  <EVENT rule="EKR:PTM" start="541" paragraph="paragraph17" uttnum="153" refid="V2231364" end="571" id="R000287">
    <type>ONT::DECREASE</type>
    <text>Ser473 phosphorylation of AKT </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2231376" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="153" end="571" id="R000288" refid="V2231364" rule="EKR:PTM" start="541" paragraph="paragraph17">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ser473 phosphorylation of AKT </text>
    <arg role=":FACTOR" id="V2231364"/>
    <arg role=":OUTCOME" id="R000287"/>
  </CC>
  <TERM end="719" paragraph="paragraph17" start="715" uttnum="154" id="R000289" refid="V2235369" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm event="V2235391" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT id="R000290" end="818" refid="V2235391" uttnum="154" paragraph="paragraph17" start="715" rule="EKR:PTM">
    <text>AKT was phosphorylated at Ser473 even in the presence of LY294002 when coexpressed with activated Ack1 </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000289"/>
  </EVENT>
  <CC paragraph="paragraph17" rule="EKR:PTM" start="715" end="818" id="R000291" refid="V2235391" uttnum="154">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT was phosphorylated at Ser473 even in the presence of LY294002 when coexpressed with activated Ack1 </text>
    <arg id="V2235391" role=":FACTOR"/>
    <arg id="R000290" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="154" refid="V2235391" id="R000292" end="818" start="715" rule="EKR:PTM" paragraph="paragraph17">
    <text>AKT was phosphorylated at Ser473 even in the presence of LY294002 when coexpressed with activated Ack1 </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2235369"/>
  </EVENT>
  <CC paragraph="paragraph17" start="715" rule="EKR:PTM" id="R000293" end="818" refid="V2235391" uttnum="154">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT was phosphorylated at Ser473 even in the presence of LY294002 when coexpressed with activated Ack1 </text>
    <arg id="V2235391" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000292"/>
  </CC>
  <TERM end="1672" paragraph="paragraph17" start="1638" uttnum="158" id="R000294" refid="V2290914" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT that is Tyr176-phosphorylated</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2290965"/>
    </features>
  </TERM>
  <EVENT uttnum="158" refid="V2290965" id="R000295" end="1672" start="1638" rule="EKR:PTM" paragraph="paragraph17">
    <text>AKT that is Tyr176-phosphorylated </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000294"/>
  </EVENT>
  <CC start="1638" rule="EKR:PTM" paragraph="paragraph17" uttnum="158" end="1672" id="R000296" refid="V2290965">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT that is Tyr176-phosphorylated </text>
    <arg id="V2290965" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000295"/>
  </CC>
  <EVENT end="1672" id="R000297" refid="V2290965" uttnum="158" paragraph="paragraph17" rule="EKR:PTM" start="1638">
    <type>ONT::DECREASE</type>
    <text>AKT that is Tyr176-phosphorylated </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2290914" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" start="1638" paragraph="paragraph17" uttnum="158" end="1672" id="R000298" refid="V2290965">
    <text>AKT that is Tyr176-phosphorylated </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2290965" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000297"/>
  </CC>
  <TERM end="477" paragraph="paragraph19" start="468" uttnum="168" id="R000299" refid="V2467123" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">that AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2467139"/>
    </features>
  </TERM>
  <EVENT uttnum="168" refid="V2467139" end="500" id="R000300" rule="EKR:PTM" start="410" paragraph="paragraph19">
    <text>significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000299"/>
  </EVENT>
  <CC paragraph="paragraph19" rule="EKR:PTM" start="410" refid="V2467139" id="R000301" end="500" uttnum="168">
    <text>significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2467139" role=":FACTOR"/>
    <arg id="R000300" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph19" start="410" rule="EKR:PTM" refid="V2467139" id="R000302" end="500" uttnum="168">
    <type>ONT::DECREASE</type>
    <text>significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2467123"/>
  </EVENT>
  <CC end="500" id="R000303" refid="V2467139" uttnum="168" paragraph="paragraph19" rule="EKR:PTM" start="410">
    <text>significant decrease in Thr308-phosphorylation confirming that AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2467139"/>
    <arg id="R000302" role=":OUTCOME"/>
  </CC>
  <TERM end="1957" paragraph="paragraph20" start="1953" uttnum="183" id="R000304" refid="V2667121" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2667137"/>
    </features>
  </TERM>
  <EVENT uttnum="183" refid="V2667137" id="R000305" end="1980" start="1953" rule="EKR:PTM" paragraph="paragraph20">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000304"/>
  </EVENT>
  <CC paragraph="paragraph20" start="1953" rule="EKR:PTM" id="R000306" end="1980" refid="V2667137" uttnum="183">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2667137"/>
    <arg role=":OUTCOME" id="R000305"/>
  </CC>
  <EVENT paragraph="paragraph20" start="1953" rule="EKR:PTM" refid="V2667137" id="R000307" end="1980" uttnum="183">
    <type>ONT::DECREASE</type>
    <text>AKT Tyr176-phosphorylation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2667121" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" start="1953" paragraph="paragraph20" uttnum="183" id="R000308" end="1980" refid="V2667137">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2667137"/>
    <arg role=":OUTCOME" id="R000307"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="93" paragraph="paragraph22" start="88" uttnum="193" id="R000309" refid="V2869657" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2869660"/>
    </features>
  </TERM>
  <EVENT uttnum="193" refid="V2869660" end="109" id="R000310" rule="EKR:PTM" start="88" paragraph="paragraph22">
    <type>ONT::INCREASE</type>
    <text>Ack1 phosphorylation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000309" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" start="88" paragraph="paragraph22" uttnum="193" end="109" id="R000311" refid="V2869660">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ack1 phosphorylation </text>
    <arg role=":FACTOR" id="V2869660"/>
    <arg id="R000310" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="193" end="109" id="R000312" refid="V2869660" rule="EKR:PTM" start="88" paragraph="paragraph22">
    <text>Ack1 phosphorylation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2869657" role=":AFFECTED"/>
  </EVENT>
  <CC end="109" id="R000313" refid="V2869660" uttnum="193" paragraph="paragraph22" start="88" rule="EKR:PTM">
    <text>Ack1 phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2869660"/>
    <arg role=":OUTCOME" id="R000312"/>
  </CC>
  <TERM end="280" paragraph="paragraph22" start="276" uttnum="195" id="R000314" refid="V2900932" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2900927"/>
    </features>
  </TERM>
  <EVENT paragraph="paragraph22" rule="EKR:PTM" start="246" refid="V2900927" end="361" id="R000315" uttnum="195">
    <text>Activated Ack1 phosphorylates AKT at Tyr176 resulting in its binding to the anionic plasma membrane phospholipid PA</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000314"/>
  </EVENT>
  <CC end="361" id="R000316" refid="V2900927" uttnum="195" paragraph="paragraph22" start="246" rule="EKR:PTM">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Activated Ack1 phosphorylates AKT at Tyr176 resulting in its binding to the anionic plasma membrane phospholipid PA</text>
    <arg role=":FACTOR" id="V2900927"/>
    <arg role=":OUTCOME" id="R000315"/>
  </CC>
  <EVENT paragraph="paragraph22" start="246" rule="EKR:PTM" refid="V2900927" id="R000317" end="361" uttnum="195">
    <type>ONT::DECREASE</type>
    <text>Activated Ack1 phosphorylates AKT at Tyr176 resulting in its binding to the anionic plasma membrane phospholipid PA</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2900932" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph22" rule="EKR:PTM" start="246" refid="V2900927" end="361" id="R000318" uttnum="195">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Activated Ack1 phosphorylates AKT at Tyr176 resulting in its binding to the anionic plasma membrane phospholipid PA</text>
    <arg role=":FACTOR" id="V2900927"/>
    <arg id="R000317" role=":OUTCOME"/>
  </CC>
  <TERM dbid="GO:0001071|GO:0001070" end="641" paragraph="paragraph22" start="614" uttnum="196" id="R000319" refid="V2916927" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>TRANSCRIPTION-FACTORS</name>
    <text>FoxO transcription factors</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V2916864"/>
    </features>
  </TERM>
  <EVENT refid="V2916864" end="688" id="R000320" uttnum="196" paragraph="paragraph22" rule="EKR:PTM" start="599">
    <type>ONT::INCREASE</type>
    <text>phosphorylates FoxO transcription factors to downregulate expression of FoxO target genes</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000319"/>
  </EVENT>
  <CC paragraph="paragraph22" start="599" rule="EKR:PTM" refid="V2916864" id="R000321" end="688" uttnum="196">
    <text>phosphorylates FoxO transcription factors to downregulate expression of FoxO target genes</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2916864" role=":FACTOR"/>
    <arg id="R000320" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="196" id="R000322" end="688" refid="V2916864" rule="EKR:PTM" start="599" paragraph="paragraph22">
    <text>phosphorylates FoxO transcription factors to downregulate expression of FoxO target genes</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2916927" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph22" start="599" rule="EKR:PTM" refid="V2916864" end="688" id="R000323" uttnum="196">
    <text>phosphorylates FoxO transcription factors to downregulate expression of FoxO target genes</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2916864"/>
    <arg id="R000322" role=":OUTCOME"/>
  </CC>
  <TERM end="141" paragraph="paragraph24" start="134" uttnum="207" id="R000324" refid="V3036124" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">of AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3036112"/>
    </features>
  </TERM>
  <EVENT id="R000325" end="141" refid="V3036112" uttnum="207" paragraph="paragraph24" start="111" rule="EKR:PTM">
    <type>ONT::INCREASE</type>
    <text>Tyr176 phosphorylation of AKT </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000324" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" start="111" paragraph="paragraph24" uttnum="207" refid="V3036112" end="141" id="R000326">
    <text>Tyr176 phosphorylation of AKT </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3036112"/>
    <arg id="R000325" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V3036112" id="R000327" end="141" uttnum="207" paragraph="paragraph24" rule="EKR:PTM" start="111">
    <type>ONT::DECREASE</type>
    <text>Tyr176 phosphorylation of AKT </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3036124" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" start="111" paragraph="paragraph24" uttnum="207" refid="V3036112" id="R000328" end="141">
    <text>Tyr176 phosphorylation of AKT </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3036112"/>
    <arg role=":OUTCOME" id="R000327"/>
  </CC>
  <TERM end="236" paragraph="paragraph25" start="209" uttnum="211" id="R000329" refid="V3091421" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT in the plasma membrane</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3091524"/>
    </features>
  </TERM>
  <EVENT uttnum="211" id="R000330" end="298" refid="V3091524" start="192" rule="EKR:PTM" paragraph="paragraph25">
    <text>demonstrate that AKT in the plasma membrane is phosphorylated at Tyr 176 and mutation of this site in AKT </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000329" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" start="192" paragraph="paragraph25" uttnum="211" refid="V3091524" end="298" id="R000331">
    <text>demonstrate that AKT in the plasma membrane is phosphorylated at Tyr 176 and mutation of this site in AKT </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3091524" role=":FACTOR"/>
    <arg id="R000330" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph25" start="192" rule="EKR:PTM" id="R000332" end="298" refid="V3091524" uttnum="211">
    <text>demonstrate that AKT in the plasma membrane is phosphorylated at Tyr 176 and mutation of this site in AKT </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3091421"/>
  </EVENT>
  <CC paragraph="paragraph25" start="192" rule="EKR:PTM" id="R000333" end="298" refid="V3091524" uttnum="211">
    <type>ONT::CAUSE-EFFECT</type>
    <text>demonstrate that AKT in the plasma membrane is phosphorylated at Tyr 176 and mutation of this site in AKT </text>
    <arg id="V3091524" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000332"/>
  </CC>
  <TERM end="866" paragraph="paragraph25" start="862" uttnum="214" id="R000334" refid="V3150183" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm type="ONT::PHOSPHORYLATION" event="V3150178"/>
    </features>
  </TERM>
  <EVENT start="823" rule="EKR:PTM" paragraph="paragraph25" uttnum="214" id="R000335" end="876" refid="V3150178">
    <text>Activated Ack1 directly phosphorylates AKT at Tyr176,</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000334"/>
  </EVENT>
  <CC id="R000336" end="876" refid="V3150178" uttnum="214" paragraph="paragraph25" start="823" rule="EKR:PTM">
    <text>Activated Ack1 directly phosphorylates AKT at Tyr176,</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3150178"/>
    <arg role=":OUTCOME" id="R000335"/>
  </CC>
  <EVENT refid="V3150178" end="876" id="R000337" uttnum="214" paragraph="paragraph25" rule="EKR:PTM" start="823">
    <type>ONT::DECREASE</type>
    <text>Activated Ack1 directly phosphorylates AKT at Tyr176,</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3150183"/>
  </EVENT>
  <CC end="876" id="R000338" refid="V3150178" uttnum="214" paragraph="paragraph25" start="823" rule="EKR:PTM">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Activated Ack1 directly phosphorylates AKT at Tyr176,</text>
    <arg id="V3150178" role=":FACTOR"/>
    <arg id="R000337" role=":OUTCOME"/>
  </CC>
  <TERM end="1315" paragraph="paragraph25" start="1311" uttnum="217" id="R000339" refid="V3184697" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm event="V3184713" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT start="1297" rule="EKR:PTM" paragraph="paragraph25" uttnum="217" refid="V3184713" end="1338" id="R000340">
    <type>ONT::INCREASE</type>
    <text>Ack1 mediated AKT Tyr176-phosphorylation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000339" role=":AFFECTED"/>
  </EVENT>
  <CC start="1297" rule="EKR:PTM" paragraph="paragraph25" uttnum="217" id="R000341" end="1338" refid="V3184713">
    <text>Ack1 mediated AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3184713"/>
    <arg id="R000340" role=":OUTCOME"/>
  </CC>
  <EVENT start="1297" rule="EKR:PTM" paragraph="paragraph25" uttnum="217" id="R000342" end="1338" refid="V3184713">
    <type>ONT::DECREASE</type>
    <text>Ack1 mediated AKT Tyr176-phosphorylation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3184697" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="217" refid="V3184713" id="R000343" end="1338" start="1297" rule="EKR:PTM" paragraph="paragraph25">
    <text>Ack1 mediated AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3184713"/>
    <arg id="R000342" role=":OUTCOME"/>
  </CC>
  <TERM end="1396" paragraph="paragraph25" start="1392" uttnum="218" id="R000344" refid="V3200180" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm event="V3200196" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT uttnum="218" end="1419" id="R000345" refid="V3200196" start="1392" rule="EKR:PTM" paragraph="paragraph25">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000344" role=":AFFECTED"/>
  </EVENT>
  <CC start="1392" rule="EKR:PTM" paragraph="paragraph25" uttnum="218" refid="V3200196" id="R000346" end="1419">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3200196" role=":FACTOR"/>
    <arg id="R000345" role=":OUTCOME"/>
  </CC>
  <EVENT start="1392" rule="EKR:PTM" paragraph="paragraph25" uttnum="218" refid="V3200196" id="R000347" end="1419">
    <type>ONT::DECREASE</type>
    <text>AKT Tyr176-phosphorylation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3200180" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000348" end="1419" refid="V3200196" uttnum="218" paragraph="paragraph25" rule="EKR:PTM" start="1392">
    <text>AKT Tyr176-phosphorylation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3200196"/>
    <arg id="R000347" role=":OUTCOME"/>
  </CC>
  <TERM dbid="UP:P31751" end="622" paragraph="paragraph27" start="614" uttnum="226" id="R000349" refid="V3337226" rule="EKR:PTM">
    <type>ONT::PROTEIN</type>
    <name>AKT-2</name>
    <text>of AKT2</text>
    <features>
      <ptm event="V3337209" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT uttnum="226" refid="V3337209" id="R000350" end="674" start="564" rule="EKR:PTM" paragraph="paragraph27">
    <text>demonstrates significant tyrosine phosphorylation of AKT2 upon coexpression of Ack1 and AKT2 in HEK293T cells,</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000349" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:PTM" start="564" paragraph="paragraph27" uttnum="226" refid="V3337209" end="674" id="R000351">
    <type>ONT::CAUSE-EFFECT</type>
    <text>demonstrates significant tyrosine phosphorylation of AKT2 upon coexpression of Ack1 and AKT2 in HEK293T cells,</text>
    <arg role=":FACTOR" id="V3337209"/>
    <arg role=":OUTCOME" id="R000350"/>
  </CC>
  <EVENT id="R000352" end="674" refid="V3337209" uttnum="226" paragraph="paragraph27" start="564" rule="EKR:PTM">
    <type>ONT::DECREASE</type>
    <text>demonstrates significant tyrosine phosphorylation of AKT2 upon coexpression of Ack1 and AKT2 in HEK293T cells,</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3337226"/>
  </EVENT>
  <CC refid="V3337209" id="R000353" end="674" uttnum="226" paragraph="paragraph27" start="564" rule="EKR:PTM">
    <type>ONT::CAUSE-EFFECT</type>
    <text>demonstrates significant tyrosine phosphorylation of AKT2 upon coexpression of Ack1 and AKT2 in HEK293T cells,</text>
    <arg role=":FACTOR" id="V3337209"/>
    <arg id="R000352" role=":OUTCOME"/>
  </CC>
  <TERM end="442" paragraph="paragraph28" start="438" uttnum="230" id="R000354" refid="V3387567" rule="EKR:PTM">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <ptm event="V3387600" type="ONT::PHOSPHORYLATION"/>
    </features>
  </TERM>
  <EVENT uttnum="230" refid="V3387600" end="492" id="R000355" rule="EKR:PTM" start="438" paragraph="paragraph28">
    <type>ONT::INCREASE</type>
    <text>AKT can be phosphorylated at Tyr176 by other receptor </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000354" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph28" rule="EKR:PTM" start="438" end="492" id="R000356" refid="V3387600" uttnum="230">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT can be phosphorylated at Tyr176 by other receptor </text>
    <arg role=":FACTOR" id="V3387600"/>
    <arg role=":OUTCOME" id="R000355"/>
  </CC>
  <EVENT end="492" id="R000357" refid="V3387600" uttnum="230" paragraph="paragraph28" start="438" rule="EKR:PTM">
    <text>AKT can be phosphorylated at Tyr176 by other receptor </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3387567" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="230" end="492" id="R000358" refid="V3387600" rule="EKR:PTM" start="438" paragraph="paragraph28">
    <text>AKT can be phosphorylated at Tyr176 by other receptor </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3387600" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000357"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="90" paragraph="paragraph0" start="76" uttnum="1" id="R000359" refid="V32067" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Its Activation</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT id="R000360" end="90" refid="V32070" uttnum="1" paragraph="paragraph0" start="76" rule="EKR:ActivateX">
    <text>Its Activation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000359"/>
  </EVENT>
  <CC uttnum="1" end="90" id="R000361" refid="V32070" start="76" rule="EKR:ActivateX" paragraph="paragraph0">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Its Activation</text>
    <arg id="V32070" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000360"/>
  </CC>
  <EVENT rule="EKR:ActivateX" start="76" paragraph="paragraph0" uttnum="1" refid="V32070" id="R000362" end="90">
    <text>Its Activation</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V32067" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph0" start="76" rule="EKR:ActivateX" refid="V32070" end="90" id="R000363" uttnum="1">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Its Activation</text>
    <arg role=":FACTOR" id="V32070"/>
    <arg role=":OUTCOME" id="R000362"/>
  </CC>
  <TERM dbid="GO:0016301" end="287" paragraph="paragraph1" start="273" uttnum="3" id="R000364" refid="V53958" rule="EKR:ActivateX">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase (PI3K)</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:ActivateX" start="273" paragraph="paragraph1" uttnum="3" refid="V54007" end="298" id="R000365">
    <text>kinase (PI3K) activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000364" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph1" start="273" rule="EKR:ActivateX" id="R000366" end="298" refid="V54007" uttnum="3">
    <type>ONT::CAUSE-EFFECT</type>
    <text>kinase (PI3K) activation </text>
    <arg role=":FACTOR" id="V54007"/>
    <arg id="R000365" role=":OUTCOME"/>
  </CC>
  <EVENT start="273" rule="EKR:ActivateX" paragraph="paragraph1" uttnum="3" refid="V54007" end="298" id="R000367">
    <type>ONT::DECREASE</type>
    <text>kinase (PI3K) activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V53958"/>
  </EVENT>
  <CC paragraph="paragraph1" start="273" rule="EKR:ActivateX" refid="V54007" end="298" id="R000368" uttnum="3">
    <text>kinase (PI3K) activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V54007"/>
    <arg id="R000367" role=":OUTCOME"/>
  </CC>
  <TERM end="454" paragraph="paragraph1" start="421" uttnum="4" id="R000369" refid="V67461" rule="EKR:ActivateX">
    <type>ONT::PROTEIN</type>
    <name>TYROSINE</name>
    <assoc-with id="V67456"/>
    <text>of a non-receptor tyrosine kinase</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V67381" id="R000370" end="454" uttnum="4" paragraph="paragraph1" rule="EKR:ActivateX" start="407">
    <type>ONT::INCREASE</type>
    <text>to activation of a non-receptor tyrosine kinase</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000369" role=":AFFECTED"/>
  </EVENT>
  <CC start="407" rule="EKR:ActivateX" paragraph="paragraph1" uttnum="4" refid="V67381" id="R000371" end="454">
    <text>to activation of a non-receptor tyrosine kinase</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V67381"/>
    <arg id="R000370" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph1" rule="EKR:ActivateX" start="407" id="R000372" end="454" refid="V67381" uttnum="4">
    <type>ONT::DECREASE</type>
    <text>to activation of a non-receptor tyrosine kinase</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V67461"/>
  </EVENT>
  <CC start="407" rule="EKR:ActivateX" paragraph="paragraph1" uttnum="4" refid="V67381" end="454" id="R000373">
    <text>to activation of a non-receptor tyrosine kinase</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V67381" role=":FACTOR"/>
    <arg id="R000372" role=":OUTCOME"/>
  </CC>
  <TERM end="707" paragraph="paragraph1" start="703" uttnum="5" id="R000374" refid="V86252" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V86256" id="R000375" end="717" uttnum="5" paragraph="paragraph1" start="703" rule="EKR:ActivateX">
    <type>ONT::INCREASE</type>
    <text>AKT activation</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000374"/>
  </EVENT>
  <CC uttnum="5" refid="V86256" id="R000376" end="717" start="703" rule="EKR:ActivateX" paragraph="paragraph1">
    <text>AKT activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V86256"/>
    <arg id="R000375" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="5" end="717" id="R000377" refid="V86256" rule="EKR:ActivateX" start="703" paragraph="paragraph1">
    <text>AKT activation</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V86252" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="5" refid="V86256" id="R000378" end="717" start="703" rule="EKR:ActivateX" paragraph="paragraph1">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation</text>
    <arg role=":FACTOR" id="V86256"/>
    <arg role=":OUTCOME" id="R000377"/>
  </CC>
  <TERM end="144" paragraph="paragraph2" start="140" uttnum="10" id="R000379" refid="V168227" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V168231" id="R000380" end="155" uttnum="10" paragraph="paragraph2" rule="EKR:ActivateX" start="140">
    <type>ONT::INCREASE</type>
    <text>AKT activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000379" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V168231" end="155" id="R000381" uttnum="10" paragraph="paragraph2" rule="EKR:ActivateX" start="140">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation </text>
    <arg role=":FACTOR" id="V168231"/>
    <arg role=":OUTCOME" id="R000380"/>
  </CC>
  <EVENT paragraph="paragraph2" rule="EKR:ActivateX" start="140" refid="V168231" end="155" id="R000382" uttnum="10">
    <text>AKT activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V168227" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V168231" id="R000383" end="155" uttnum="10" paragraph="paragraph2" start="140" rule="EKR:ActivateX">
    <text>AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V168231" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000382"/>
  </CC>
  <TERM dbid="GO:0016301" end="602" paragraph="paragraph2" start="595" uttnum="11" id="R000384" refid="V193607" rule="EKR:ActivateX">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V193610" id="R000385" end="630" uttnum="11" paragraph="paragraph2" start="588" rule="EKR:ActivateX">
    <text>to its kinase activation &lt;xref&gt;[10]&lt;/xref&gt;</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000384" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph2" start="588" rule="EKR:ActivateX" id="R000386" end="630" refid="V193610" uttnum="11">
    <text>to its kinase activation &lt;xref&gt;[10]&lt;/xref&gt;</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V193610" role=":FACTOR"/>
    <arg id="R000385" role=":OUTCOME"/>
  </CC>
  <EVENT start="588" rule="EKR:ActivateX" paragraph="paragraph2" uttnum="11" id="R000387" end="630" refid="V193610">
    <text>to its kinase activation &lt;xref&gt;[10]&lt;/xref&gt;</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V193607"/>
  </EVENT>
  <CC refid="V193610" id="R000388" end="630" uttnum="11" paragraph="paragraph2" rule="EKR:ActivateX" start="588">
    <type>ONT::CAUSE-EFFECT</type>
    <text>to its kinase activation &lt;xref&gt;[10]&lt;/xref&gt;</text>
    <arg role=":FACTOR" id="V193610"/>
    <arg role=":OUTCOME" id="R000387"/>
  </CC>
  <TERM end="798" paragraph="paragraph2" start="794" uttnum="13" id="R000389" refid="V223396" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="13" end="808" id="R000390" refid="V223399" start="794" rule="EKR:ActivateX" paragraph="paragraph2">
    <text>AKT activation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000389"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="794" paragraph="paragraph2" uttnum="13" refid="V223399" end="808" id="R000391">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation</text>
    <arg role=":FACTOR" id="V223399"/>
    <arg role=":OUTCOME" id="R000390"/>
  </CC>
  <EVENT start="794" rule="EKR:ActivateX" paragraph="paragraph2" uttnum="13" refid="V223399" id="R000392" end="808">
    <type>ONT::DECREASE</type>
    <text>AKT activation</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V223396" role=":AFFECTED"/>
  </EVENT>
  <CC start="794" rule="EKR:ActivateX" paragraph="paragraph2" uttnum="13" refid="V223399" end="808" id="R000393">
    <text>AKT activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V223399"/>
    <arg role=":OUTCOME" id="R000392"/>
  </CC>
  <TERM end="1143" paragraph="paragraph2" start="1139" uttnum="15" id="R000394" refid="V256859" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V256862" id="R000395" end="1154" uttnum="15" paragraph="paragraph2" start="1139" rule="EKR:ActivateX">
    <type>ONT::INCREASE</type>
    <text>AKT activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000394" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="15" refid="V256862" end="1154" id="R000396" start="1139" rule="EKR:ActivateX" paragraph="paragraph2">
    <text>AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V256862" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000395"/>
  </CC>
  <EVENT start="1139" rule="EKR:ActivateX" paragraph="paragraph2" uttnum="15" refid="V256862" id="R000397" end="1154">
    <text>AKT activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V256859"/>
  </EVENT>
  <CC uttnum="15" refid="V256862" id="R000398" end="1154" start="1139" rule="EKR:ActivateX" paragraph="paragraph2">
    <text>AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V256862" role=":FACTOR"/>
    <arg id="R000397" role=":OUTCOME"/>
  </CC>
  <TERM end="1411" paragraph="paragraph2" start="1407" uttnum="16" id="R000399" refid="V270796" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="16" end="1421" id="R000400" refid="V270799" start="1407" rule="EKR:ActivateX" paragraph="paragraph2">
    <type>ONT::INCREASE</type>
    <text>AKT activation</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000399"/>
  </EVENT>
  <CC refid="V270799" id="R000401" end="1421" uttnum="16" paragraph="paragraph2" rule="EKR:ActivateX" start="1407">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation</text>
    <arg id="V270799" role=":FACTOR"/>
    <arg id="R000400" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V270799" end="1421" id="R000402" uttnum="16" paragraph="paragraph2" start="1407" rule="EKR:ActivateX">
    <text>AKT activation</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V270796" role=":AFFECTED"/>
  </EVENT>
  <CC start="1407" rule="EKR:ActivateX" paragraph="paragraph2" uttnum="16" id="R000403" end="1421" refid="V270799">
    <text>AKT activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V270799" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000402"/>
  </CC>
  <TERM end="1765" paragraph="paragraph2" start="1761" uttnum="18" id="R000404" refid="V315467" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="18" id="R000405" end="1776" refid="V315470" start="1761" rule="EKR:ActivateX" paragraph="paragraph2">
    <type>ONT::INCREASE</type>
    <text>AKT activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000404"/>
  </EVENT>
  <CC id="R000406" end="1776" refid="V315470" uttnum="18" paragraph="paragraph2" rule="EKR:ActivateX" start="1761">
    <text>AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V315470"/>
    <arg id="R000405" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="18" refid="V315470" id="R000407" end="1776" start="1761" rule="EKR:ActivateX" paragraph="paragraph2">
    <text>AKT activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V315467"/>
  </EVENT>
  <CC uttnum="18" refid="V315470" id="R000408" end="1776" start="1761" rule="EKR:ActivateX" paragraph="paragraph2">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation </text>
    <arg id="V315470" role=":FACTOR"/>
    <arg id="R000407" role=":OUTCOME"/>
  </CC>
  <TERM end="1991" paragraph="paragraph2" start="1987" uttnum="19" id="R000409" refid="V331771" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="19" end="2027" id="R000410" refid="V331774" start="1978" rule="EKR:ActivateX" paragraph="paragraph2">
    <type>ONT::INCREASE</type>
    <text>for full AKT activation in situ &lt;xref&gt;[23]&lt;/xref&gt;</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000409"/>
  </EVENT>
  <CC uttnum="19" id="R000411" end="2027" refid="V331774" rule="EKR:ActivateX" start="1978" paragraph="paragraph2">
    <text>for full AKT activation in situ &lt;xref&gt;[23]&lt;/xref&gt;</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V331774"/>
    <arg id="R000410" role=":OUTCOME"/>
  </CC>
  <EVENT start="1978" rule="EKR:ActivateX" paragraph="paragraph2" uttnum="19" id="R000412" end="2027" refid="V331774">
    <text>for full AKT activation in situ &lt;xref&gt;[23]&lt;/xref&gt;</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V331771" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="19" refid="V331774" end="2027" id="R000413" start="1978" rule="EKR:ActivateX" paragraph="paragraph2">
    <text>for full AKT activation in situ &lt;xref&gt;[23]&lt;/xref&gt;</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V331774" role=":FACTOR"/>
    <arg id="R000412" role=":OUTCOME"/>
  </CC>
  <TERM end="2122" paragraph="paragraph2" start="2118" uttnum="20" id="R000414" refid="V347531" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="20" refid="V347535" end="2133" id="R000415" rule="EKR:ActivateX" start="2118" paragraph="paragraph2">
    <type>ONT::INCREASE</type>
    <text>AKT activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000414"/>
  </EVENT>
  <CC end="2133" id="R000416" refid="V347535" uttnum="20" paragraph="paragraph2" start="2118" rule="EKR:ActivateX">
    <text>AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V347535" role=":FACTOR"/>
    <arg id="R000415" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V347535" end="2133" id="R000417" uttnum="20" paragraph="paragraph2" rule="EKR:ActivateX" start="2118">
    <type>ONT::DECREASE</type>
    <text>AKT activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V347531" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph2" start="2118" rule="EKR:ActivateX" id="R000418" end="2133" refid="V347535" uttnum="20">
    <text>AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V347535" role=":FACTOR"/>
    <arg id="R000417" role=":OUTCOME"/>
  </CC>
  <TERM dbid="GO:0016301" end="372" paragraph="paragraph3" start="365" uttnum="22" id="R000419" refid="V370632" rule="EKR:ActivateX">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>kinase</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="22" refid="V370635" id="R000420" end="389" start="358" rule="EKR:ActivateX" paragraph="paragraph3">
    <text>to its kinase activation &lt;xref&gt;</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000419" role=":AFFECTED"/>
  </EVENT>
  <CC start="358" rule="EKR:ActivateX" paragraph="paragraph3" uttnum="22" id="R000421" end="389" refid="V370635">
    <type>ONT::CAUSE-EFFECT</type>
    <text>to its kinase activation &lt;xref&gt;</text>
    <arg role=":FACTOR" id="V370635"/>
    <arg role=":OUTCOME" id="R000420"/>
  </CC>
  <EVENT refid="V370635" id="R000422" end="389" uttnum="22" paragraph="paragraph3" rule="EKR:ActivateX" start="358">
    <text>to its kinase activation &lt;xref&gt;</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V370632"/>
  </EVENT>
  <CC paragraph="paragraph3" start="358" rule="EKR:ActivateX" id="R000423" end="389" refid="V370635" uttnum="22">
    <type>ONT::CAUSE-EFFECT</type>
    <text>to its kinase activation &lt;xref&gt;</text>
    <arg role=":FACTOR" id="V370635"/>
    <arg role=":OUTCOME" id="R000422"/>
  </CC>
  <TERM end="900" paragraph="paragraph3" start="896" uttnum="25" id="R000424" refid="V411974" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V411978" end="911" id="R000425" uttnum="25" paragraph="paragraph3" rule="EKR:ActivateX" start="896">
    <type>ONT::INCREASE</type>
    <text>AKT activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000424" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph3" rule="EKR:ActivateX" start="896" refid="V411978" id="R000426" end="911" uttnum="25">
    <text>AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V411978"/>
    <arg id="R000425" role=":OUTCOME"/>
  </CC>
  <EVENT rule="EKR:ActivateX" start="896" paragraph="paragraph3" uttnum="25" id="R000427" end="911" refid="V411978">
    <text>AKT activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V411974" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V411978" end="911" id="R000428" uttnum="25" paragraph="paragraph3" start="896" rule="EKR:ActivateX">
    <text>AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V411978"/>
    <arg role=":OUTCOME" id="R000427"/>
  </CC>
  <TERM dbid="GO:0016301" end="1050" paragraph="paragraph3" start="1032" uttnum="25" id="R000429" refid="V412219" rule="EKR:ActivateX">
    <type>ONT::PROTEIN</type>
    <name>KINASE</name>
    <text>subsequent kinase</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT start="1032" rule="EKR:ActivateX" paragraph="paragraph3" uttnum="25" end="1060" id="R000430" refid="V412222">
    <text>subsequent kinase activation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000429"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="1032" paragraph="paragraph3" uttnum="25" id="R000431" end="1060" refid="V412222">
    <text>subsequent kinase activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V412222"/>
    <arg role=":OUTCOME" id="R000430"/>
  </CC>
  <EVENT paragraph="paragraph3" rule="EKR:ActivateX" start="1032" refid="V412222" id="R000432" end="1060" uttnum="25">
    <type>ONT::DECREASE</type>
    <text>subsequent kinase activation</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V412219"/>
  </EVENT>
  <CC uttnum="25" end="1060" id="R000433" refid="V412222" start="1032" rule="EKR:ActivateX" paragraph="paragraph3">
    <text>subsequent kinase activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V412222"/>
    <arg role=":OUTCOME" id="R000432"/>
  </CC>
  <TERM end="924" paragraph="paragraph12" start="920" uttnum="107" id="R000434" refid="V1499684" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="107" end="963" id="R000435" refid="V1499687" rule="EKR:ActivateX" start="920" paragraph="paragraph12">
    <type>ONT::INCREASE</type>
    <text>AKT activation (or Ser473 phosphorylation, </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000434"/>
  </EVENT>
  <CC paragraph="paragraph12" start="920" rule="EKR:ActivateX" end="963" id="R000436" refid="V1499687" uttnum="107">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation (or Ser473 phosphorylation, </text>
    <arg role=":FACTOR" id="V1499687"/>
    <arg id="R000435" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V1499687" end="963" id="R000437" uttnum="107" paragraph="paragraph12" start="920" rule="EKR:ActivateX">
    <type>ONT::DECREASE</type>
    <text>AKT activation (or Ser473 phosphorylation, </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1499684"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="920" paragraph="paragraph12" uttnum="107" id="R000438" end="963" refid="V1499687">
    <text>AKT activation (or Ser473 phosphorylation, </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1499687"/>
    <arg role=":OUTCOME" id="R000437"/>
  </CC>
  <TERM end="1654" paragraph="paragraph12" start="1650" uttnum="110" id="R000439" refid="V1557294" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:ActivateX" start="1636" paragraph="paragraph12" uttnum="110" refid="V1557298" end="1664" id="R000440">
    <text>in subsequent AKT activation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000439" role=":AFFECTED"/>
  </EVENT>
  <CC start="1636" rule="EKR:ActivateX" paragraph="paragraph12" uttnum="110" end="1664" id="R000441" refid="V1557298">
    <text>in subsequent AKT activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1557298"/>
    <arg id="R000440" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph12" rule="EKR:ActivateX" start="1636" id="R000442" end="1664" refid="V1557298" uttnum="110">
    <text>in subsequent AKT activation</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1557294"/>
  </EVENT>
  <CC paragraph="paragraph12" start="1636" rule="EKR:ActivateX" end="1664" id="R000443" refid="V1557298" uttnum="110">
    <text>in subsequent AKT activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1557298" role=":FACTOR"/>
    <arg id="R000442" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="91" paragraph="paragraph15" start="79" uttnum="123" id="R000444" refid="V1773114" rule="EKR:ActivateX">
    <type>ONT::PROTEIN</type>
    <name>ACK-1</name>
    <assoc-with id="V1773109"/>
    <text>Ack1 kinase</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="123" refid="V1773117" id="R000445" end="119" rule="EKR:ActivateX" start="79" paragraph="paragraph15">
    <type>ONT::INCREASE</type>
    <text>Ack1 kinase activation &lt;xref&gt;[25]&lt;/xref&gt;</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000444" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="123" refid="V1773117" id="R000446" end="119" rule="EKR:ActivateX" start="79" paragraph="paragraph15">
    <text>Ack1 kinase activation &lt;xref&gt;[25]&lt;/xref&gt;</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1773117" role=":FACTOR"/>
    <arg id="R000445" role=":OUTCOME"/>
  </CC>
  <EVENT start="79" rule="EKR:ActivateX" paragraph="paragraph15" uttnum="123" refid="V1773117" id="R000447" end="119">
    <text>Ack1 kinase activation &lt;xref&gt;[25]&lt;/xref&gt;</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1773114"/>
  </EVENT>
  <CC paragraph="paragraph15" start="79" rule="EKR:ActivateX" refid="V1773117" id="R000448" end="119" uttnum="123">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ack1 kinase activation &lt;xref&gt;[25]&lt;/xref&gt;</text>
    <arg id="V1773117" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000447"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="774" paragraph="paragraph15" start="767" uttnum="127" id="R000449" refid="V1845791" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>of Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph15" rule="EKR:ActivateX" start="740" id="R000450" end="775" refid="V1845772" uttnum="127">
    <type>ONT::INCREASE</type>
    <text>to constitutive activation of Ack1,</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000449"/>
  </EVENT>
  <CC uttnum="127" id="R000451" end="775" refid="V1845772" rule="EKR:ActivateX" start="740" paragraph="paragraph15">
    <text>to constitutive activation of Ack1,</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1845772" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000450"/>
  </CC>
  <EVENT start="740" rule="EKR:ActivateX" paragraph="paragraph15" uttnum="127" end="775" id="R000452" refid="V1845772">
    <text>to constitutive activation of Ack1,</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V1845791"/>
  </EVENT>
  <CC uttnum="127" refid="V1845772" id="R000453" end="775" rule="EKR:ActivateX" start="740" paragraph="paragraph15">
    <text>to constitutive activation of Ack1,</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1845772" role=":FACTOR"/>
    <arg id="R000452" role=":OUTCOME"/>
  </CC>
  <TERM end="1464" paragraph="paragraph15" start="1461" uttnum="131" id="R000454" refid="V1884273" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="131" refid="V1884266" end="1464" id="R000455" rule="EKR:ActivateX" start="1449" paragraph="paragraph15">
    <text>to activate AKT</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000454"/>
  </EVENT>
  <CC end="1464" id="R000456" refid="V1884266" uttnum="131" paragraph="paragraph15" start="1449" rule="EKR:ActivateX">
    <text>to activate AKT</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1884266"/>
    <arg id="R000455" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="131" refid="V1884266" end="1464" id="R000457" start="1449" rule="EKR:ActivateX" paragraph="paragraph15">
    <type>ONT::DECREASE</type>
    <text>to activate AKT</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1884273" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V1884266" id="R000458" end="1464" uttnum="131" paragraph="paragraph15" rule="EKR:ActivateX" start="1449">
    <text>to activate AKT</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V1884266" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000457"/>
  </CC>
  <TERM end="78" paragraph="paragraph16" start="74" uttnum="133" id="R000459" refid="V1921937" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="133" refid="V1921940" id="R000460" end="105" start="70" rule="EKR:ActivateX" paragraph="paragraph16">
    <type>ONT::INCREASE</type>
    <text>for AKT activation &lt;xref&gt;[1]&lt;/xref&gt;</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000459"/>
  </EVENT>
  <CC uttnum="133" end="105" id="R000461" refid="V1921940" start="70" rule="EKR:ActivateX" paragraph="paragraph16">
    <type>ONT::CAUSE-EFFECT</type>
    <text>for AKT activation &lt;xref&gt;[1]&lt;/xref&gt;</text>
    <arg id="V1921940" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000460"/>
  </CC>
  <EVENT paragraph="paragraph16" start="70" rule="EKR:ActivateX" end="105" id="R000462" refid="V1921940" uttnum="133">
    <type>ONT::DECREASE</type>
    <text>for AKT activation &lt;xref&gt;[1]&lt;/xref&gt;</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V1921937" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V1921940" id="R000463" end="105" uttnum="133" paragraph="paragraph16" start="70" rule="EKR:ActivateX">
    <text>for AKT activation &lt;xref&gt;[1]&lt;/xref&gt;</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V1921940"/>
    <arg id="R000462" role=":OUTCOME"/>
  </CC>
  <TERM end="1594" paragraph="paragraph16" start="1590" uttnum="142" id="R000464" refid="V2056815" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph16" rule="EKR:ActivateX" start="1587" refid="V2056818" id="R000465" end="1627" uttnum="142">
    <type>ONT::INCREASE</type>
    <text>to AKT activation (&lt;xref&gt;&lt;bold&gt;Fig. 2B, </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000464" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph16" start="1587" rule="EKR:ActivateX" refid="V2056818" id="R000466" end="1627" uttnum="142">
    <text>to AKT activation (&lt;xref&gt;&lt;bold&gt;Fig. 2B, </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2056818" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000465"/>
  </CC>
  <EVENT paragraph="paragraph16" rule="EKR:ActivateX" start="1587" refid="V2056818" id="R000467" end="1627" uttnum="142">
    <text>to AKT activation (&lt;xref&gt;&lt;bold&gt;Fig. 2B, </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2056815" role=":AFFECTED"/>
  </EVENT>
  <CC end="1627" id="R000468" refid="V2056818" uttnum="142" paragraph="paragraph16" start="1587" rule="EKR:ActivateX">
    <text>to AKT activation (&lt;xref&gt;&lt;bold&gt;Fig. 2B, </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2056818" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000467"/>
  </CC>
  <TERM end="1978" paragraph="paragraph16" start="1974" uttnum="144" id="R000469" refid="V2083019" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph16" rule="EKR:ActivateX" start="1961" refid="V2083022" id="R000470" end="1989" uttnum="144">
    <text>EGF mediated AKT activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000469"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="1961" paragraph="paragraph16" uttnum="144" refid="V2083022" end="1989" id="R000471">
    <text>EGF mediated AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2083022" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000470"/>
  </CC>
  <EVENT rule="EKR:ActivateX" start="1961" paragraph="paragraph16" uttnum="144" end="1989" id="R000472" refid="V2083022">
    <type>ONT::DECREASE</type>
    <text>EGF mediated AKT activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2083019"/>
  </EVENT>
  <CC uttnum="144" refid="V2083022" end="1989" id="R000473" rule="EKR:ActivateX" start="1961" paragraph="paragraph16">
    <text>EGF mediated AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2083022" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000472"/>
  </CC>
  <TERM end="675" paragraph="paragraph17" start="671" uttnum="153" id="R000474" refid="V2233847" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph17" rule="EKR:ActivateX" start="671" id="R000475" end="685" refid="V2233851" uttnum="153">
    <text>AKT activation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000474" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph17" start="671" rule="EKR:ActivateX" refid="V2233851" id="R000476" end="685" uttnum="153">
    <text>AKT activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2233851"/>
    <arg role=":OUTCOME" id="R000475"/>
  </CC>
  <EVENT uttnum="153" refid="V2233851" id="R000477" end="685" rule="EKR:ActivateX" start="671" paragraph="paragraph17">
    <text>AKT activation</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2233847"/>
  </EVENT>
  <CC start="671" rule="EKR:ActivateX" paragraph="paragraph17" uttnum="153" end="685" id="R000478" refid="V2233851">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation</text>
    <arg role=":FACTOR" id="V2233851"/>
    <arg role=":OUTCOME" id="R000477"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="169" paragraph="paragraph18" start="164" uttnum="160" id="R000479" refid="V2322327" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph18" rule="EKR:ActivateX" start="159" refid="V2322349" end="182" id="R000480" uttnum="160">
    <text>when Ack1 was activated</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000479" role=":AFFECTED"/>
  </EVENT>
  <CC start="159" rule="EKR:ActivateX" paragraph="paragraph18" uttnum="160" end="182" id="R000481" refid="V2322349">
    <type>ONT::CAUSE-EFFECT</type>
    <text>when Ack1 was activated</text>
    <arg role=":FACTOR" id="V2322349"/>
    <arg id="R000480" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="160" end="182" id="R000482" refid="V2322349" start="159" rule="EKR:ActivateX" paragraph="paragraph18">
    <text>when Ack1 was activated</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2322327"/>
  </EVENT>
  <CC id="R000483" end="182" refid="V2322349" uttnum="160" paragraph="paragraph18" start="159" rule="EKR:ActivateX">
    <type>ONT::CAUSE-EFFECT</type>
    <text>when Ack1 was activated</text>
    <arg role=":FACTOR" id="V2322349"/>
    <arg role=":OUTCOME" id="R000482"/>
  </CC>
  <TERM end="565" paragraph="paragraph18" start="495" uttnum="162" id="R000484" refid="V2354225" rule="EKR:ActivateX">
    <type>ONT::GENE</type>
    <name>GENE</name>
    <text>of target genes [1], [11], [12]</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="162" end="565" id="R000485" refid="V2354199" start="479" rule="EKR:ActivateX" paragraph="paragraph18">
    <text>transactivation of target genes &lt;xref&gt;[1]&lt;/xref&gt;, &lt;xref&gt;[11]&lt;/xref&gt;, &lt;xref&gt;[12]&lt;/xref&gt;</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000484" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="162" refid="V2354199" end="565" id="R000486" start="479" rule="EKR:ActivateX" paragraph="paragraph18">
    <type>ONT::CAUSE-EFFECT</type>
    <text>transactivation of target genes &lt;xref&gt;[1]&lt;/xref&gt;, &lt;xref&gt;[11]&lt;/xref&gt;, &lt;xref&gt;[12]&lt;/xref&gt;</text>
    <arg id="V2354199" role=":FACTOR"/>
    <arg id="R000485" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V2354199" end="565" id="R000487" uttnum="162" paragraph="paragraph18" rule="EKR:ActivateX" start="479">
    <type>ONT::DECREASE</type>
    <text>transactivation of target genes &lt;xref&gt;[1]&lt;/xref&gt;, &lt;xref&gt;[11]&lt;/xref&gt;, &lt;xref&gt;[12]&lt;/xref&gt;</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2354225"/>
  </EVENT>
  <CC paragraph="paragraph18" rule="EKR:ActivateX" start="479" id="R000488" end="565" refid="V2354199" uttnum="162">
    <type>ONT::CAUSE-EFFECT</type>
    <text>transactivation of target genes &lt;xref&gt;[1]&lt;/xref&gt;, &lt;xref&gt;[11]&lt;/xref&gt;, &lt;xref&gt;[12]&lt;/xref&gt;</text>
    <arg id="V2354199" role=":FACTOR"/>
    <arg id="R000487" role=":OUTCOME"/>
  </CC>
  <TERM end="276" paragraph="paragraph19" start="272" uttnum="167" id="R000489" refid="V2453496" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="167" id="R000490" end="288" refid="V2453500" rule="EKR:ActivateX" start="272" paragraph="paragraph19">
    <type>ONT::INCREASE</type>
    <text>AKT activation, </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000489" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000491" end="288" refid="V2453500" uttnum="167" paragraph="paragraph19" rule="EKR:ActivateX" start="272">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation, </text>
    <arg role=":FACTOR" id="V2453500"/>
    <arg role=":OUTCOME" id="R000490"/>
  </CC>
  <EVENT start="272" rule="EKR:ActivateX" paragraph="paragraph19" uttnum="167" end="288" id="R000492" refid="V2453500">
    <text>AKT activation, </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2453496"/>
  </EVENT>
  <CC id="R000493" end="288" refid="V2453500" uttnum="167" paragraph="paragraph19" rule="EKR:ActivateX" start="272">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation, </text>
    <arg role=":FACTOR" id="V2453500"/>
    <arg id="R000492" role=":OUTCOME"/>
  </CC>
  <TERM end="53" paragraph="paragraph22" start="49" uttnum="193" id="R000494" refid="V2869590" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:ActivateX" start="49" paragraph="paragraph22" uttnum="193" refid="V2869594" id="R000495" end="64">
    <text>AKT activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000494" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="193" refid="V2869594" id="R000496" end="64" rule="EKR:ActivateX" start="49" paragraph="paragraph22">
    <text>AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2869594" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000495"/>
  </CC>
  <EVENT refid="V2869594" id="R000497" end="64" uttnum="193" paragraph="paragraph22" rule="EKR:ActivateX" start="49">
    <type>ONT::DECREASE</type>
    <text>AKT activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2869590"/>
  </EVENT>
  <CC start="49" rule="EKR:ActivateX" paragraph="paragraph22" uttnum="193" refid="V2869594" end="64" id="R000498">
    <text>AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2869594"/>
    <arg id="R000497" role=":OUTCOME"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="158" paragraph="paragraph22" start="153" uttnum="194" id="R000499" refid="V2885176" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT start="153" rule="EKR:ActivateX" paragraph="paragraph22" uttnum="194" end="234" id="R000500" refid="V2885208">
    <type>ONT::INCREASE</type>
    <text>Ack1 could also be activated in some tumors by autoactivating somatic mutations, </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000499"/>
  </EVENT>
  <CC uttnum="194" id="R000501" end="234" refid="V2885208" rule="EKR:ActivateX" start="153" paragraph="paragraph22">
    <type>ONT::CAUSE-EFFECT</type>
    <text>Ack1 could also be activated in some tumors by autoactivating somatic mutations, </text>
    <arg role=":FACTOR" id="V2885208"/>
    <arg role=":OUTCOME" id="R000500"/>
  </CC>
  <EVENT start="153" rule="EKR:ActivateX" paragraph="paragraph22" uttnum="194" refid="V2885208" id="R000502" end="234">
    <text>Ack1 could also be activated in some tumors by autoactivating somatic mutations, </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2885176" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph22" rule="EKR:ActivateX" start="153" refid="V2885208" end="234" id="R000503" uttnum="194">
    <text>Ack1 could also be activated in some tumors by autoactivating somatic mutations, </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2885208"/>
    <arg role=":OUTCOME" id="R000502"/>
  </CC>
  <TERM end="544" paragraph="paragraph22" start="533" uttnum="195" id="R000504" refid="V2901443" rule="EKR:ActivateX">
    <type>ONT::PROTEIN</type>
    <name>AKT</name>
    <assoc-with id="V2901438"/>
    <text>AKT kinase</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT start="522" rule="EKR:ActivateX" paragraph="paragraph22" uttnum="195" refid="V2901447" id="R000505" end="554">
    <type>ONT::INCREASE</type>
    <text>to optimal AKT kinase activation</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000504"/>
  </EVENT>
  <CC paragraph="paragraph22" rule="EKR:ActivateX" start="522" id="R000506" end="554" refid="V2901447" uttnum="195">
    <text>to optimal AKT kinase activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V2901447" role=":FACTOR"/>
    <arg id="R000505" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph22" rule="EKR:ActivateX" start="522" id="R000507" end="554" refid="V2901447" uttnum="195">
    <type>ONT::DECREASE</type>
    <text>to optimal AKT kinase activation</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V2901443"/>
  </EVENT>
  <CC start="522" rule="EKR:ActivateX" paragraph="paragraph22" uttnum="195" refid="V2901447" id="R000508" end="554">
    <text>to optimal AKT kinase activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2901447"/>
    <arg id="R000507" role=":OUTCOME"/>
  </CC>
  <TERM end="205" paragraph="paragraph23" start="201" uttnum="198" id="R000509" refid="V2932965" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph23" rule="EKR:ActivateX" start="201" end="216" id="R000510" refid="V2932968" uttnum="198">
    <text>AKT activation </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000509"/>
  </EVENT>
  <CC uttnum="198" id="R000511" end="216" refid="V2932968" rule="EKR:ActivateX" start="201" paragraph="paragraph23">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation </text>
    <arg role=":FACTOR" id="V2932968"/>
    <arg role=":OUTCOME" id="R000510"/>
  </CC>
  <EVENT paragraph="paragraph23" start="201" rule="EKR:ActivateX" end="216" id="R000512" refid="V2932968" uttnum="198">
    <type>ONT::DECREASE</type>
    <text>AKT activation </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2932965" role=":AFFECTED"/>
  </EVENT>
  <CC id="R000513" end="216" refid="V2932968" uttnum="198" paragraph="paragraph23" start="201" rule="EKR:ActivateX">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation </text>
    <arg role=":FACTOR" id="V2932968"/>
    <arg role=":OUTCOME" id="R000512"/>
  </CC>
  <TERM dbid="XFAM:PF07714|HGNC:19297|UP:Q07912|XFAM:PF11555|XFAM:PF14604|UP:O54967|XFAM:PF09027" end="480" paragraph="paragraph23" start="475" uttnum="200" id="R000514" refid="V2953167" rule="EKR:ActivateX">
    <type>ONT::GENE-PROTEIN</type>
    <name>ACK-1</name>
    <text>Ack1</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:ActivateX" start="460" paragraph="paragraph23" uttnum="200" refid="V2953155" id="R000515" end="480">
    <type>ONT::INCREASE</type>
    <text>EGFR activated Ack1 </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000514" role=":AFFECTED"/>
  </EVENT>
  <CC start="460" rule="EKR:ActivateX" paragraph="paragraph23" uttnum="200" refid="V2953155" id="R000516" end="480">
    <type>ONT::CAUSE-EFFECT</type>
    <text>EGFR activated Ack1 </text>
    <arg id="V2953155" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000515"/>
  </CC>
  <EVENT rule="EKR:ActivateX" start="460" paragraph="paragraph23" uttnum="200" id="R000517" end="480" refid="V2953155">
    <text>EGFR activated Ack1 </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2953167" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="460" paragraph="paragraph23" uttnum="200" id="R000518" end="480" refid="V2953155">
    <type>ONT::CAUSE-EFFECT</type>
    <text>EGFR activated Ack1 </text>
    <arg role=":FACTOR" id="V2953155"/>
    <arg id="R000517" role=":OUTCOME"/>
  </CC>
  <TERM end="536" paragraph="paragraph23" start="532" uttnum="201" id="R000519" refid="V2966852" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V2966883" end="634" id="R000520" uttnum="201" paragraph="paragraph23" start="532" rule="EKR:ActivateX">
    <type>ONT::INCREASE</type>
    <text>AKT is frequently activated in pancreatic cancer which has been shown to be highly correlated to HER-2</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000519"/>
  </EVENT>
  <CC id="R000521" end="634" refid="V2966883" uttnum="201" paragraph="paragraph23" start="532" rule="EKR:ActivateX">
    <text>AKT is frequently activated in pancreatic cancer which has been shown to be highly correlated to HER-2</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V2966883"/>
    <arg role=":OUTCOME" id="R000520"/>
  </CC>
  <EVENT id="R000522" end="634" refid="V2966883" uttnum="201" paragraph="paragraph23" start="532" rule="EKR:ActivateX">
    <type>ONT::DECREASE</type>
    <text>AKT is frequently activated in pancreatic cancer which has been shown to be highly correlated to HER-2</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V2966852" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="201" end="634" id="R000523" refid="V2966883" rule="EKR:ActivateX" start="532" paragraph="paragraph23">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT is frequently activated in pancreatic cancer which has been shown to be highly correlated to HER-2</text>
    <arg id="V2966883" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000522"/>
  </CC>
  <TERM end="1070" paragraph="paragraph23" start="1066" uttnum="204" id="R000524" refid="V3005784" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:ActivateX" start="1066" paragraph="paragraph23" uttnum="204" end="1081" id="R000525" refid="V3005788">
    <type>ONT::INCREASE</type>
    <text>AKT activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000524"/>
  </EVENT>
  <CC refid="V3005788" end="1081" id="R000526" uttnum="204" paragraph="paragraph23" start="1066" rule="EKR:ActivateX">
    <text>AKT activation </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3005788"/>
    <arg id="R000525" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="204" refid="V3005788" end="1081" id="R000527" rule="EKR:ActivateX" start="1066" paragraph="paragraph23">
    <text>AKT activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3005784" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph23" rule="EKR:ActivateX" start="1066" id="R000528" end="1081" refid="V3005788" uttnum="204">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation </text>
    <arg id="V3005788" role=":FACTOR"/>
    <arg id="R000527" role=":OUTCOME"/>
  </CC>
  <TERM end="1339" paragraph="paragraph23" start="1335" uttnum="205" id="R000529" refid="V3017539" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT rule="EKR:ActivateX" start="1335" paragraph="paragraph23" uttnum="205" end="1367" id="R000530" refid="V3017542">
    <type>ONT::INCREASE</type>
    <text>AKT activation &lt;xref&gt;[37]&lt;/xref&gt;</text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000529"/>
  </EVENT>
  <CC end="1367" id="R000531" refid="V3017542" uttnum="205" paragraph="paragraph23" rule="EKR:ActivateX" start="1335">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation &lt;xref&gt;[37]&lt;/xref&gt;</text>
    <arg id="V3017542" role=":FACTOR"/>
    <arg id="R000530" role=":OUTCOME"/>
  </CC>
  <EVENT start="1335" rule="EKR:ActivateX" paragraph="paragraph23" uttnum="205" end="1367" id="R000532" refid="V3017542">
    <type>ONT::DECREASE</type>
    <text>AKT activation &lt;xref&gt;[37]&lt;/xref&gt;</text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3017539"/>
  </EVENT>
  <CC paragraph="paragraph23" rule="EKR:ActivateX" start="1335" refid="V3017542" id="R000533" end="1367" uttnum="205">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation &lt;xref&gt;[37]&lt;/xref&gt;</text>
    <arg id="V3017542" role=":FACTOR"/>
    <arg id="R000532" role=":OUTCOME"/>
  </CC>
  <TERM end="71" paragraph="paragraph24" start="67" uttnum="206" id="R000534" refid="V3032590" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT uttnum="206" end="81" id="R000535" refid="V3032593" start="67" rule="EKR:ActivateX" paragraph="paragraph24">
    <text>AKT activation</text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000534" role=":AFFECTED"/>
  </EVENT>
  <CC start="67" rule="EKR:ActivateX" paragraph="paragraph24" uttnum="206" end="81" id="R000536" refid="V3032593">
    <text>AKT activation</text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3032593"/>
    <arg role=":OUTCOME" id="R000535"/>
  </CC>
  <EVENT refid="V3032593" id="R000537" end="81" uttnum="206" paragraph="paragraph24" rule="EKR:ActivateX" start="67">
    <text>AKT activation</text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3032590" role=":AFFECTED"/>
  </EVENT>
  <CC paragraph="paragraph24" rule="EKR:ActivateX" start="67" refid="V3032593" end="81" id="R000538" uttnum="206">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation</text>
    <arg id="V3032593" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000537"/>
  </CC>
  <TERM end="165" paragraph="paragraph24" start="161" uttnum="207" id="R000539" refid="V3036194" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V3036198" id="R000540" end="176" uttnum="207" paragraph="paragraph24" start="161" rule="EKR:ActivateX">
    <type>ONT::INCREASE</type>
    <text>AKT activation </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="R000539"/>
  </EVENT>
  <CC refid="V3036198" end="176" id="R000541" uttnum="207" paragraph="paragraph24" start="161" rule="EKR:ActivateX">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation </text>
    <arg id="V3036198" role=":FACTOR"/>
    <arg id="R000540" role=":OUTCOME"/>
  </CC>
  <EVENT refid="V3036198" end="176" id="R000542" uttnum="207" paragraph="paragraph24" rule="EKR:ActivateX" start="161">
    <text>AKT activation </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3036194" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V3036198" end="176" id="R000543" uttnum="207" paragraph="paragraph24" rule="EKR:ActivateX" start="161">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation </text>
    <arg role=":FACTOR" id="V3036198"/>
    <arg role=":OUTCOME" id="R000542"/>
  </CC>
  <TERM end="711" paragraph="paragraph28" start="707" uttnum="231" id="R000544" refid="V3416466" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT refid="V3416469" end="754" id="R000545" uttnum="231" paragraph="paragraph28" start="707" rule="EKR:ActivateX">
    <type>ONT::INCREASE</type>
    <text>AKT activation by any of the Tyr-modifications </text>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000544" role=":AFFECTED"/>
  </EVENT>
  <CC uttnum="231" end="754" id="R000546" refid="V3416469" rule="EKR:ActivateX" start="707" paragraph="paragraph28">
    <text>AKT activation by any of the Tyr-modifications </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg role=":FACTOR" id="V3416469"/>
    <arg id="R000545" role=":OUTCOME"/>
  </CC>
  <EVENT paragraph="paragraph28" rule="EKR:ActivateX" start="707" refid="V3416469" id="R000547" end="754" uttnum="231">
    <text>AKT activation by any of the Tyr-modifications </text>
    <type>ONT::DECREASE</type>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 id="V3416466" role=":AFFECTED"/>
  </EVENT>
  <CC refid="V3416469" end="754" id="R000548" uttnum="231" paragraph="paragraph28" rule="EKR:ActivateX" start="707">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation by any of the Tyr-modifications </text>
    <arg role=":FACTOR" id="V3416469"/>
    <arg id="R000547" role=":OUTCOME"/>
  </CC>
  <TERM end="1017" paragraph="paragraph28" start="1006" uttnum="232" id="R000549" refid="V3439197" rule="EKR:ActivateX">
    <type>ONT::PROTEIN</type>
    <name>AKT</name>
    <assoc-with id="V3439192"/>
    <text>AKT kinase</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT paragraph="paragraph28" rule="EKR:ActivateX" start="1006" refid="V3439201" id="R000550" end="1029" uttnum="232">
    <text>AKT kinase activation, </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000549" role=":AFFECTED"/>
  </EVENT>
  <CC rule="EKR:ActivateX" start="1006" paragraph="paragraph28" uttnum="232" id="R000551" end="1029" refid="V3439201">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT kinase activation, </text>
    <arg role=":FACTOR" id="V3439201"/>
    <arg id="R000550" role=":OUTCOME"/>
  </CC>
  <EVENT uttnum="232" refid="V3439201" end="1029" id="R000552" start="1006" rule="EKR:ActivateX" paragraph="paragraph28">
    <type>ONT::DECREASE</type>
    <text>AKT kinase activation, </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3439197"/>
  </EVENT>
  <CC uttnum="232" end="1029" id="R000553" refid="V3439201" rule="EKR:ActivateX" start="1006" paragraph="paragraph28">
    <text>AKT kinase activation, </text>
    <type>ONT::CAUSE-EFFECT</type>
    <arg id="V3439201" role=":FACTOR"/>
    <arg id="R000552" role=":OUTCOME"/>
  </CC>
  <TERM end="1186" paragraph="paragraph28" start="1182" uttnum="233" id="R000554" refid="V3453230" rule="EKR:ActivateX">
    <type>ONT::PROTEIN-FAMILY</type>
    <members>
      <member dbid="UP:P31749" type="ONT::PROTEIN"/>
      <member dbid="UP:P31751" type="ONT::PROTEIN"/>
      <member dbid="UP:Q9Y243" type="ONT::PROTEIN"/>
    </members>
    <name>AKT</name>
    <text normalization="">AKT</text>
    <features>
      <active>TRUE</active>
    </features>
  </TERM>
  <EVENT start="1182" rule="EKR:ActivateX" paragraph="paragraph28" uttnum="233" end="1221" id="R000555" refid="V3453233">
    <text>AKT activation for survival and growth </text>
    <type>ONT::INCREASE</type>
    <predicate>
      <type>ONT::INCREASE</type>
    </predicate>
    <arg2 id="R000554" role=":AFFECTED"/>
  </EVENT>
  <CC end="1221" id="R000556" refid="V3453233" uttnum="233" paragraph="paragraph28" rule="EKR:ActivateX" start="1182">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation for survival and growth </text>
    <arg id="V3453233" role=":FACTOR"/>
    <arg role=":OUTCOME" id="R000555"/>
  </CC>
  <EVENT uttnum="233" id="R000557" end="1221" refid="V3453233" start="1182" rule="EKR:ActivateX" paragraph="paragraph28">
    <type>ONT::DECREASE</type>
    <text>AKT activation for survival and growth </text>
    <predicate>
      <type>ONT::DECREASE</type>
    </predicate>
    <arg2 role=":AFFECTED" id="V3453230"/>
  </EVENT>
  <CC id="R000558" end="1221" refid="V3453233" uttnum="233" paragraph="paragraph28" rule="EKR:ActivateX" start="1182">
    <type>ONT::CAUSE-EFFECT</type>
    <text>AKT activation for survival and growth </text>
    <arg role=":FACTOR" id="V3453233"/>
    <arg id="R000557" role=":OUTCOME"/>
  </CC>
</ekb>
